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Summary
Upon infection, HSV-1 genes are transcribed by the host cell RNA polymerase 
II. The analysis of polypeptides synthesized during the course of HSV-1 lytic infection 
led to the identification of three co-ordinately regulated groups of genes, characterized 
by their specific temporal expression. The immediate-early or a  genes are synthesized 
immediately following infection. Synthesis of immediate-early polypeptides is 
followed by the expression of early or (3 genes, whilst the synthesis of late or y  genes 
occurs subsequent to the onset of viral DNA synthesis.
The expression of these temporal classes of genes is controlled by various 
virally-encoded transactivators, one of which is the immediate-early polypeptide 
Vmwl75. Vmwl75 is encoded by the IE-3 gene, an unspliced open reading frame 
situated within the short repeat region of the HSV-1 genome. The isolation of a number 
of temperature-sensitive viruses containing lesions in the IE-3 gene led to the 
elucidation of the role of the Vmwl75 polypeptide during the viral lytic cycle. The 
majority of these viruses showed a lack of early and late gene expression and an over­
production of immediate-early products at the non-permissive temperature. These 
observations illustrated the importance of Vmwl75 in early and late gene expression, 
and suggested that it may also play a role in the repression of immediate-early genes.
Whilst in vitro studies have demonstrated the possible involvement of Vmwl75 
DNA binding activity in the mechanism of viral gene transactivation, mutational 
analysis of early gene promoters within HSV-1 has demonstrated that no additional 
sequences other than those shown to bind cellular transcription factors are required for 
early gene transactivation during the normal course of infection. It has been proposed 
that such studies do not provide a true representation of the mechanism of Vmwl75 
transactivation, as viral infection supplies other virally-encoded transactivating 
proteins. However, it seems clear that for the transactivation of viral genes during a 
normal course of infection, Vmwl75 does not require the presence of specific DNA 
binding sites within the viral genome. This suggests two possibilities: either Vmwl75 
mediates transactivation not through the interaction with viral DNA but through the 
modification of components of the cellular transcription machinery; or that Vmwl75 is 
able to bind to a divergent range of DNA sequences, so that removal of a specific 
region of DNA does not abolish the binding activity of the protein in vivo.
The first scenario seems unlikely, as a wide range of mutational analyses have 
demonstrated that the DNA binding activity of Vmwl75 is essential for gene
transactivation both in vitro and in vivo. In addition, statistical analysis has revealed 
that putative Vmwl75 binding sites are distributed throughout the viral genome, with 
an average occurrence of 1 site to 250 genic bases and 1 site per 760 non-genic bases. 
This data supports the hypothesis that removal of specific regions of gene promoters 
will not remove all available sites for the interaction of Vmwl75 with promoter- 
regulatory DNA sequences.
A wide range of mutational studies have illustrated that the abolition of the 
DNA binding activity of Vmwl75 also led to a loss of transactivation and 
autoregulation activity both in vitro and in vivo (DeLuca and Schaffer, 1988; Paterson 
and Everett, 1988a, b; Shepard et al., 1989; this thesis). However, certain mutant 
Vmwl75 molecules do not fit this general pattern. In particular, a mutant Vmwl75 
molecule, ril2, which is described in greater detail below, appears to support the viral 
replication cycle in tissue culture whilst exhibiting no in vitro DNA binding properties.
The aim of this project was to identify regions of the Vmwl75 molecule 
involved in contacting the DNA helix through mutational analysis, and to investigate 
whether the DNA binding properties of Vmwl75 as measured in vitro correlate with 
the ability of the protein to support the viral life cycle in cell culture.
Vmwl75 has been separated into 5 domains based on its homology with the 
VZV regulatory protein, 140K. Previous mutational analyses have shown that region 2 
of Vmwl75 is essential to its DNA binding and transactivational properties, and the 
DNA binding domain of the protein has also been mapped to this region. Analysis of 
the primary structure of the protein has shown that a helix-turn-helix predicted 
secondary structure motif is present within region 2, encompassing amino acids 445- 
487. This type of motif is present in many other DNA binding proteins, and has been 
shown in several studies to be a motif essential for DNA-protein interactions. The 
region spanning residues 445-487 of Vmwl75 is also extremely highly conserved 
between regulatory proteins of alpha herpesviruses, and insertion mutations constructed 
within this region eliminate the in vitro DNA binding properties of the protein. In order 
to study the function of this motif within Vmwl75, a detailed mutational analysis of 
the region was carried out.
16 single point amino acid mutations and 2 double amino acid mutations were 
introduced within the helix-turn-helix motif. In addition, a point base pair deletion 
mutation was isolated which resulted in an in-frame stop codon at amino acid 454, 
resulting in the production of a truncated polypeptide containing only the first helix of 
the proposed motif. Internal deletions of both proposed helices of the motif were also 
constructed. All mutations were expressed as non-fusion DNA binding domain 
polypeptides in bacteria using the pET vector system. The mutant polypeptides were 
analysed for their ability to bind to DNA probes containing a consensus Vmwl75 DNA 
binding sequence by gel retardation analysis. It was found that the mutations resulted in
three different DNA binding phenotypes. Several point mutant polypeptides showed no 
change in DNA binding ability, as compared to a wild type DNA binding domain 
polypeptide. A second group, including several point mutant polypeptides and one 
double mutant polypeptide, exhibited a ts defect in DNA binding; they bound to DNA 
at room temperature but failed to bind at 37°C. Finally, three single point mutant 
polypeptides, one double mutant polypeptide, the truncated polypeptide and the 
polypeptides containing internal deletions were unable to bind to DNA at any 
temperature. The single amino acid mutations which eliminated the DNA binding 
ability of the polypeptide were all situated around the turn of the motif.
It has been shown that Vmwl75 binds to DNA as a dimer and that the 
expressed DNA binding domain of the protein exists as a dimer in solution (Everett et 
al., 1991b). Although it has not been shown conclusively that the protein monomers 
cannot bind to DNA, it has been suggested that mutations which eliminate the ability of 
the protein to dimerize will also eliminate the ability of the protein to bind to DNA. As 
a dimerization motif has not been identified within Vmwl75, the mutant polypeptides 
were analysed for dimerization activity.
Glutaraldehyde cross-linking assays were used to investigate the dimerization 
properties of some mutant polypeptides which exhibited a ts DNA binding defect, both 
at room temperature and at 37°C. For those ts mutants that were investigated, the DNA 
binding defect was not due to a defect in dimerization. The dimerization properties of 
two point mutant polypeptides which do not bind to DNA at any temperature were also 
investigated. By gel filtration chromatography, it was shown that both mutant 
polypeptides exist as dimers in solution. These results suggest that the proposed helix- 
turn-helix motif is important for the DNA binding but not the dimerization properties 
of Vmwl75.
The virus vril2 constructed by DeLuca et al. (Shepard and DeLuca, 1991b) 
contains a six amino acid insertional mutation and a base pair substitution within the 
IE-3 reading frame. This virus is able to grow in cell lines not expressing Vmwl75, but 
Vmwl75 isolated from cells infected with vril2 was unable to bind to DNA upon gel 
retardation analysis. This has been the only example of a Vmwl75 mutant which 
cannot bind to DNA in vitro but which can support the growth of virus in tissue 
culture. A portion of the Bam fy' fragment from vril2 was sequenced, and found to 
contain a single base pair mutation resulting in an ala-val mutation at codon 345. The 
DNA binding domain of Vmwl75 containing the ril2 mutation was expressed in 
bacteria and gel retardation analysis demonstrated that this mutant polypeptide has a ts 
defect in DNA binding activity. Glutaraldehyde cross-linking assays demonstrated that 
this defect was not due to a lack of dimerization activity at higher temperatures.
A series of three amino acid insertional mutations have been introduced into 
various positions within the IE-3 coding region. Several of these mutations have been
introduced into the DNA binding domain of the protein, and it has been shown that 
mutations that affected the in vitro DNA binding properties of Vmwl75 also affected 
the ability of the protein to transactivate and repress HSV-1 promoters in transient 
transfection assays. In order to also determine whether the DNA binding properties of 
Vmwl75 are essential for its transactivation and repression properties in vivo, the 
insertional mutations have been introduced into the DNA binding domain of Vmwl75 
within the viral genome. The mutant viruses were constructed by co-transfection of the 
plasmids carrying the insertional mutations within the IE-3 coding region with genomic 
DNA from the virus D30EBA. The virus D30EBA contains two large deletions which 
remove both copies of the IE-3 gene. As D30EBA cannot express Vmwl75, it can only 
replicate in cells which express complementary Vmwl75 from the cellular genome.
The resultant recombinant viruses were tested for their ability to grow in BHK 
cells which do not express Vmwl75. It was found that viruses carrying mutations 
within the IE-3 gene which eliminate the ability of Vmwl75 to bind to DNA in vitro 
cannot support viral growth in tissue culture. These results support the proposal that the 
DNA binding properties of Vmwl75 are essential for its role in the regulation of viral 
gene expression.
Finally, certain point and deletion mutations whose construction is described 
above were introduced into the viral genome. The growth of such recombinant viruses 
in non-complementing cell lines was analysed to determine the in vivo activity of the 
mutant Vmwl75 molecules. Again, it was found that mutations which eliminated the 
DNA binding activity of a Vmwl75 DNA binding domain polypeptide in vitro also 
abolished the ability of the protein to support viral replication. However, interesting 
results were obtained with two mutations previously found to result in a ts defect in 
DNA binding activity in vitro. Whilst one mutation resulted in a Vmwl75 molecule 
unable to support viral growth, the second mutant protein resulted in a recombinant 
virus viable in BHK cells. The ts defect in DNA binding as measured in vitro 
represents an impairment in the function of the protein molecule, and it is possible that 
whilst interaction with other cellular factors may restore the activity of certain ts 
mutant proteins, other mutations disrupt the protein structure sufficiently to abolish its 
transactivation and repression functions in vivo.
In conclusion, the mutational analysis of a proposed helix-turn-helix motif 
within Vmwl75 has illustrated that this region plays a role in the DNA binding but not 
the dimerization activity of the protein. In addition, the introduction of several 
mutations into the viral genome has illustrated a link between the DNA binding activity 
of Vmwl75 as measured in vitro, and the ability of the protein to support the viral lytic 
cycle in cell culture.
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E: early
EBV: Epstein-Bair virus
EDTA: sodium ethylenediamine tetra-acetic acid
EHV-1 equine herpesvirus type 1
ELISA: enzyme-linked immuno-sorbent assay
EtBR: ethidium bromide
G-O-R: Gamier-Osguthorpe-Robson
G: guanine
g: grams
GCG: genetics computer group 
gD: glycoprotein D
GMEM: Glasgow's modified Eagles mediuM 
h: hour(s)
HCMV: human cytomegalovirus
HEPES: N-2 hydroxyethylpiperazine-N’-2-ethanesulphonic acid
HHV-6: human herpesvirus-6
HRP: horseradish peroxidase
HSV-1: herpes simplex virus type 1
HSV-2: herpes simplex virus type 2
HVT: herpesvirus of turkeys
IE: immediate-early
IRl: long internal repeat
IRs: short internal repeat
K: kilo
Kb: kilobases
L: late
1: litre
LAT's: latency associated transcripts
LFP: large fragment polymerase
LPF: late processing factor
m. o. i.: multiplicity of infection
M: molar
|i: micro
mA: milliamps
MDV: Marek's disease virus
mg: milligrams
mi: mock infected
min: minutes
ml: millilitres
mm: millimetres
MOPS: 3-(N-morpholine)propanesulphonic acid
mRNA: messenger ribonucleic acid 
N-terminal: amino-terminal 
n: nano
nm: nanometre 
NP40: Nonidet P40
OD26o‘ optical density at wavelength 260nm 
Ori: origin of replication 
p: pico
PAGE: polyacrylamide gel electrophoresis
PEG: polyethylene glycol
pfu: plaque forming units
PMSF: phenylmethylsulphonylfluoride
poly (A): poly adenylic acid
PRV: pseudorabies virus
RE: restriction enzyme
RF: replicative form
RNA: ribonucleic acid
RNase: ribonuclease
rpm: revolutions per minute
rRNA: ribosomal ribonucleic acid
RT: room temperature
SDS: sodium dodecyl sulphate
sec: seconds
snRNP: small nuclear ribonuclear protein 
ss: single stranded 
SV40: simian virus 40
syn: syncitial plaque morphology locus (syn+= non-syncitial; syn~= syncitial) 
T: thymine
TEMED: N,N,N',N’-tetramethylethylene diamine
tk: thymidine kinase
TLC: thin layer chromatography
TRl : long terminal repeat
tRNA: transfer ribonucleic acid
TRS: short terminal repeat
ts: temperature sensitive
u: unit
Ul: long unique region 
Us: short unique region 
uv: ultraviolet
V: volts 
v: volume 
vol: volumes
VZV: varicella zoster virus 
W: watts 
w: weight 
WT: wild type
AMINO ACID SYMBOLS
A alanine 
C cvsteine 
D aspartate 
E glutamate 
F phenylalanine
G glycine 
H histidine 
I isolsucine 
K lysine 
L leucine
M methionine 
N asparagine 
P proline 
Q glutamine 
R arginine
S serine 
T threonine
V valine
W tryptophan
Y tvrosine
(The three letter code abbreviations are underlined).
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1A. Biology of Herpes Simplex Virus Type 1.
1A.1. Herpesvirus Characterization.
Viruses are classified as members of the family Herpesviridae on the basis of the 
structure of the viral particle. Herpesvirus particles contain four major architectural 
elements; a central core containing the genomic DNA, an icosahedral capsid, 
approximately 100-120nm in diameter, an amorphous proteinaceous tegument, and an 
outer lipid envelope containing glycoprotein spikes.
The core of the virus is an electron dense mass within the capsid containing the 
genomic DNA, which exists as a linear double stranded molecule of 80-150xl06Da 
molecular weight (reviewed by Dargan, 1986). The viral DNA was thought to form a 
toroid structure wound around a central cylindrical plug (Furlong et al., 1972; Nazerian, 
1974). However, recent cryoelectron microscopy analysis of herpesvirus particles has 
suggested that this structure was an artifact caused by the method of specimen 
preparation or was an intermediate structure in herpesvirus particle maturation. It has 
now been proposed that the DNA is packaged in a liquid-crystalline configuration, 
forming a universally dense ball which extends to die inner surface of the viral capsid 
(Booy etaL , 1991).
The morphology of the viral capsid is characteristic of all members of the family 
Herpesviridae. It is an icosahedral structure, 100-120nm in diameter, containing 162 
hollow, elongated capsids, 150 of which are hexameric and 12 of which are pentameric 
(Wildy et al., 1960).
The tegument layer is situated between the viral capsid and outer lipid membrane 
and varies in thickness between members of the herpesvirus family. It consists of an ill- 
defined proteinaceous mass which occasionally appears to be fibrous in negatively 
stained virus particles (Roizman and Furlong, 1974).
The outer envelope of herpesvirus particles has a trilaminar appearance, typical of 
a plasma membrane (Epstein, 1962). This envelope contains numerous glycoprotein 
spikes, estimated to be 8nm long (Wildy et al., 1960; Wildy and Watson, 1963; Heine et
1
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al.y 1972). The stage at which a herpesvirus capsid acquires its envelope has been the 
subject of many studies, and is discussed in more detail in Section 1 A.5.4.
Nearly 100 herpesviruses have been partially characterized (Roizman, 1990), and 
the members of this family infect a wide variety of hosts. At present, seven 
herpesviruses have been isolated from humans, these are discussed in further detail in 
Section 1A.4.
In addition to sharing conserved structural features, members of the 
Herpesviridae family also share a number of common biological properties. The 
replication cycle of the virus, including viral DNA synthesis and capsid assembly, occurs 
within the nucleus. Infection of host cells with herpesviruses and the subsequent 
replication and production of infectious particles results in the destruction of infected 
cells. Finally, all herpes viruses examined share the ability to establish a latent infection 
in the host. This is discussed further in Section 1 A.7.
1A.2. Herpesvirus Classification.
Herpesviruses have been classified on the basis of their biological properties into 
three subfamilies - the alpha-, beta- and gamma-herpesviruses (Roizman, 1982; 
Matthews, 1982; Roizman, 1990).
Alphaherpesviruses have a variable host range in tissue culture, and exhibit a 
short reproductive cycle followed by destruction of infected cells and rapid spread in cell 
culture. These viruses readily establish latent infection in the ganglia. This subfamily 
includes the human viruses herpes simplex virus subtypes 1 and 2 and varicella zoster 
virus. Betaherpesviruses are characterized by a longer reproductive cycle and slow 
development of cytopathic effect in cell culture. Infection with betaherpesviruses 
frequently results in enlargement of the infected cell (cytomegalia) both in tissue culture 
and in vivo. This subfamily includes the human and murine cytomegaloviruses.
Gammaherpesviruses are identified mainly on the basis of the host range of the 
virus and characteristics of the latent infection. In vivo, the host range of the virus is 
limited to the family or order to which the natural host belongs. In vitro, members of this 
subfamily are restricted to replication in lymphoblastic cell cultures and occasionally may 
infect some epithelial and fibroblastic cell lines. These viruses frequently establish latent 
infections within lymphoid tissue. Two members of this subfamily are Epstein-Barr 
virus and herpesvirus saimiri.
Such biological classification does not take into account the evolutionary 
relatedness of the herpesviruses. As more sequence data becomes available, 
herpesviruses can also be classified on the basis of the conservation of genes and gene
2
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clusters, as well as the conservation of reiterated sequences within the genome. At 
present, the analysis of the genome content of many herpesviruses has led to the 
confirmation of classification of the viruses into the three subfamilies described above 
(see, for example, McGeoch et al., 1988a; Davison and Taylor, 1987). Two exceptions 
to this method of classification are the Marek’s disease virus and human herpesvirus 6.
Marek’s disease virus (MDV) and the closely related herpesvirus of turkeys 
(HVT) have been classified as gammaherpesviruses on the basis of their ability to 
establish infection in lymphoid tissue and, in the case of Marek's disease virus, to result 
in the formation of T-cell lymphomas in the infected host (Roizman, 1982). Human 
herpesvirus 6 was also provisionally classified as a gammaherpesvirus on the basis of its 
ability to infect lymphoid tissue both in vitro and in vivo and the isolation of HHV-6 
genome sequences in some B-cell tumours. However, partial sequence analysis of the 
three viruses and comparison of predicted reading frames with those of other viruses has 
shown that MDV and HVT exhibit high homology to the alphaherpesvirus VZV, whilst 
HHV-6 exhibits high homology to the betaherpesvirus HCMV (Buckmaster et al., 1988; 
Lawrence et al., 1990). Both studies have shown that the viruses in question display a 
lower genetic homology to the gammaherpesvirus Epstein-Barr virus. Therefore, on the 
basis of sequence and mapping data, it appears that MDV and HVT belong to the 
alphaherpesvirus subfamily and HHV-6 to the betaherpesvirus subfamily, rather than the 
gammaherpesvirus subfamily.
Although these studies appear to present discrepancies between the biological and 
genomic methods for classification of the herpesviruses, genomic information may not 
directly reflect the fundamental properties of the virus in vivo. For example, in Marek's 
disease virus, several open reading frames identified as conserved and colinear with 
those of varicella zoster virus are not expressed during latency or in transformed cells 
(Buckmaster et al., 1988). Therefore, several viruses may have evolutionarily adapted in 
order to lose or gain biological properties, leading to the expression of the biological 
properties of one herpesvirus subfamily whilst retaining genetic similarity to members of 
a second herpesvirus subfamily.
1 A.3. Pathogenicity of Human Herpesviruses.
Seven herpesviruses are known to establish infection in man - the herpes simplex 
viruses subtypes 1 and 2; varicella zoster virus; human cytomegalovirus; Epstein-Barr 
virus; human herpesvirus 6; and human herpesvirus 7.
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The herpes simplex viruses primarily infect epithelial tissue through mucosal 
surfaces or abraded skin, followed by transport of virions or capsids to neuronal ganglia 
where the viruses establish a latent infection. Viruses can be reactivated from latency by a 
variety of stimuli. Primary HSV-1 infections are generally asymptomatic, with the 
occasional occurrence of fever and sore throat. Reactivation results in the formation of 
vesicular lesions at the site of primary infection. Infection with HSV-2 results in 
formation of genital lesions (reviewed in Wildy, 1990).
Immunocompromised patients have an increased susceptibility for HSV 
infection. The latent herpes simplex viruses may reactivate at multiple sites, and patients 
can develop a progressive disease involving the respiratory or gastrointestinal tracts. The 
increase in occurrence of acquired immune deficiency syndrome has resulted in 
widespread outbreaks of such opportunistic HSV infections, together with the isolation 
of many acyclovir-resistant strains of HSV (reviewed in Masur, 1992). Recent studies 
have suggested that HSV infection can trigger replication of proviral forms of the human 
immunodeficiency virus through a transcriptional mechanism involving the transcription 
factor NFkB (Vlack and Pitha, 1992).
Occasionally, infection with HSV can result in herpes simplex encephalitis, a 
sporadic, fatal disease involving fever and progressively deteriorating levels of 
consciousness (Olson et al., 1967).
Primary infection with varicella-zoster virus usually occurs in childhood and 
is initially asymptomatic, with appearance of a rash after a 14-15 day incubation. 
Infection in older patients produces the initial symptoms of a fever accompanied by 
backache and headache. After the incubation period, a vesicular rash appears, 
predominantly concentrated on the scalp and trunk (reviewed in Gelb, 1990). Herpes 
zoster results from reactivation of latent virus from neuronal ganglia in older or 
immunocompromised hosts. Reactivation results in the formation of skin lesions situated 
around the infected nerve endings (Hope-Simpson, 1965).
Hum an cytom egalovirus infection is widespread, with a generally 
asymptomatic primary infection resulting in mononucleosis, followed by recurrent 
infection caused by chronic infection, reinfection by different genetic strains of the virus; 
or reactivation of latent virus (reviewed in Alford and Britt, 1984). Again, HCMV 
infection is increased in occurrence and severity in immunocompromised hosts. HCMV 
is one of the more common opportunistic infective agents associated with acquired 
immune deficiency syndrome, causing symptoms such as gastroenteritis and retinitis. It 
has been suggested that HCMV potentiates human immunodeficiency virus infectivity by 
a transactivational mechanism (Davis et al., 1987).
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Primary infection with Epstein-Barr virus is generally asymptomatic, 
although in older children and adults, EBV infection results in infectious mononucleosis. 
EBV has been implicated in the formation of Burkitt's lymphoma (Andiman et al., 1985; 
de The et al., 1987) and nasopharyngeal carcinoma (Raab-Traub et al., 1987).
Human herpesvirus 6 was first isolated from the peripheral lymphocytes of 
patients with acquired immune deficiency syndrome and T-cell leukaemia (Salahuddin et 
al., 1986). It is now thought that HHV-6 infection is widespread in the adult population 
(reviewed in Lopez and Honess, 1990). The virus is strongly linked to the childhood 
disease exanthum subitum (Roseala infantum; Yamanishi et al., 1988). Most other cases 
involve isolation of HHV-6 from patients exhibiting some form of immunosuppression, 
such as patients with acquired immune deficiency syndrome or transplant recipients. 
Initial reports that HHV-6 may be involved in the progression of AIDS have not been 
supported by recent studies (Lopez and Honess, 1990).
Human herpesvirus-7 was isolated from activated T-cells of a healthy 
individual, and was found to exhibit typical herpesvirus morphology upon electron 
micrograph analysis. The virus exhibited cytopathic effect in cell culture and limited 
homology to HHV-6 by Southern hybridization (Frenkel et al., 1990). As yet, no 
disease associated with HHV-7 has been described.
1A.4. HSV-1 Genome Structure.
The initial purification of DNA from nucleocapsids of HSV-1 and -2 showed that 
the viral DNA existed as a double stranded linear molecule with a molecular weight of 
95+/-5 x 106 Da. This DNA molecule exhibited evidence of random single stranded 
nicks throughout the genome (Kieff et al., 1971). Comparison of DNA from HSV-1 and 
-2 revealed that the genomes were of similar size, similar G+C content (67% and 69% 
respectively), and exhibited 50% homology (Kieff et al., 1971; Wadsworth et al., 1975).
Electron micrograph analysis of self-annealed DNA molecules from HSV-1 strain 
F suggested that the genome contained terminally redundant sequences that were inverted 
and repeated internally (Wadsworth et al., 1975; Sheldrick and Berthelot, 1974). These 
repeated sequences flank unique long and short regions of the HSV genome (see Figure 
1A.1). Partial denaturation analysis revealed that preparations of HSV-1 DNA contain an 
equimolar mixture of four isomers of the HSV-1 genome (Wadsworth et al., 1975; 
reviewed in Roizman, 1979). One of these four isomers, the P isomer, is used as the 
prototype of the HSV-1 genome and is illustrated in Figure 1A.1.
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Figure 1A.1. Structure of the HSV-1 Genome.
The HSV-1 genome is represented as two covalently linked linear unique 
segments, Ul and Us, spanned by major repeat elements, TRl, TRs, IRl and IRs. The a 
sequence and the internal inverted repeat a' sequence are also shown.
Isomers of the HSV-1 genome are formed by inversion o f the covalently linked L 
and S segments, and are illustrated as the molecules P, II, Is and Ils
Restriction enzyme mapping illustrated the existence of the four isomers of HS V 
DNA. These studies also showed that the genome contained multiple copies of a 
sequence present at the joint of the long and short sequences, and also at the termini of 
the molecule (Wagner and Summers, 1978). In the simplest form of this model, only one 
copy of the repeated sequence was present at the joint of the segments.
This repeat sequence, termed the “a” sequence, is 401bp in size in the HSV-1 
strain 17 syn+ (McGeoch et al., 1988a). Sequence analysis of the HSV-1 strain F DNA 
led to the elucidation of the structure of the a sequence, which can be represented as:
IPR l I U b - 1DR21 |D R 4|,,~ ■ U c tDRfl
Where DR1, DR2 and DR4 = direct repeats of 20bp, 12bp and 37bp 
Uc and Ub = "unique" segments of 58bp and 64bp 
n = 19-22 in HSV-1 strain F 
m = 2-3 in HSV-1 strain F.
The structure and size of the a sequence varies from strain to strain due to the 
differing numbers of DR2 and DR4 repeats (Mocarski and Roizman, 1982). Sequence 
analysis of the termini of a HSV-1 strain F DNA molecule showed that viral genomes 
were produced from concatameric molecules by cleavage within the DR1 element of the a 
sequence, resulting in overhanging 3' residues at the termini of the molecules (Mocarski 
and Roizman, 1982).
Complete genomic sequence data has now been obtained for four herpesviruses 
of man - HSV-1 (McGeoch et al., 1986, 1988a); VZV (Davison and Scott, 1986);
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HCMV (Chee et al., 1990); and EBV (Baer et al., 1984); and also for the channel catfish 
virus (Davison, 1992). The HSV-1 strain 17 syn+ has a genome length of approximately 
152000 residues and base composition of 68.3% G+C content. Analysis of the sequence 
of this genome led to the prediction of 72 open reading frames, as illustrated in Figure 
1A.2, 52 of which corresponded to previous mRNA transcript mapping data. The 
function of the protein products of 33 of these genes were proposed (McGeoch et al., 
1988a). The identified proteins fell into three general categories - immediate early 
proteins; proteins involved in DNA replication or metabolism; and proteins involved in 
the structure or assembly of viral particles. Certain genes within the long unique region 
of the genome were shown to be non-essential for viral growth in tissue culture, 
including UL23, UL24, UL39, UL44, UL50 and UL56 (McGeoch et al., 1988a).
Since this study, a further three genes of HSV-1 have been described, namely 
UL26.5 (Liu and Roizman, 1991a, b); RL1 (Chou and Roizman, 1990; Dolan et al., 
1992); and UL49.5 (Barker and Roizman, 1992) or UL49A (Barnett et al., 1992). Of 
these three genes, only one has been assigned a function - the gene UL26.5, which 
encodes the ICP35 family of capsid proteins (Liu and Roizman, 1991a).
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Figure 1A.2. The Coding Content of the HSV-1 Genome.
The HSV-1 genome is represented as the P isomer, showing the location o f the 
open reading frames. Open reading frames are indicated by arrows. The genes UL1- 
UL56 are indicated by genes 1-56 on the top three lines, whilst genes US1-US12 are 
indicated by genes 1-12 on the bottom line. Orii and Oris indicate the viral origins of 
replication.
Reproduced from McGeoch, 1989, with the incorporation o f three additional 
genes; UL265, UL49.5 and yl 34.51RL1 (see text).
1A.5. The Lytic Cycle of HSV-1.
1A.5.1. Adsorption, Penetration and Uncoating.
HSV-1 adsorption and penetration occurs by a pH independent pathway, 
involving fusion of the viral and cellular membranes (Fuller and Spear, 1987). This is a 
function of the viral glycoproteins. At least ten glycoproteins are encoded by HSV-1, 
designated gB, gC, gD, gE, gG, gH, gJ, gK and gL (Spear, 1985; Roizman and Sears, 
1990; Fuller and Lee, 1992). Neutralization studies (Fuller and Spear, 1987; Highlander 
et al., 1988; Fuller et al., 1989) and characterization of mutant viruses (Ligas and
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Johnson, 1988; Desai et al., 1988; Cai et al., 1988; Forrester et al., 1992) have shown 
that glycoproteins B, D and H are essential for viral replication in cell culture, and block 
viral penetration at a step following cellular attachment
Viral attachment to the cell surface has been proposed to occur via two stages. 
The initial attachment to the cell surface is mediated through heparan sulphate (WuDunn 
and Spear, 1989), and this attachment may involve the viral glycoproteins B or C 
(Herold et al., 1991). Analysis of a deletion mutant virus lacking glycoprotein C coding 
sequences has led to the proposal that although the protein is dispensable for the viral 
lytic cycle, it facilitates adsorption by its interaction with heparan sulphate (Herold et al.,
1991).
The second stage of viral penetration is postulated to involve the interaction of 
viral glycoproteins with a specific, high affinity cellular receptor. Kaner et al. (1990) 
have proposed that the basic fibroblast growth factor (bFGF) receptor acts as the specific 
high-affinity portal of entry for HSV-1. However, later studies have led to the 
suggestion that the inhibition of viral attachment to the cellular surface by bFGF as 
observed by Kaner et al. was due to the sequestering and saturation of heparan sulphate 
molecules on the cellular surface by bFGF (Muggeridge et al., 1992; Mirda et al., 1992).
The mechanism by which viral glycoproteins act to initiate fusion with and 
penetration of the cell membrane has not been clearly defined. A wide variety of evidence 
has emerged to suggest that glycoprotein D binds to a cellular receptor (Johnson and 
Ligas, 1988; Johnson et al., 1990). The fact that gD expressing cell lines are resistant to 
superinfection by HSV-1 has led to the suggestion that gD is sequestering a component 
of the cell membrane, but later work has shown that this interference is mediated through 
gD molecules present in the virion envelope (Campadelli-Fiume et al., 1990; Dean et al.,
1992). Additionally, studies with a HSV-1 virus lacking glycoprotein H coding 
sequences has led to the suggestion that gH acts in viral-cellular penetration at a step 
subsequent to the action of gD (Forrester et al., 1992).
A recent electron micrograph analysis of infectious HSV-1 particles and particles 
neutralized with anti-gD or -gH antibodies (Fuller and Lee, 1992) has resulted in the 
development of a model for HSV-1 adsorption and penetration, illustrated in Figure 
1 A.3. The authors proposed that viral adsorption and penetration occurs in five distinct 
stages, each of which can be observed during electron micrograph analysis of HSV-1 
infection.
The five stages described by the authors involve the initial attachment of the virus 
to cell surface heparan sulphate molecules as described previously, followed by a stable 
or secondary attachment probably mediated by gD. Following attachment, formation of a 
fusion bridge is initiated, possibly through conformational changes of viral glycoproteins 
D and H. Expansion of the bridge follows, resulting in the condensation of the viral 
envelope and tegument and release of some tegument proteins into the cellular cytoplasm.
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Finally, viral adsorption and penetration is completed by movement of the viral 
nucleocapsid into the cellular cytoplasm.
Following penetration of the cellular membrane, viral nucleocapsids are 
transported along microfilaments to the nuclear membrane (Lycke et al., 1984). From 
electron micrograph analysis of a temperature sensitive mutant of HSV-1, it appears that 
the viral DNA dissociates from the nucleocapsid and enters the nucleus through nuclear 
pores (Batterson et al., 1983). A HSV-1 mutant with a temperature-sensitive defect in 
uncoating and late gene expression has been isolated (Knipe et al., 1981; Batterson et al.,
1983). This mutation has been mapped to a 300bp region within the UL36 gene 
(McGeoch et al., 1988a).
1A.5.2. The Effect of HSV-1 Infection on Host Cell Macromolecular Synthesis.
Upon infection, herpes simplex viruses redirect the host macromolecular 
synthesis machinery in order to allow replication of the viral genome (reviewed in 
Fenwick, 1984). Initial studies illustrated that as viral infection proceeded, synthesis of 
cellular DNA declined, whilst synthesis of viral DNA increased (Roizman and Roane, 
1964). Host cell protein synthesis (Sydiskis and Roizman, 1966, 1967) and cellular 
RNA levels (Hay et al., 1966; Pizer and Beard, 1976) were also found to decline.
Whilst the prevalent effect of HSV infection is to inhibit host cell macromolecular 
synthesis, the activation of a subset of cellular genes has also been observed. Latchman 
and co-workers have illustrated that activation of certain cellular genes is dependent upon 
the presence of active Vmwl75 (Latchman et al., 1987; Kemp and Latchman, 1988), 
whilst cellular promoters introduced into the cell by transfection are activated by HSV 
infection in a mechanism involving the HSV-1 immediate-early proteins VmwllO and 
Vmwl75 (Everett, 1985). The mechanism by which Vmwl75 activates certain cellular 
promoters is still not fully understood, and is dealt with in greater detail in Section 1B.5. 
Interestingly, it appears that induction of certain cellular genes involves the binding of 
HSV-1 to the cell surface, but is independent of viral gene expression (Kemp et al., 
1986; Preston, 1990) and that cellular transformation by herpes simplex viruses also 
results in the overexpression of a number of cellular genes (Macnab et al., 1985).
The HSV-1 mutant tsK contains a temperature-sensitive defect in the gene 
encoding Vmwl75. Infections with this virus at the non-permissive temperature results 
in the induction of cellular heat shock proteins (Notariani and Preston, 1982; Estridge et 
al., 1989). These proteins are also induced upon HSV-2 infection (LaThangue et al.,
1984). Further analysis of this cellular response has suggested that the heat shock 
proteins are expressed in response to high levels of an abnormal form of Vmwl75 
(Russell et a l, 1987a).
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Host cell macromolecular synthesis shut-off is achieved through two clearly 
defined steps - the disassociaton of host cellular mRNA from polyribosomes and 
disaggregation of polyribosomes (Sydiskis and Roizman, 1967; Nishioka and 
Silverstein, 1978); and the degradation of mRNA (Nishioka and Silverstein, 1978). This 
degradation is not confined to host mRNA transcripts - HSV infection results in the 
degradation of virally-encoded RNA (Kwong and Frenkel, 1987; Oraskar and Read, 
1987). In addition to the degradation of pre-existing mRNA, several groups have 
reported the repression of host RNA transcription by HSV infection (Kemp and 
Latchman, 1988; Smiley et al., 1991). Whilst Kemp and Latchman (1988) have 
suggested that this transcriptional repression is caused by the immediate-early gene 
product ICP22, Smiley et al. (1991) have presented evidence that repression of cellular 
transcription only occurs in the presence of functional Vmwl75. It is possible that the 
repression observed is not caused by the action of a specific virally-encoded protein, 
rather, it is a indirect result of the redirection of the cellular transcriptional machinery by 
HSV-1, resulting in the ’'hijacking" of factors essential for the transcription of cellular 
genes.
The shut-off of host macromolecular synthesis occurs in two distinct stages - 
"early" and "delayed" shut-off. "Early" host cell shut-off is mediated by a virion 
component, whilst "delayed" shut-off requires viral gene expression (Nishioka and 
Silverstein, 1978; Fenwick and Clark, 1982; Fenwick, 1984). Further analyses 
demonstrated that different strains of virus may have differing mechanisms for host cell 
shut-off, HSV-1 strain KOS demonstrating no requirement for "delayed" shut-off 
(Schek and Bachenheimer, 1985; Smiley et al., 1991). In addition, HSV-2 strain G 
exhibits stronger host cell shut-off, which again does not require viral gene expression 
(Pereira et al., 1977; Fenwick and Walker, 1978).
Read and Frenkel (1983) isolated a series of HSV-i strain KOS mutants with 
defects in early host cell shut-off - designated vhs mutants. Analyses of these mutants 
demonstrated that the early and delayed shut-off phenotypes were functions of separate 
genes, that the early shut-off function was non-essential for viral replication in cell 
culture, and that a defect in host cell shut-off resulted in over-expression of viral genes. 
This over-expression of viral gene products by vhs mutants was shown to be due to the 
stabilization of viral RNA (Kwong and Frenkel, 1987; Oraskar and Read, 1987). 
Although non-essential for viral growth in tissue culture, the early host cell shut-off 
function may be advantageous under limiting growth conditions in vivo. The 
destabilization of viral as well as cellular mRNAs may prevent the over-expression of 
cellular promoters by Vmwl75, halt disturbance of nucleotide metabolism by over- 
expressed early HSV gene products, and facilitate rapid changeover during the temporal 
cascade of viral gene expression (described by Honess and Roizman, 1975).
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These vhs mutations have been mapped to the HSV-1 gene UL41 (McGeoch et 
al., 1988a). Fenwick and Everett (1990) designed a series of experiments to determine 
whether the differences in host cell shut-off exhibited by various HSV strains were 
attributable to the UL41 gene product. Construction and analysis of recombinant viruses 
showed that the HSV-2 UL41 gene was solely responsible for the strong early shut-off 
phenotype. In contrast to these results, super-infection of HSV-1 (17+) infected cells 
with HSV-2 (G) resulted in the domination of the weaker HSV-1 phenotype (Hill et al., 
1985). Fenwick and Everett (1990) explained this paradox by suggesting that UL41 
functions as a dimeric molecule, acting on a cellular target (possibly a nuclease). 
Therefore, coinfection with HSV-1 and HSV-2 could allow the HSV-1 UL41 dimer 
which exhibits weaker shut-off characteristics to occupy the target site, thus inhibiting 
the action of the HSV-2 UL41 gene product. However, expression of the two genes 
from one viral genome could result in the occurrence of a heterodimeric molecule, in 
which the stronger shut-off phenotype is dominant.
Analysis of the UL41 coding sequences from various HSVstrains has shown that 
differences in viral host cell shut-off phenotype are reflected in their genetic content 
(Everett and Fenwick, 1990). The development of an antiserum to the UL41 gene 
product has allowed the identification of the 58KDa protein product and demonstrated 
that the protein is, as predicted, a component of the virion particle (Smibert et al., 1992).
1 A.5.3. HSV DNA Replication.
HSV DNA replication is thought to involve a rolling-circle method of replication, 
due to the identification of concatamers of the HSV genome within infected cells (Jacob 
et al., 1979). Biochemical analysis of the c/s-acting sequences and viral genes required 
for HSV DNA replication has resulted in the elucidation of some aspects of the 
replication process (reviewed in Challberg, 1991).
The viral origins of DNA replication were first identified from analysis of 
defective genomes obtained from propagation of HSV in tissue culture (Frenkel et al., 
1975; 1976; Schroder et al., 1975), and were shown to direct viral replication in transient 
transfection assays (Stow and McMonagle, 1983; Weller ef al., 1985). HSV-1 contains 
three origins of replication: two copies of oriS, situated within the short repeat region of 
the genome and one copy of oriL, situated within the long unique region of the genome. 
It seems that the two origins of replication are functionally equivalent; only mutations 
affecting both oriS and oriL have a deleterious effect on viral replication (Longnecker and 
Roizman, 1986; Polvino-Bodnar et al., 1987; Challberg, 1991). In addition, mutational 
analysis has shown that sequences essential for the function of oriS are also conserved in 
oriL (Weller et al., 1985; Lockshon and Galloway, 1988; Deb and Doelberg, 1988; 
Hernandez et al., 1991; Weir and Stow, 1990).
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The essential regions of the origin of replication are illustrated in Figure 1A.4. 
The minimal core region of the origin contains the sequences essential for viral DNA 
replication, whilst addition of flanking sequences increases the efficiency of replication, 
an aspect of viral DNA replication also observed in adenovirus and SV40. The minimal 
core contains three binding sites for the UL9 origin-binding protein, discussed in greater 
detail below, and a central AT-rich region. The flanking regions of the oriS contain the 
promoter/regulatory regions of the IE-3 and IE-4/5 promoters. These sequences contain 
binding sites for a variety of cellular and viral transactivating proteins, such as Vmw65, 
Spl, and N F -m . Binding of these proteins to the regulatory sequences increases the 
efficiency of replication. The mechanism of this enhancement is not fully understood, 
and may involve inhibition of nucleosome formation, local unwinding of the duplex 
DNA or interaction between transcription factors and proteins involved in DNA 
replication (Wong and Schaffer, 1991).
5 - G ^AGTGAGAACG 33AAG DGTTCGCACTT XS TOOC AATATATA TATATTAGGGCG \AGTGCGAGO C
C rTCACTCTTGC 3CITC< XTAAGCGTGAA GCAGGGT TATATATATATAATCCCGC T  T CACGCTCG G -5'
SITE in  SITE I SITED
Figure 1A.4. Sequence of the H5V-1 Ori8 Core Domain.
The sequence of the HSV-1 Oris core domain, showing the llb p  consensus 
recognition elements o f the three UL9 binding sites as open boxes. The arrow indicates 
the centre of a 53 bp hyphenated palindrome. Reproduced from Challberg, 1991.
The elucidation of the genomic sequence of HSV-1 led to the identification of 
several genes proposed to be involved in viral DNA metabolism, including a thymidine 
kinase, a ribonucleotide reductase, a nuclease, a single-stranded DNA binding protein, 
an origin binding protein, a primase and a helicase (McGeoch et al., 1988a). Subsequent 
studies have led to the identification of seven genes which are necessary and sufficient 
for viral DNA replication (Challberg, 1986; Wu et al., 1988; McGeoch et al., 1988b). 
The genes which are essential for viral DNA replication are UL5, UL8, UL9, UL29, 
UL30, UL42 and UL52. Expression of these seven genes from baculovirus vectors 
allows the replication of viral origin-containing DNA in insect cells and may provide a 
basis for the biochemical analysis of the gene products (Stow, 1992).
The HSV-1 UL9 gene encodes the origin-binding protein (Elias et al., 1986; 
McGeoch et al., 1988a). Footprinting and mutational analyses have shown that the 
protein binds to three sites within the oriS minimal region, designated sites TIH (Weir et 
al., 1989; Olivo et al., 1988; Elias et al., 1990). These three binding sites, together with 
the AT-rich sequence, are essential for the full function of the origin of replication.
Binding of UL9 to sites I and II is co-operative (Elias et al., 1990) and binding of 
the protein to the two sites induces conformational changes in the central AT rich region
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(Lockshon and Galloway, 1988; Koff et al., 1991; Challberg, 1991). Distortion of the 
central AT tract requires the situation of two adjacent UL9 binding sites on the same side 
of the DNA helix (Lockshon and Galloway, 1988; Challberg, 1991), and may involve 
interaction between two UL9 molecules bound to these sites (Fierer and Challberg, 
1992a).
The in vivo function of the UL 9 protein is still unclear. The DNA binding 
function of the protein has been mapped to the carboxy-terminal 317 amino acids of the 
protein (Weir et a l, 1989; Deb and Deb, 1991). The protein exists as a dimer in solution 
and has been shown to exhibit limited helicase activity, which is enhanced by the 
addition of ICP8 (Fierer and Challberg, 1992b). The amino-terminal two-thirds of the 
protein contains six sequence motifs conserved within a superfamily of DNA and RNA 
helicases. Mutational analysis of the protein has shown that five of these conserved 
motifs are essential for the full function of the protein in transient transfection assays 
(Martinez et al., 1992).
The products of the UL30 and UL42 genes form the functional viral DNA 
polymerase. Although the UL30 protein (the pol protein) is able to support DNA 
synthesis in the absence of UL42, the protein is isolated predominantly from infected 
cells as a heterodimer with the UL42 polypeptide, and UL42 acts to increase the 
processivity of the HSV-1 DNA polymerase in in vitro assays (Crate and Lehman, 1989; 
Gottlieb et al., 1990; Hernandez and Lehman, 1990). The presence of the UL42 subunit 
increases the affinity of the UL30 subunit for DNA by 5 to 10-fold, decreasing the rate at 
which DNA polymerase disassociates from the template (Challberg, 1991).
The products of the UL5, UL8 and UL52 genes are subunits of the viral helicase- 
primase complex (Crate et al., 1989; Dodson et al., 1989; Crate and Lehman, 1991). A 
complex of the UL5 and UL52 gene products contains the helicase and primase activities 
(Calder and Stow, 1990; Dodson and Lehman, 1991). The UL5 gene product contains 
six motifs which are conserved within a superfamily of DNA and RNA helicases. 
Mutations within these motifs inhibit the helicase properties of UL5, both in vitro and in 
vivo (Zhu and Weller, 1992). However, the UL5 protein does not express helicase 
activity in the absence of the UL52 protein (Calder and Stow, 1990; Dodson and 
Lehman, 1991). It seems that UL8 acts to increase the efficiency of primer utilization by 
increasing the stability of the primer-template complex.
The final gene involved in viral DNA replication, the UL29 gene, has long been 
recognised to encode the viral major DNA binding protein (dbp), ICP8 (Bayliss et al., 
1975; Purifoy and Powell, 1976). Binding studies with this protein have illustrated that it 
exhibits high affinity for single-stranded DNA and that binding is non-sequence specific 
(Ruyechan and Weir, 1984). The protein acts to stimulate the activity of viral DNA 
polymerase (Ruyechan and Weir, 1984), is required for the synthesis of long stretches of 
DNA (Hernandez and Lehman, 1990) and specifically increases the DNA helicase
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activity of the UL9 protein (Fierer and Challberg, 1992b). ICP8 may form multiple 
interactions with other replication proteins. Immunofluorescence studies have illustrated 
that functional ICP8 is required for the reorganisation of the cellular DNA replication 
machinery into viral replicative compartments within the nucleus (deBruyn Kops and 
Knipe, 1988), and directs DNA polymerase (UL30) to specific pre-replicative sites 
within the nucleus (Bush et al., 1991).
1A.5.4. Maturation and Egress of HSV-1.
The replication of HSV-1 DNA results in the production of concatemeric DNA 
molecules consisting of head to tail repeats of the viral genome. The packaging of viral 
DNA involves the cleavage of concatemeric molecules into viral genomic molecules, a 
function of the viral 'a' sequences (Stow et al., 1983; Deiss et al., 1986; Varmuza and 
Smiley, 1985; Smiley et al., 1992). Once cleaved, the viral genome is inserted into 
preformed nucleocapsids (Perdue et al., 1976; Ladin et al., 1980; Preston et al., 1983). 
Analysis of defective HSV-1 particles suggested that only capsids containing full 
genomic length DNA molecules were processed further to form fully mature virion 
particles (Vlazny et al., 1982).
The elucidation of the process of viral capsid maturation has been promoted by 
the identification of three forms of viral capsids within the infected cell nucleus. These 
forms have been termed light or A, intermediate or B and heavy or C capsids (Perdue et 
al., 1976; Rixon, 1992). A capsids and B capsids contain no viral DNA. C capsids 
contain viral DNA and represent the fully mature virion nucleocapsid, whilst B capsids 
are intermediate structures formed during assembly.
Initial studies showed that B nucleocapsids contained large amounts of a 
structural or scaffolding protein termed VP22a (also termed p40 or ICP35) which is lost 
upon maturation to C capsids (Preston et al., 1983; Rixon et al., 1988). Analysis of a 
temperature sensitive mutant of HSV-1 mapped the VP22a open reading frame to the 
gene UL26 (Preston et al., 1983). Further analysis has identified a gene designated 
UL26.5 which is present within, and in frame with, the UL26 open reading frame. The 
two reading frames have unique 5' termini but share a common 3' terminus, resulting in 
the expression of two proteins with identical carboxy-terminal portions (Liu and 
Roizman, 1991a).
The product of the UL26 gene has been shown to exhibit proteolytic properties. 
This protease will cleave the UL26.5 gene product at a region close to the carboxy- 
terminal of the protein, yielding the VP22a polypeptide. It will also catalyse a proteolytic 
cleavage within the UL26 protein, resulting in the formation of the VP24 and VP21 
proteins (Liu and Roizman, 1991b; Liu and Roizman, 1992; Preston et al., 1992; 
Deckman et al., 1992). The cleavage sites are illustrated in Figure 1 A.5. Both VP21 and
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VP24 have been shown to be components of HSV virions (Davison et al., 1992). 
However, only VP24 remains in fully mature nucleocapsids.
UL26
VP24 n
UL26.5 
 ►
b
Figure 1A.5. The Organization of the UL26 and UL26.5 genes.
The UL26 and UL265 open reading frames are indicated by arrowed lines. 
Proteolytic cleavage sites o f the gene products are ishown as the boxes a and b. Cleavage 
of the UL26 gene product results in the proteins VP21 and VP24, whilst VP22a is the 
result o f proteolytic cleavage of the UL265 gene product.
The assembly of nucleocapsids appears to follow a pathway beginning with the 
formation of large-cored B capsids containing viral structural proteins. These capsids are 
processed to small-cored B capsids in a process that requires the proteolytic activity of 
UL26 and production of VP22a (Preston et al., 1983). DNA is then packaged into these 
B capsids, triggering the removal of VP21 and VP22a proteins and resulting in the 
formation of fully mature C capsids, which then acquire a tegument and envelope during 
egress from the cell (Rixon, 1992).
The site at which virion nucleocapsids acquire their tegument and envelope is the 
subject of much speculation. Roffman et al., (1990) have suggested that HHV-6 
nucleocapsids acquire their tegument at a structure called the tegusome, membrane 
bounded cytoplasmic structures present at the outer nuclear membrane. Passage of HS V- 
1 in cell culture results in the production of L particles, consisting of enveloped tegument 
structures (Szilagyi and Cunningham, 1991). These L particles have been observed to be 
formed in the absence of capsid assembly (Rixon et al., 1992), illustrating that 
tegumentation can occur independently of other assembly processes.
Initial analyses of lipid metabolism in infected cells suggested that herpesvirus 
capsids acquired their envelope at the nuclear membrane (Asher et al., 1969). However, 
during multiple electron micrography studies, unenveloped capsids were observed within
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the infected cell cytoplasm, often juxtaposed to cytoplasmic membranes (reviewed in 
Roizman and Sears, 1990). Two explanations have been proposed for the occurrence of 
unenveloped nucleocapsids within the cell cytoplasm. Firstly, that the viral capsid 
undergoes a series of envelopments and de-envelopments during its egress from the cell 
(Stackpole, 1969; Roffman, et al., 1990). Secondly, that the unenveloped cytoplasmic 
capsids were products of fusion between the viral envelope, acquired at the nuclear 
membrane, and the membrane of cytoplasmic vesicles in which viral particles were 
transported to the cell surface (Campadelli-Fiume et al., 1990; 1991). The second 
suggestion is based upon the observation that viral gD interferes with fusion of plasma 
membranes, viruses containing mutant forms of gD resulting in a higher proportion of 
unenveloped cytoplasmic capsids. However, previous analysis of a gD" mutant virus 
suggested that the lack of gD did not interfere with the egress of virus from the cell 
(Ligas and Johnson, 1988).
The majority of evidence contained in these studies involves electron micrograph 
analyses of infected cells. These photographs provide frozen images of viral infection, 
but yield no indication of the direction of nucleocapsid transport. This presents 
difficulties in the interpretation of such images.
1A.6. The Latent Cycle of HSV-1.
HSV infection is characterized by the the ability of the virus to establish a latent 
infection in host cells, predominantly in neuronal ganglia. This latent infection was 
initially studied using mouse latency models, in which latent virus was reactivated by 
transplantation of ganglia. The use of this technique has also illustrated the existence of 
latent virus in human ganglia (reviewed in Ho, 1992). More recently, the development of 
in vitro models of latency have provided a means for the biochemical analysis of the 
latent state of the virus (Wighdal et al., 1984; Russell and Preston, 1986). Studies of the 
activity of mutant HSV-1 viruses in these in vitro models have suggested that Vmwl 10 
plays a part in the reactivation from latency (Russell et al., 1987b; Harris et al., 1989).
The HSV genome has been shown to exist in an endless or concatemeric state in 
latently infected cells (Rock and Fraser, 1983; 1985; Efstathiou et al., 1986). Analysis of 
cellular DNA by CsCl gradient centrifugation has illustrated that the viral DNA exists as 
an extrachromosomal molecule (Mellerick and Fraser, 1987). The latent viral genome is 
packaged into nucleosomes, and this has been suggested as a mechanism by which viral 
transcription is limited (Deshmane and Fraser, 1989).
During latency, viral transcription is limited to a region within the long repeat of 
the genome which overlaps with the 3' portion of the open reading frame for the viral
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immediate-early protein, VmwllO. Two transcripts from this region were originally 
detected, termed the latency associated transcripts or LATs (Stevens et al., 1987; Deatly 
et al., 1987; see Figure 1 A.2). They are colinear transcripts of approximately 2.0Kb (the 
major LAT) and 1.5Kb (the minor LAT). The minor LAT is produced from the major 
LAT by a splicing reaction (Wagner et al., 1988b; Wechsler et al., 1988).
Initially, it was proposed that the two transcripts contained a conserved open 
reading frame. However, the transcripts exhibit no evidence of polyadenylation (Wagner 
et al., 1988a, b), and although a protein product has been detected, it is not of the 
predicted molecular weight (Doerig et al., 1991).
Recent in situ hybridisation studies have allowed the detection of an RNA 
molecule which extends upstream of the major LAT. region. Further analysis of this 
transcript has shown that it is a 8.3Kb polyadenylated species. As the LAT’s contain 
putative splice signals, and do not appear to be polyadenylated, it has been suggested that 
they are stable introns formed from the splicing of this large primary transcript 
(Zwaagstra et al., 1990).
The LAT promoter has been mapped by a series of mutational analyses and 
transient transfection assays to a region approximately 30bp upstream from the large 
primary transcript (Dobson et al., 1989; Batchelor and OHare, 1990; 1992; Zwaagstra et 
al., 1990; 1991). Deletion of this region results in the loss of latency-associated 
transcription. The promoter contains many elements common to RNA polymerase II 
promoters and also additional elements with a possible involvement in transcriptional 
regulation. These include a TATA box, potential CAAT box, several Spl sites, a 
Vmwl75 binding site (Batchelor and OHare, 1990), a binding site for a LAT promoter 
binding factor (LPBP, Zwaagstra et al., 1990), and a cAMP resonse element (Leib et al., 
1991). The interaction of Vmwl75 with its proposed binding site has been shown to 
down-regulate transcription from the promoter, and may be involved in repression of 
latency during the lytic cycle (Batchelor and OHare, 1990). Binding of the LPBF seems 
to up-regulate transcription in neuronal and non-neuronal cell lines (Zwaagstra et al.,
1990).
A region upstream of the proposed minimal promoter has been suggested to 
confer neuronal specificity on the transcription unit (Zwaagstra et al., 1990; Batchelor 
and OHare, 1990; 1992). Batchelor and OHare (1992) have mapped a binding site for a 
neuronal specific factor, the IC-1 factor, to a 70bp region within this upstream element.
In addition, the cAMP response element mapped by Leib et al., (1991) may play 
a role in the mechanism of reactivation. Deletion of this element results in a significant 
delay in reactivation in vivo, whilst induction of intracellular cAMP increased the activity 
of the latency-associated promoter. Interestingly, many physiological and external stimuli 
which result in the reactivation of latent HSV also lead to an increase in intracellular 
cAMP levels.
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The function of the LAT's in the mechanism of latency establishment, 
maintenance and reactivation is still unclear. It is possible that they function as antisense 
messengers to the VmwllO open reading frame, thus inhibiting its function in 
reactivation (Stevens et al., 1987); or else they represent a species of RNA molecule 
which are transcribed upon reactivation (Steiner et al., 1989). The analysis of mutations 
within the LAT promoter region which disrupt transcription has demonstrated that the 
LAT's do not appear to function in latency establishment or maintenance. However, 
mutant viruses lacking LAT's displayed delayed reactivation kinetics (Steiner et al., 
1989; Sedarati et al., 1989; Hill et al., 1990). This observation does not correlate with 
the proposed role of the LAT's as antisense messengers. It has been suggested that the 
LAT's act to express a protein that is essential for reactivation (Hill et al., 1990).
Establishment of HSV latency may involve a reduction in activity of the viral 
transactivating protein Vmw65 (Roizman and Sears, 1990). This hypothesis is supported 
by the observation that a viral mutant defective in Vmw65 activity can establish latency in 
vitro and is reactivated by VmwllO but not Vmw65 (Harris and Preston, 1991). This 
mutant virus is also impaired in lytic infection and is predisposed to latency in vivo 
(Steiner et al., 1990). Kemp et al. (1990) have reported the existence of an octamer 
binding protein distinct from the protein Oct-1. This protein is present predominately in 
neuronal cells, and appears to interfere with the function of Vmw65. It is possible that 
this protein plays a role in the establishment of latency.
IB. An Overview of HSV-1 Gene Expression.
1B.1. Temporal Regulation of HSV-1 Gene Expression.
Upon infection, HSV genes are transcribed by the host cell RNA polymerase II 
(Costanzo et al., 1977; Ben-Zeev and Becker, 1977). The analysis of polypeptides 
synthesized during the course of HSV-1 lytic infection led to the identification of three 
co-ordinately regulated groups of genes, characterized by their specific temporal 
expression (Honess and Roizman, 1974; 1975; Clements et al., 1977). The a  or 
immediate-early polypeptides are synthesized immediately upon infection, whereas p or 
early proteins are synthesized following the expression of immediate-early genes, 
reaching a maximum at 5-7 hours post infection. The final class of genes, the y2 or true 
late genes are synthesized following the onset of viral DNA replication at approximately
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2 hours post infection. Late gene expression increases to a maximum at approximately 12 
hours post infection. An additional subclass, termed Yi or leaky-late genes, are expressed 
at low levels prior to viral DNA synthesis, but require the onset of viral DNA replication 
for maximal expression (Wagner, 1985).
The use of metabolic inhibitors has led to the elucidation of certain biochemical 
aspects of the temporal cascade of HSV-1 gene expression (Honess and Roizman, 1974; 
1975; Clements et al., 1977; Jones and Roizman, 1979). The immediate-early viral 
proteins are the only gene products expressed in the absence of other viral protein 
synthesis. These genes are controlled in part by a rra/w-activating protein present in the 
virion particle (see Section 1B.2 below). The transcription of early genes requires the 
presence of viral immediate-early proteins, as illustrated by the lack of early gene 
expression during inhibition of viral protein synthesis. Finally, expression of the true late 
genes occurs upon the induction of DNA synthesis, and also requires the presence of 
immediate-early viral proteins (Sacks et al., 1985; McCarthy et al., 1989; Preston, 1979; 
Watson and Clements. 1980; Dixon and Schaffer, 1980; Everett, 1986). Figure 1B.1 
illustrates the viral proteins known to be involved in the control of HSV gene expression, 
and indicates their role in the temporal cascade.
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Figure 1B.1. HSV Gene Products Which Regulate Transcription.
The top line represents the HSV-1 genome, indicating the positions of the genes 
encoding transcriptional regulatory proteins (not drawn to scale). The role of each protein 
in the regulation o f viral transcription is indicated. Adapted from an original diagram by 
R. D. Everett.
IB.2. Regulation of Immediate-Early Gene Expression.
1B.2.1. Sequences Within the Immediate-Early Genes Required for Viral-Induced 
Transactivation.
The positions of all five IE gene transcripts within the HSV-1 genome have now 
been mapped (Clements et al., 1979; Rixon et al., 1982; Murchie and McGeoch, 1982; 
McGeoch et al., 1985; 1986; 1988b; Perry et al., 1986). The IE genes are concentrated 
within the two repeat regions of the genome, with only the IE-2 gene located within the
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unique long segment. Although HSV £NA is rarely spliced (Wagner, 1985), three of the 
five IE proteins are translated from spliced mRNAs. The RNAs for the IE4 and IE5 
genes are transcribed from a common promoter situated within the short repeat region of 
the genome. The common leader sequences of the genes are spliced to individual open 
reading frames situated at either end of the short unique segment.
Analysis of the four HSV-1 EE promoters has defined two separable regions 
(Mackem and Roizman, 1982a; 1982b; Cordingley et al., 1983; Preston et al., 1984; 
Kristie and Roizman, 1984; Bzik and Preston, 1986): (i) the minimal promoter region 
consisting of a functional TATA box and proximal upstream sequences which directs 
basal transcription, and (ii) an upstream enhancer element which mediates the 
transactivation of IE gene expression by a component of the virion particle, later shown 
to be the virion protein Vmw65 (see Section IB.2.2 below).
Sequence analysis of the IE promoters initially defined two conserved motifs 
within the IE enhancer regions - the TAATGARAT motif, and a GC rich motif (Mackem 
and Roizman, 1982b; Murchie and McGeoch, 1982; Preston et al., 1984). Transfection 
experiments with mutant and chimaeric forms of HSV-1 IE and E promoters illustrated 
that these and possibly additional regulatory elements conferred Vmw65-mediated 
transactivation on both minimal IE and E promoters (Preston et al., 1984; Kristie and 
Roizman, 1984). The linkage of an oligonucleotide containing the TAATGARAT motif 
to the EE4/5 minimal promoter sequences restored Vmw65-mediated transactivation 
(Gaffney et al., 1985).
Sequences other than the defined TAATGARAT motif are also required for 
optimal expression of the IE genes. A GA-rich sequence upstream of the TAATGARAT 
motif within the IE3 promoter was shown to be necessary for the full activation of the 
promoter by Vmw65 (Triezenberg et al., 1988a; 1988b; Bzik and Preston, 1986). The 
IE4/5 and DE2 promoters also contained motifs with homology to this region. Proteins 
which bind specifically to this region, termed the (IEF)g, or IE facilitator proteins have 
been purified. However, these proteins do not seem to mediate transactivation of IE 
genes by the Vmw65 protein (LaMarco and McKnight, 1989).
Analysis of the GC rich sequences illustrated the presence of GC box motifs, 
which had previously been identified as the binding site for the cellular transcription 
factor Sp-1. DNase I footprinting analysis of the HSV-1 short repeat region showed that 
Sp-1 bound to the GC boxes within the EE3 and IE4/5 promoters (Jones and Tjian, 
1985). These Sp-1 sites increase the efficiency of expression of both IE and E promoters 
(see also Section 1B.3).
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IB.2.2. Identification and Characterization of the Proteins Interacting with the 
Regulatory Sequences of IB Genes and Mediating IE Transactivation.
Early experiments showed that a protein component of the virion particle 
mediated IE gene transactivation, whilst further transfection assays illustrated that the 
mediator of viral IE transactivation was the virion protein Vmw65, also termed VP 16 or 
a-TlF (Post et al., 1981; Campbell et al., 1984). This regulatory protein is located 
within the tegument of the virion particle (Batterson and Roizman, 1983). The 
observation that this protein exhibited no DNA binding properties raised questions about 
the function of the TAATGARAT motif within the IE promoter enhancer region 
(Marsden et al., 1987; Preston et al., 1988; OHare et al., 1988).
The discovery that the cellular protein NF-III bound to a TAATGARAT motif 
within an adenovirus * (Pruijn et al., 1986) suggested that HSV-1 IE
transactivation by Vmw65 may be mediated by a cellular DNA-binding factor. In fact, it 
was soon discovered that a cellular factor did bind to the HSV-1 IE TAATGARAT motif. 
This factor was termed a-H l (Kristie and Roizman, 1987); H3 (Preston et al., 1988) 
and TRF (O'Hare and Goding, 1988). By the analysis of the sequences required for the 
formation of this complex, O'Hare and Goding (1988) identified the cellular factor as the 
factor NF-III, also termed Oct-1 or OTF-1.
The addition of an infected cell extract to this binding reaction resulted in the 
formation of a specific infected cell complex (Preston et al., 1988; O'Hare et al., 1988). 
The use of an anti-Vmw65 antibody and purified Vmw65 demonstrated that the specific 
infected cell complex contained Vmw65. Mutational analysis of the TAATGARAT motif 
illustrated that the first four base pairs of the motif mediated the interaction with OTF-1, 
whilst mutations within the GARAT portion of the motif interfered with the formation of 
the infected cell specific complex without inhibiting the DNA-binding activity of OTF-1. 
These mutations also inhibit the Vmw65 mediated activation of IE genes, illustrating the 
involvement of the infected cell complex in the mechanism of transactivation of IE genes 
(O'Hare etal., 1988; OHare and Goding, 1988).
The mechanism by which the OTF-1 factor mediates the interaction of Vmw65 
with DNA is poorly understood. It is possible that the interaction of the two proteins 
creates a conformational change within Vmw65 which facilitates its interaction with 
DNA. Alternatively, the binding of OTF-1 to the TAATGARAT motif may induce a 
conformational change in the DNA helix, again allowing the Vmw65 protein to bind to 
DNA. Finally, an additional cellular protein may interact with the 3' portion of the 
TAATGARAT motif, allowing the recruitment of Vmw65 to the complex.
Some experimental evidence exists to support the latter hypothesis. The analysis 
of complex formation in the absence of DNA has suggested that Vmw65 interacts with a 
cellular protein distinct from OTF-1 (Goding and O'Hare, 1989). In addition, several
23
Chapter 1. Introduction.
groups demonstrated that cellular factors present in partially purified cellular extracts 
were required for formation of the infected cell complex with affinity purified Vmw65 
and OTF-1 (Gerster and Roeder, 1988; Kristie et al., 1989; Katan et al., 1990). Katan et 
al. (1990) identified and purified a complex forming factor (CFF) from HeLa cells. The 
CFF was found to be a protein of approximately 70kDa molecular weight, which 
exhibited no DNA binding activity in isolation, but which allowed the interaction of 
OTF-1 and Vmw65 with the full TAATGARAT sequence.
A HSV-1 virus (m l814) has been constructed which encodes a mutant Vmw65 
protein (Ace et al., 1989).This Vmw65 molecule is fully functional in its role in virion 
structure, but is unable to interact with OTF-1. The virus has a high particle:pfu ratio, 
and is unable to replicate at low multiplicities of infection in vitro, whilst it is essentially 
avirulent in vivo. Loss of Vmw65-OTF-l interaction results in a 5-10 fold reduction in 
expression of IE1 and IE4/5, whilst the IE2 and IE3 genes show only a small or 
negligible reduction in expression. The properties of this virus mirror those of a 
VmwllO deletion mutant virus (Stow and Stow, 1986; Sacks and Scaffer, 1987; 
Everett, 1989), and may reflect the inability of wl814 to efficiently express VmwllO.
1B.2.3. Regions of the Vmw65 Protein Involved in Transactivation.
Mutational analysis of the Vmw65 protein has identified domains involved in 
both infected cell complex formation and IE gene transactivation, again suggesting that 
complex formation is an essential step in the mechanism of IE gene transactivation. 
Certain mutant Vmw65 proteins able to support IE gene expression were unable to 
rescue an HSV-2 assembly mutant virus, suggesting that another domain of Vmw65 is 
involved in the structural function of the protein. These results may represent a 
multiplicity of interactions between Vmw65 and cellular or viral proteins - one set of 
interactions mediating IE gene transactivation, whilst another set of interactions mediate 
virion assembly (Ace et al., 1988).
Deletion of the C-terminal 80 amino acids of Vmw65 results in the loss of 
transactivating function of the protein, whilst the N-terminal 403 amino acids of the 
protein still retain the ability to form a cell specific complex (Greaves and OHare, 1989). 
The C-terminal 80 amino acid domain of Vmw65 contains a putative highly acidic 
amphipathic a-helix, which exhibits homology to the transcriptional domains of the yeast 
transcription factors GAL4 and GCN4 (Sadowski et al., 1988; Goding and O’Hare, 
1989). Deletion of this transcriptional domain results in a mutant form of Vmw65 which 
interferes with the transcriptional ability of wild type Vmw65, presumably by competing 
with wild type Vmw65 for the formation of a transactivation competent infected cell 
complex (Triezenberg et al., 1988a; Friedman et al., 1988).
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It is believed that the acidic activator domain of Vmw65 acts through the 
interaction with one or more components of the basal transcription apparatus, although 
the identity of the interacting cellular factor(s) is not clearly defined. The mechanism of 
transactivation by Vmw65 is discussed in further detail in Section 1D.2.1.
1B.3. Regulation of HSV-1 Early Genes.
Analysis of temperature-sensitive mutant viruses has illustrated that Vmwl75 
function is essential for the activation of early and late genes (Marsden et al., 1976; 
Courtney et al., 1976; Watson and Clements, 1978; 1980; Preston, 1979a; Dixon and 
Staffer, 1980), whilst further transient transfection assays illustrated that two out of the 
five IE gene products, Vmwl75 and VmwllO, were sufficient for the transactivation of 
several early promoters. These two proteins were able to transactivate early gene 
expression independently. In addition, several studies illustrated that the two proteins 
acted synergistically in early gene transactivation whilst other studies did not observe this 
synergistic cooperation (Everett, 1984b; 1986; O'Hare and Hayward, 1985a, b; Gelman 
and Silverstein, 1985; Quinlan and Knipe, 1985). These differences in the in vitro 
properties of Vmwl75 and VmwllO may be explained by the observation of Everett 
(1988b) that experimental details such as cell type and transfection protocol can affect the 
transactivation properties of viral proteins in this assay. Although these experiments 
illustrated that the two proteins may interact to increase early gene expression, the use of 
a cell line stably expressing Vmwl75 from the cellular genome illustrated that Vmwl75 
was sufficient to activate certain early promoters within a superinfecting viral genome 
(Persson et al., 1985).
Some aspects of the mechanism of early gene transactivation by the two proteins 
are still unclear. Although VmwllO activates early gene expression independently of 
Vmwl75 in transfection assays, viruses containing temperature sensitive mutations in 
Vmwl75 exhibit no early gene transcription at the non-permissive temperature (see for 
example, Dixon and Schaffer, 1980; Watson and Clements, 1980; DeLuca and Schaffer, 
1985). It has been suggested that this property is due to the trans-dominance of the 
mutant Vmwl75 molecule over the wild type VmwllO (Gelman and Silverstein, 1986; 
Everett, 1987b). In fact, some temperature-sensitive mutant forms of Vmwl75 
accumulate in the cytoplasm and seem to interfere with the transport of Vmwl 10 to the 
nucleus (Knipe and Smith, 1986), whilst similar mutant forms of Vmwl75 inhibit the 
transactivation activity of VmwllO in transient expression assays (Gelman and 
Silverstein, 1986). However, this hypothesis cannot account for the fact that Vmwl 10 is 
not sufficient to support the viral lytic cycle in the absence of functional Vmwl75
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(DeLuca et al., 1985; DeLuca and Schaffer, 1988; Shepard and DeLuca, 1989; this 
thesis).
Initial studies of HSV-1 early gene expression concentrated on the elucidation of 
sequences within early viral promoters specific for the viral trans-inducing activity. Such 
sequences have been discovered within viral IE promoters; these mediate the trans- 
inducing effect of the viral protein Vmw65 (see Section 1B.2.1).
Several groups constructed cell lines biochemically transformed with the viral 
thymidine kinase (tk) gene. This technique allowed the mutational analysis of the viral tk 
promoter, which could be assayed for activity both constitutively within the cellular 
genome, and also following transactivation by super-infecting virus. These studies 
illustrated the importance of the integrity of the 109bp fragment upstream of the tk capsite 
for both cellular and viral trans-induced expression of the gene (Smiley et al., 1983; El 
Kareh et al., 1985). However, such studies were limited by the integration of multiple 
copies of the tk gene in the cellular genome, and by the selection of tk expression, which 
may force the promoter into activity.
The development of transient expression techniques allowed a more sensitive 
analysis of the essential sequences of viral promoters. Studies have concentrated on two 
early HSV-1 promoters - the gD and tk promoters. For clarity, studies involving each 
promoter will be dealt with separately.
1B.3.1. Analysis of the Viral Glycoprotein D (gD) Promoter.
Transfection of reporter constructs containing gD promoter sequences followed 
by superinfection with HSV-1 resulted in the activation of the transfected promoter by 
viral proteins. Deletion mutational analysis of the gD promoter in this assay system 
illustrated that a fragment 83bp upstream of the gD capsite was required for efficient viral 
transactivation (Everett, 1983). The linkage of the SV40 enhancer region upstream of the 
gD minimal promoter region also allowed for the analysis of cellular mediated cis- 
activation of the promoter. Further mutational analyses demonstrated that transactivation 
by viral proteins required no additional sequences than those already found to be 
essential for cellular-mediated cis-activation (Everett, 1984a). These sequences included 
a G-rich sequence, an inverted CAAT box (described below), a TATA box and a 
functional cap-site. Therefore, it appeared that transactivation of the HSV-1 gD promoter 
required no specific sequences other than those previously utilized by the cellular 
transcription machinery.
The discovery that Vmwl75 exhibited DNA binding properties (Freeman and 
Powell, 1982; Faber and Wilcox, 1986) led to the investigation of its ability to bind to 
viral promoter sequences. These studies identified three specific Vmwl75 binding sites 
within the gD promoter region - two upstream and one downstream of the capsite (Faber
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and Wilcox, 1986; Tedder and Pizer, 1988; Tedder et al., 1989). The removal of the 
proximal upstream binding site reduced the transactivation of the promoter in a transient 
transfection assay, whilst the insertion of multiple Vmwl75 binding sites increased the 
activation by Vmwl75 (Tedder and Pizer, 1988). Further analysis illustrated that deletion 
of any one of the three Vmwl75 binding sites reduced the transactivation of the promoter 
by Vmwl75 in an in vitro transcription assay (Tedder et al., 1989). Although these 
results implied that the specific Vmwl75 binding sites may play a role in the Vmwl75- 
mediated transactivation of the gD promoter, the removal of all three binding sites within 
the viral genome had little or no effect on gD expression during HSV-1 infection in cell 
culture (Smiley et al., 1992). In addition, the Vmwl75 binding site investigated above is 
not contained within the sequence shown by Everett (1983,1984a) to be necessary and 
sufficient for gD transactivation. Therefore, as concluded by Everett (1983, 1984a), it 
seems that no specific sequences within the gD promoter mediate transactivation by 
Vmwl75.
1B.3.2. Analysis of the Viral Thymidine Kinase (tk) Promoter.
Microinjection of a reporter construct containing HSV-1 tk promoter sequences 
demonstrated that this promoter was expressed constitutively in Xenopus laevis oocytes 
(McKnight et al., 1981). Mutational analysis of the promoter region demonstrated that 
the constitutive expression required the integrity of four sites within the promoter - the 
TATA box and three upstream sequences - two GC boxes and one CAAT motif 
(McKnight and Kingsbury, 1982). These upstream elements were shown to bind two 
cellular factors, a CAAT-binding transcription factor (CBP or CTF) and the cellular 
transcription factor Sp-1, which has also been demonstrated to bind to and transactivate 
HSV-1 IE promoters (Jones et al., 1985; Jones and Tjian, 1985).
Transient assays of the viral-mediated transactivation of the tk promoter, as 
described for the gD promoter in Section 1B.3.1, have allowed the delineation of 
promoter sequences essential for viral transactivation of the tk gene. These studies 
demonstrated that viral-mediated transactivation required only the sequences defined by 
McKnight and Kingsbury (1982). This again suggested that transactivation of the HSV-1 
tk promoter required no specific sequences other than those previously utilized by the 
cellular transcription machinery. The introduction of mutations into the tk promoter 
within the HSV-1 genome illustrated that deletions within the upstream elements reduced 
tk expression 2-5 fold, whilst deletion of the tk TATA box virtually abolished expression 
from the promoter (Coen et al., 1986).
The combined studies described above have suggested that Vmwl75-mediated 
transactivation of early viral promoters requires a functional TATA box together with 
upstream binding sites for cellular factors such as CBP or Sp-1. However, Imbalzano et
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al (1991) have carried out an analysis of the effects of mutations within the viral tk 
promoter in the presence and absence of Vmwl75. They discovered that whilst the 
removal of the CAAT motif had a similar effect both in the presence and absence of 
Vmwl75, deletion of the Sp-1 binding sites resulted in a 20-fold reduction in expression 
in the absence of Vmwl75. The addition of Vmwl75 in trans limited this effect to a 
modest 3-fold reduction in activity, similar to the results obtained by Coen et al. (1986). 
The authors speculated that these results illustrated the ability of Vmwl75 to functionally 
substitute for Sp-1 in transactivation of viral early genes. As Sp-1 acts to increase cellular 
transcription through interaction with an adaptor or coactivator molecule (Pugh and 
Tjian, 1990), the authors postulated that Vmwl75 may interact with this same adaptor 
protein. Alternatively, the interaction of Vmwl75 with the cellular transcriptional 
machinery may bypass requirements for an upstream factor. It is possible that although 
the upstream sites are not required for Vmwl75 transactivation and regulation of the tk 
gene with early kinetics, functional Sp-1 may be required to activate tk expression to 
levels required for the viral replicative cycle.
In conclusion, although recent studies have cast doubt on the integral 
requirements of functional Sp-1 binding sites, transactivation of viral early promoters by 
Vmwl75 requires certain upstream elements together with a functional TATA box. The 
absolute requirement of a functional TATA box supports the hypothesis that Vmwl75 
mediates viral gene activation through an interaction with the cellular TFIID transcription 
factor. This proposed mechanism for Vmwl75 transactivation is described in fuller detail 
in Section ID.
IB.4. Regulation of HSV-1 Late Genes.
Transactivation of the late genes of HSV-1 involves three out of the five 
immediate-early proteins. Analyses of temperature-sensitive mutant viruses illustrated 
that functional Vmwl75 was essential for the activation of late genes (Marsden et al., 
1976; Courtney etal., 1976; Watson and Clements, 1978; 1980; Preston, 1979a; Dixon 
and Schaffer, 1980), and that the lack of a functional Vmw63 molecule led to over­
expression of early gene products and no detectable late gene expression (Sacks et al.,
1985). The analysis of Vmw63 deletion mutant viruses also suggested that the protein 
was essential for late gene expression and possibly involved in the down-regulation of 
early genes (McCarthy et al., 1989). Transfection assays illustrated that Vmwl75 and 
Vmwl 10 transactivated late gene promoters, whilst the effect of Vmw63 was varied (for 
example, see Everett, 1984b, 1986; Shapira et al., 1987; Sekulovich et al.> 1988).
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Recent data has suggested that Vmw63 enhances late gene expression through a post- 
transcriptional mechanism (see Section 1B.7.2).
The observations made about the expression of late genes within the viral genome 
suggest two possible modes of transactivation - either the promoters are transactivated by 
a virally-encoded protein synthesized after the onset of viral DNA replication, or 
transactivation is mediated by an event associated with viral DNA synthesis. Mavromara- 
Nazos and Roizman (1987) demonstrated that a c/s-acting element mediated by viral 
DNA replication allowed the temporal expression of late genes. Cells were infected with 
HSV-1, and infection allow to proceed until late times were reached. The cells were then 
superinfected with HSV-1 in the presence of an inhibitor of DNA synthesis. It was 
found that late genes in the superinfecting and unreplicated template were not expressed. 
As the initial infection provided all virally-encoded factors, it was concluded that DNA 
replication was essential for late gene expression.
1B.4.1. C/5-acting Signals Within Late Gene Promoters.
A number of studies have been carried out in order to determine the specific ex­
acting control signals within late promoters which control their kinetics of expression and 
mediate their requirement for template replication before the induction of transcription. 
Initial analyses involved the transformation of cells with reporter constructs containing 
late promoters fused to tk structural sequences. Superinfection of these transformed cell 
lines enabled the investigation of the activation of late gene promoters by viral proteins. 
All reporter constructs tested were found to be activated by HSV-1 superinfection. 
However, late promoters resident in the cellular genome were expressed with the kinetics 
of early promoters (Dennis and Smiley, 1984), and were expressed in the presence of 
DNA replication inhibitors (Silver and Roizman, 1985). Therefore, it appeared that the 
local environment of the promoter controlled its requirement for template replication prior 
to induction.
A comprehensive series of mutational studies have defined the region of the true 
late gC promoter required for temporal control of expression. Initially, a series of 
deletions within the promoter region were introduced into the gC locus of HSV-1. These 
studies defined a region between -34 and +124 of the gC promoter which was solely 
required for expression following DNA replication. Unlike the studies of early gene 
promoters (described in Section 1B.3), these studies identified no upstream sequences 
other than a functional TATA box required for late gene expression (Homa et al., 1986). 
Replacement of the tk TATA box with that of the gC promoter conferred late kinetics of 
expression on the tk gene, whilst the tk TATA box alone was unable to support gene 
expression during viral infection. Further mutational analyses narrowed down the region 
required for late gene expression to a 15bp fragment encompassing the TATA box of the
29
Chapter 1. Introduction.
gC promoter (Homa et al., 1988; 1991). Although results obtained by Imbalzano and 
DeLuca (1992) did not correlate with this observation, it was suggested that these 
discrepancies were due to sequences surrounding the TATA box.
Transient expression experiments also confirmed that sequences 34bp upstream 
of the gC cap site were sufficient for the HSV-induced activation of the promoter 
(Shapira et a/., 1987). The expression of the gC promoter from a plasmid template in this 
transient expression assay did not require the replication of template DNA. This mirrored 
the results obtained with transformed cell lines - that removal of late genes from the viral 
genome resulted in a loss of the requirement for template replication prior to 
transcription.
The conclusion that the gC promoter required only a functional TATA box for 
expression was supported by results obtained by Johnson and Everett (1986a, b). 
Deletion of the upstream sequences of the true late US 11 promoter illustrated that a 
functional TATA box was sufficient for viral mediated-transactivation in a transient 
expression assay. This promoter required the replication of template DNA for 
expression. In addition, the deletion of sequences upstream of the gD TATA box and 
linkage of the promoter to a viral origin of replication allowed for the expression of gD at 
late times in infection (Johnson and Everett, 1986).
Figure 1B.2 is a diagrammatical representation of the promoter requirements of 
the three classes of HSV-1 genes. This demonstrates that, as viral infection proceeds, 
each class of viral promoter exhibits a lower complexity of upstream signals required for 
activation of expression. It seems that early genes require the interaction of certain 
cellular factors with upstream sequences to boost expression early in infection, whilst 
late classes of genes are capable of expression from a TATA box alone. The dilution of 
cellular factors during viral infection mediated by the shut-off of host cell protein 
synthesis could result in the shut-off of early gene expression.
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Figure 1B.2. The Essential Regions of the Three Classes of HSV-1 Gene 
Promoters.
The diagram shows representations o f the three classes o f HSV-1 gene 
promoters. All classes of promoters contain a TATA box and RNA CAP site. IE and E 
promoters in addition contain upstream regulatory regions, which bind a variety of 
cellular factors. In addition, IE genes also contain an upstream TAATGARAT regulatory 
region required for activation by the viral protein Vmw65. Late genes, in contrast, 
require only linkage to a functional origin of replication.
This theory implies that the TATA boxes incorporated within late gene promoters 
are stronger initiators of transcription, and is supported by several observations. Firstly, 
that the isolated tk TATA box is insufficient to direct transcription (Homa et al., 1986; 
1991), whilst the addition of the tk upstream elements to the gC TATA box resulted in 
the expression of gC early in infection (Homa et al., 1988; 1991). In addition, gel shift 
experiments have illustrated that the gC TATA box has a stronger affinity for the TATA 
binding protein than the tk TATA box (Imbalzano and DeLuca, 1992).
However, this simplistic model of the sequence requirements within late gene 
promoters cannot explain the observations made during the mutational analysis of the 
US 11 promoter sequences. This study illustrated that expression of the US 11 gene late 
in infection required the incorporation of US 11 capAeader sequences (Kibler et al., 
1991). These observations are supported by other reports that non-coding 5' leader 
sequences increase the expression of certain late genes (Blair et al., 1987; Flanagan et 
al., 1991; Weir and Narayanan, 1990; Pederson et al., 1992). These leader sequences 
may act through the stabilization of mRNA molecules, or through the binding of cellular 
or viral factors which activate initiation at the TATA box. Interestingly, Romanelli et al. 
(1992) have shown that incorporation of y42 leader sequences into the tk promoter of 
HSV-1 increases the expression of the tk gene; whilst the same group has shown that 
these leader sequences contain a binding site for Vmwl75 (Mavromara-Nazos et al., 
1987; Michael et al., 1988). Mutation of the Vmwl75 binding sites within the 
recombinant virus results in a loss of activation of the gene. This is the only reported 
example of the direct involvement of a Vmwl75 binding site in the transactivation of a 
viral promoter (Romanelli et al., 1992). The requirement of additional capAeader
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sequences for efficient expression may be an indication of the relative efficiency of the 
TATA box in directing transcription (Kibler et al., 1991).
1B.4.2. A Model for the Role of Viral DNA Replication in Late Gene Expression.
Two hypotheses have been proposed to explain the requirement for viral DNA 
replication in late gene expression (Homa et al., 1991). Both scenarios assume that all 
factors required for late gene transactivation are present in infected cells prior to the 
initiation of viral DNA replication.
The first model suggests that late gene expression is blocked by an inhibitory 
factor, and that the replication of viral DNA removes the inhibitor, allowing expression 
to proceed. This inhibitory block could be the chromatin structure of the viral DNA, or a 
bound cellular or viral protein. The hypothesis that chromatin structure plays a role in 
transactivation by viral gene products could also account for the expression of selected 
cellular genes during viral infection (see Section 1B.5). The cellular factors binding to 
the upstream elements of early genes could render the genes insensitive to this inhibition 
of transcription. Interestingly, Sp-1 has been shown to interfere with the chromatin- 
mediated repression of cellular transcription (Croston etal., 1991).
Alternatively, activation of late genes may require the organization of the DNA 
into specific nuclear compartments. Knipe and co-workers have demonstrated that during 
viral DNA replication, certain viral proteins are co-localized with DNA into globular 
compartments termed replicative compartments (Knipe et al., 1987; de Bruyn Kops and 
Knipe, 1988; Bush et al., 1991). This localization may facilitate the expression of late 
genes.
IB.5. The Activation of Cellular Promoters by HSV-1 Products.
Latchman and colleagues have demonstrated that a subset of cellular genes are 
activated during HS V infection, and that expression of some of these genes requires the 
presence of functional Vmwl75 (Patel et al., 1986; Kemp and Latchman, 1988). The 
incorporation of viral promoters into the cellular genome has illustrated that they too can 
be activated by superinfection with HSV (Sandri-Goldin et al., 1983; Dennis and 
Smiley, 1984; Silver and Roizman, 1985). This observation led to the suggestion that 
promoters within the cellular genome which are activated by HSV products share specific 
ds-regulatory sequences with viral promoters. However, it was found that the p-globin 
gene, which is not expressed during normal viral infection, was expressed by HSV 
products when it was introduced by transfection or incorporated into the genome of
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transformed cells (Everett, 1985). The conclusions that can be drawn from such an 
experiment are limited by the possible incorporation of multiple promoter sequences into 
the cellular genome, and by the rather artificial conditions of transient expression assays, 
in which high numbers of promoter sequences are exposed to viral regulatory proteins 
for longer periods of time than the usual length of a viral replicative cycle. In order to 
reduce such experimental artifacts, the regulation of cellular promoters was tested within 
the environment of the viral genome.
Smiley et al. (1987) introduced the p-globin gene under the control of its own 
promoter or the early gD promoter into the tk locus of HSV-1. p-globin was expressed 
from both constructs with early kinetics, and required Vmwl75 for expression. The 
transfer of the reporter construct to the gC locus had no effect on the kinetics of 
expression. These results support other conclusions that the expression of promoters by 
Vmwl75 requires no additional ris-acting sequences other than those previously used by 
the cellular transcription machinery (see Section 1B.3).
In contrast, the transfer of the adenine phosphoribosyl transferase (aprt) gene into 
the viral genome results in the loss of transcription (Tackney et al., 1984). This gene 
does not contain functional TATA box sequences. The analysis of viral early and late 
promoters has suggested that viral transactivation is mediated through the TATA box, 
and it seems likely that Vmwl75 acts to increase transcription through an interaction with 
proteins that bind to the TATA box (see discussion in Section 1D.4). This would account 
for the inability of HSV transactivators to direct the expression of the aprt gene.
Further analysis has indicated that the a-globin gene which is normally expressed 
constitutively during transient expression assays in the absence of viral proteins is 
expressed with early kinetics when introduced into the viral genome (Smiley et al., 
1991). It is possible that the HSV genome exerts an inhibitory effect on the expression of 
viral genes, which is overcome by the action of viral or cellular transactivating proteins, 
or by DNA replication. Such a mechanism would account for the limited viral gene 
expression in the absence of IE gene products.
In conclusion, studies on the activation of cellular promoters by HSV products 
support the hypothesis that viral-mediated transactivation does not require the presence of 
specific as-acting sequences within the viral promoter. Viral transactivators therefore act 
through sequences previously required for the cellular transcription machinery, probably 
by the modification of or interaction with pre-existing factors. As the major HSV 
transactivating protein is Vmwl75, it is probable that the activation of cellular promoters 
within the viral genome is mediated through Vmwl75. The absolute requirement of a 
functional TATA box demonstrated by the results of Tackney et a l  (1984) supports the 
hypothesis that Vmwl75 mediates viral gene activation through an interaction with the 
cellular TFIID transcription factor. This proposed mechanism for Vmwl75 
transactivation is described in fuller detail in Section 1D.4.
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IB.6. Repression of Immediate-Early Gene Expression.
1B.6.1. Early Observations of Herpes Simplex Virus Immediate-Early Gene Expression.
Initial studies of protein synthesis during HSV-1 infection defined the immediate- 
early genes as those which were expressed during HSV-1 infection in the absence of de 
novo protein synthesis. These studies showed that IE protein synthesis began at lh post 
infection, and suggested that synthesis was shut-off at 3-4h post infection (Honess and 
Roizman, 1974,1975)
However, later studies questioned some of the conclusions made during these 
initial analyses. A detailed analysis of mRNA accumulation during HSV-1 lytic infection 
showed that the mRNA for the IE1 and IE3 genes could be detected at late times in 
infection. This analysis also illustrated that in the absence of protein synthesis, IE1 and 
IE3 mRNA accumulated to high levels, suggesting that some virally-encoded protein 
controlled the reduction of RNA transcription for these two genes at least (Harris- 
Hamilton and Bachenheimer, 1985).
Weinheimer and McKnight (1987) studied the rate of RNA transcription and 
mRNA accumulation for three IE genes. This study found that although IE1 and IE3 
mRNA accumulated with similar kinetics, increasing from l-6h post infection, the rate of 
transcription of only the IE3 gene was reduced after lh post infection. In addition, the 
accumulation of the RNA from the IE4/5 promoter followed a similar pattern to the 
accumulation of early transcripts. During the inhibition of protein synthesis, whilst IE1 
and IE3 mRNA accumulated, no accumulation of IE4/5 RNA was observed. These 
observations led the authors to suggest that HSV-1 IE expression can be regulated 
independently of transcriptional control.
1B.6.2. Transient Transfection Assays of Immediate-Early Gene Expression.
Several groups have demonstrated the transcriptional repression of certain IE 
promoters during transient expression assays (OHare and Hayward, 1985a, b, 1987; 
Gelman and Silverstein, 1985, 1986, 1987a, b; Resnick et al.y 1989; Everett, 1986; 
Everett and Orr, 1991). The repression of the promoters appears to be dependent on the 
relative ratio of Vmwl75, VmwllO and Vmw65 in the transfected cell (O'Hare and 
Hayward, 1985a, b, 1987; Gelman and Silverstein, 1986, 1987a, b). The repression of 
the promoters by Vmwl75 alone differed - whilst the IE1 and IE3 promoters were 
strongly repressed, the IE2 promoter was weakly repressed and the IE4/5 promoter was 
not repressed at all (Gelman and Silverstein, 1987a, b). The interpretation of these 
assays was complicated by the widely varying results produced by duplicate assays
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carried out in differing cell lines. This again demonstrates the problems of short-term 
transfection assays, as illustrated by Everett (1988b).
It was found that the ability of Vmwl75 to bind to IE promoter sequences 
mirrored its ability to repress transcription from the promoter. The IE3 promoter was 
shown to contain a strong Vmwl75 binding site at its capsite which exhibited homology 
to the consensus sequence published by Faber and Wilcox (1986). This consensus 
sequence was also contained in a site within the upstream regulatory sequences of the 
EE1 promoter. The association of Vmwl75 with the IE2 and IE4/5 promoters, in 
contrast, was found to be weak (Faber and Wilcox, 1988; Kristie and Roizman, 1986a, 
b). Whilst it has been proposed that Vmwl75 represses IE3 transcription by associating 
strongly with a site downstream to the TATA box, thus hindering the movement of RNA 
polymerase (Muller, 1987; Roberts et al., 1988; Faber and Wilcox, 1988), the position 
of the Vmwl75 binding site upstream from the IE1 TATA box suggests that the IE1 
promoter cannot be repressed by a similar mechanism. Faber and Wilcox (1988) 
observed that the Vmwl75 binding site within the IE1 promoter overlapped with the 
binding sites for the cellular transcription factors Sp-1 and CBP, and suggested that the 
binding of Vmwl75 resulted in the dissociation of the cellular proteins, thus reducing 
transcription from the promoter. Alternatively, DiDonato and Muller (1989) reported that 
the Vmwl75 binding sites within the IE1 and IE3 promoters are equidistant from the 
TATA box, and presented data to show that binding of Vmwl75 to either site resulted in 
a conformational change at the TATA box. This may then promote the disassociation of 
preformed transcription complexes, or prevent transcription complexes from assembling 
on the promoter.
Transient transfection assays have demonstrated that mutation or deletion of the 
Vmwl75 binding sites within the IE1 and IE3 promoters abolishes the binding of 
Vmwl75 to DNA and also abolishes the repression of transcription in vitro (Roberts et 
al., 1988; Resnick et al., 1989). In addition, with only one exception (Paterson et al., 
1989), mutations which result in a reduction or loss of the DNA binding activity of 
Vmwl75 also result in the loss of autoregulatory activity. These results point to a strong 
correlation between the binding of Vmwl75 to the IE1 and IE3 promoters and the 
repression of transcription.
1B.6.3. Analysis of Immediate-Early Gene Expression Through the Construction of 
Mutant Viral Strains.
Although transient transfection assays have illustrated the importance of the 
Vmwl75 DNA binding activity in its transcriptional repression of two IE promoters, it is 
important to study the importance of the DNA binding activity of the protein during a 
normal course of infection. To this end, mutations have been introduced into the
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Vmwl75 binding site upstream of the IE1 TATA box within HSV-1 (Everett and Orr,
1991). The mutations introduced were shown to abolish binding of Vmwl75 and 
repression of transcription during a transient expression assay. However, introduction of 
the mutations into the virus resulted in no detectable change in the accumulation of 
VmwllO. Whilst the effect of the mutations on the transcription of IE1 RNA was not 
demonstrated, the authors argued that the observed accumulation of VmwllO was 
indicative of the expression of the IE 1 gene, and that repression of IE1 transcription was 
of little importance during a productive viral infection. Although no mutational analysis 
of the binding site at the IE3 capsite within HSV-1 has been published, DeLuca and 
Schaffer (1988) implied that mutations within this site which interfere with repression 
during transient assays also reduced IE3 repression during a viral infection.
1B.6.4. Conclusions Regarding the Expression of Immediate-Early Genes.
Whilst initial studies of HSV-1 gene expression suggested that immediate-early 
gene expression as a whole is repressed during viral infection, it now appears that the 
transcriptional control of this subset of genes is rather more complex. Studies of RNA 
transcription and accumulation of transcripts have illustrated that the kinetics of 
expression of the various IE genes varies during infection, as discussed in Section
IB.6.1.
Studies of the levels of IE proteins during HSV-1 infection in cell culture have 
illustrated that both VmwllO and Vmwl75 are present in high quantities at late times 
during infection (Metzler and Wilcox, 1985; Everett and Orr, 1991). Metzler and Wilcox 
(1985) suggested that this represented the high stability of the Vmwl75 protein. Whether 
this is true for the VmwllO protein also is unknown. It is interesting to note that IE1 
transcription rate and mRNA accumulation have been shown to be higher later during 
infection than that of the IE3 gene (Harris-Hamilton and Bachenheimer, 1985; 
Weinheimer and Mcknight, 1987). In fact, taken as a whole, all experimental evidence 
suggests that the IE3 gene is the only gene from which transcription is repressed by 
Vmwl75 during viral infection.
Vmwl75 is the most potent transactivating protein of HSV-1, as demonstrated by 
the inability of Vmwl75 deletion mutant viruses to transactivate early and late genes 
(DeLuca and Schaffer, 1988). Therefore, overexpression of this protein would lead to 
abnormalities in both viral and possibly cellular gene expression. Avoidance of such a 
situation would require the fine control of Vmwl75 expression, which appears to be 
mediated in part by the autoregulatory properties of the protein.
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IB.7. IE Products of HSV-1 Involved in the Transcriptional Regulation 
of HSV Early and Late Genes.
HSV-1 encodes five immediate-early proteins. Table 1B.1 summarizes the 
immediate-early genes, and the terms used to identify their protein products.
Glasgow nomemclature Chicago nomenclature
Gene * Gene § Product Gene Product
IE-1 IE110 VmwllO a0 ICPO
IE-2 UL54 Vmw63 a l l ICP27
IE-3 IE175 Vmwl75 a4 ICP4
IE-4 US1 Vmw68 a l l ICP22
IE-5 US12 Vmwl 2 a47 ICP47
UL39 R1 ICP6
* Original nomenclature (Clements et al., 1979).
§ Later designation (McGeoch et al., 1988a)
Table IB.L The IE Products of HSV-1.
As described in previous sections, biochemical analyses have illustrated the 
importance of three immediate-early proteins in the transcriptional regulation of HSV-1 
genes, these are the Vmwl75, VmwllO and Vmw63 proteins. These proteins are dealt 
with in greater detail in later sections. The role of the other two IE proteins in HSV gene 
regulation is less clear. Viruses with deletions in the genes encoding Vmwl2 and 
Vmw68 have been isolated and shown to be viable in tissue culture (Longnecker and 
Roizman, 1986; Post and Roizman, 1981). Although a virus containing a deletion within 
the carboxy-region of Vmw68 was shown to produce lower amounts of some late genes 
(Sears et al., 1985), the role of this protein in the control of late gene expression has not 
been elucidated.
1B.7.1. The IE Protein VmwllO.
The properties of VmwllO observed in transient transfection assays have been 
described in detail in Sections 1B.3 and 1B.4. The conclusions from these experiments 
are that Vmwl 10 in isolation can transactivate a variety of HSV-1 immediate-early, early 
and late gene promoters, and that it can also act synergistically with Vmwl75.
The Vmwl 10 protein is a phosphorylated molecule which is located at specific 
sites within the nucleus both upon transfection and during viral infection (Everett, 1987a;
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1988b, 1989; personal communication; Knipe and Smith, 1986). Cotransfection of the 
Vmwl75 protein appears to result in the diffuse distribution of the Vmwl 10 throughout 
the nucleus (Gelman and Silverstein, 1986). Sequence analysis of the coding region of 
the IE 1 gene has identified a cysteine-rich sequence between residues 99-156 (Perry et 
al., 1986). This motif has been identified as a novel motif conserved within several 
eukaryotic proteins. The motif resembles the well-studied zinc finger motif, in that it 
contains a regular spacing of cysteine and histidine residues (Freemont et al., 1991) and 
an isolated polypeptide encompassing the motif within VmwllO does bind zinc, 
although the exact stoichiometry of this binding has not been elucidated (Everett, 
personal communication). Although the protein has been shown to interact non- 
specifically with DNA (Hay and Hay, 1980), no direct evidence has been shown that the 
cysteine-rich motif is involved in the interaction with DNA. In fact, the isolated zinc 
finger region of Vmwl 10 when expressed as a polypeptide in bacteria exhibits no DNA 
binding properties and none of the related proteins exhibit any sequence-specific DNA- 
binding activity (Freemont et al., 1991; Everett et al.y 1991c).
The regions involved in the transactivatory properties of VmwllO have been 
examined by a variety of mutational analyses (reviewed in Everett et al., 199Id). Everett 
(1987b) found that mutations within five regions of the protein reduced its 
transactivatory ability in in vitro assays. Two of these regions were relatively large tracts 
within the molecule, region 5 located towards the carboxy terminal region of Vmwl 10, 
and region 1 located between amino acids 150-222, which incorporates the C-terminal 
portion of the cysteine-rich motif. Further analysis suggested that region 5 plays some 
role in mediating the interaction between VmwllO and Vmwl75. Several viruses 
containing insertional and deletion mutations within the IE 1 open reading frame have also 
been constructed and characterized (Everett, 1989; Chen and Silverstein, 1992). The 
results mirrored those obtained in the transfection assays described above. One important 
point found during these mutational analyses was that mutations within the cysteine-rich 
domain of VmwllO result in a differing ability to support viral growth in different cell 
lines. It is possible that this region of the protein mediates an interaction with cellular 
factors which are present in varying amounts in different cell types.
This hypothesis is also supported by the data of Weber and Wighdahl (1992), 
who found that truncated Vmwl 10 polypeptides encompassing the N-terminal portion of 
the protein act as dominant transcriptional repressors which interfere with the 
transactivatory properties of both VmwllO and Vmwl75 (Weber and Wighdahl, 1992). 
It is possible that the N-terminal domain interacts with a cellular factor essential for the 
transactivation activity of Vmwl 10, and the above data implies that both Vmwl 10 and 
Vmwl75 interact with this cellular factor. It would be interesting to determine whether 
the cysteine-rich domain of Vmwl 10 is essential for this trans-dominant inhibitory 
effect. Cai and Scaffer (1989) have also suggested that a functional site of VmwllO
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maps within its N-terminal domain, and have shown that a polypeptide consisting of the 
N-terminal 427 amino acids of Vmwl 10 is sufficient to transactivate a variety of viral 
promoters in a transient transfection assays.
The analysis of HSV-1 viruses containing non-fimctional VmwllO molecules or
deletions within the IE1 reading frame has assisted in the elucidation of the probable role
V \
of Vmwl 10 within the lytic cycle of the virus (Stow and Stow, 1986; Sacks and Scaffer, 
1987; Everett, 1988a; Chen and Silverstein, 1992). The viruses exhibited no impairment 
in the production of viral particles, but differed in their growth efficiency as measured by 
one step growth curves. The analysis of infection in a range of cell lines also illustrated a 
difference in viral growth efficiency at low m.o.i., with different cell types exhibiting a 
variety in permissiveness. At low multiplicities of infection, all viruses exhibited an 
impairment in growth efficiency and infectious viral yield.
It appears that functional Vmwl 10, whilst not essential for viral growth in tissue 
culture, plays a role in the general transactivation of viral genes. A defect in this protein 
results in the impairment of viral replication and delay in early and late gene expression. 
These effects are most distinct during infections involving a low number of viral 
particles. The phenotype of Vmwl 10 negative viruses may be explained by an inability 
to efficiently transactivate the IE3 gene. At low multiplicities of infection, the reduced 
expression of Vmwl75 may present a block to subsequent viral gene expression. 
Infection with a high number of viral particles providing more templates for IE3 
expression may provide sufficient Vmwl75 to trigger transactivation of viral early genes 
and enable the virus to enter the lytic cycle of infection.
The mechanism of the interaction (if any) between Vmwl75 and VmwllO is not 
clearly understood. Everett (1987b) suggested that the two proteins may not utilize 
similar mechanisms to transactivate viral promoters. For example, whilst Vmwl75 may 
fumction through the direct enhancement of transcription, VmwllO may act to increase 
the stability of viral transcripts. This proposal seems more valid in the light of the 
discovery of a family of proteins containing the distinctive cysteine-rich motif which is 
present within VmwllO (Freemont et al., 1991). No member of this family has been 
shown to direct enhancement of gene transcription. This mechanism may also account 
for the apparent requirement for a specific nuclear distribution of Vmwl 10 during viral 
infection (R. D. Everett, personal communication), and for the requirement of a 
functional Vmwl75 molecule for VmwllO activity during both transient expression 
assays (Gelman and Silverstein, 1986) and viral infection (DeLuca et al.t 1985; DeLuca 
and Schaffer, 1988; Shepard and DeLuca, 1989; this thesis).
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1B.7.2. The IE Protein Vmw63.
The first evidence for a role for the viral IE product Vmw63 in the regulation of 
HSV-1 gene expression came from the study of temperature-sensitive viruses containing 
mutations within the IE2 gene. These viruses are non-viable in tissue culture at the non- 
permissive temperature and exhibit an over-expression of early gene products and no 
detectable late gene expression under restrictive conditions (Sacks et al., 1985). Analysis 
of Vmw63 deletion mutant viruses also suggested that the protein was essential for late 
gene expression and possibly also involved in the down-regulation of early genes 
(McCarthy et al., 1989).
Transient expression assays were then used to define more clearly the role of 
Vmw63 in the transactivation of late genes. Vmw63 in isolation had no effect upon gene 
expression. However, in conjunction with Vmwl75 and VmwllO, Vmw63 either 
increased transactivation (with the yi gB and VP5 promoters), repressed transactivation 
(with the (5 tk promoter), or had no effect (with the Y2 gC promoter) (Everett, 1986; 
Sekulovich et al., 1988; Shapira et al., 1987; Rice and Knipe, 1988). The variable 
results in transient expression assays made it difficult to assign a specific transactivatory 
property to Vmw63. The observation of Everett (1988b) that differences in cell type and 
transfection protocol leads to a wide variance in the results of transient expression assays 
illustrates the limitations of the short term transfection assay in determining the in vivo 
transactivatory property of a viral protein.
In addition, transient transfection assays illustrated that Vmw63 may play a dual 
role in HSV-1 gene regulation, and may act post-transcriptionally to control mRNA 31 
polyadenylation and reduce the expression of spliced genes (Rice and Knipe, 1990; 
Sandri-Goldin and Mendoza, 1992; Chapman et al., 1992). McLauchlan et al. (1989) 
illustrated that HSV-1 encodes a factor, termed LPF, which selectively increases the 3' 
processing at the poly(A) signal of the UL38 transcript (a true late transcript). This factor 
does not affect the processing of additional immediate early transcripts. McLauchlan et 
al. (1992) illustrated that this process is independent of the late gene promoter and is 
mediated by an IE product. The analysis of mutant viral extracts and further transient 
expression assays indicated that Vmw63 was essential for this processing of late poly(A) 
signals,
Although it is now becoming apparent that Vmw63 may mediate its affect on viral 
gene expression through a post-transcriptional mechanism, it is still not clear how the 
protein utilizes this mechanism in the activation and repression of early and late genes.
40
Marsden et a l (1976).
Chapter 1. Introduction.
1B.7.3. The IE Protein Vmwl75.
The early isolation of temperature-sensitive mutations in the gene encoding the 
viral protein Vmwl75 enabled the elucidation of its role in viral gene expression. 
Vmwl75 is a potent transactivator, and is essential for the viral replicative cycle. Loss of 
a functional Vmwl75 molecule results in the lack of early and late gene expression, 
together with the over-expression of some immediate-early genes (Preston, 1979a; Dixon 
and Schaffer, 1980; Watson and Clements, 1980).
A great deal of evidence has been compiled concerning the in vitro and in vivo 
properties of Vmwl75; this data may be of use in the determination of the mechanism by 
which the protein mediates viral gene activation and repression. The properties of the 
protein and their possible role in the mechanism of transactivation by Vmwl75 are 
described in detail in Section 1C.
1C. A Detailed Analysis of the IE Protein Vmwl75.
1C.1. Structural Properties of the Vm wl75 Protein.
The immediate-early polypeptide Vmwl75 is encoded by the IE-3 gene, an 
unspliced open reading frame situated within the short repeat region of the HSV-1 
genome. This gene has an unusually high G+C content (81.5%), and the Vmwl75 
protein contains high amounts of the four amino acids lysine, arginine, isoleucine and 
methionine. The predicted molecular weight of the protein from amino acid composition 
is 132,835Da. However, the observed molecular weight of the protein upon SDS- 
polyacrylamide gel electrophoresis is nearer 175,000Da (McGeoch et al., 1986).
The difference in the observed and predicted molecular weights of the protein 
suggests that Vmwl75 is post-translationally modified. In fact, it has been shown that 
Vmwl75 is a nuclear-localized phosphoprotein (Pereira et al., 1977; Metzler and Wilcox, 
1985). Phosphorylation occurs at serine/threonine residues within the protein (Metzler 
and Wilcox, 1985), involving residues both within the serine-rich tract situted between 
amino acids 170-250 and also at sites carboxy-terminal to amino acid 309 (DeLuca and 
Schaffer, 1988). Analysis of [32P] radiolabelled polypeptides synthesized during the 
HSV-1 replicative cycle illustrated that Vmwl75 exists as three phosphorylated forms 
which exhibit different mobilities upon gel electrophoresis. The phosphate group cycles
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on and off two of these forms during a lytic infection, whereas the third form is stably 
phosphorylated (Wilcox et al., 1980).
Further studies have illustrated that the phosphorylation state of Vmwl75 affects 
its ability to bind to different gene leader sequences (Papavassiliou et al.y 1991). 
Dephosphorylation of the protein reduces its ability to bind to lower affinity, non­
consensus binding sites. Phosphorylation was found to be required for the binding of the 
protein to sites within the leader sequences of early (tk) and true late (UL38) promoters, 
whilst the dephosphorylated protein could bind to the IE-3 gene cap site.
Vmwl75 is also post-translationally poly(ADP ribosyl)ated during infection 
(Preston and Notarianni, 1983; Blaho et al., 1992). However, the importance of 
poly(ADP ribosyl)ation to the transactivation and DNA binding functions of Vmwl75 is 
unclear.
Vmwl75 is located within the nucleus during infection, possibly through a 
proposed nuclear localisation signal situated between amino acids 727-730 (DeLuca and 
Schaffer, 1987; Paterson, 1989). Studies of the nuclear localisation of several 
temperature sensitive Vmwl75 mutants illustrated that certain mutations interfere with the 
nuclear localization of the protein. These mutant forms of Vmwl75 also interfere with 
the nuclear localization of VmwllO, suggesting that the two proteins utilize the same 
nuclear localization pathway (Knipe and Smith, 1986). Varying results have been 
obtained with the tsK mutant form of Vmwl75 (described in further detail in Section
1C.3). Whilst one group reported wild type nuclear distribution of this mutant protein 
(Knipe and Smith, 1986; Knipe et al., 1987), Preston (1979b) reported that the protein 
did not associate with the nuclear fraction of infected cells. These observed differences 
could be due to differences in cell type or multiplicity of infection used in the 
experiments.
Knipe et al (1987) also demonstrated that Vmwl75 co-localized with ICP8 in 
specific globular compartments within the nucleus late in infection. These compartments, 
termed replicative compartments, are the site of viral DNA replication. The authors 
suggested that these compartments are also the site of late gene transcription, and that 
Vmwl75 is required to associate into these complexes in order to transactivate late viral 
genes. Several temperature sensitive mutants of Vmwl75 have been isolated which 
transactivate early but not late genes at the non-permissive temperature (DeLuca et al., 
1984; Paterson et a l , 1990). It would be of interest to determine whether these mutations 
interfere with the association of Vmwl75 into these replication compartments.
The sequence analysis of other a-herpesvirus regulatory proteins which are 
analogous to Vmwl75 has illustrated that this family of proteins shares a specific pattern 
of sequence conservation. All the proteins can be divided into five regions, based upon 
their amino acid homology (McGeoch et al., 1986; Davison and McGeoch, 1986; 
Grundy et al.t 1989; Cheung, 1989; Anderson et al., 1992; see Figure 1C.1). The
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regions 2 and 4 exhibit greatest amino acid conservation, and mutational analysis of 
Vmwl75 has illustrated that these regions are important for the in vitro and in vivo 
properties of the protein (see Section 1C.3).
(a) HSV-1 genome:
(b) Vmwl75:
1 2 3 4  5
i i i-------------------------1-----------------------------------1----------------1
1 314 490 796 1224 1298aa
1 I low homology HH 30-50% H  over 80%
homology homology
Figure 1C.1. Conserved Regions of Vmwl75.
(a). A diagramatical representation of the HSV-1 genome, indicating the position 
of the gene IE-3, encoding Vmwl75.
(b). The protein Vmwl75. divided into five sections based upon its homology 
with the VZV regulatory protein 140K (McGeoch et al., 1986). The lower numbers 
indicate codon number within the IE-3 ORF. Analysis o f the regulatory proteins of other
a-herpesviruses indicates that they too share the conserved regions indicated (see text for 
details).
The ability of the HSV-2 and VZVTegulatory proteins to substitute for Vmwl75 
in the replicative cycle of HSV-1 has been investigated. Whilst the HSV-2 equivalent of 
Vmwl75 is functionally interchangeable with Vmwl75 (Smith and Schaffer, 1987), the 
VZV regulatory protein (140K) exhibited some slight defects in its ability to replace 
Vmwl75 during the viral life cycle. A HSV-1 virus with both copies of the IE-3 reading 
frame replaced by the 140K reading frame was able to propagate but unable to form 
plaques in tissue culture in the absence of complementing Vmwl75. In addition, this 
virus exhibited low expression of certain late genes, and was unable to efficiently 
transactivate early and late genes at low multiplicities of infection (Disney and Everett, 
1990a).
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1C.2. The Early Genetic Characterization of Vmwl75.
The investigation of the role of Vmwl75 in the lytic cycle of HSV-1 has been 
enhanced by the isolation of a number of temperature-sensitive viruses containing lesions 
in the gene encoding this protein. The majority of these viruses showed a lack of early 
and late gene expression and an over-production of immediate-early products at the non- 
permissive temperature (Marsden et al., 1976; Courtney et al., 1976; Watson and 
Clements, 1978; 1980;; Preston, 1979a; Dixon and Schaffer, 1980). These observations 
illustrated the importance of Vmwl75 in early and late gene expression, and suggested 
that it may also play a role in the repression of immediate-early genes, a phenomenom 
described in greater detail in Section IB.6 . Temperature shift experiments illustrated that 
Vmwl75 is synthesized but is non-functional at the non-permissive temperature 
(Preston, 1979a). In addition, temperature upshift experiments have illustrated that 
functional Vmwl75 is required throughout the course of infection for the efficient 
expression of the full range of viral genes (Watson and Clements, 1980; Dixon and 
Scaffer, 1980). This observation is supported by the data of Metzler and Wilcox (1985) 
who illustrated the presence of stable Vmwl75 protein in infected cells at late times 
during infection, after Vmwl75 synthesis has decreased.
Certain of the mutations contained in these temperature sensitive viruses have 
been mapped to precise positions within the IE-3 open reading frame. One such mutant, 
tsK, which synthesizes solely immediate-early transcripts at the non-permissive 
temperature, has been mapped to within region 2 of the protein (Davison et al., 1984). 
Additional mutations which do not exhibit such tight restrictions on gene expression have 
been mapped to positions towards the carboxy-terminus of the protein (Paterson et al., 
1990).
The construction of cell lines transformed with fragments of DNA containing 
HSV-1 promoter sequences has allowed for the further analysis of details of early and 
late promoter activation. Infection of such cell lines with the temperature sensitive viruses 
described above illustrated the requirement for Vmwl75 in the transactivation of such 
promoters (Dennis and Smiley, 1984; Silver and Roizman, 1985).
The construction of cell lines stably expressing Vmwl75 from the cellular 
genome demonstrated that Vmwl75 was solely required for the activation of early genes 
in the context of the viral genome (Persson et al., 1985). However, such cell lines could 
not facilitate the activation of late viral genes in the absence of additional protein 
synthesis, suggesting that some other factor was required for late gene activation. These 
cell lines have enabled the construction of mutant viruses containing engineered lesions 
and point mutations within the IE-3 open reading frame for further mutational analyses of 
Vmwl75 (see Section 1C.3).
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As described in Section 1C.2, the isolation of a number of temperature-sensitive 
mutant forms of Vmwl75 have facilitated the study of the function of Vmwl75 during 
the viral life cycle. From the study of a number of temperature-sensitive lesions within 
Vmwl75, it appeared that the more amino-terminal lesions exhibited a tighter phenotype, 
in that such lesions abolished the transactivation of all early and late viral genes. This 
type of temperature sensitive lesion of Vmwl75 is represented by the widely studied 
mutation tsK (Preston, 1979a, b; Watson and Clements, 1978; 1980; Preston, 1981; 
Davison et al., 1984). This mutation is situated within a highly conserved portion of 
region 2  of the protein, and the importance of this region of the protein to its in vitro and 
in vivo functions has been highlighted by a number of mutational studies outlined below.
Another class of temperature sensitive mutations within region 4 of Vmwl75, 
which do not display such a tight restriction of viral gene expression have been 
described. DeLuca et al. (1984) studied two temperature-sensitive mutant viruses, fs48 
and ts303 which contain lesions mapping within region 4 of Vmwl75. These viruses 
overexpress immediate-early products and also produce certain early products at the non- 
permissive temperature. Although these viruses express early gene products at the non- 
permissive temperature, they replicate to 15-50% of wild type viral DNA levels. 
Transient transfection assays illustrated that these mutant proteins have a slight activatory 
effect on certain IE promoters, which may account for the observed over-production of 
immediate-early proteins (DeLuca and Schaffer, 1985).
Paterson et al. (1990) isolated and characterised five temperature sensitive viruses 
containing lesions within a similar region of Vmwl75. Three of the temperature sensitive 
mutations, ts 1219, ts 1221 and to 1225, were mapped to conserved amino acids within 
region 4 of the protein, whilst the other two mutations, ttl211 and rsl223, were mapped 
to a domain further towards the carboxy-terminus of the protein, within the same region 
as the mutations tt48 and ts303. These viruses also overexpressed immediate-early 
products and expressed certain early proteins at the non-permissive temperature. Again, 
the phenotypes of these five mutant viruses suggest that the conserved region 4 of 
Vmwl75 plays a role in the activation of late viral genes. These results are supported by 
the data of DeLuca and Schaffer (1988) described below.
No evidence has been obtained to explain why such mutants were defective for 
expression of the late class of viral genes. DeLuca et al. (1984) suggested that the defect 
in late gene activation may have been due to a lack of interaction between mutant 
Vmwl75 and other regulatory proteins, or differences in phosphorylation of the mutant 
proteins. It would be interesting to study the intranuclear localization of these proteins, as 
other mutant Vmwl75 molecules with lesions in the carboxy-terminal region of the
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protein which exhibit similar activation properties fail to associate with the replicative 
compartments suggested to be sites of late gene activation (Knipe et al., 1987; DeLuca 
and Schaffer, 1988).
Several workers have constructed and characterised insertional and deletion 
mutations within Vmwl75, in order to attempt to define regions of the protein essential 
for its autoregulation, transactivation and DNA binding properties. (DeLuca and 
Schaffer, 1987, 1988; Paterson and Everett, 1988a, b; Shepard et al., 1989). The 
construction of cell lines expressing Vmwl75 from the cellular genome has enabled the 
introduction of such mutations into the IE-3 reading frame within HSV-1 (DeLuca et al.y 
1985; DeLuca and Schaffer, 1988; Shepard et al., 1989; Imbalzano et al., 1990; Paterson 
et al., 1990; Shepard and DeLuca, 1991a, b).
DeLuca and Schaffer (1987,1988) created a series of nonsense mutations within 
Vmwl75. In transient transfection assays, it was found that the N-terminal 60% of 
Vmwl75 was sufficient for the transactivation of the early tk promoter and the 
autoregulation of the IE-3 promoter. However, this polypeptide was unable to 
complement a mutant virus containing a large deletion within the IE-3 open reading 
frame. A polypeptide lacking the N-terminal 90 amino acids of Vmwl75 (the n6 
polypeptide) exhibited wild type transactivation, autoregulation and complementation 
properties, illustrating that this region of the protein is inessential for its properties both 
in vitro and in vivo.
The same nonsense and additional deletion mutations were also analysed in the 
context of the viral genome. It was found that all the mutant Vmwl75 molecules 
analysed, with the exception of the n6 polypeptide, were unable to support the growth of 
HSV-1 in tissue culture. From the analysis of the polypeptide profiles of cells infected 
with the mutant viruses, the Vmwl75 proteins were separated into three classes. Class I, 
which consisted of the n6 polypeptide alone, exhibited wild type expression of early and 
late viral polypeptides. Class II comprised the deletion mutant and nonsense mutant 
polypeptides which lacked residues within the first 60% of Vmwl75. These viruses 
exhibited very low levels of early and late gene expression, and overexpressed the 
immediate early genes. Interestingly, this class of mutants also expressed the ICP6  
polypeptide, the product of a supposedly early gene. Deletion mutant Vmwl75 viruses 
have also been observed to express this protein in addition to immediate-early products 
(DeLuca et al., 1985; this thesis, Section 3F.1). The final group, Class III, comprised 
truncated polypeptides which contained 60% or more of the amino-terminal portion of 
Vmwl75. These viruses expressed a higher level of early products than Class II viruses. 
However, they expressed no true late products and also exhibited no viral DNA 
synthesis.
These Class HI Vmwl75 molecules exhibit similar phenotypes to the temperature 
sensitive mutant viruses described previously (DeLuca et al.y 1984; Paterson et al.y
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1990). Interestingly, one Class III polypeptide, the «208 polypeptide which consists of 
the N-terminal 774 amino acids of Vmwl75, was not distributed into replicative 
compartments at late times during viral infection. This supports the hypothesis that 
Vmwl75 is required to associate into such complexes in order to express late viral genes 
(Knipe et al., 1987).
Further analysis of deletion polypeptides mapped the nuclear localisation signal 
of Vmwl75 to a region between amino acids 590-773, and DeLuca and Schaffer located 
a potential nuclear localization signal centred around amino acid 728. These results are in 
agreement with those of Paterson (1989) who mapped the nuclear localization signal to a 
region encompassing amino acids 682-774.
The results obtained from this study of nonsense and deletion mutations of 
Vmwl75 are summarized in Figure 1C.2. In conclusion, it was found that the N- 
terminal 774 amino acids of Vmwl75 are sufficient for the DNA binding, autoregulation 
and early gene transactivation properties of Vmwl75, whilst the N-terminal region is 
essential for late gene expression and possibly viral DNA replication, and may determine 
the intranuclear localisation of Vmwl75.
Vmwl75
Nuclear 
localization
Phosphorylation
Inessential
DNA 
binding
Transactivation/ 
Autoregulation
DNA synthesis 
and late gene expression
Figure 1C.2. Functional Domains of Vmwl75 as Proposed by DeLuca 
and Schaffer, 1988.
Boxes indicate the possible functional domains decribed in the conclusions of 
DeLuca and Schaffer, 1988. The top line repressents the Vmwl75 protein, divided into 
five structural domains as described by McGeoch et al., 1986
Following this initial analysis of the functional domains of Vmwl75, two more 
detailed mutational studies of the protein were carried out. Shepard et al. (1989) created a 
series of two amino acid insertional mutations throughout the whole of the «208 
polypeptide. The parent «208 polypeptide consists of the N-terminal 774 amino acids of 
Vmwl75, and is able to transactivate the early tk promoter, autoregulate the IE-3 
promoter and bind to the IE-3 cap site in vitro. However, this polypeptide is defective in 
its ability to support viral growth in tissue culture (DeLuca and Schaffer, 1988). The
m
□
□
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mutant polypeptides were tested for transactivation of the tk promoter, autoregulation of 
the IE-3 promoter, and DNA binding ability in vitro. Initially, the mutants were tested for 
their ability to bind to the consensus Vmwl75 binding site situated at the IE-3 cap site. It 
was found that mutations which affected the DNA binding activity of n20S were situated 
proximal to or within region 2 of the protein. These mutations appeared to result in two 
DNA binding phenotypes. Mutations within the region encompassing amino acids 263- 
338 reduced but did not eliminate DNA binding activity, whereas mutations within the 
region encompassing amino acids 449-487 abolished the DNA binding activity of the 
protein. An insertion mutation at amino acid 386, which is situated between these two 
regions, exhibited wild type DNA binding activity. The mutant polypeptides were then 
tested for their ability to interact with a non-consensus Vmwl75 binding site situated 
within the tk promoter. All mutations which reduced or abolished the binding of 
Vmwl75 to a consensus DNA binding site eliminated the ability of the protein to interact 
with non-consensus DNA binding sites. Interestingly, the region defined by these 
mutations to be essential for the protein-DNA interaction, situated within amino acids 
449-487 shows high conservation in other members of the a-herpesvirus regulatory 
protein family (see Section 3A). This region also contains the site of the tsK mutation 
described above. Therefore, it appears that the integrity of region 2, and particularly this 
carboxy-terminal portion of region 2 is essential for the DNA binding activity of 
Vmwl75.
The mutant polypeptides were then tested in transient transfection assays for their 
ability to transactivate the tk promoter and to autoregulate the IE-3 promoter. The results 
mirrored those obtained in the DNA binding assays; that is, the mutations which affected 
DNA binding also affected the transactivation and autoregulation properties of Vmwl75.
Two insertional mutations were introduced into the viral genome to test whether 
their in vitro properties were an indication of their ability to support viral growth in tissue 
culture. The mutations tested were representative of the two types of mutations which 
exhibited reduced DNA binding properties. Both mutant proteins were unable to induce 
early and late gene expression or to autoregulate the IE-3 gene, and viruses containing 
these mutations were non-viable in tissue culture in the absence of complementing wild 
type Vmwl75.
In addition, a series of deletion mutations were introduced into the n208 
polypeptide to test the functional importance of sequences N-terminal to amino acid 274. 
These deletions removed amino acids 31-210,31-274 and 143-210. All deletions did not 
affect the ability of the polypeptide to transactivate early promoters or bind to a 
consensus DNA binding site, but did reduce the transactivation of the tk early promoter. 
These deletions remove a serine-rich region of the protein encompassing amino acids 
176-206, which the authors proposed played a role in the transactivatory function of 
Vmwl75. However, the authors cited data which showed that the deletion mutations
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tested did not affect the transactivation properties of the whole Vmwl75 protein. In 
addition, a virus containing a deletion of amino acids 162-229 is viable in tissue culture, 
further showing that deletion of the serine-rich tract does not have a deleterious effect on 
the in vivo properties of the protein (Paterson and Everett, 1990).
A second study involved the construction and characterization of a series of four 
amino acid insertional mutations throughout the whole of the IE-3 reading frame 
(Paterson and Everett, 1988a, b). These mutant proteins were tested for DNA binding, 
transactivation and autoregulation properties in vitro. The most clear-cut results were 
obtained with insertional mutations within region 2. Although these mutations were not 
in complete agreement with those of Shepard et al. (1989) (see Figure 1C.3), most 
mutations proximal to or within region 2 of the protein reduced or abolished the DNA 
binding activity of Vmwl75. This was with the exception of the mutation 113, situated at 
amino acid 324, which exhibited near wild type DNA binding properties. However, a 
polypeptide containing this mutation exhibited no DNA binding activity in gel retardation 
assays (R. D. Everett, personal communication).
The transactivation and autoregulation properties of these mutant proteins 
mirrored their ability to bind to DNA; that is, those that reduced DNA binding activity 
also reduced transactivation and autoregulation activity.
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Figure 1C.3. Insertional Mutagenesis of Vmwl75.
The open boxes represent regions 1 and 2 ofVmwl75, as defined by McGeoch 
et al., 1986, with numbers above indicating codon number within the IE-3 ORF. Below 
are shown the positions of insertional mutations introduced by Paterson, 1989 (I series) 
and Shepard etal., 1989 (i series). The ability o f mutant Vmwl75 molecules to bind to 
DNA is indicated. + = wild type binding activity; - = below wild type binding activity.
The results obtained with mutations in region 4 of Vmwl75 were more 
complicated. For example, several mutations which reduced DNA binding and 
transactivation activity did not affect the autoregulatory activity of the protein. These
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mutations may have been exerting their effects through the destabilisation of protein 
conformation, an observation also made about temperature-sensitive mutations within 
this region (Paterson et al., 1990).
The analysis of deletion mutants of Vmwl75 in these assays also gave quite 
varied results. Many deletions within the IE-3 coding region may result in a deleterious 
effect on protein conformation and stability, and so the most informative evidence from 
such an analysis stems from the observation of deletions which have little negative effect 
on the activity of the protein. The main conclusion from this deletion mutational analysis 
was again that the integrity of region 2 is important for the DNA binding activity of 
Vmwl75.
All the mutational analyses discussed so far have suggested that the DNA 
binding, transactivation and autoregulation properties of Vmwl75 are properties of 
similar regions of the protein, and that no separable domain is responsible for any one 
function of the protein. These results support the hypothesis that the DNA binding 
activity of Vmwl75 is essential for its full function in vitro and in vivo. However, a 
recent piece of evidence has arisen which appears to contradict this hypothesis.
The evidence arises from the characterization of the virus vil2 (Shepard and
DeLuca, 1991b). This virus contains a two amino acid insertional mutation at residue
320 of the IE-3 open reading frame. The Vmwl75 molecule containing this mutation was
found to exhibit no detectable DNA binding activity in vitro, and the virus vil2 was non-
viable in tissue culture in the absence of complementing levels of wild type Vmwl75.
During the propagation of vil2 on non-complementing cell lines, a pseudo-revertant
virus, vril2 was isolated. Sequence analysis of the Vmwl75 molecule encoded by this
virus showed that the protein contained a second mutation at amino acid 342, although
recent sequence data has suggested that the mutation may lie at residue 345 (this thesis).
This pseudo-revertant virus was viable in tissue culture in the absence of complementing
wild type Vmwl75, and gave a polypeptide profile similar to that of wild type virus. The
transcription rates of the Vmwl75, Vmw63 and tk genes in both vril2 and vil2 were
analysed, and it was found that whilst vil2 over expressed the two IE products and
r
showed a reduced level of tk transcription, the rates of transcription of v il2  genes were 
identical to that of wild type virus. The ril2  Vmwl75 molecule exhibited no DNA 
binding activity both in infected cell extracts and in isolation. This has been the sole 
example of a mutant Vmwl75 molecule that exhibits no DNA binding function in vitro 
but is able to transactivate viral genes, and support the growth of HSV-1 in tissue 
culture. However, there are certain factors which must be taken into consideration when 
analysing these results, such as the relevance of the in vitro DNA binding assays in 
measuring the in vivo properties of Vmwl75. The properties of this mutant protein are 
described in further detail in Section 1C.4.
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1C.4. The DNA Binding Properties of Vmwl75.
The early biochemical characterization of Vmwl75 illustrated that the protein 
could interact non-specifically with calf thymus DNA (Freeman and Powell, 1982). 
Further experiments with partially purified Vmwl75 from infected cell extracts illustrated 
that Vmwl75 protected one site within the upstream regulatory sequences of the gD 
promoter and two sites within pBR322 vector sequences. Comparison of the DNA 
sequence of these three sites led to the identification of conserved residues within all 
three sites. The consensus sequence ATCGTCNNNNYCGRC (N = any base; Y = 
pyrimidine; R = purine) was proposed to represent an essential core sequence present 
within the binding sites of Vmwl75 (Faber and Wilcox, 1986).
Further footprinting analyses identified other Vmwl75 binding sites containing 
this consensus sequence in both the upstream regulatory sequences of the IE-1 promoter 
(Kristie and Roizman, 1986b; Kattar-Cooley and Wilcox, 1989) and the cap site of the 
IE-3 gene (Muller, 1987; Faber and Wilcox, 1988). The involvement of these sequences 
in the mechanism of IE gene repression by Vmwl75 is discussed in Section 1B.6. 
Additional immunoprecipitation, gel retardation and South-Western experiments 
illustrated that Vmwl75 directly and specifically interacted with sequences within many 
promoter sequences, including the upstream and leader sequences of the tk gene 
(Papavassiliou and Silverstein, 1990; Imbalzano et al., 1990); the upstream sequences of 
the IE-2 gene (Kristie and Roizman, 1986a); the upstream sequences of the gD gene 
(Tedder et al., 1989); the leader sequences of the Vmw65 gene (Michael et al., 1988); the 
upstream regulatory and leader sequences of the 72^2 gene (Michael et al., 1988; Michael 
and Roizman, 1989); and the leader sequences of the UL38 gene (Flanagan et al., 1991). 
Whilst certain of these binding sites contain the previously proposed Faber and Wilcox 
consensus sequence, many of the sites contain very little homology to this binding site. 
Therefore, it appears that Vmwl75 can interact with a wide variety of divergent DNA 
sequences. This observation has been supported by a recent statistical analysis of 
Vmwl75 DNA binding sites.
Statistical and missing contact analysis of several Vmwl75 DNA binding sites 
led to the suggestion that Vmwl75 preferentially binds to sequences which contain a 
more divergent consensus sequence RTCGTCNNYNYSG (N = any base; Y = 
pyrimidine; R = purine; S = G or C) (DiDonato et al., 1991). From this data, the 
development of a matrix illustrating the probability of any one base occurring at each site 
within the 13-base core Vmwl75 binding site allowed the accurate prediction of 
Vmwl75 binding sites within a given DNA sequence. Analysis of the HSV-1 genome 
with this matrix mean model allowed the examination of the distribution of Vmwl75 
binding sites within the genome. This analysis revealed that Vmwl75 binding sites are
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distributed throughout the genome, with an average occurrence of 1 site to 250 genic 
bases and 1 site per 760 non-genic bases. The highest density of binding sites was found 
to occur within the IE-3 gene and several glycoprotein genes including the gD gene. This 
data supports the hypothesis that removal of specific regions of gene promoters will not 
remove all available sites for the interaction of Vmwl75 with promoter-regulatory DNA 
sequences. The consensus sequence suggested by DiDonato et al. (1991) is in good 
agreement with a second consensus sequence suggested after extensive mutational 
analysis of a DNA binding site within the gD promoter (ATCGTNNNNNYSG, Everett 
etal.t 1991a, b).
1C.4.1. The Role of DNA Binding in Transactivation by Vmwl75.
A wide range of mutational studies have illustrated that the abolition of the DNA 
binding activity of Vmwl75 also led to a loss of transactivation and autoregulation 
activity both in vitro and in vivo (DeLuca and Schaffer, 1988; Paterson and Everett, 
1988a, b; Shepard et al.t 1989; this thesis). However, certain mutant Vmwl75 
molecules do not fit this general pattern.
Several temperature-sensitive forms of Vmwl75 (r  ^1 2 1 1 , tel219, tel221 and 
ts1223) do not exhibit DNA binding activity whilst activating certain early viral genes, 
whereas one mutant protein (tel225) which can bind to DNA at the non-permissive 
temperature fails to autoregulate the IE-3 gene (Paterson et al., 1990). These Vmwl75 
molecules gave complexes with an abberant mobility upon gel retardation analysis, 
suggesting that the mutant proteins were partially unfolded. In the case of the mutants 
tel211, tel219, rs 122land 151223, the lack of autoregulatory activity is mirrored by the 
lack of the proteins to bind to the IE3 cap site. Interaction of the mutant proteins with 
additional cellular or viral factors may enable sufficient DNA binding activity for early 
gene transactivation. However, the fact that the tel225 protein, whilst able to bind to the 
IE-3 cap site in vitro, is unable to autoregulate the IE-3 gene suggests that other 
properties of the protein are required for the efficient repression of transcription from the 
IE-3 promoter.
In addition, one double mutant Vmwl75 protein, the ril2  protein, exhibits no 
DNA binding properties in vitro but is able to support the viral growth cycle in tissue 
culture (Shepard and DeLuca, 1991b). The interpretation of such data is complicated, as 
it is difficult to be sure that DNA binding activity as measured in vitro is a true reflection 
of the actual properties of the protein in vivo. In the case of the mutant ril2, a DNA 
binding polypeptide of Vmwl75 containing both mutations exhibits DNA binding 
activity in vitro at lower temperatures (this thesis). Also, as mentioned above, the 
interaction of Vmwl75 with other cellular factors during viral infection may mediate the 
binding of the protein to DNA under certain circumstances. With respect to this latter
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suggestion, two pieces of evidence have been presented which demonstrate the 
interaction of Vmwl75 with the cellular transcription factors TF11B and 1F11D (Smith 
and DeLuca, 1992; Pizer et al., 1992). Whilst such in vitro experiments may identify 
protein-protein interactions which do not occur in vivo, it is interesting to note that 
addition of TF11B to binding reactions increases the DNA binding activity of Vmwl75 
and also restores the DNA binding activity of several DNA binding defective mutants of 
Vmwl75, including the ril2 protein (Smith and DeLuca, 1992).
The function of specific Vmwl75 DNA binding sites in the transactivation of 
viral early genes has also been discussed in Section 1B.3. It seems clear that for the 
transactivation of viral genes during a normal course of infection, Vmwl75 does not 
require the presence of specific DNA binding sites within the target promoter. The only 
Vmwl75 binding site for which evidence exists to implicate its importance in the 
mechanism of transactivation by Vmwl75 is the site present within the leader sequence 
of the y42 gene (Romanelli et al., 1992; see Section 1B.4). This suggests two 
possibilities; either Vmwl75 mediates transactivation not through the interaction with 
viral DNA but through the modification of components of the cellular transcription 
machinery; or that Vmwl75 is able to bind to a divergent range of DNA sequences, so 
that removal of a specific region of DNA does not abolish the binding activity of the 
protein in vivo. In light of the recent statistical analysis of Vmwl75 binding sites 
discussed above, and the fact that a great number of mutations which abolish the DNA 
binding activity of Vmwl75 also abolish its transactivatory activity, the latter hypothesis 
seems more likely.
In conclusion, it appears that the majority of evidence concerning the possible 
mechanism of transactivation by Vmwl75 supports the hypothesis that the protein 
requires an interaction with DNA in order to efficiently transactivate the full range of viral 
genes. The size of the protein and its interaction with a wide range of divergent DNA 
sequences suggests that the protein may utilize a variety of mechanisms to activate 
different classes of viral genes, including the interaction with a variety of cellular proteins 
to mediate the transactivation of different promoters. However, the mechanism of 
transactivation by Vmwl75 is insufficiendy resolved to verify such speculations.
1C.5. The Dimerization Properties of Vmwl75.
The partial purification of Vmwl75 from infected cells under nondenaturing 
conditions revealed that the protein existed as a homodimeric complex (Metzler and 
Wilcox, 1985). Analysis of partial peptides of Vmwl75 synthesized from the viral 
genome or through in vitro translation has illustrated that the protein binds to DNA as a
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dimer (Shepard and DeLuca, 1989; Shepard eta l., 1990; Shepard and DeLuca, 1991a; 
Roberts and Hayward, 1991). In contrast to other dimeric DNA binding proteins, such 
as the leucine zipper proteins (Vinson et al., 1989), the proposed consensus DNA 
binding site for Vmwl75 as defined by DiDonato et al. (1991) exhibits no palindromic 
symmetry. How the Vmwl75 dimer interacts with such an assymetrical site has still to 
be investigated.
Many studies illustrated that the dimerization of a DNA-binding proficient and a 
DNA-binding deficient Vmwl75 peptide led to the formation of a heterodimeric complex 
which exhibited DNA binding activity upon gel retardation analysis (Shepard and 
DeLuca, 1989; Shepard et al., 1990; Shepard and DeLuca, 1991a; Roberts and 
Hayward, 1991). Two possible explanations exist for such a scenario: (i) the 
heterodimer interacts with DNA through the DNA-binding proficient monomeric subunit, 
or (ii) the formation of the heterodimeric Vmwl75 complex restores the DNA-binding 
activity of the DNA-binding deficient monomeric subunit. The data obtained so far with 
these heterodimeric complexes cannot illustrate which of the two possible explanations 
holds.
The co-expression of peptides of Vmwl75 which retain specific properties of the 
whole protein molecule during mixed infections of mutant viruses led to the 
complementation of the partial peptides (Shepard and DeLuca, 1989). As described 
above, this complementation was shown to occur through the formation of heterodimeric 
molecules which retained the full range of activities expressed by a wild type Vmwl75 
molecule.
In contrast, cell lines which express a deletion mutant form of Vmwl75 (X25) 
were shown to interfere with the normal growth characteristics of HSV-1, presumably 
through the formation of heterodimeric Vmwl75 molecules. The mutant polypeptide 
X25 contains two deletions which remove amino acids 774-1298 and 32-275. These 
deletions remove a domain of the protein believed to be essential for the transactivational 
activity of Vmwl75 and another which is a major site of phosphorylation. They result in 
a polypeptide which exhibits wild type multimerization, DNA binding and autoregulation 
properties, but which fails to transactivate early and late genes (Shepard et al., 1989). 
Immunological analysis illustrated that the wild type Vmwl75 monomeric subunit within 
the X25-Vmwl75 heterodimeric molecule contained a conformational alteration within a 
carboxy-terminal epitope. Whilst the heterodimeric molecule exhibited wild type DNA- 
binding activity, this alteration presumably resulted in a reduced transactivation activity, 
which led to the reduced growth rate of HSV-1 in the X25-expressing cell line (Shepard 
et al., 1990).
Both the above studies involved the formation of heterodimeric Vmwl75 
complexes which exhibited wild type DNA-binding activity in vitro. Shepard and 
DeLuca (1991a) illustrated that the formation of heterodimers between an insertional
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mutant form of Vmwl75 (il2) and the X25 polypeptide resulted in a complex which 
exhibited no DNA binding activity in vitro, but which was able to activate a subset of 
viral early and leaky-late (yi) genes. The lack of DNA-binding activity in vitro may not 
be a true representation of the situation during the course of a viral infection, 
nevertheless, it seemed paradoxical that a heterodimeric complex with greatly reduced 
DNA binding ability was able to transactivate a subset of viral genes. This situation is 
similar to that observed with the mutant virus vril2 (Shepard and DeLuca, 1991b; see 
Section 1C.4). In the case of the heterodimeric il2-X25 complex, whilst the Vmwl75 
complex was correctly distributed into nuclear replicative compartments, and viral DNA 
replication was not inhibited to a level which interfered with late gene expression, this 
heterodimer could not direct the activation of true late (72) genes.
The analysis of heterodimer formation between partial peptides and deletion 
mutants of Vmwl75 suggests that the sequences necessary for dimer formation must lie 
between amino acids 309-774 (Shepard and DeLuca, 1989; Shepard et al., 1990; 
Shepard and DeLuca, 1991a). The observation that a peptide encompassing amino acids 
275-523 of Vmwl75 expressed from bacteria forms homodimeric molecules delineates 
the dimerization motif further, to a site situated between amino acids 309-523 (Everett et 
al., 1991b). Evidence presented in this thesis shows that the dimerization motif does not 
lie between amino acids 445-487, suggesting that sequences within amino acids 309-445 
or 487-523 contribute towards the dimerization of the protein.
1C.6. The DNA Binding Domain of Vmwl75.
Mutational analyses of Vmwl75 illustrated that alterations within region 2 of the 
protein had the most deleterious effect on its in vitro DNA binding activity (DeLuca and 
Schaffer, 1988; Paterson and Everett, 1988a, b; Shepard et al., 1989). In order to more 
closely define the regions of the protein involved in DNA binding activity, Everett et al. 
(1990) digested Vmwl75 with protease K to reveal a protease resistent DNA binding 
polypeptide. Analysis of the ability of mutant forms of Vmwl75 to yield this protease 
resistant DNA binding domain illustrated that the N-terminus of the polypeptide was 
situated between amino acids 229 and 292 whilst its C-terminus was situated between 
amino acids 495 and 518. Therefore, this proposed protease resistant DNA binding 
domain consisted of a proximal portion of region 1, together with the whole of region 2  
and a proximal portion of region three of Vmwl75.
In a parallel study, Wu and Wilcox (1990) expressed portions of the IE-3 reading 
frame as trpE fusion polypeptides in bacteria, and tested the ability of these polypeptides 
to bind a consensus Vmwl75 binding site in vitro. Analysis of these polypeptides
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demonstrated that residues 186 to 256 were not required for DNA binding and that a 
polypeptide encompassing residues 262 to 490 formed a high affinity DNA binding 
polypeptide, whilst a polypeptide encompassing residues 275 to 490 formed a lower 
affinity DNA binding domain. These polypeptides encompass the whole of region 2 
together with a proximal portion of region 1 of Vmwl75. DNase footprinting 
experiments illustrated that the larger DNA binding polypeptide protected the Vmwl75 
consensus binding site situated within the upstream regulatory sequences of the IE-1 
promoter. In addition, gel retardation experiments revealed that the DNA binding domain 
polypeptide bound to probes containing several consensus and non-consensus Vmwl75 
binding sites. These results illustrated that the expressed DNA binding domain exhibited 
similar DNA binding specificity as the whole Vmwl75 protein.
The expression of similar regions of the open reading frames for the major 
regulatory proteins of VZV and PRV resulted in the definition of DNA binding 
polypeptides for both proteins. The DNA binding domain of each protein was found to 
lie within residues 417 to 647 (VZV 140K protein) and 448 to 696 (PRV IE180 protein) 
(Wu and Wilcox, 1991). The three DNA binding polypeptides described above were 
found to give a DNase footprint at the cap site of the corresponding gene, suggesting that 
each protein shared a similar mechanism for autoregulation of gene expression. Further 
mutational analysis has illustrated that the DNA binding domain of the VZV 140K 
protein lies within residues 472 to 633 (Tyler and Everett, 1993).
Expression of portions of the IE-3 reading frame as non-fusion polypeptides in a 
bacterial T7 expression system has demonstrated that polypeptides encompassing amino 
acids 252 to 273 and 276 to 523 of Vmwl75 bind to a consensus Vmwl75 DNA 
binding site in vitro. Whilst both polypeptides demonstrated DNA binding activity, 
analysis of the ability of the two peptides to bind to mutant probes revealed that the 
smaller polypeptide had a slightly relaxed DNA binding specificity (Pizer et al., 1991). 
Further analysis of these DNA binding domain polypeptides demonstrated that both 
existed as homodimeric complexes in solution (Everett et al., 1991b). This bacterial 
expression system provided a means by which a more detailed mutational analysis of the 
DNA binding domain could be carried out, and it is this expression system which 
provided a basis for the analysis presented in this thesis.
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ID. RNA Polymerase II Transcription and the 
Mechanisms of Transactivation.
1D.1. RNA Polymerase II and the Cellular Transcription Machinery.
Eukaryotic organisms utilize three DNA-dependent RNA polymerases for the 
transcription of subsets of cellular genes. RNA polymerase I transcribes rRNA 
precursors, RNA polymerase in  transcribes 5SRNA and tRNA genes, whilst RNA 
polymerase II transcribes the largest subset of cellular genes to produce pre-mRNA 
(reviewed in Young, 1991). Genes transcribed by RNA polymerase II contain two 
elements that direct basal transcription from the promoter - the TATA box, at which the 
preinitiation complex forms, and the initiator element (Inr), the site of RNA transcription 
initiation. Whilst some eukaryotic promoters do not contain an obvious TATA box, 
transcription from such promoters utilizes a similar basic transcription machinery 
(reviewed in Saltzman and Weinmann, 1989).
ID. 1.1. RNA Polymerase II.
RNA polymerase II is a multi-protein complex, comprising 8-10 subunits, 
ranging in molecular weight from 240-10kDa. All 10 subunits of the yeast RNA 
polymerase II enzyme have been cloned and characterized. The two largest subunits, 
termed RPB1 and RPB 2 are analagous to the prokaryotic RNA polymerase subunits p' 
and p. The largest subunit of the complex has been cloned from several eukaryotic 
sources, including yeast, hamster, mouse, Drosophila and humans. The mouse subunit 
has been found to exist in three forms - RNAPIIo, a 240kDa phosphorylated protein, 
RNAPHa, the 215kDa dephosphorylated protein, and RNAPUb, a proteolytically 
degraded form found in in vitro preparations of the enzyme, but not detected in vivo. 
Photoaffinity labelling of an actively transcribing RNA polymerase II complex detected 
only the RNAPIIo form, whereas the RNAPIIa form preferentially associated with the 
preinitiation complex. Therefore, it appears that RNA polymerase II is phosphorylated 
coincidentally with or very soon after the initiation of transcription (Saltzman and 
Weinmann, 1989; Woychik and Young, 1990; Corden, 1990; Zawel and Reinberg, 
1992).
The site of this phosphorylation reaction is the conserved carboxyl-terminal 
domain (CTD) of the large subunit. This domain consists of repeats of the heptapeptide 
sequence Pro-Thr-Ser-Pro-Ser-Tyr-Ser. The number of repeats within the CTD varies 
from species to species, with higher eukaryotes containing the highest number of
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repeated sequences. Two kinases have been found to specifically phosphorylate this 
conserved CTD region. The first identified kinase was found to be homologous to the 
mammalian p 3 4 cdc2/CDC28 M-phase promoting factor (Nurse, 1990). The second 
identified kinase activity was found to migrate with the basal transcription factor TFllH 
(see below). The function of this phosphorylation reaction is unclear. Whilst deletions of 
the CTD of the large subunit of RNA polymerase II are lethal in mouse and yeast 
(Corden, 1990), the proteolysed form RNAPIIb which lacks the majority of the CTD 
repeat sequences can still support in vitro reconstituted transcription systems (Zehring et 
al., 1988; Buratowski and Sharp, 1990). It was found that the basal transcription factor 
TM1D specifically interacted with RNAPIIa (but not RNAPIIo), via the heptapeptide 
repeat sequences (Zawel and Reinberg, 1992; Usheva et a l , 1992). This observation led 
to the suggestion that phosphorylation of the largest subunit of RNA polymerase n  
releases the enzyme from its interaction with the preinitiation complex, leaving it free to 
form elongated transcripts (Zawel and Reinberg, 1992). Other suggestions for the 
function of this phosphorylation reaction include the involvement of phosphorylation in 
promoter specificity; in the interaction with DNA; in the interaction with upstream 
factors; and in the removal of histones from the transcribed template (Coiden, 1990).
ID. 1.2. Formation of the Preinitiation Complex.
The chromatographic analysis of crude nuclear extracts demonstrated that in vitro 
transcription systems utilized several components, termed basal transcription factors. 
These factors associate with RNA polymerase II to form the preinitiation complex, which 
is assembled on the TATA box of transcribed promoters in an ordered fashion. The order 
of addition of certain individual transcription factors has been determined by the analysis 
of intermediate preinitiation complexes (Buratowski et al., 1989). This assembly 
pathway is illustrated in Figure 1D.1.
The initial interaction with template DNA is mediated by the transcription factor 
lTliD, which binds to the TATA box sequence of the promoter. This interaction is 
stabilized by the binding of the TFUA factor, which may remain or leave the preinitiation 
complex. TFHB recognises the TFIIA-TF11D-DNA or TFIID-DNA complex and binds, 
forming a platform for the interaction of RNA polymerase n. RNA polymerase II enters 
the complex already bound by the TF1IF factor. The formation of the preinitiation 
complex is completed by the entry of TFIDE and H (Zawel and Reinberg, 1992).
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Figure 1D.1. Schematic Representation of the Assembly of a 
Transcription Complex.
The diagram illustrates the pathway o f assembly of a cellular transcription 
complex on the TATA box. The recruitment o f the major basal transcription factors and 
RNA polymerase II is shown. The exact protein - protein interactions between the sub­
components of this complex are not yet clearly defined. Therefore, this representation of 
the transcription complex is purely diagrammatical.
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Certain basal transcription factors have been cloned and characterized (Ha et al, 
1991; Kao et al., 1990; Peterson et al., 1990; Peterson et al., 1991; Aso et al., 1992; 
reviewed in Zawel and Reinberg, 1992). The majority of them show some homology to 
the prokaryotic a  factor, suggesting an evolutionary relationship between the two 
transcription systems. The functions of these individual factors as understood at present 
will now be dealt with in greater detail (for a review, see Zawel and Reinberg, 1992).
Initially, it was thought that the factor TFIIA was inessential for transcription by 
RNA polymerase II. Reinberg et al. (1987) found that TFIIA was required for in vitro 
transcription reactions which contained highly purified TFUD. The studies of Cortes et 
al. (1991) illustrated that TFIIA consisted of two activities, termed TFIIA and TFIU. The 
TFIU factor was required for transcription reactions with highly purified or recombinant 
TPILD, but the incorporation of crude preparations of TPllD eliminated this requirement. 
In contrast, TFIIA stimulated transcription when crude but not purified TPllD was 
incorporated into the transcription mixture. It was found that TFIIA removed a 
component that negatively atoregulated TPllD activity (Zawel and Reinberg, 1992). This 
component, termed Dr-2, bears similarity to other negative regulators of transcription, 
described in further detail in Section 1D.2.
The factor TFllB has recently been implicated in the mediation of activation by 
factors bound at upstream activating sequences or enhancer elements. The experimental 
evidence and implications of this mechanism for transactivation are described in greater 
detail in Section 1D.2.
The cloning of the TATA binding protein (TBP) of the TFIID factor from 
mammalian cells (Kao et al., 1990; Peterson et al., 1990) showed it to be a 38kDa 
protein, with homology to proteins of similar function from yeast and Drosophila. 
Sequence comparison of these proteins illustrated that they shared a conserved 180 
amino acid carboxyl-terminal region but contained variable amino-terminal regions. Pugh 
and Tjian (1990) found that the recombinant Drosophila TBP was able to support basal 
but not activated transcription, and presented data to suggest that upstream activation was 
mediated through coactivator proteins present in semi-purified mammalian and 
Drosophila TFUD fractions. In addition, an amino-terminal truncated form of the 
Drosophila TBP was unable to support activated transcription, suggesting that the variant 
amino-terminal region of TBP mediated this interaction with coactivators. Dynlacht et al. 
(1990) and Tanese et al. (1990) have purified these coactivator proteins or TBP 
associated factors (TAF's) from TFIID and illustrated that they mediate induction by 
certain activating factors. Whilst the amino-terminal region of TBP mediates the 
interaction with these TAF’s, it is possible that the conserved carboxy-terminal domain
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of TBP interacts with the CTD of the large subunit of RNA polymerase II (Usheva et al., 
1992; Pugh and Tjian, 1992).
The TFIID fraction of HeLa cells has been found to exist as two multicomponent 
complexes (Timmers and Sharp, 1991). One complex has a molecular weight of over 
700kDa, whilst the other has a molecular weight of approximately 300kDa. The two 
complexes exhibit many different properties, including differences in the ability to 
support transcriptional activation. This evidence suggests that the TFIID complex is in a 
continual state of flux within mammalian cells, containing differing compositions of 
TBP-associated factors. Further evidence suggests that the previously identified TBP is 
also involved in RNA polymerase I and RNA polymerase ID transcription (Comai et al.y 
1992; Margottin et al., 1991; White et al.y 1992; reviewed by Sharp, 1992).
The final basal transcription factor which has been extensively characterized over 
recent years is the factor TFUH. This factor has been implicated as the specific kinase 
which phosphorylates the CTD of the large subunit of RNA polymerase II (Lu et al., 
1992; Feaver et al., 1991; reviewed in Peterson and Tjian, 1992). Purification of the 
CTD kinase activity illustrated that the activity copurified with the TFllH factor. In 
addition, an antibody directed against the 62kDa subunit of TFIIH inhibited both 
transcription and CTD kinase activity (Peterson and Tjian, 1992). Although this 
phosphorylation function of TFUH is an important step in the initiation of transcription 
by RNA polymerase n, the TFUH factor comprises five subunits, and may carry out 
additional functions, such as interaction with the additional factors TFEDE and TFIU.
1D.2. The Activation of RNA Polymerase II Transcription.
1D.2.1. The Mechanism of Action of Transactivating Proteins.
The activation of transcription by RNA polymerase n  is mediated by upstream 
activating sequences within the promoter and the more distant enhancer elements, 
together with the protein fra^s-activating factors which bind to such sequences. The two 
types of regulatory elements are defined by their position within the promoter. Upstream 
regulatory sequences are situated relatively close to the TATA box of the promoter, 
whilst enhancer elements exert their effects regardless of position or orientation. Whilst 
upstream regulatory elements such as GC-rich boxes or CAATT boxes are present within 
a wide variety of genes, enhancer elements are often cell-type or promoter specific, for 
example the steroid hormone receptor enhancer element (reviewed in Maniatis et al., 
1987; Saltzman and Weinmann, 1989).
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Initial results suggested that all frans-activating factors contained two domains, 
controlling the DNA-binding and transactivation functions of the protein (reviewed in 
Ptashne, 1988). Domain-swap experiments demonstrated that these domains were 
readily separable, and that a chimaeric protein containing DNA-binding and 
transactivation domains from two proteins could activate gene expression both in vivo 
and in vitro (for example, see Brent and Ptashne, 1985). Additional transcription 
activators have since been characterized which contain only one of these defined 
domains, for example, the herpes simplex virus transactivating protein, Vmw65, which 
contains just a transactivation domain (see Section 1B.2). Whilst the structure of the 
DNA-binding domains of many such proteins have been determined (see Section 1D.3), 
the transactivation domains are not so precisely defined. The transactivation domains 
investigated so far can be divided into three rough categories - the glutamine-rich 
domains, contained in the factor Spl (Courey and Tjian, 1988); the acidic domains, 
contained in the yeast factors GCN4 and GAL4 and the viral factor Vmw65 (Hope and 
Struhl, 1986; Ma and Ptashne, 1987; Triezenberg et al., 1988); and the proline-rich 
domain, contained in the mammalian factor AP-2 (Williams et al., 1988).
The mechanisms by which these proteins induce RNA polymerase II 
transcription are poorly understood. However, recent work has begun to provide clues 
as to some aspects of the activation mechanism. Most of this work has been carried out 
using acidic activation domains, normally represented by the transactivating domain of 
the viral protein Vmw65.
The earliest arguments suggested that activating proteins bound to a site within or 
proximal to the promoter, and contacted a component of the basic transcription 
machinery, with the intervening stretch of DNA looping out to allow such a connection 
to occur (Ptashne, 1988). This interaction may increase the rate at which the preinitiation 
complex assembles upon the activated promoter. This suggestion was supported by the 
observation of a phenomenom termed 'squelching', whereby high concentrations of an 
acidic transactivation domain sequestered some unknown component of the cellular 
transcription machinery, thus inhibiting transcription from a heterologous promoter (Gill 
and Ptashne, 1988).
Initial affinity chromatography experiments with the acidic transactivation domain 
of the Vmw65 protein illustrated that it specifically interacted with the TFIID fraction of 
the mammalian basal transcription machinery and also to the cloned yeast TATA-binding 
protein (Stringer et al., 1990). Additional evidence illustrated that activation by the Spl 
frans-activating protein was mediated through adaptor or coactivator proteins present in 
semipurified TFIID fractions which mediated interactions between activating proteins and 
the TATA-binding protein (Pugh and Tjian, 1990; 1992). Further analysis demonstrated 
that these coactivator proteins were found associated with the TATA-binding protein in 
the TFIID fraction, and were termed TBP-associated factors (see Section 1D.1).
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During an investigation of the 'squelching1 phenomenom previously observed 
with acidic activator domains, Berger et al. (1990) observed two types of inhibition of 
heterologous promoters in yeast systems, which they termed fra/tf-inhibition and cis- 
inhibition. The reasoning behind their proposed explanation for the two observed effects 
was intricate, and will not be outlined here. However, the conclusions of Berger et al. 
(1990) agreed with the observations of Pugh and Tjian (1990, 1992), in that the acidic 
activator domain was contacting an adaptor molecule which mediated the connection 
between upstream activating proteins and the basal transcription machinery. Berger et al. 
suggested that the member of the basal transcription machinery involved in this process 
interacted with DNA, and was in fact TFIID, although no evidence for the involvement 
of this particular factor was presented (reviewed in Lewin, 1990).
Kelleher et al. (1990) observed that the inhibition of transcription from 
heterologous promoters in yeast extracts by acidic activator domains could be relieved by 
the addition of a semipurified yeast fraction, which they suggested contained an adaptor 
molecule, analogous to the adaptor molecule proposed by Berger et al. (1990). 
However, as discussed by Ptashne and Gann (1990), this additional factor could also be 
a basal transcription factor required for an essential step following the interaction of the 
activator protein with TFIID. What this additional factor could be was not discussed.
To further complicate the issue, recent work by Lin and Green (1991) has 
demonstrated that an acidic activator domain acts through the recruitment of the basal 
transcription factor TFIIB into the preinitiation complex. TFIIB enters the preinitiation 
complex following the stable association of TPllD with the TATA box, and thus fits the 
requirements of the factor proposed by Ptashne and Gann (1990). Affinity 
chromatography experiments of Lin and Green (1991) demonstrated that the acidic 
activation domain interacted with both TFIID and TFIIB, but that the interaction with 
TFIIB was of a higher affinity. The factor TFIID was retained on the affinity column 
when chromatography was carried out under the conditions outlined by Stringer et al. 
(1990), suggesting that experimental conditions greatly influence the proteinrprotein 
interactions observed in vitro.
Such interactions of transactivating proteins with two target basal transcription 
. factors could result in the functional co-operativity of multiple activators which is 
sometimes observed in vitro (reviewed in Roeder, 1991).
1D.2.2. The Role of Chromatin Structure in the Regulation of Transcription.
One criticism of the in vitro assays of transactivator proteins has been that the 
levels of transactivation observed in vitro (approximately 2 -1 0  fold) do not match the 
transactivation levels of up to 100 fold or greater observed in vivo. One clue as to the 
reason for this discrepancy came from the observation that nucleosome formation in vitro
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inhibited basal transcription. This inhibition could be overcome by the addition of the 
transcription factor TFIID or the formation of initiation complexes before assembly of 
nucleosomes on the DNA template (Workman and Roeder, 1987). The use of this in 
vitro nucleosome assembly system has been extremely useful in determining the probable 
action of transactivator proteins in vivo.
Studies using the pseudorabies virus EE protein, which is analogous to Vmwl75, 
illustrated that the protein increased the interaction of the transcription factor TFIID with 
the TATA box (Abmayr et al., 1988). Further studies illustrated that whilst in the 
absence of nucleosomes the IE protein exhibited a 2-fold stimulation of transcription, 
assembly of nucleosomes on the DNA template in the presence of PRV IE led to a 40 
fold stimulation of transcription by the IE protein. This increase in induction of 
transcription by the transactivating protein was not due to an overall increase in 
transcription activity; rather, the assembly of nucleosomes had an inhibitory effect on 
basal transcription which was relieved by incorporation of the PRV IE protein in the 
assembly mix, a phenomenom termed antirepression. The transactivatory protein had 
little effect if it was added after the nucleosomes had been assembled, suggesting that the 
transactivator competed with nucleosomal proteins for binding sites on the DNA 
template. The exclusion of individual transcription factors illustrated that the factor TFIID 
was essential for this induction by the IE protein (Workman et al., 1988).
Further analysis of the GAL4-Vmw65 chimaeric protein illustrated that it too 
resulted in a 100  fold induction of transcription if added at the same time as nucleosomal 
factors. This effect required the presence of the acidic activating domain, as the GAL4 
DNA binding domain alone had no stimulatory activity. In addition, the GAL4-Vmw65 
protein did not require the presence of basal transcription factors for the antirepression 
activity. Addition of GAL4-Vmw65 together with nucleosomal factors committed the 
template to a higher level of transcription activity when the basal transcription machinery 
was later added (Workman et al., 1991).
Studies by Croston et al. (1990) illustrated that the histone HI protein alone had 
an inhibitory effect on basal transcription, and that the factors Spl and GAL4-Vmw65 
could relieve this repression, leading to similar levels of induction as observed in vivo. 
These factors were also able to relieve HI-mediated repression when added after the 
formation of HI-DNA complexes, a situation not abserved with nucleosomal assembly 
assays (see above). However, these studies have been criticised, as the interaction of HI 
with DNA does not represent the true nucleosomal structure in vivo. To answer these 
criticisms, Layboum and Kadonoga (1991) carried out a detailed analysis of nucleosomal 
assembly in vitro. They isolated the core histone proteins and assembled HI-deficient 
nucleosomes on DNA templates in vitro. This nucleosomal structure repressed basal 
transcription only four fold, and it was found that Spl and GAL4-Vmw65 activated 
these templates to the same degree as obtained with naked DNA templates. The
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subsequent addition of HI in the presence or absence of Spl or GAL4-Vmw65 resulted 
in the observation of up to 2 0 0  fold induction of transcription by the transactivating 
proteins. It was also found that the transactivating proteins could not relieve the Hl- 
mediated repression if added after the Hl-nucleosomal structures had assembled on the 
DNA, an observation in agreement with the results of Workman et al. (1988,1991).
It has been assumed from these studies that the activating proteins compete with 
nucleosomal factors for binding sites on the DNA template and thus displace 
nucleosomes from the promoter region. This action could take place during DNA 
replication in vivot when newly synthesized DNA is being assembled into chromatin 
structures. The transactivating proteins therefore appear to play a dual role - the 
interaction with transcription factors to increase levels of basal transcription and the 
displacement of histones to relieve chromatin-mediated repression (reviewed in Komberg 
and Lorch, 1991).
The in vitro models of such transcription systems may not represent the true 
situation in vivo, however, as the exact position of nucleosomes within the gene of 
interest both in vitro and in vivo would contribute to the transcriptional activity 
measured. Such maps of nucleosomal structure have not yet been obtained. However, 
the biochemical relevance of the regulation of gene transcription by chromatin has been 
demonstrated by several studies of histone mutants in yeast (reviewed in Komberg and 
Lorch, 1991; Felsenfeld, 1992).
1D.2.3. Other Factors Involved in the Negative Regulation of Gene Transcription.
Several studies have also identified factors associated with the transcription factor 
TFIID which negatively regulate basal transcription. It appears that the interaction of 
such negative factors interferes with the association of TFIID with TFIIA and thus 
inhibits the formation of initiation complexes. The addition of such factors into in vitro 
transcription systems leads to an increase in the transactivation activity of several cellular 
factors, in manner similar to that observed with studies on the nucleosomal repression of 
transcription. The identification of these nuclear factors suggests that the negative 
regulation of gene transcription is an important process in the control of gene expression 
in vivo (Meisteremst et al., 1991; Meisteremst and Roeder, 1991)
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1D.3. DNA Binding Motifs of Transactivating Proteins.
In recent years, a number of studies have concentrated on the identification of and 
elucidation of the structure of protein DNA binding motifs. As a result, a vast amount of 
data has accumulated both on the sequence conservation within DNA binding motifs and 
the structure of such conserved motifs. Sequence analysis has led to the identification of 
a number of families of DNA-binding proteins. Predictive methods and structural 
analyses have helped to identify the prominent secondary structural features of such 
motifs. This section will concentrate on four predominantly helical motifs, as the 
sequence conservation and structure of these motifs are most relevant to the work 
presented in this thesis.
1D.3.1. The Prokaryotic Helix-Tum-Helix Motif.
A number of prokaryotic DNA-binding proteins interact with DNA through a 
highly conserved 20 amino acid motif termed the helix-tum-helix motif (reviewed in 
Pabo and Sauer, 1984). Sequence analysis has illustrated that this motif is widely 
conserved within prokaryotic DNA-binding proteins. Dodd and Egan (1987, 1990) 
developed a method for the detection and statistical evaluation of potential DNA binding 
motifs exhibiting homology with known prokaryotic helix-tum-helix motifs. This 
method is described in more detail in Section 3A.4.1. Use of this analysis led to the 
identification of eukaryotic DNA-binding proteins containing related motifs. A large 
majority of the proteins identified in this analysis contained the homeodomain DNA- 
binding motif, a domain with many similarities to the helix-tum-helix motif (see Section
ID.3.2).
X-ray crystallographic studies of the purified proteins identified the structural 
features of the helix-tum-helix motif in isolation, and model-building studies allowed the 
evaluation of the possible structures of the complex between protein and DNA (reviewed 
in Pabo and Sauer, 1984). Cocrytallization of these proteins with synthetic DNA binding 
sites led to the elucidation of the crystal structure of such complexes (for example, see 
Anderson et al., 1985; Jordan and Pabo, 1988). In all of the analyses, it was found that 
the first helix of the motif lies above and across the major groove, whilst the second 
recognition helix fitted into the major groove, facilitating interactions with the DNA 
duplex. The conformation of this structure is stabilized by hydrophobic interactions 
between the two helices. Residues within the recognition helix make contacts with bases 
and phosphate groups of the DNA helix. This structure shows similarities to the complex 
formed between eukaryotic homeodomain proteins and DNA (see Section 1D.3.2).
66
Chapter 1. Introduction.
The models generated by the studies described above allowed the prediction of 
amino acid residues which would play a role in determining the specificity of the 
interaction of helix-tum-helix proteins with DNA. These predictions were supported by 
mutagenesis studies of helix-tum-helix motifs, in which replacement of residues of one 
helix-tum-helix protein with those of another protein changed the DNA-binding 
specificity of the molecule (Wharton and Ptashne, 1985).
1D.3.2. The Homeodomain Motif.
The homeodomain is a 60-amino acid motif contained in a wide range of 
eukaryotic developmental genes, including the vertebrate Hox genes and Drosophila 
homeotic genes (Gehring, 1987; Tabin, 1991). In addition, the homeobox domain is 
contained within the POU-domain, first identified in three mammalian transcription 
factors and a developmental gene from Caenorhabditis elegans (Herr et al., 1988). Upon 
the basis of amino acid homology, the homeodomain proteins fall into several 
subsections, with highest conservation exhibited between homeodomain proteins from 
the same species (Frain etal., 1989).
Nuclear magnetic resonance studies demonstrated that the Antennapedia 
homeodomain contained three a-helices (Otting et al., 1988). Sequence comparisons 
suggested that two of these a-helices formed a motif similar to the prokaryotic helix- 
tum-helix motif described in Section 1D.3.1 (Shepard etal., 1984). Mutational analyses 
of Drosophila homeotic proteins demonstrated that residue 9 of helix 3 of the 
homeodomain motif determined the specificity of protein-DNA interactions (Hanes and 
Brent, 1989; Treisman et al., 1989).
The crystal structure of a complex containing the engrailed homeodomain peptide 
bound to a DNA site has recently been determined (Kissinger et al., 1990). This 
structure showed that the first two helices of the domain pack against each other and lie 
above the major groove, whilst the third recognition helix lies roughly perpendicular to 
the first two helices, within the major groove of the DNA helix. This structure exhibits 
some similarity with that of helix-tum-helix motif-DNA complexes, in which a protein 
helix lies above the DNA helix, and stabilizes a recognition helix, which lies within the 
major groove and facilitates contact with the DNA molecule. However, some differences 
exist between the two structures, in that the DNA exists in a slightly different 
conformation in the two complexes; that the homeodomain recognition helix is longer 
than that of the helix-tum-helix motif; and that a N-terminal arm of the homeodomain 
motif makes additional contacts with the DNA molecule. These additional contacts result 
in the differences observed in the position of the DNA helix in the homeodomain-DNA 
and repressor-DNA complexes (discussed in Kissinger et al., 1990). In addition, whilst
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the prokaryotic helix-tum-helix proteins bind to DNA sites as dimers, homeodomain 
proteins interact as monomeric units.
Analysis of the contacts made between protein residues and the DNA helix 
support the genetic data of Hanes and Brent (1989) and Treisman et al. (1989). In 
particular, a highly conserved sequence, WFQNKRR, within the recognition helix 
appears to be important for the interaction with DNA. Interestingly, this sequence also 
appears to be conserved within the regulatory proteins from four a-herpesviruses (this 
thesis).
1D.3.3. The Helix-Loop-Helix Motif.
The helix-loop-helix motif was first identified in two immunoglobulin enhancer 
binding proteins, E12 and E47; Drosophila developmental proteins; the MyoD muscle 
determination protein; and the myc protein family (Murre et al., 1989a). These proteins 
were identified on the basis of sequence homology, and all exhibited the ability to bind to 
DNA and to dimerize. The helix-loop-helix domain consists of two amphipathic helices 
separated by a loop of variable length, which often contains one or more helix-breaking 
residues. Preceding this region is a domain containing a high proportion of basic 
residues. Hence, the helix-loop-helix motif can also be termed the basic helix-loop-helix 
motif (bHLH).
The helix-loop-helix motif was shown to be essential for the myogenic properties 
of MyoD (Tapscott et al., 1988). In addition, Murre et al. (1989b) illustrated that 
dimerization of heterologous bHLH proteins required the intact helix-loop-helix domain, 
and that this heterodimerization resulted in the enhancement of DNA binding efficiency. 
Further mutational analysis demonstrated that the helix-loop-helix region mediated the 
dimerization of the proteins, whilst the basic domain mediated the interaction with DNA 
by protein dimers (Davis et al., 1990). The heterodimerization of helix-loop-helix 
proteins could provide a mechanism for the fine control of their activity in vivo. This 
hypothesis is supported by the identification of two proteins, extramacrochaetae (Ellis et 
al.9 1990; Garrell and Modolell; 1990) and Id (Benezra et al., 1990) which negatively 
regulated other helix-loop-helix proteins. Sequence analysis of these proteins 
demonstrated that they contained only the helix-loop-helix region, and lacked the basic 
domain. Such proteins may therefore interfere with the DNA binding activity of other 
proteins by the formation of heterodimers. This mechanism of control by 
heterodimerization may also apply to leucine zipper proteins, which again need to 
dimerize in order to interact with DNA (reviewed in Jones, 1990). Whilst it has been 
proposed that the bHLH motif is predominantly helical in nature, no direct structural 
information concerning the motif has been published.
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1D.3.4. The Leucine Zipper Motif.
The leucine zipper motif was first identified in the CAATT binding factor, 
C/EBP, which exhibited sequence similarities to a region of the myc, fos and jun 
transforming proteins as well as to the yeast gene regulatory protein GCN4. The 28 
amino acid motif of the C/EBP molecule when arranged on a schematic helical wheel was 
found to exhibit amphipathy, with a periodic spacing of leucine residues situated on one 
face of the helix. Sequence analysis illustrated that other proteins containing this motif 
also exhibited a periodic array of leucine residues. It was proposed that these conserved 
leucine residues interacted in a zipper-like manner to facilitate dimerization of proteins 
containing this motif (Landschulz et at., 1988).
This domain also contains a region adjacent to the leucine rich region which has a 
strong concentration of basic amino acid residues. Mutational analysis has demonstrated 
that whilst the leucine-rich domain mediates dimerization, the basic motif is essential for 
the interaction with DNA, and that conservation of the spacing between the two domains 
is essential for the interaction with DNA (Neuberg et al., 1989; Gentz et al., 1989; 
Vinson etal., 1989).
Computer model-building studies led to the prediction that leucine zipper motifs 
bound DNA through a "scissors grip" structure. The leucine zipper regions of the motif 
were proposed to dimerize and form a coiled coil structure, the helices of which would 
bifurcate at the basic motif. This would form a Y shaped molecule, the helical arms of 
which would track into the major groove of the DNA helix. This model was supported 
by chemical and DNase footprinting data, which illustrated that the leucine zipper motif 
protected a DNA sequence with exact dyad symmetry and of the correct spacing to fit the 
computer-generated model (Vinson et al., 1989).
X-ray crystallographic analysis of a complex formed between the GCN4 basic- 
leucine zipper peptide and DNA has illustrated that the motif does in fact bind to DNA as 
an uninterrupted a-helix, the leucine-rich domain forming a coiled coil, whilst the basic 
domain helices diverge to track into the major groove of the DNA duplex. The coiled coil 
region of the dimer is stabilized by the formation of salt bridges, whilst residues within 
the basic domain form contacts with the DNA molecule. This model does not support the 
prediction of Vinson et al. (1989) that the basic a-helix contains a kink to allow further 
interactions with the major groove of the DNA duplex (Ellenberger et al., 1992).
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1D.4. A Model for Transactivation by Vmwl75.
At present, information concerning the possible mechanisms of transactivation by 
Vmwl75 is limited. Whilst mutational analyses of the protein suggest that the DNA 
binding function of the protein is essential for transactivation, the protein does not seem 
to require the presence of specific DNA binding sites in order to activate viral or cellular 
promoters (see Sections IB and 1C). Preliminary evidence has also suggested that 
interaction between Vmwl75 and cellular factors may modify the DNA binding 
properties of Vmwl75, questioning the validity of some measurements of in vitro DNA 
binding activity (Smith and DeLuca, 1992). In fact, the only function of Vmwl75 which 
appears to require the presence of a specific, high-affinity DNA binding site for Vmwl75 
is the autoregulation of the IE3 gene. This autoregulation appears to be mediated by a 
strong interaction between Vmwl75 and the cap site of the IE3 promoter, possibly 
leading to the steric hindrance of the movement of the basal transcription machinery on 
the promoter.
The activation of viral genes appears to require the interaction of Vmwl75 with 
DNA, in a manner which does not require that the binding sites be located at fixed 
positions within the promoter. The protein does not exhibit a strong sequence specificity 
and may interact at a number of sites within the promoter, thus acting as a viral enhancer- 
like protein. Transactivation may be brought about by the interaction of Vmwl75 with 
basal transcription factors, preliminary evidence for which has been obtained (Smith and 
DeLuca, 1992; Pizer et al., 1992). This would provide some similarity between the 
mechanism of action of Vmwl75 and other cellular transactivating proteins (see Section 
1D.2.1). In cases where a mutant Vmwl75 molecule may interact only weakly with 
upstream promoter sequences, interactions with DNA-bound cellular factors may help to 
assemble the activating complex on the promoter template.
Studies on a protein analogous to Vmwl75, the pseudorabies virus IE protein, 
have illustrated that this protein may act through an interaction with the cellular 
transcription factor TFIID (Abmayr et al., 1988). This may also be the case with 
Vmwl75, as mutational analysis has illustrated that transactivation by Vmwl75 requires 
the presence of a functional TATA box (Everett, 1984a; Coen et al., 1986; Johnson and 
Everett, 1986a, b; Homa etal., 1988; 1991). Preliminary data that Vmwl75 interacts 
directly with the TATA-binding protein (Pizer et al., 1992) together with the data of 
Pugh and Tjian (1990; 1992), suggest that Vmwl75 may act as a co-activator molecule 
(see Section ID. 1.3).
Additional studies on the mechanism of action of the pseudorabies IE protein also 
illustrated that the protein counteracted the repression of transcription mediated by the 
assembly of nucleosomes on the DNA template (Workman et al., 1988). This
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antirepression property may be an important feature of the in vivo action of 
transactivating proteins (see Section 1D.2.2). It would be interesting to investigate the 
ability of Vmwl75 to exhibit such antirepression activity. The structure of lytic HSV-1 
DNA has not been stringently investigated. If such DNA were packaged into 
nucleosomes, this may represent a means by which viral gene expression is limited in the 
early stages of infection, and one function of Vmwl75 may be to release the transcription 
machinery from such constraints. Alternatively, Vmwl75 may act to prevent the 
formation of nucleosomes on viral DNA.
The replication of viral DNA would displace nucleosomes from the template, thus 
allowing further binding of the cellular transcriptional machinery to the genome. 
Interestingly, viral genes which do not require prior DNA replication for expression 
contain binding sites for additional cellular factors (see Section IB). The multiple effects 
of viral and cellular factors may allow the expression of genes normally silenced by 
chromatin-mediated repression. The investigation of the positions of nucleosomes within 
promoter regions of viral genes would yield additional information on the role of 
nucleosome assembly in the control of viral gene transcription.
IE. The Aims of the Research Presented in this Thesis.
The initial aim of the work presented in this thesis was to identify and to carry out 
a detailed mutational analysis of regions within the DNA binding domain of Vmwl75 
thought to be involved in contacting the DNA molecule. Target regions were identified 
by sequence analysis of the protein in comparison to other viral and cellular 
transactivators, together with the analysis of information obtained from previous 
mutational analyses of Vmwl75.
Mutant forms of Vmwl75 created by this study were expressed as DNA binding 
domain polypeptides in bacteria, and assayed for DNA binding and dimerization 
properties in vitro. It was hoped that these assays would lead to the identification of 
regions and/or residues of the DNA binding domain of Vmwl75 essential for its DNA 
binding and dimerization properties. In addition, such analyses may lead to the 
separation of the DNA binding and dimerization properties of the domain.
In order to determine whether the ability of Vmwl75 to bind to DNA correlates 
with its ability to transactivate viral promoters, mutant forms of the protein were 
introduced into the HSV-1 genome. The mutant Vmwl75 molecules used in this part of 
the study included previously constructed insertional mutants (Paterson, 1989) as well as
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point and deletion mutants which were constructed during the course of this work. 
Analysis of the ability of such recombinant viruses to replicate in tissue culture would 
give an indication of the transactivation activity of each mutant protein.
derived from BHK-21 cells
Chapter 2. Materials and Methods
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2A. Materials.
2A.1. Cells
(i) BHK-21 clone 13 (Macpherson and Stoker, 1962), a fibroblastic cell line 
originally derived from baby hamster kidney cells, was generally used for growth of 
HSV-1 strain 17 svn+> transfection assays and recombination experiments.
(ii) M64A cells (obtained from Dr. N. D. Stow of this Institute) express 
Vmwl75 and were used to complement the growth of the virus D30EBA (Paterson and 
Everett, 1990) which contains a lethal mutation in IE gene 3. M64A cells are 
equivalent to the cell line M65 described by Davison and Stow (1985) and are a mixed 
cell line derived from BHKtk" cells which had been cotransformed with the HSV-1 
large Hind III-Xho I subfragment of Xho Ic, from which oris had been deleted, and a 
fragment containing the HSV thymidine kinase (tk) gene, and selcted for thymidine 
kinase gene expression.
(iii) RR1 cells (obtained from Dr. P. A. Johnson, UCSD Medical School) also 
express Vmwl75 and were used to complement the growth of the virus D30EBA. 
These cells were also used to quantitate D30EBA viral preparations by means of a 
plaque assay. As the cell line has not been transformed with DNA fragments containing 
HSV-1 oris or 'a* sequences, this results in a reduced risk of recombination between the 
virus D30EBA and Vmwl75 coding sequences. A DNA fragment carrying the 
neomycin resistance gene (neoR) had been introduced with the Vmwl75 coding 
sequences, allowing selection of transformed cells in medium containing the antibiotic 
Geneticin (G418). (Hirth et al., 1982).
2A.2. Media.
(i) BHK cells were grown in Glasgow Modified Eagle’s Medium (GMEM) 
(Busby et al., 1964) supplemented with lOOunits/ml penicillin, lOOpg/ml streptomycin, 
0.2p.g/ml amphotericin, 0.002% phenol red and 10% newborn calf serum. (=EC10).
(ii) M64A cells were grown in EF10 supplemented with lng/ml aminopterin, 
5ng/ml thymidine, 15ng/ml hypoxanthine and 15ng/ml glycine (=HAT medium). 
[EF10=GMEM supplemented with lOOunits/ml penicillin, lOOjig/ml streptomycin, 
0.2pg/ml amphotericin, 0.002% phenol red and 10% foetal calf serum].
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(iii) RR1 cells were grown in Dulbecco's Modified Eagle's Medium 
supplemented with lOOunits/ml penicillin, 100p.g/ml streptomycin, 0.002% phenol red 
and 10% foetal calf serum. G418, final concentration 400jig/ml, was included in 
alternate passages.
2A.3. Viruses.
All viruses used in this study were derivatives of the HSV-1 Glasgow strain 17 
Syn+, which forms non-synajtial plaques on BHK cells (Brown et al., 1973).
Derivative D30EBA contains a large deletion from nucleotides 246-3806 within both
copies of the IE-3 gene (Paterson and Everett, 1990).
2A.4. Bacteria.
All plasmids used in this study were propagated in E. coli strains HB101 (F~; 
RamCl; ProA2; galK2; strA; recA; Boyer & Roulland-Dussoix, 1969) or DH5 
(SupE44; hsdR17; recAl; endAl; gyrA96; thi-1; relAl; Low, 1968). The pET vectors 
used in this study were grown in E. coli strain BL21 DE3 pLysS (hsdS; gal(XcIts857; 
indl; Sam7; nin5; /<zcUV5-T7 gene/; Studier & Moffatt, 1986) for induction of 
polypeptide expression, M13 bacteriophage vectors were propagated in E. coli strains 
JM101 (supEA(lac-ProAB); F'[traD36; proAB+; laclQ; lacZAMl5], /Messing, 1979) 
or TGI (supE; hsdA5; thi; A(lac-proAB); F'[traD36; proAB+; laclQ; lacZAM\5] 
Gibson, 1984).
2A.5. Bacterial Culture Media.
HB101 and DH5 strains of bacteria were grown on L-Broth (10g/l NaCl, 10g/l 
Difco Bactopeptone, 5g/l yeast extract, pH7.5 prior to sterilization). All other strains 
were grown on 2YT Broth (5g/l NaCl, 16g/l Difco Bactotryptone, 10g/l yeast extract). 
TGI strain was grown on glucose/minimal media plates (containing lxM9 salts 
[10xM9 salts=60g/l Na2HP04, 30g/l KH2 PO4 ,10g/l NH4 CI, 5g/l NaCl]; ImM Mg 
SO4 ; ImM thiamine.HCl; O.lmM CaCl2; 0.2% (w/v) glucose; 1.5% (w/v) agar) for 
selection for the F plasmid. Agar plates contained 1.5% (w/v) agar in L-broth and 
where appropriate the medium was supplemented with lOOjig/ml ampicillin or 25|Xg/ml 
chloramphenicol. Top agar contained 10g/l Difco Bactotryptone, 8g/l NaCl, 8g/l agar.
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2A.6. Plasmids.
The following plasmids were kindly provided by the acknowledged authors: 
p l75: (Everett, 1987). The HSV-1 IE-3 gene is cloned on a BamHI-SstI fragment 
spanning IRs and IRl of HSV-1 under the control of the SV40 early promoter and 
enhancer.
pI9-pI20: (Paterson & Everett, 1988a). Derivatives of pl75 created by insertion of a 
12bp EcoRI linker into Smal, Nael, Alul or Rsal sites within the IE-3 coding region. 
pA585.4: (C. M. Preston, unpublished). A derivative of the plasmid pET8c (Studier et 
al., 1990) created by removal of the HindlH site of the parent pBR322 vector and 
insertion of oligonucleotide linkers containing a Hindin restriction site between the 
NcoI/BamHI sites of the T7 promoter/terminator sequences.
p585T7a, b, c: (J. Tyler, unpublished). Derivatives of the plasmid pA585.4, created by 
the removal of the EcoRI site; removal of the PvuD/Sphl fragment; and addition of the 
pUC19 multiple restriction site polylinker within the T7 promoter/terminator region. 
All three plasmids also contain Ncol/EcoRI oligonucleotide linkers within the Ncol site 
at coordinate 607 to enable expression of cloned fragments in all three reading frames. 
(See Figure 3C.1).
2A.7. Reagents.
Oligonucleotides were synthesized in this Institute by Dr. John McLauchlan 
using a Biosearch 8600 DNA Synthesizer.
Most analytical grade chemicals were purchased from BDH Chemicals UK or 
Sigma Chemical Co.; TEMED, gelatin and ammonium persulphate were obtained from 
Bio-Rad Laboratories; caesium chloride from Melford Laboratories Ltd.; boric acid 
from Koch-Light Laboratories; nitrocellulose paper from Scleicher and Schuell Inc.; 
Hybond-N+ paper from Amersham LKB Ltd,; 0.25mm silca gel TLC plates were
A
obtained from Camlab; unlabelled dNTPs and double stranded poly dI:polydC were 
obtained from Pharmacia; formamide from Fluka; and G418 (Geneticin) was from 
Gibco.
2A.8. Radiochemicals.
Radiochemicals were obtained from Amersham at the following specific 
activities:
5'[a-32P] dNTP s, 3000Ci/mmol 
5'[y-32.p] ATP, 5000Ci/mmol 
L-33S-methionine, around 1 OOOCi/mmol
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DNase I, RNase A and lysozyme were supplied by Sigma; Proteinase K, DNA 
polymerase holoenzyme, T4 polynucleotide kinase, T4 DNA ligase, and most 
restriction enzymes were purchased from Boehringer Mannheim. Klenow fragment 
polymerase was expressed by Dr. E. Telford and purified in the Institute. Sequenase™ 
T7 polymerase and sequencing kits were purchased from United States Biochemical.
2A.10. Antibodies.
The anti-ICP4 polyclonal antibody was a kind gift from Dr. K. Wilcox (Wu and 
Wilcox, 1990). Horse-radish peroxidase conjugated protein A was purchased from 
Sigma.
2A.11. Solutions.
CLB (cell lysis buffer): 0.5% SDS, 20mM Tris-HCl (pH 7.5), 2mM EDTA. 
Coomassie Brilliant Blue stain: 2mg/ml Coomassie Brilliant Blue in 
methanol:H20:acetic acid (200:200:28)
50x Denhardt's: 1% Polyvinylpyrrolidone, 1% BSA, 1% Ficol
20x dNTPs: ImM dATP, dCIP, dGTP, and dTTP.
5x gel loading buffer lx TBE, 1% SDS, 50% glycerol, plus bromophenol
Hybridisation mix: 6x SSC, 5x Denhardt's, 0.1% SDS, 50(ig/ml denatured 
salmon sperm DNA.
5x kinase buffer: 350mM Tris-HCl (pH 7.5), 50mM MgCl2,25mM DTT.
5x ligase buffer: 250mM Tris-HCl (pH 7.5), 50mM MgCl2, lOOmM DTT,
50|lg/ml BSA.
MonoS buffer A: 0.1M NaCl, 50mM HEPES pH7.5,0.01% (w/v) CHAPS,
ImM PMSF, O.lmM DTT.
Gel soak I: 
Gel soak II: 
Giemsa stain:
2xHBS:
200x HAT:
blue.
0.5M NaOH, 1.5MNaCl.
1.5M NaCl; 0.5M Tris-HCl pH 7.2; 0.001M EDTA. 
1.5% suspension of Giemsa in glycerol, heated at 56°C 
for 2h and diluted with an equal volume of methanol. 
0.2mg/ml aminopterin, 1 mg/ml thymidine, 3mg/ml 
hypoxanthine, 3mg/ml glycine, pH to 10 to dissolve. 
280mM NaCl, 50mM HEPES, 1.5mM Na2HP04, pH to 
7.12.
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MonoS buffer B: 1M NaCl, 50mM HEPES pH7.5,0.01% (w/v) CHAPS,
ImM PMSF, O.lmM DTT.
PBS-A: 170mM NaCl, 3.4mM KC1, lOmM Na2HP04,2mM
KH2PO4  (pH 7.2).
PBSc: PBS-A plus CaCl2.H20 and MgCl2.6H20 at lg/1.
Resuspension buffer: 0.1M NaCl, 50mM HEPES, 0.4% (w/v) CHAPS, ImM 
PMSF, O.lmM DTT.
RGB (SDS-PAGE resolving gel buffer): 181.5g Tris, 4g SDS, 11H2 O, pH to 
8.9 at RT with HC1.
SDS boiling mix: 1ml SGB, 0.8ml 25% SDS, 0.5ml P-mercaptoethanol,
bromophenol blue.
SDS tank buffer: 6.32g Tris, 4g glycine, lg SDS, 11H2 O.
SGB (SDS-PAGE stacking gel buffer): 59g Tris, 4g SDS, 11H2 O, pH to 6.7 at 
RT with HC1.
20x SSC: 174g/l NaCl, 88.2g/l Trisodium Citrate.
20x SSPE: 3.6M NaCl, 0.2M NaH2P04,0.02M EDTA, pH7.7.
STET: 8 % sucrose, 5% Triton X-100, 50mM EDTA, 60mM
Tris-HCl (pH 8).
Superose buffer: 0.5M NaCl, 50mM HEPES (pH 7.5), 0.01% (w/v)
CHAPS, ImM PMSF, O.lmM DTT.
20x TBE: 2.5M Tris, 800mM boric acid, 54mM EDTA, not pH'd.
lOx TBE (for gel retardation assays): 890mM Tris-HCl, 890mM Boric Acid, 
25mM EDTA, notpH'd.
TBS (for transfections): 25mM Tris-HCl (pH 7.5), 137mM NaCl, 5mM KC1,
0.7mM CaCl2 , 0.5mM MgCl2 , 0.6mM Na2HP04, pH to 
7.4 with HC1.
lOmM Tris-HCl (pH 7.5), ImM EDTA (pH 8 ).
2mM Tris-HCl pH 8 ; 0.02mM EDTA.
150mM NaCl, 40mM Tris-HCl, ImM EDTA, pH 7.5. 
ImM Tris-HCl (pH 7.5), 0.05mM EDTA.
0.25% (w/v) trypsin dissolved in Tris-saline.
0.6mM EDTA in PBS-A plus 0.002% w/v phenol red.
TE:
TE/5:
TEN:
TEP:
Trypsin:
Versene:
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2B.1. Tissue Culture.
BHK cells were routinely passaged in 8 5 0 c m ^  roller bottles seeded with 
approximately 5x10? cells at 37°C in 100ml EC 10 and an atmosphere of 5% CO2  in 
air. Confluent monolayers were harvested in 20ml EC 10 after two versene washes and 
brief trypsinization with Trypsin:versene (1:4). Cells were resuspended by pipetting 
and remained viable for at least five days stored at 4°C.
M64A and RR1 cells were routinely passaged in 175cm^ (Nunclon) flasks in 
appropriate medium and harvested in 10ml medium. These cells did not remain viable 
at 4°C and for long term storage harvested cells were pelleted and resuspended in 
medium plus 5% glycerol and 15% foetal calf serum, aliquoted and frozen slowly to 
-140°C. Recovery was by rapid thawing and resuspension in growth medium.
2B.2.Preparation of Stocks of Infectious Virus.
An 80% confluent monolayer of BHK or RR1 cells was seeded with 10^ pfu of 
virus per roller bottle in 40ml appropriate medium (a moi of 0.003pfu/cell) and 
incubated for 2-4 days until the cells exhibited obvious cpe. The cells were shaken into 
the medium and pelleted at 3000rpm for 15 min at 4°C. Cell associated virus (CAV) 
was prepared by sonicating the pellet in 2ml medium. Cell released virus (CRV) was 
pelleted from the supernatant at 12000rpm for 2 hours at 4°C and gently resuspended 
in 2ml supernatant and sonicated in a sonibath. Sterility checks were performed by 
streaking on blood agar plates and incubating at 37°C for 5 days. Virus stocks were 
stored at -70°C.
2B.3. Titration of Virus Stocks.
Appropriate indicator cells were seeded at 0.7x10^ cells per 35mm plate in 
2.5ml medium. The following day cells were infected with serial 10-fold virus dilutions 
in 0.3ml medium. After lhr adsorption time (gently mixing every 10 minutes) plates 
were overlaid with the appropriate medium containing 5% human serum, to prevent 
secondary plaque formation, and incubated for 2-3 days prior to fixing with Cidex and 
staining with Giemsa stain. The plates were washed after 15 minutes and plaques 
counted using a dissection microscope.
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2B.4. Preparation of Cell Released Viral DNA.
Viral particles in the culture medium were pelleted as described in Section 2B.2 
above and resuspended in 1ml TE plus lOOmM NaCl. SDS was then added to 1% v/v 
and viruses disrupted by gentle inversion at 37°C. DNA was then extracted by serial 30 
minute extractions, with gentle inversion (twice with phenol, then once with 
phenol/chloroform and once with chloroform). DNA was precipitated with 0.05 
volumes of 5M NaCl and 2.5 volumes of ethanol, washed twice, dessicated and 
resuspended overnight in TE. DNA was quantitated on agarose gels compared to 
known standards and stored at -20°C.
2B.5. Preparation of Total Infected Cell DNA.
10mm linbro wells were seeded with 1x10^ permissive cells and infected the 
following day with a moi of 0.001 pfu/cell. After 2-3 days, when cpe became apparent, 
the supernatant was removed and stored as CRV stock. 0.2ml of cell lysis buffer (CLB) 
containing 0.1 mg/ml proteinase K was added to the cell monolayer and incubated at 
37°C for 3-5 hours. The glutinous extract was transferred to 1.5ml Eppendorf tubes 
and 15jxl 5M NaCl added. Serial 30 minute phenol then chloroform extractions were 
performed, with gentle inversion, followed by precipitation with 2.5 volumes of 
ethanol, resuspension in 0.3M Na Acetate pH5, a further ethanol precipitation, one 
wash with 70% ethanol, dessication and finally resuspension overnight at 4°C in 50|il 
TE.
2B.6. Analysis of Polypeptides.
2B.6.1 Pulse labelling of polypeptides.
Sub-confluent permissive cells (1x10^ cells on a 10mm linbro well) were 
infected at a moi of 5 pfu/cell in 0.3ml medium. After a lh adsorption period (shaking 
every 10 min), cells were overlaid with growth medium and infection allowed to 
proceed at 37°C. The next day cells were washed with PBSc and labelled for 30mins in 
200p.l PBS containing 50-100|iCi [^^S] methionine. Cells were then washed and 
harvested in lOOjil SDS boiling mix. Extracts were stored at -20°C prior to analysis by 
SDS polyacrylamide gel electrophoresis.
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2B.6.2 SDS polyacrylamide gel electrophoresis.
Electrophoresis was carried out as described by Marsden et al., 1978. 
Polypeptides were resolved on 0.75mm thick 7.5% or 12.5% single concentration 
polyacrylamide gels using a Bio-Rad Mini-Protean™ II electrophoresis kit. Gel plates 
were washed with dilute Decon, distilled water, then ethanol and left to dry. Gels were 
made up as follows:
Solution 7.5% resolving gel 12.5% resolving 
gel
stacking gel
30% acrylamide 
(2.5% cross-linker)
2.5ml 4.17ml 0.4ml
resolving gel buffer 2.5ml 2.5ml
stacking gel buffer 2.5ml
distilled H2 O 5ml 3.33ml 1.4ml
10% APS 80|il 80pl 20|il
TEMED 8|il 8|il 3|il
The resolving gel was overlaid with butan-2-ol and allowed to set. After 
washing, the stacking gel was prepared and overlaid, wells were created with a teflon 
comb.
Protein samples were boiled for 2 min in 1 or 2 volumes of SDS boiling mix 
prior to loading. Gels were run at a constant voltage of 200V until the dye front reached 
the bottom of the gel. Gels of [35s]methionine labelled polypeptides were fixed for lh 
in methanol: acetic acid: water (50: 70: 50) before drying down under vacuum at 80°C 
onto a sheet of Whatman 3mm paper and exposing to Kodak S XS-1 film for 3-24h. 
Gels of non-radiolabelled polypeptides were stained for 2 min with Coomassie Brilliant 
Blue before destaining overnight in protein gel destain.
2B.6.3 Western blot analysis.
The Western blotting technique was that of Towbin et al., 1979, with several 
modifications. Protein extracts were electrophoresed on 12.5% SDS-polyacrylamide 
gels as described in Section 2.6.2 and then transferred onto nitrocellulose using a Bio- 
Rad mini Trans-blot™ apparatus. Two foam pads and two sheets of Whatman 3mm 
chromatography paper were presoaked in transfer buffer (192mM Glycine, 25mM Tris- 
HCl pH 8.3, and 20% Methanol) along with the nitrocellulose sheet to be used in the 
transfer. The gel was laid on one presoaked filter paper, and the nitrocellulose sheet 
and second filter paper laid on top. This assembly was held between two foam pads and
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placed within the transfer tank with the nitrocellulose sheet towards the anode. Proteins 
were transferred electrophoretically in transfer buffer at 250mA for 3h at room 
temperature.
Following transfer, the nitrocellulose was blocked in blocking buffer (3% 
gelatin, lx TBS, 0.05% Tween-20) at 37°C for 1 hour, the buffer being changed after 
30 min, and then washed twice for 5 min in lx TBS, 0.05% Tween-20 at room 
temperature. Antibody solutions were made up to the desired concentration in 1% 
gelatin, lx TBS, 0.05% Tween-20. The dilutions were added to the nitrocellulose and 
incubated overnight at room temperature.
The following day, six five minute washes were carried out in lx TBS, 0.05% 
Tween-20 at room temperature and the blot then incubated for lh at room temperature 
in a 1/1000 dilution of protein A:HRP conjugate (diluted in 1% gelatin, lx TBS, 0.05% 
Tween-20). The filter was then washed twice in lx TBS, 0.05% Tween-20 for 5 min at 
room temperature and once in lx TBS for 5 min at room temperature before addition of 
the colour reagent. 20mls of an ice cold solution of 3mg/ml HRP colour developer 
reagent in methanol and lOOmls of 0.015% H2 O2  in lx TBS were mixed and 
immediately added to the nitrocellulose filter. The filter was incubated in the dark for 
10-30 min, until colour developed, and the reaction stopped by washing the filter in 
running water.
Alternatively, proteins were visualized with the Amersham ECL™ detection 
system, according to the manufacturer's instructions.
2B.7. Transfection of Cells with Viral DNA for Marker Rescue.
Subconfluent BHK cells were transfected on 35mm plates using the calcium 
phosphate precipitation method of Corsalo & Pearson (1981). 0.5(ig of intact viral 
DNA plus a 10-fold molar excess of linearized plasmid and 2-5|ig calf thymus DNA 
were made to a final volume of 140|il with TEP. 20|il of 2M CaCl2 was added 
dropwise to the solution with frequent mixing, and this mixture in turn added dropwise 
to 160(0.1 2xHBS. After standing for 30 min the medium was removed from the cells 
and the precipitate added. The cells were then incubated for 40 min at 37°C or 38.5°C, 
growth medium replaced, and incubation continued for a further 3-4 h. The cells were 
washed once with growth medium, overlaid with 25% DMSO in lx HBS for 30sec, 
washed a final time, and overlaid with growth medium. After 2-4 days incubation at 
31°C or 37°C the cells exhibited extensive cpe, or plaques; the cells were then scraped 
into the medium and sonicated to release infectious virus. Virus stocks were stored at 
-70°C.
81
2B.8. Gel Retardation Assay.
Chapter 2. Materials and Methods
The binding of DNA binding domain polypeptides to the IE gene 3 capsite was
assayed as described by Muller (1987). The 45bp Aval/BamHI and 135bp
EcoRI/BamHI fragments spanning the IE-3 capsite (-17 to +27 and -108 to +27
respectively) were end-labelled by filling in using Klenow fragment polymerase as
described in Section 2B.24.2 and purified on an 8% polyacrylamide gel. Binding
reactions were carried out at the appropriate temperature for 20 minutes in a 20(il mix
containing ljig poly(dI).poly(dC), about lng probe (2000cpm) and l-10|il protein
extract in lOmM Tris-HCl pH 7.5, ImM EDTA, 0.1M NaCl, 0.1% NP40. Samples
were resolved on 4% polyacrylamide gels (3.3% cross linker) run in 0.5x TBE
(prepared from lOx TBE stock), and dried down before autoradiography. Where
e
binding reactions were carried out at 0°C, elctrophoresis was carried out at 4°C.
2B.9. Large Scale Plasmid DNA Preparations.
Isolated single colonies on plates selective for a plasmid-borne resistance 
marker were inoculated into 3ml L-broth and grown overnight. These were added to 
350ml L-broth in 21 flasks and grown shaking at 37°C overnight.
Plasmid DNA was prepared by the "maxi-boiling" technique (Holmes and 
Quigley, 1981). Cells were pelleted at 10000 rpm for 6min (Sorvall GS3 rotor) and 
resuspended in 17ml STET per 350ml culture. 2ml lOmg/ml lysozyme in STET was 
added for a lmin incubation prior to bringing the suspension to the boil for 45sec. The 
lysate was cleared by centrifugation at 20000 rpm for 45 min at 4°C (Sorvall SS34 
rotor) and DNA precipitated from the supernatant by addition of 0.9 vol isopropanol. 
After pelleting at 3000 rpm at room temperature for 10 min (Beckman GPR 
centrifuge), the drained pellets were resuspended in TE and CsCl added to give a final 
density of 1.6mg/ml and EtBr to 0.5mg/ml. The solution was cleared by spinning at 
3000 rpm for 10 min at room temperature after a 15min incubation on ice. The DNA 
was banded by centrifugation at 40000 rpm at 15°C for 16-48 h in the vertical TV865 
rotor. The DNA was visualized by daylight or long-wave uv illumination and the 
lower, supercoiled plasmid DNA recovered with a large bore needle and syringe, after 
removal of the upper, linearized chromosomal DNA band. The DNA was extracted 
twice with butan-l-ol (TE saturated), dialysed against TE at RT for 3h, treated with 
50|ig/ml RNase (lh/65°C), then 50p.g/ml proteinase K plus 0.1% SDS (lh/37°C) 
before extraction with phenol/chloroform then chloroform and precipitated twice with 
ethanol. The DNA was lyophilized, resuspended and its concentration determined by 
spectrophometry (OD26O 1.0 = 50|ig DNA/ ml).
82
Chapter 2. Materials and Methods
2B.10. Miniprep Plasmid DNA Preparation.
Single plasmid-transformed bacterial colonies were grown overnight in 2ml L- 
broth. 1.5ml stationary phase culture was pelleted at 12000 rpm for 15sec (benchtop 
microcentrifuge) and cells resuspended in 200pl STET. The cell suspension was 
immediately placed in a 100°C water bath for 45sec after addition of 5pl lysozyme 
(lOmg/ml), then centrifuged at 12000 rpm for lOmin. The pellet was removed and 
DNA precipitated and pelleted from the supernatant by addition of 0.9 vol isopropanol 
and spinning at 12000 rpm for 5min. The pellets were washed with 70% ethanol, dried 
and resuspended in 20pl TE. Miniprep DNA was stored at -20°C and 5|il was used for 
restriction enzyme analysis. (0.2pl 1 mg/ml RNAase was added to digestions of 
miniprep DNA).
2B.11. Restriction Enzyme Digests.
Restriction enzyme (RE) digests were generally carried out in 20|il volumes of 
the appropriate RE buffer, using 0.5pg DNA and lu enzyme for lh. Most digests were 
carried out using the Boehringer Mannheim buffer system, with commercially supplied 
lOx concentration buffers.
EcoRI and BamHI double digestions were always carried out in buffer H. All 
digests were carried out at 37°C. Preparative rather than diagnostic RE digestions used 
increased amounts of DNA and RE under similar conditions, in 20-50|il volumes.
2B.12. Separation and Purification of Purified DNA Restriction 
Fragments.
2B.12.1 Non-denaturing agarose gels.
Slab gels of 0.5-1.5% agarose in lx TBE were run submerged at up to 12V/cm. 
Sampled were loaded in 0.2 vol loading buffer. Gels were run for l-3h, until the dye 
almost ran off the end, and then stained for 5min in 1 mg/ml EtBr and examined and 
photographed with short-wave uv illumination (long-wave uv was used to reduce DNA 
damage when preparative gels were being analysed).
To purify a resolved DNA fragment from a gel the DNA was run onto a strip of 
DE-81 paper inserted in front of the desired band, (DE-81 paper was presoaked in 
2.5M NaCl overnight, then stored in ImM EDTA at 4°C). After electrophoresing the 
fragment onto the paper it was eluted by pulverization and agitation in 1.5M NaCl, lx 
TE for 2-16 h at 37°C, strained through siliconized glass wool, clarified and then 
ethanol precipitated.
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2B.12.2 Non-denaturing polyacrylamide gels.
In order to resolve accurately DNA fragments 40-400bp in length, 4-8% 
polyacrylamide (acrylamide:bisacrylamide, 19:1) gels were run in lx TBE. Gels were 
prepared in 1.5mm thick vertical glass plate sandwiches, and cross-linked with 
O.OOlvol TEMED, catalysed with O.Olvol 10% APS. Samples were loaded as above 
and electrophoresed at a maximum voltage of 16V/cm, and DNA visualized by 
autoradiography or EtBr staining. ^^P-labelled DNA fragments were cut out of the gel 
after detection by autoradiography and eluted by pulverization and agitation in TE for 
16 h at 37°C. Acrylamide was removed from the mixture by straining through 
siliconized glass wool, and DNA purified by ethanol precipitation.
2B.12.3 Denaturing polyacrylamide gels.
0.35mm thick gels prepared to final concentration of 6-8% acrylamide 
(acrylamide:bisacrylamide, 19:1), lx TBE and 7M urea were used to resolve the 
products of DNA sequencing reactions. DNA sequencing samples were denatured at 
95°C for 2min and run at 40W (20cm wide gels) or 70W (40cm wide gels; BRL S2 
sequencing gel apparatus) for 2-5h on gels which had been pre-run for 30min. Gels 
were dried down and exposed to Kodak X-Omat S XS-1 film for 16-24h at room 
temperature without an intensifying screen.
2B.12.4 Sephadex columns ( gel exclusion chromatography)
Sephadex G-50 "nick" columns obtained from Pharmacia were pre-equilibrated 
with 2 column volumes of lx TE, 0.1% SDS. Columns were loaded with 100-120pl 
sample (containing bromophenol blue dye) and the fastest eluted fractions (detected by 
scintillation counting) taken as purified DNA.
2B.13. DNA Ligations.
DNA ligations were performed in lx ligase buffer, with 50-500ng DNA and 1- 
2u DNA ligase. DNA was heated to 65-70°C for 5min prior to transformation of 
competent bacteria.
2B.14. Preparation of Competent E. coli. strains HB101, JM101 and DH5.
A colony purified overnight culture of bacteria was diluted 1/100 into fresh L- 
broth and grown shaking at 37°C until reaching an OD5 4 0  of 0.3-0.6. Using sterile,
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ice cold procedures throughout, cells were pelleted at 3000 rpm for 10 min (Beckman 
GPR centrifuge), resuspended in 1/4 vol 0.1M MgCl2 and immediately pelleted again 
at 3000 rpm for 10 min. After resuspension in 1/20 vol 0.1M CaCl2 the cells were left 
for 45min on ice, resuspended in the same volume of 0.1M MOPS, 50mM CaCl2, 20% 
glycerol and left 20min before aliquoting into 100-500pl and snap freezing and storing 
at -70°C.
2B.15. Preparation of Competent/?, coli strain TGI.
TGI cells were streaked onto glucose/minimal media plates and incubated 
overnight at 37°C, following which they could be stored at 4°C for up to 4 weeks. A 
single colony was inoculated into 10ml 2YT broth and grown shaking at 37°C. The 
following day, the culture was diluted 1/100 into 40ml fresh 2YT and grown shaking at 
37°C for 2h or until OD5 5 0  = 0.3. Using sterile, ice cold techniques throughout, the 
cells were pelleted at 3000 rpm for 5 min (Beckman GPR centrifuge) and resuspended 
in 1/2 vol 0.1M CaCl2, ImM MgCl2- After 20min incubation on ice, the cells were 
again pelleted at 3000 rpm for 5min and resuspended in 1/10 vol 0.1M CaCl2, ImM 
MgCl2* Competent cells were stored for at least lh on ice before transformation.
2B.16. Preparation of Competent E. coli strain BL21 (DE3) plysS.
A glycerol stock of bacteria was streaked onto an agar plate containing 25|ig/ml 
chloramphenicol and incubated overnight at 37°C. The following day a single colony 
was inoculated into 10ml 2YT + 25|ig/ml chloramphenicol and grown shaking at 37°C 
for 2h. Using sterile, ice cold techniques throughout, cells were pelleted at 3000 rpm 
for 10 min (Beckman GPR centrifuge) and resuspended in 1/4 vol 0.1M CaCl2. The 
cells were immediately pelleted at 3000 rpm for 10 min and resuspended in 1/20 vol 
0.1M CaCl2- Competent cells were stored for at least lh on ice before transformation.
2B.17. Transformation of Competent E. coli strains HB101, DH5 and 
BL21 (DE3) plysS.
100-200|il cells were thawed on ice, 100-300ng of DNA (either ligation mix, 
miniprep plasmid or purified plasmid) added, and the mixture incubated on ice for 
30min. The cells were heat shocked at 37°C for lmin, 500|il prewarmed L-broth added 
and the mixture incubated at 37°C for 30min prior to plating the mixture out onto 
plates containing appropriate antibiotic. Plates were incubated at 37°C overnight, 
following which they could be stored at 4°C for up to two weeks.
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2B.18. Transformation of Competent E. coli strains TGI and JM101.
300|il competent TGI cells or 100}il competent JM101 cells were used for each 
transformation. Approximately l-200ng M l3 DNA was added and the mixture 
incubated on ice for 40min. TGI cells were then heat shocked at 42°C for 45sec and 
placed on ice for 5min before plating out. 200jil of stationary phase TGI or JM101 
culture and 3-4ml molten top agar (at 42°C) was added to each tube and the mixture 
poured onto dry, prewarmed agar plates. After the top agar had set, plates were 
incubated inverted overnight at 37°C, after which they could be stored at 4°C for up to 
two weeks.
2B.19. Small-Scale Preparation of Replicative Form and Template DNA’s 
from Bacteria Transformed with M l3 Vectors.
200|il of a fresh overnight culture of E. coli JM101 bacteria was added to 20ml 
2YT broth. Single, isolated plaques, freshly picked with a sterile pasteur pipette, were 
added to 1.5ml aliquots of this suspension in sterile universals. The cultures were 
grown shaking at 37°C for 5-6h. The final infected culture was transferred to a 1.5ml 
eppendorf vial and centrifuged twice at 12000 rpm for 2min, turning through 180° 
between spins. Single-stranded template DNA and replicative form (RF) DNA were 
then prepared as follows.
2B. 19.1 Template DNA
800|il of supernatant was transferred to a tube containing 200|il of 20% PEG, 
2.5M NaCl, the rest of the supernatant being stored as bacteriophage stock. The 
supernatant and PEG mixture was mixed and left at room temperature for 30min or at 
4°C overnight. Precipitated bacteriophage were recovered by centrifugation at 12000 
rpm for lOmin in a bench top microcentrifuge. All the supernatant was carefully 
removed using a sterile, disposable pipette tip and the pellet resuspended in lOOpl TE. 
100|il phenol (equilibrated with TE) was added and the contents of the tube mixed well 
and then centrifuged at 12000 rpm for lOmin. The phenol phase was removed and 
DNA precipitated from the aqueous phase with 1/10 vol 4M Na acetate and 2.5 vols 
ethanol. DNA was then collected by centrifugation at 12000 rpm for lOmin, washed 
with 70% ethanol, lyophilized and resuspended in 20|il TE/5.
86
Chapter 2. Materials and Methods
2B.19.2RFDNA.
The pellet of infected bacteria from above was resuspended in 200|il STET and 
RF DNA prepared by the method described in Section 2B.10.
2B.20. Preparation of Large Scale Single-Stranded Template DNA from 
Bacteria Transformed with M l3 Vectors.
For mutagenesis reactions, large scale preparations of single-stranded template 
DNA were carried out as follows.
100ml 2YT broth was inoculated with 1ml fresh overnight JM101 culture and
2-5|il bacteriophage stock. This mixture was then grown shaking at 37°C for 5-6h. 
Cells were pelleted by centrifugation at 6500 rpm for 30 min at 4°C (SS34 rotor) and 
the supernatant transferred to a clean tube. 0.2 vol of 20% PEG, 2.5M NaCl was added 
and the mixture left to stand at 4°C for lh. Precipitated bacteriophage were recovered 
by centrifugation at 6500 rpm for 20 min at 4°C, and the supernatant discarded. The 
pellet was again centrifuged at 6500 rpm for 5 min and remaining supernatant removed 
with a sterile pasteur pipette. Precipitated bacteriophage were resuspended in 500fil TE 
and transferred to a clean 1.5ml Eppendorf tube. Any remaining cells were removed by 
centrifugation at 12K rpm/ lOmin in a benchtop microcentrifuge and transfer of the 
supernatant to a fresh tube. 200|il 20% PEG/ 2.5M NaCl was added to the supernatant 
and the mixture left to stand for 15min at room temperature or overnight at 4°C. 
Precipitated bacteriophage were again collected by centrifugation at 12K rpm/ lOmin 
and all supernatant carefully removed. The pellet was resuspended in 500|xl TE and 
extracted once with phenol (equilibrated with TE) and twice with chloroform. The 
aqueous phase was then divided between two tubes and DNA precipitated with 1/10 
vol 3M Na acetate (pH 5) and 2.5 vols ethanol. DNA was collected by centrifugation at 
12000 rpm for 15 min, washed with 70% ethanol, lyophilized and resuspended in 50p.l 
TE. DNA concentration was determined by spectrophometry (OD260 1.0 = 40fig/ml 
single stranded DNA) and adjusted to give a final concentration of 1 mg/ml. Single­
stranded DNA was stored at 4°C.
2B.21. Dideoxy Sequencing of DNA.
Products of site-directed mutagenesis reactions and plasmid constructs were 
sequenced by the dideoxynucleotide chain termination method of Sanger et a l , (1977). 
DNA was sequenced with either Klenow large fragment polymerase or Sequenase™ 
T7 polymerase. Both sequencing reactions utilized 1/10 of a template M l3 DNA small 
scale preparation or 2-6|ig CsCl purified plasmid DNA. Plasmid DNA was denatured
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with 0.4M NaOH at room temperature for lOmin before neutralization and 
precipitation with 1/10 vol 3M Na acetate (pH 5) and 3 vols ethanol.
For the Klenow LFP reactions, template DNA was annealled to 5pmoles of 
appropriate primer in a final volume of lx sequencing buffer (lOmM Tris-HCl pH 8.5, 
lOmM MgCl2) at 37°C for 20-30 min. 2 units of Klenow LFP were added to the 
annealled DNA and 2|il aliquots dispensed into 4 corresponding T, C, G and A wells of 
a round bottomed 96-well microwell plate (Nunclon). To each well was added 2|il of 
the appropriate sequencing mix containing dNTP’s and specific ddNTP's (see below), 
dATP at a final concentration of 0.09pM, and 4pCi [a-^^P] dATP. The tray was spun 
briefly and the reaction allowed to proceed at 37°C for 15min. 2pl of chase mix (4x 
cold dNTP's each at 0.25mM) were added to each well and the reaction continued at 
37°C for a further 30min. The reaction was stopped by addition of 2pl formyl dyes 
mixture (0.1% bromophenol blue (w/v), 0.1% xylene cyanol (w/v), in deionized 
formamide). The plate was heated at 90° C for 2min and 2-4[il of each reaction 
resolved on adjacent lanes of a denaturing polyacrylamide sequencing gel (Section 
12.3).
Sequencing solutions:
dA-0 dT-0 dC-0 dG-0
5mMdTTP 20(J.l lpl 20|il 20(il
5mMdCTP 20|il 20pl lpl 20pl
5mM 7-deaza dGTP 20(il 20|ti 20|il lpl
lOx seq buffer 50|il 50|il 50|il 50|il
H2 O 540|il 370pl 370|il 370jil
seq buffer = lOmM Tris-HCl (pH 8.5), lOmM MgCl2
Nucleotide concentrations in sequencing mixes:
dN-0 mixes ddNTP H2 O
Tseq 500pl 500pl (600pM ddTTP) 0^1
Cseq 500pl 105pl (140pM ddCIP) 395^1
Gseq 500pl 155|il (200|iM ddGTP) 345|xl
Aseq 500|il 250|il (140|iM ddATP) 370|il
Sequenase™ reactions were carried out using a Sequenase™ Version 2.0 
sequencing kit, according to manufacturers instructions.
2B.22. Oligonucleotide-Mediated Site Directed Mutagenesis.
Mutagenesis of the Vmw 175 DNA binding domain was performed with the 
Amersham oligonucleotide-directed in vitro mutagenesis system Version 2, following
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the manufacturers instructions. The Amersham system is based on the protocol of 
Eckstein et a l ., (Sayers et al., 1988). The region of Vmwl75 to be mutated was cloned 
into M13mpl8 and single-stranded template DNA was prepared. Before carrying out 
the mutagenesis reaction, the mutagenic oligonucleotide was used in sequencing 
reactions with the template DNA. Provided the mutagenic oligonucleotide generated 
the correct sequence, the following protocol was carried out.
2B.22.1 Hybridization of oligonucleotides to template DNA and primer extension.
The mutagenic oligonucleotide was phosphorylated as described in Section 
2B.24.1. 5|xg of template DNA and approximately 4pmoles oligonucleotide were 
annealled in a final volume of 17|il, by heating to 70°C for 3min and then incubating at 
37°C for a further 30min. The mixture was then placed on ice, a nucleotide mix 
containing a phosphothiorate derivative of the deoxyribonucleotide dCTP (dCTP aS) 
was added and the primer extension and ligation carried out using 3 units Klenow LFP 
and 3 units T4 DNA ligase at 15°C for 16 h.
2B.22.2 Filtration of heteroduplex replicative form molecules.
Single-stranded and heteroduplex RF molecules were separated by means of a 
single filtration through nitrocellulose, which binds and retains ssDNA molecules.
2B.22.3 Nicking and exonuclease reactions.
The resultant heteroduplex RF DNA molecules consist of the original non­
mutant DNA strand annealled to a mutant DNA strand which contains phosphothiorate 
derivatives of the deoxyribonucleotide dCTP. The non-mutant DNA strand was then 
selectively nicked with the enzyme Neil, which cannot cleave the phosphothiorate 
substituted mutant DNA strand, and digestion with Exonuclease HI.
The purified heteroduplex DNA was incubated with 4 units Neil at 37°C for 90 
min followed by incubation with 50 units Exonuclease III at 37°C for 15 min. 
Enzymes were then inactivated by heating at 70°C for 15min.
2B.22.4 Repolymerization and ligation of the digested DNA.
The digested strand was filled-in and religated with 1.25 units DNA polymerase 
I and 1.5 units T4 DNA ligase at 15°C for 3 h. The final DNA molecules were purified 
by precipitation with 1 vol 4M ammonium acetate (pH 5.4) and 4 vols ethanol, 'washed 
with 70% ethanol, lyophilized and resuspended in lOOjil TE.
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2B.22.5 Transformation of competent E. coli strains JM101 or TGI and screening for 
mutants.
20fil of the above DNA mix was used to transform TGI or JM101 as described 
in Section 2.18. Plaques obtained were picked and small scale single-stranded template 
DNA preparations made. Plaques containing mutant phage were identified by dideoxy 
DNA sequencing, and large scale replicative form DNA preparations made from 
mutant clones, for further cloning reactions.
2B.23. Large Scale Replicative Form M l3 DNA Preparations.
5 |il bacteriophage stock was inoculated into 350ml L-broth containing 1ml 
fresh overnight JM101 culture, and grown shaking at 37°C overnight. Bacteria were 
then pelleted and replicative form DNA prepared by the method described in Section 
2B.9.
2B.24. Radioactive Labelling of DNA.
2B.24.1. 5-end labelling.
Purified oligonucleotides which did not contain 5' phosphate groups were 5!- 
end labelled using T4 polynucleotide kinase and [y-32pj dATP. Phosphorylation was 
carried out in a final volume of 10|il lx  kinase buffer containing 10 pmols 
oligonucleotide, 10 units T4 polynucleotide kinase and excess 5'-[y-^^P] dATP 
(usually 10-30|iCi) at 37°C for 45 min. The labelled oligonucleotides were purified by 
gel electrophoresis.
Phosphorylation of oligonucleotides for mutagenesis reactions was carried out 
in a similar fashion but using ImM cold dATP and 50pmols oligonucleotide in the 
kination reaction. The reaction was stopped at 70°C.
2B.24.2. 3-end labelling.
3-ends of DNA fragments were labelled by filling in 5'-overhangs with Klenow 
LFP. Digests of 0.5-lp.g of DNA were filled in after stopping the restriction digest at 
65°C. LFP reactions were carried out in lx REact 2 buffers, and used 2u enzyme 
incubated at 37°C for 20min with appropriate*’°A^j^-[cx-32p]) ancf^ ^  ' ^ n ¥Ps
ACA /ddioaufiCfl?
followed by a 10 min chase with all four ^  dNTPs. LFP was inactivated by 
incubation at 65-70°C prior to second enzyme digestions or DNA purifications, as 
described in Section 2.12.2.
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2B.24.3. Internal labelling by random priming.
Random prime labelling of DNA fragments was carried out as described by 
Feinberg and Vogelstein (1983). 50ng DNA was boiled for 5min in a final volume of 
20|il then incubated for 3-6h at RT in a 30pl mix containing 10pl random prime buffer 
(concentrated solution containing dATP, dGTP, dTTP, Tris-HCl pH7.5, MgCl2, and |$- 
mercaptoethanol), 0.4jil 50mg/ml BSA, lpl ImM dGTP, 50|iCi [a-^^P] dCTP and 2u 
Klenow LFP. The reaction was stopped by the addition of 80|il NT stop and labelled 
DNA purified on a Sephadex G-50 column (Section 12.4).
2B.25. Southern Transfer of DNA to Nitrocellulose.
Restricted DNAs for Southern transfer (Southern, 1975) were run on agarose 
gels in lx  TBE. Following electrophoresis the gel was shaken first in Gel Soak I for 
45min then Gel Soak II for 45min. The DNA was blotted overnight onto presoaked 
Hybond-N+ paper using lOx SSPE, a wick of Whatman 3mm paper and a weighted 
capillary stack of absorbent paper towelling. DNA was fixed onto the Hybond-N+ 
paper by soaking in 0.4M NaOH for l-60min prior to hybridization.
2B.26. DNA-DNA Hybridization.
Nitrocellulose filters were prehybridized in fresh hybridization mix, containing 
the appropriate concentration of formamide, for 2-4h at 65°C. lO^-lO^ Cpm of probe 
DNA was denatured by the addition of 0.04 vol 5M NaOH for lOmin then 
neutralization with 5M HC1 before adding to the filter bag and hybridizing overnight 
under the same conditions as for prehybridization. The filter was then washed twice at 
RT in 2x SSPE, 0.1% SDS for 20min each before autoradiography at -70°C with an 
intensifying screen.
2B.27. Preparation of Bacterial Extracts for Gel Retardation Analysis.
BL21 (DE3) pLysS competent cells were transformed with appropriate small 
scale plasmid DNA preparations or purified plasmid DNA as described in Section 2.17. 
The cells were plated out on agar plates containing chloramphenicol and ampicillin and 
incubated overnight at 37°C. The next day 4-6 colonies were inoculated into 50ml of 
2YT + appropriate antibiotics, and the cultures grown shaking at 37°C until OD5 4 0  = 
0.5 (approx. 4h). The cultures were then cooled to 26°C and IPTG added to a final 
concentration of 200^ M. Expression of the cloned gene was induced by shaking 
incubation of the cultures at 26°C for a further 2h. The bacteria were pelleted by
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centrifugation at 3000 rpm for 10 min (Beckman GPR centrifuge) and resuspended in 
1/100 vol of TE, ImM PMSF, O.lmM DTT. Resuspended pellets were frozen 
overnight at -20°C.
2B.27.1. Preparation of Extracts Treated with Polyethylenimine.
The following day, the bacteria were thawed on ice and lysed by the addition of 
lysozyme to a final concentration of lOOjig/ml and sodium deoxycholate to a final 
concentration of 0.5%, followed by incubation on ice for lOmin. Following lysis, 
DNAase was added to a final concentration of 20jig/ml, RNAase added to a final 
concentration of 10|ig/ml and MgCl2 added to a final concentration of 5mM. After a 
30 min incubation on ice, NaCl was added to a final concentration of 1M and digested 
nucleotides pelleted by addition of a final concentration of 0.2% polyethylenimine and 
centrifugation at 15000 rpm for 20 min (Sorvall SS34 rotor). The supernatant was 
removed to a fresh tube and saturated (NH4 )2 S0 4  added to a final concentration of 
30%. After a lh incubation on ice, precipitated proteins were pelleted by centrifugation 
at 10000 rpm for 10 min (Sorvall SS34 rotor). The (NH4)2SC>4 supernatant was 
removed and pelleted proteins resuspended in 150|il resuspension buffer. Insoluble 
proteins were removed by centrifugation at 10000 rpm for 15 min, and polypeptide 
content of final extracts determined by SDS-polyacrylamide gel electrophoresis 
followed by Western blot analysis.
2B.27.2. Preparation of Untreated Extracts.
The following day, the bacteria were thawed on ice and lysed by the addition of 
lysozyme to a final concentration of 100|ig/ml and sodium deoxycholate to a final 
concentration of 0.5%, followed by incubation on ice for lOmin. Using ice cold 
procedures throughout, NaCl was added to a final concentration of 2M and cell debris 
removed by centrifugation at 40000 rpm for 2h (Beckman TLA 100.2 rotor). 
Supernatant was removed to a fresh tube and (NH 4)2S04 added to a final 
concentration of 30% saturation. After a lh incubation on ice precipitated proteins were 
pelleted by centrifugation at 10000 rpm for 10 min (Sorvall SS34 rotor). All 
(NH4 )2 S0 4  supernatant was carefully removed and the pellets resuspended in 150|il 
resuspension buffer. Any insoluble proteins were removed by centrifugation at 10000 
rpm for 5 min (Sorvall SS34 rotor), and the polypeptide content of the final soluble 
extract determined by SDS polyacrylamide gel electrophoresis and Western blot 
analysis.
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2B.28. Preparation of Bacterial Extracts for FPLC Purification and 
Glutaraldehyde Cross-Linking Assays.
BL21 (DE3) pLysS competent cells were transformed with appropriate small 
scale plasmid DNA preparations or purified plasmid DNA as described in Section 2.17. 
The cells were plated onto agar plates containing chloramphenicol and ampicillin and 
incubated overnight at 37°C. The following day 10 colonies were inoculated into 11 
2YT + ampicillin and cultures grown shaking at 37°C until OD5 4 0  = 0.5. Expression 
of cloned genes was induced by cooling cultures to 26°C, adding IPTG to a final 
concentration of lOOyUM and continuing the incubation at 26°C for a further 2h. 
Bacteria were then pelleted by centrifugation at 5000 rpm for 5min (Sorvall GS3 rotor) 
and resuspended in 1/100 vol resuspension buffer. Resuspended pellets were frozen 
overnight at -20°C.
The following day, bacteria were thawed on ice and extracts made as follows, 
using ice cold procedures throughout. Bacteria were lysed by 3x lOsec sonications at 
80-90W with a 5mm soniprobe, DNAase added to a final concentration of 20|ig/ml, 
RNAase added to a final concentration of lOjig/ml and MgCl2 added to a final 
concentration of 5mM. After a 30 min incubation on ice, NaCl was added to a final 
concentration of 1M and digested nucleotides pelleted by addition of a final 
concentration of 0.2% polyethylenimine and centrifugation at 15000 rpm for 20 min 
(Sorvall SS34 rotor). It was found that the addition of polyethylenimine resulted in the 
loss of some more insoluble polypeptides. In these cases, polyethylenimine was 
ommitted from the extraction prodcedure. The supernatant was removed to a fresh tube 
and saturated (NH4)2SC>4 added to a final concentration of 30%. After a lh incubation 
on ice, precipitated proteins were pelleted by centrifugation at 10000 rpm for 10 min 
(Sorvall SS34 rotor). The (NH4)2SC>4 supernatant was removed and pelleted proteins 
resuspended in 5ml resuspension buffer per 11 starting culture. Insoluble proteins were 
removed by centrifugation at 10000 rpm for 15 min, and polypeptide content of final 
extracts determined by SDS-polyacrylamide gel electrophoresis followed by staining 
with Coomassie Brilliant Blue. Final soluble extracts were dialysed at 4°C against 
MonoS buffer A to remove remaining (NH4)2SC>4 before storage at -70°C.
2B.29. FPLC Chromatography.
Bacterial extracts were dialysed against 50mM HEPES pH7.5, 0.1M NaCl, 
lOOmM PMSF, O.lmM DTT and 0.01% CHAPS to remove ammonium sulphate, prior 
to ion exchange chromatography. Insoluble proteins were removed by centrifugation at 
10000 rpm for 10 minutes at 4°C. Extracts were then loaded onto a 1ml Pharmacia 
MonoS column equilibrated in the above buffer. Chromatography was performed on an
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automated Pharmacia FPLC system and polypeptides eluted with a 20ml 0.1-1M NaCl 
gradient.
Polypeptides that were eluted in flow-through fractions were further purified by 
the treatment of fractions with 0.2% polyethylenimine and removal of insoluble 
material by centrifugation at 15000 rpm for 20 min at 4°C (Sorvall SS34 rotor). The 
supernatant was removed to a fresh tube and saturated (NH4 )2 S0 4  added to a final 
concentration of 30%. After a lh incubation on ice, precipitated proteins were pelleted 
by centrifugation at 10000 rpm for 10 min (Sorvall SS34 rotor).
Polypeptides analysed further by gel filtration chromatography were 
concentrated by centrifugation in Centricon 10 concentrators at 5000rpm and 4°C, 
(Sorvall SS34 rotor).
Concentrated polypeptides were loaded onto Pharmacia Superose 12 or 
Superdex 75 columns previously equilibrated in 50mM HEPES pH 7.5, 0.5M NaCl, 
0.01% CHAPS, ImM PMSF and O.lmM DTT. Chromatography was performed on an 
automated Pharmacia FPLC system and polypeptides eluted in the above buffer.
2B.30. Glutaraldehyde Cross-Linking Assay.
Bacterial extracts containing DNA binding domain polypeptides were incubated 
in a reaction mixture containing 50mM HEPES pH7.5, 0.1M NaCl, ImM PMSF and 
0.01% or 0.02% glutaraldehyde (freshly diluted from a 25% glutaraldehyde stock in 
50mM HEPES pH7.5, 0.1M NaCl). Cross-linking assays were carried out at various 
temperatures for 20 minutes and the reaction stopped by the addition of SDS boiling 
mix.
2B.31. Computing.
Computer analyses of DNA and protein sequences were performed on the 
MicroVAX II computer in this department, using the University of Wisconsin Genetics 
Computer Group software package (Devereux et al., 1984).
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3A: Structural and Sequence Analysis of the DNA 
Binding Domain of Vmwl75.
Expression of polypeptides encompassing portions of the Vmwl75 protein in 
bacteria has confirmed the location of the DNA binding domain of Vmwl75 (see 
Section 1C.6). The domain lies within the limits of a region spanning codons 275-490 
(Wu and Wilcox, 1989; Pizer et al., 1991; Everett et al., 1991a, b). Similar studies of 
the homologous DNA binding and transactivating immediate early protein of VZV, the 
140K protein, has shown that its DNA binding domain lies within the region spanning 
codons 417-646 (Tyler and Everett, 1993; Wu and Wilcox, 1991). In order to carry out 
a detailed mutational analysis of essential regions within the DNA binding domain of 
Vmwl75, it is useful to review the homology of this region to the DNA binding region 
of the VZV 140K protein, and also to the known sequences of other a-herpesvirus 
transactivating proteins.
This section presents sequence alignments of these sequences and secondary 
structure predictions for homologous regions of the proteins. Previous mutational 
analyses of the DNA binding domain of Vmwl75 are reviewed, and a portion of the 
DNA binding domain highlighted by these analyses is compared to several conserved 
motifs of other DNA binding protein families.
Computer analyses of DNA and protein sequences were performed on the 
MicroVAX II computer in this department, using the University of Wisconsin Genetics 
Computer Group software package (Devereux et al., 1984).
3A.1. Regions of Homology Shared Between Known and Predicted DNA 
Binding Domains of the a-Herpesvims Regulatory Proteins.
In order to determine the sequence homology between the DNA binding 
domains of Vmwl75 and the varicella zoster virus 140K protein, and the 
transactivating immediate-early proteins of equine herpesvirus type 1 and pseudorabies 
virus, the polypeptide sequences were aligned using the GCG Pileup programme. The
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Figure 3A.1. Alignment of the DNA Binding Domains of the a-H erpesvirus 
Regulatory Proteins.
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Legend to Figure 3A.1. The DNA binding domain of the VZV 140K protein, the IE 
proteins of EHV-1 and PRV and the I9X DNA binding domain polypeptide of HSV-1 
Vmw 175 were aligned using the GCG Pileup program. The sequence of the IE protein 
of PRV was obtained from Cheung (1989). The positions of amino acids conserved in 
three out of four proteins and amino acids identical between all four proteins are 
indicated.
Chapter 3. Results
largest DNA binding domain polypeptides tested for DNA binding activity encompass 
codons 252-523 of Vmwl75 (the I9X polypeptide, Pizer et al., 1991) and codons 417- 
646 of 140K (Tyler and Everett, 1993). The sequences encompassing these amino acids 
were aligned with the amino acid sequence of the EHV IEl protein (Grundy et al., 
1989), and the PRV IE180 protein (Cheung, 1989).
The GCG Pretty programme was used to determine the amino acid residues 
conserved between at least three proteins, and the amino acid residues identical 
between all four proteins. The alignments of the four proteins within the region of the 
Vmwl75 and 140K DNA binding domains is shown in Figure 3A.1, together with the 
sequence of conserved and identical amino acids.
3A.2. Structural Features of the Vm wl75 DNA Binding Domain and 
Conservation of These Features in the Homologous a-Herpesvirus 
Transactivating Proteins.
Four types of secondary structural motifs have been identified within globular 
protein molecules - the a-helix, (3-sheet, reverse turn and random coil. It is possible to 
predict, to a limited degree of certainty, the probability of specific areas of primary 
protein sequence forming such secondary structural motifs. The GCG programme 
Peptidestructure uses the predictive methods of Chou and Fashman (1974) and Gamier, 
Osguthorpe and Robson (1978) to predict the secondary structure of input primary 
amino acid sequence.
Figure 3A.2 shows the secondary structure predictions made for amino acid 
sequences from the PRV IE 180, EHV-1 IEl and VZV 140K proteins which are 
homologous to the portion spanning codons 442-485 of Vmwl75. This region was 
chosen for further analysis as it is highly conserved between regulatory proteins of the 
a-herpesviruses, and previous mutational analyses have illustrated the importance of 
this region to the DNA binding activity of Vmwl75 (see Section 3A.3). It can be seen 
that the first 15 residues of the motif in all four homologous proteins are predicted to 
exist in a helical conformation, both by the Chou and Fashman and the G-O-R 
predictive methods. This prediction of a-helical structure is probably due to the highly 
hydrophobic nature of this region of the proteins.
The secondary structure predictions for the portion of the motifs carboxy- 
terminal to this predicted helix are less clear cut. For example, within Vmwl75, the 
Chou-Fashman method results in the prediction of a random coil and reverse turn 
followed by a 10 amino acid stretch with a low probability of a-helical structure and a 
10 amino acid stretch with a high probability of a-helical structure. However, the G-O-
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R method results in a different prediction of a 15 amino acid stretch containing a turn, 
(3-sheet and random coil followed by the last 10 amino acid helical structure. 
Secondary structure predictions for the other proteins also demonstrate that the 
proposed helix-tum-helix secondary structural motif predicted for Vmwl75 by the 
Chou-Fashman method is not conserved in the other a-heipesvirus regulatory proteins.
3A.3. Identification of a Possible Motif Involved in the DNA Binding 
Function of Vmwl75.
Two linker-scanning mutational analyses of Vmwl75 have previously been 
carried out, in order to define functionally significant regions of the molecule (Paterson 
and Everett, 1988a, b; Paterson, 1989; Shepard et al., 1989). As described in Section 
1C.3 and illustrated in Figure 1C.3, the results of these studies were in general 
agreement. Analysis of one series of insertional mutations created by Shepard et al. 
(1989) suggested that two portions of region 2 of the protein contributed to the DNA 
binding, transactivation and autoregulation properties of Vmwl75. The authors 
proposed that the region of Vmwl75 spanning codons 445-487 contained a motif with 
a predicted helix-tum-helix secondary structure which is essential for the interaction 
with DNA. A high degree of homology is shown within most of this motif in the 
regulatory proteins of four a-herpesviruses (see Section 3A.1). In addition, a widely 
studied temperature sensitive mutant of Vmwl75, tsK (described in Section 1C.3), 
which fails to support viral replication under restrictive conditions, contains a point 
mutation within this region. These pieces of evidence suggest that the portion of 
Vmwl75 encompassing amino acids 445-487 is of functional significance, and 
therefore it was decided that this region was worthy of a more detailed mutational 
analysis.
3A.4. Analysis of Sequence Similarities Between the Vmwl75 "Helix- 
Tum-Helix" Motif and Other Known DNA Binding Protein Consensus 
Motifs.
3A.4.1. Homology to the Prokaryotic Helix-Tum-Helix Motif.
The prokaryotic helix-tum-helix DNA binding motif was first discovered in the 
bacteriophage XCro, Xcl and the Escherichia coli CAP proteins (for review, see Pabo 
and Sauer, 1984; discussed in Section 1D.3.1).
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As the region spanning the Vmwl75 codons 445-487 was proposed to contain a 
secondary structural helix-tum-helix motif (see Sections 3A.2 and 3A.3), an analysis of 
the similarity of this region to the consensus sequence for the prokaryotic helix-tum- 
helix motifs was carried out. In order to avoid confusion between the two motifs, the 
Vmwl75 motif is referred to as the "helix-tum-helix" region or motif.
Dodd and Egan (1987, 1990) have reported a method for the location and 
statistical evaluation of potential DNA binding motifs exhibiting sequence homology 
with the prokaryotic helix turn helix motif, as illustrated by the X,Cro protein. This 
approach utilizes a master set of proteins exhibiting homology to the XCro motif to 
create a weight matrix indicating the probability of a particular amino acid occurring at 
each position of the motif. Favoured amino acids have positive weights and 
disfavoured amino acids have negative weights. Addition of the weights of amino acids 
under analysis yields a score representative of the probability of that particular 
sequence being a member of the master set versus it being a random sequence. For 
analysis of a whole protein, the weight matrix is applied to all segments of the protein 
to find the highest scoring segment.
The statistical significance of the method is increased with the number of 
protein sequences used to create the weight matrix. In order to increase the number of 
protein sequences contributing to the weight matrix, a master set of known prokaryotic 
helix turn helix motifs whose tertiary structure has been solved by X-ray 
crystallographic analysis has been used to scan protein databases. Protein sequences 
showing homology to the master set and yielding a statistically significant score upon 
application of the weight matrix have been incorporated, and additional information 
has been used to update the weight matrix.
Dr A. Bailey in this institute has developed a computer programme for the 
statistical analysis of protein sequences by the Dodd and Egan method. The weight 
matrix used for this analysis was derived from 198 proteins, all of which have been 
shown to bind to DNA. The weight matrix used in this programme is larger than that 
developed by Dodd and Egan (1990), and so should yield results of higher statistical 
significance. Table 3A.1 shows the segments of the immediate early proteins of HSV-1 
and EHV-1 which resulted in a positive score upon analysis with this programme. 
Interestingly, the segment yielding the highest score in each protein aligns with the 
"helix-tum-helix" motif of Vmwl75 (see Figure 3A.1).
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Protein Region
(a)
Score
(b)
HSV-1 Vmwl75 445 394
HSV-1 Vmwl75 81 337
HSV-1 Vmwl75 827 177
HSV-1 Vmwl75 256 115
EHV-1IE1 548 306
EHV-1IE1 372 179
EHV-1 IE1 477 29
Table 3A.1. Analysis of the Regions of the Regulatory proteins of a-herpesviruses 
Showing Homology to the Prokaryotic Helix-Turn-Helix Motif.
The regions o f homology were determined by computer analysis, using a programme 
based on the statistical analysis of Dodd and Egan (1987,1990).
(a) The first codon of the region homologous to the 20 amino acid prokaryotic helix- 
turn-helix motif Codons are numbered starting from 1 at the ATG start codon.
(b) Statistical scores were determined as described by Dodd and Egan (1987, 1990). 
The average score for a prokaryotic helix-tum-helix motif was found to be around 
2000 (Dodd and Egan, 1987).
3A.4.2. Homology to the Homeobox Motif.
The homeobox was identified originally in many Drosophila homeotic proteins. 
It consists of a highly conserved 60 amino acid sequence (reviewed in Gehring, 1987) 
which contains a tertiary helix turn helix DNA recognition motif (Kissinger et al., 
1990; discussed in Section 1D.3.2).
In order to determine whether the Vmwl75 DNA binding domain contains a 
homeodomain motif, a consensus sequence for the homeodomain motif was derived. 
As the members of the homeodomain family fall into subgroups in which the proteins 
show higher homology to members of their particular subgroup than to other members 
of the homeobox family, two different approaches were taken to create consensus 
amino acid sequences representative of the homeodomain. Analysis of 15 
homeodomain sequences as detailed in Frain et al., (1989) with the GCG Pileup and 
Profilemake programmes led to the creation of a matrix indicating the probability of a 
particular amino acid occurring at each position of the 30 amino acid segment 
encompassing the three proposed helices of the motif. In addition, the same 
programmes were used to create a profile from the homeobox motifs of five 
Drosophila homeodomain proteins (Eve, En, H2.0, Ubx and Antp, described in Frain et 
al., 1989). The GCG Profilegap programme was used to align these profiles with the
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amino acid sequence of the DNA binding domain of Vmwl75 (Figures 3A.3 and 
3A.4).
Both homeodomain profiles exhibited highest homology with a sequence 
spanning Vmwl75 amino acids 353-396, with the Drosophila profile exhibiting 
homology to an extended sequence encompassing amino acids 337-396. This region 
lies outwith the "helix-tum-helix" motif but still within the limits of the DNA binding 
domain of Vmwl75. Interestingly, a region within the homeobox consensus sequence 
which is important for DNA interaction (Kissinger et al., 1990) showed high homology 
to a region spanning residues 390-395 of Vmwl75. This protein sequence is also 
highly conserved within other a-herpesvirus regulatory proteins, suggesting a possible 
functional role for this region.
3A.4.3. Homology to the Helix Loop Helix Motif.
The eukaryotic helix loop helix motif consists of two short amphipathic helices 
separated by a loop sequence of between 6 and 21 amino acids in length and varying 
amino acid content The helix loop helix motif has been shown to mediate dimerization 
of the protein, whilst a cluster of basic amino acids immediately preceding the first 
helix has been shown to be involved in the interaction with the DNA helix (Davis et 
al., 1990; discussed in Section 1D.3.3).
A consensus sequence for the two helices of this motif has been derived by 
analysis of ten human and Drosophila proteins (Murre et al., 1989) with the GCG 
Pileup and Pretty programmes. These two consensus sequences were aligned with the 
amino acid sequences for the proposed DNA binding domains of the regulatory 
proteins of HSV-1, VZV, PRV and EHV-1. The alignments were carried out using the 
GCG Bestfit programme, and are shown in Figures 3A.5 and 3A.6. The consensus 
sequence for the first helix exhibited low level homology to a region spanning 
Vmwl75 codons 350-380, outwith the "helix-tum-helix" region. The consensus 
sequence for the second helix exhibited very limited homology with a region spanning 
Vmwl75 codons 444-468, which is situated within the "helix-tum-helix" region.
3A.5. Representation of the Proposed "Helix-Tum-Helix" Motif on Helical 
Wheel Models.
As discussed in Section 3A.2, the region spanning codons 445-487 of Vmwl75 
has been predicted to contain two different secondary structure motifs upon application 
of secondary structure prediction programmes using both G-O-R and Chou and
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Fashman rules. Both analyses predict the existence of an a-helix spanning amino acids 
445-454, the analyses differ in the prediction of the limits of the second helix. Shepard 
et al., (1989) proposed that an a-helix spans the region encompassing amino acids 459- 
487. However, the analysis presented in Section 3A.2 showed that this helix may be 
limited to a region spanning codons 465-487. The GCG Helicalwheel programme was 
used to represent the three proposed helices as helical wheels. The resultant models are 
illustrated in Figure 3A.7.
3A.6. Discussion.
Analysis of conserved residues within a family of proteins has long been 
accepted as a method useful in pinpointing regions of a protein which contribute to its 
in vivo activity, especially in the case of DNA binding proteins. In order to analyse 
Vmwl75 in this way, the protein has to be aligned correctly with other members of the 
a-herpesvirus regulatory protein family. The alignment in Figure 3A.1 agrees well with 
previously published analyses (see, for example, Grundy et al., 1989); and the region 
determined by this alignment which is proposed to encode the PRV IE 180 DNA 
binding domain correlates with the observation that a bacterially expressed polypeptide 
spanning codons 448-696 of the PRV IE 180 protein produces a DNAasel footprint at 
the IE-3 capsite, and binds to several other sites in the VZV gene 62 promoter (Wu and 
Wilcox, 1991). The majority of conserved and identical amino acid residues fall within 
region 2 of the proteins. This is to be expected, as region 2 is one of the two most 
homologous regions of the a-herpesvirus transactivating proteins (McGeoch et al., 
1986). Of particular interest is one highly conserved stretch of amino acids spanning 
residues 442-475 of Vmwl75. This region exhibits 92% conservation and 68% identity 
between the four proteins, suggesting that it may play a functional role in the activity of 
this region of the protein.
The importance of the less homologous region 1 to the activity of the DNA 
binding domain of the four proteins is unclear. Studies have shown that the IIOX 
polypeptide encompassing codons 275-523 of Vmwl75 exhibits DNA binding activity 
in gel retardation analysis, but fails to produce a DNAasel footprint at the IE-3 capsite 
(R. Everett, personal communication). This polypeptide contains a smaller portion of 
region 1 as compared to the I9X DNA binding domain polypeptide, which is able to 
footprint the same DNA sequence. Only region 2 of the 140K protein is essential for 
the DNA binding activity of the molecule, as a polypeptide spanning codons 472-646 
shows DNA binding activity in gel retardation analysis. But again, this protein does not 
footprint the same DNA sequences and incorporation of region 1 sequences into this
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polypeptide are required to restore its footprinting activity (Tyler and Everett, 1993). 
The portions of region 1 incorporated into the larger DNA binding domain 
polypeptides of these proteins show limited homology to each other and to the two 
immediate early proteins of PRV and EHV-1 (see Figure 3A.1). The function of these 
amino terminal regions is unclear - it is possible that the specific amino acid content of 
the region is unimportant, but that addition of protein segments increases the 
conformational stability of the isolated DNA binding domain polypeptide in such a 
way that a DNasel footprint becomes visible.
Predictive methods for determining the secondary structure of a protein are not 
entirely accurate. For example, Gamier et al. (1978) reported that their predictive 
method resulted in an average success rate of 62% when predictions were made for 26 
proteins of known secondary conformation. Therefore, implications inferred about the 
secondary structure of primary amino acid sequence must be verified by nuclear 
magnetic resonance or X-ray crystallographic structural data before any conclusions 
can be made about the secondary and tertiary conformation of particular regions.
This observation is supported by the fact that the predictions obtained with the 
GCG Peptidestructure programme detailed in Section 3A.2 differ widely from a 
published observation that application of Chou and Fashman rules to the region of 
Vmwl75 spanning codons 445-487 results in a clear secondary structure prediction of 
a helix-tum-helix motif, the turn being situated at amino acids 458-461 (Shepard et al., 
1989). It is possible that the region of the motif carboxy terminal to amino acid 441 
may form a helical structural motif, but the probability for this occurring appears to be 
low. The differences in conclusions about the conformation of this motif may result 
from the varying methods of application of the Chou and Fashman rules, due to 
ambiguities in the descriptions of the predictive methods.
Comparison of conserved regions of interest of Vmwl75 with other motifs of 
DNA binding proteins would show whether the protein falls into a larger family of 
conserved proteins. This would enable identification of amino acid residues essential 
for contact with the DNA helix. Unfortunately, the region encompassing amino acids 
445-487, which is highly conserved and appears to be essential for the DNA binding 
activity of the protein, shows very little, if any, homology to recognised DNA binding 
motifs.
Although the segment spanning codons 445-487 yielded the highest score upon 
analysis with the Dodd and Egan programme to determine regions homologous to the 
prokaryotic helix turn helix motif (see Table 3A.1), the score determined for this region 
of the protein was lower than the limit considered to be statistically viable by Dodd and 
Egan. For example, Dodd and Egan (1987) found that if a protein scored between 
1400-1499, then it had a 56% probability of being a Cro-like helix-tum-helix domain. 
This implies that the Vmwl75 "helix-tum-helix" motif may be distantly related to the
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prokaryotic helix turn helix motif, but is not a member of that protein motif family. In 
addition, the proposed "helix-tum-helix" motif within Vmwl75 is larger than the 
prokaryotic 20 amino acid helix-tum-helix motif. As this region is highly conserved in 
all four a-herpesvirus regulatory proteins, it is not surprising that analysis of the EHV 
IE-1 protein with the Dodd and Egan programme results in a similar score for this 
region.
Alignment of other consensus motifs with the four a-herpesvirus regulatory 
proteins showed that the region of interest exhibits no obvious homology to the 
homeobox domain and limited homology to a portion of the helix loop helix domain.
However, the homeobox domain shows some homology to Vmwl75 residues 
353-396, and it is of interest to note that the highly conserved homeobox residues trp 
phe X asn X arg (shown in Gehring, 1987) which lie towards the carboxy terminal of 
the recognition helix, align with a highly conserved region of the four a-herpesvirus 
regulatory proteins. This region spans amino acids 390-395 of Vmwl75, and exhibits 
some homology to both homeobox consensuses. Mutational analyses have illustrated 
that the glutamine residue within this sequence of Drosophila homeodomain proteins 
determines the DNA-binding specificity of the protein (Hanes and Brent, 1989; 
Treisman et al., 1989). In addition, X-ray crystallographic analysis of the Drosophila 
engrailed homeotic protein has demonstrated that five out of the six amino acids in this 
short sequence either make direct contacts with the DNA duplex or stabilize the overall 
tertiary structure of the homeodomain. Whether this region of Vmwl75 is of 
importance to the DNA binding activity of the protein has not been determined, 
although insertional mutations created in the vicinity of this region disrupt the DNA 
binding properties of Vmwl75 (Paterson and Everett, 1988b; see Figure 1C.3).
Helix two of the helix loop helix motif exhibits some homology with a region 
spanning Vmwl75 codons 444-468, however, the region proposed to be homologous to 
the first helix is 64 amino acids upstream. This results in two helices separated by over 
60 amino acids of primary sequence, a region longer than the usual loop length of 6-21 
amino acids, implying that Vmwl75 is not a member of this class of DNA binding 
proteins.
Finally, if the region of Vmwl75 encompassing amino acids 445-487 does 
contain two a-helices, it would be interesting to investigate the nature of the helices. It 
has been shown that the helix loop helix and leucine zipper motifs contain amphipathic 
helices , and that many DNA binding proteins contact DNA through basic amino acid 
residues (Jones, 1990; Vinson et al., 1989). Therefore, the GCG Helicalwheel 
programme was used to determine the existence of such amphipathic helices within the 
Vmwl75 "helix-tum-helix" region. Figure 3A.7 illustrates the observation that no helix 
exhibited amphipathic properties. The first helix contains predominately hydrophobic 
residues, and whilst the second helix contains a higher proportion of hydrophilic polar
103
Chapter 3. Results
or charged amino acid residues, there appears to be no concentration of hydrophilic 
residues on any one face of the helix. Therefore, although the region may be 
predominately a-helical in nature, the helices exhibit very few characteristics common 
to other DNA binding proteins.
Although the region exhibits a low degree of homology to other classes of DNA 
binding proteins, it must be remembered that it exhibits an unusual high degree of 
conservation within the family of a-herpesvirus regulatory proteins, and that disruption 
of this region has an extremely deleterious effect on the properties of the molecule. The 
possibility exists that this region of Vmwl75 encodes a DNA interaction motif, and 
further mutational analysis may indicate the importance of residues within this motif to 
the properties of the protein molecule.
3B. Oligonucleotide-Directed Mutagenesis of the DNA 
Binding Domain of Vmwl75.
The primary aim of the work presented in this thesis was to carry out a 
detailed mutational analysis of a proposed "helix-tum-helix" motif within the DNA 
binding domain of Vmwl75 in order to determine the function of the motif and its 
importance relative to the in vitro and in vivo properties of Vmwl75. This section 
describes the construction of point and in-frame deletion mutations within the motif; 
later sections deal with the analysis of the effects of these mutations on the properties 
of Vmwl75.
3B.1 Constructs M13T7I9 and M13T7I10.
The constructs M13T7I9 and M13T7I10 (obtained from R. D. Everett) 
were cloned from plasmids pI9 and pIlO (Paterson, 1989). Plasmids pI9 and pIlO, 
based on the plasmid pl75 (Everett, 1987b), carry the IE-3 coding region cloned on a 
BamHI-SstI fragment containing most of IRs, the 'a' sequence and part of IRl of HSV- 
1, linked to the SV40 early promoter and enhancer (see Figure 3B.1). The IE-3 
nucleotide sequence is numbered from +1 at the first base of the ATG start codon in the 
open reading frame, and the Vmwl75 amino acid sequence is numbered from +1 at the 
ATG start codon. Plasmids pI9 and pIlO contain in-frame insertional mutations within 
the IE-3 coding region at nucleotides 752 and 823 (codons 252 and 276) respectively.
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These mutations consist of the EcoRI dodecamer linker 5'CCCGAATTCGGG3' 
inserted at blunt ended Smal and Nael restriction sites within the IE-3 coding region. 
As p i75 contains no other EcoRI restriction site, plasmids pI9 and pi 10 contain unique 
EcoRI restriction sites at the point of insertion. The IE-3 coding region also contains a 
BamHI restriction site at nucleotide 1725; the EcoRI-BamHI fragments of pI9 and 
pIlO, spanning nucleotides 725-1725 and 823-1725 respectively, encode protein 
sequences which include the DNA binding domain of Vmwl75.
Constructs M13T7I9 and M13T7I10 contain the above EcoRI-BamHI 
restriction fragments from plasmids pI9 and pi 10 cloned between the EcoRI and 
BamHI sites of the bacteriophage vector MBmp 18. Single stranded DNA prepared 
from these vectors was used as a template for oligonucleotide-directed mutagenesis of 
selected portions of the DNA binding domain of Vmwl75.
3B.2 Random Mutagenesis of the DNA Binding Domain of Vmwl75.
The method employed, as described by Blacklow and Knowles (1991), 
utilizes "spiked" oligonucleotide preparations in directed mutagenesis to create a series 
of random point base pair mutations. Four overlapping oligonucleotides 
complementary to a region spanning the proposed helix-tum-helix motif (nucleotides
1332-1428 of the IE-3 coding region, see Figure 3B.2) were synthesized using a C 
precursor mix which had been contaminated with the A phosphoramidite at such a ratio 
as to produce one random C to A mutation per oligonucleotide molecule (McNeil and 
Smith, 1985). When used in oligonucleotide- directed mutagenesis, these 
oligonucleotides would result in the production of random G to T mutations in the 
upper strand of the DNA helix, throughout the helix-tum-helix region.
Site-directed mutagenesis was carried out using the Amersham in vitro 
mutagenesis system, based upon the protocol of Eckstein et al. (Sayers et al., 1988), 
essentially as described in Section 2B.22. Mutagenesis was carried out with each of the 
four "spiked" oligonucleotides (LA15-18, see Figure 3B.2) and either M13T7I9 or 
M13T7I10 template DNA. The resultant M13 DNA was used to transform competent 
TGI or JM101 cells. Individual clones were screened by dideoxy sequence analysis as 
described in Section 3B.4.1.
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3B.3. Creation of Internal Deletions Within the Helix-Tum-Helix Motif.
In order to determine the function, if any, of the individual helices within 
the proposed helix-tum-helix motif, in-frame deletion mutations were constructed. Two 
oligonucleotides (LA21 and LA22) were designed, which when used in an 
oligonucleotide-directed mutagenesis system would result in 7 amino acid and 10 
amino acid deletions within helices 1 and 2, respectively (see Figure 3B.3). These 
oligonucleotides contain Xhol restriction sites, resulting in the incorporation of unique 
Xhol restriction sites within resultant mutant constructs. Mutagenesis was carried out 
with the Amersham in vitro mutagenesis system as described in Section 2B.22, using 
either LA21 or LA22 with M13T7I10 template DNA. The resultant M13 DNA was 
used to transform competent TGI or JM101 cells. Individual clones were screened by 
restriction enzyme digestion and dideoxy sequence analysis, as described in Section 
3B.4.2.
3B.4 Characterization of Mutations Created Within the DNA Binding 
Domain of Vmwl75.
3B.4.1 Characterization of Point Mutations.
Resultant clones from random "spiked" oligonucleotide-directed 
mutagenesis were screened by dideoxy sequence analysis. Individual plaques were 
picked, and small-scale preparations of template DNA were made as described in 
Section 2B.19.2. Single stranded DNA was sequenced using either Klenow DNA 
polymerase or Sequenase™ T7 DNA polymerase, with M13 universal primer or the 
primer LA19 (S’-CCCCTCGTCATCTGCGC-S’) which anneals to M13T7I9/I10+ 
DNA, approximately 80-150bp downstream of the site of mutation. Resultant 
sequencing ladders were resolved on 6% or 8% denaturing polyacrylamide gels, and 
the sequence compared to that of wild type IE-3 coding sequence. Figure 3B.4 shows a 
representative analysis of nine clones from a round of mutagenesis with the LA 18 
"spiked" oligonucleotide. As can be seen, both wild type and mutant clones were 
obtained.
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T C G A  T C G  A T C G A T C G A T C G A
J S M
T C G A T  C G  A T C G  A T  C G A
Figure 3B.4. Representative Sequence Analysis o f  Clones from  In  Vitro 
Site Directed Mutagenesis.
Clones generated by in vitro site-directed mutagenesis were sequenced by the 
dideoxy chain termination method, using Klenow DNA polymerase, as described in 
Section 2B.21. Radiolabelled fragments generated by the sequencing reaction were 
electrophoresed on a denaturing 8% acrylamide gel, and fragments visualized by 
autoradiography. The Figure illustrates sequences generated from  9 clones. Two o f 
the clones illustrated contain point T to G mutations.
The sequence shown, starting from  the top o f the figure, reads:
5'  CAGAAGGGCTTCCTGCTGACCAGCCTGCGCCC 3'
Table 3B.1 shows the number of mutations isolated and the mutation 
efficiency of each round of mutagenesis, and Figure 3B.5 shows sequence analysis of 
four single mutations situated in the proposed second helix, isolated from a round of
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mutagenesis with LA 18. The overall mutagenesis efficiency was 37%, lower than that 
normally achieved with the Amersham system. In total, 20 single base pair mutants, 5 
double base pair mutants and 1 deletion mutant were isolated from four rounds of 
mutagenesis with the "spiked" oligonucleotides.
Spiked
oligo­
nucleotide
(a)
Number
clones
sequenced
Number 
wild type 
clones
Number
mutant
clones
Mutation
efficiency
(b)
Number of mutants 
obtained 
(c)
Single Double Deln.
LA15 84 47 37 44% 6 1 1
LA16 52 43 9 17% 5 1 -
LA 17 65 39 26 40% 4 2 -
LA18 28 15 13 46% 5 1 -
TOTAL 229 144 85 37% 20 5 1
Table 3B.1: Mutation Efficiency of Random Oligonucleotide-Directed 
Mutagenesis.
(a) The sequences o f the spiked oligonucleotides used for in vitro mutagenesis 
reactions are shown in Figure 3B2.
(b) The mutation efficiency for each oligonucleotide is represented as the percentage of 
clones screened which were found to contain mutations.
(c) Represents the number of individual clones obtained from one round o f mutagenesis 
with the given oligonucleotide which result in either a single amino acid alteration, 
double amino acid alteration or base pair deletion. Several additional silent base pair 
mutations were also isolated.
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T C G A T C G A  T C G A  T C G A  
1 2 3 4
Figure 3B.5. Sequence Analysis of Four Mutant Clones 
Isolated from In Vitro Site-Directed Mutagenesis.
Clones generated by in vitro site-directed mutagenesis were sequenced by the 
dideoxy chain termination method, using a Sequenase Version 2.0 sequencing kit or 
Klenow DNA polymerase, as described in Section 2B.21. Radiolabelled fragments 
generated by the sequencing reaction were electrophoresed on a denaturing 8% 
acrylamide gel, and fragments visualized by autoradiography. The Figure illustrates 
sequences generated from  four mutant clones.
The sequence o f each mutant clone, starting from the top o f the figure, reads:
1: 5 ' CGACCGCGCGCAGAATTGCTTCCTGCTGA 3'
2: 5'  CGACCGCTCGCAGAAGGGCTTCCTGCTGA 3'
3: 5'  CGA CCGCGCGCA GAA GTGCTTCCTGCTGA 3'
4: 5 ' CGACCGCGCGCATAAGGGCTTCCTGCTGA 3'
3B.4.2. Characterization of Internal In-Frame Deletion Mutations.
Resultant clones from site-directed m utagenesis using the 
oligonucleotides LA21 and LA22 were initially screened by Xhol restriction enzyme 
digestion. From an initial screen of 12 clones, the mutation efficiency was foundl to be 
75% with LA21 and 80% with LA22. Clones containing Xhol restriction sites; were 
further analysed by dideoxy sequencing reactions, as described in Section 3B.4.1. A 
small number of clones were found to have large DNA rearrangements; the maijority 
gave the correct sequence. Figure 3B.6 shows representative sequence analy sis of 
clones obtained from mutagenesis with the LA22 oligonucleotide.
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T C G A T C G A
Figure 3B.6. Representative Sequence Analysis of Clones from In 
Vitro Site Directed Mutagenesis.
Clones generated by in vitro site-directed nutagenesis were sequenced by the dideoxy 
chain termination method, using a Sequerase Version 2.0 sequencing kit, as described 
in Section 2B.21. Radiolabelled fragments generated by the sequencing reaction were 
electrophoresed on a denaturing 8% acryUmide gel, and fragments visualized by 
autoradiography. The Figure illustrates sequences generated from  2 clones. The clones 
illustrated contain deletion mutations introduced by the mutagenic oligonucleotide 
LA22.
The sequence shown, starting from the arrowed C and proceeding downwards, reads: 
5'
CCGCGCGCA GAAGGGCTTCCTGCTGACCAGCCTCGA GAA CGCGGCGCTGA 
CGGGGGCCGCGGGGAGCCCCGGCGCCGG 3'
The Xhol restriction site introduced by the mutagenesis is underlined.
3B.5. Discussion.
Random mutagenesis of the 'helix-turn-helix" motif was achieved by the 
introduction of G to T mutations throughout the region encompassing nucleotides
1333-1428. This approach was used, rather than the introduction of specific amino acid 
alterations throughout the motif, as little was known about the function of portions of 
the region, and the Vmwl75 motif fitted no known consensus sequences for other 
DNA binding proteins, which may have highlighted specific target residues for 
mutagenesis (see Section 3A.6). Of the twelve possible combinations of base pair 
alterations that could be introduced, the G to T alteration was used to carry out
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mutagenesis of the amino acid sequence, as it was determined that alteration of 
individual G residues throughout the motif to T residues would result in the maximum 
number of mutations of conserved amino acids. In addition, alteration of G residues to 
T residues would not result in the introduction of stop codons within the target region.
Mutagenesis with the "spiked" oligonucleotides resulted in an overall 
mutation efficiency of 37%, which is lower than that normally achieved with the 
Amersham system. With other, non-"spiked" oligonucleotide mutagenesis reactions, 
the mutation efficiency was as expected (eg. 75% with LA21, see Section 3B.4.2). 
Therefore, it appears that this drop in efficiency is due solely to the use of the "spiked" 
oligonucleotides. Degradation of the "spiked" oligonucleotides LA 15-18 was observed 
when the oligonucleotides were used as primers for dideoxy sequencing reactions. This 
degradation may have led to the reduced efficiency due to problems created during the 
annealling step of the mutagenesis protocol. In addition, the synthesis of "spiked" 
oligonuceotides results in a final preparation containing at least 50% of 
oligonucleotides with a wild type sequence. The use of such a mixture in 
oligonucleotide-directed mutagenesis would result in a drop in the mutation efficiency, 
as observed.
Although the mutation efficiency of the system was relatively low, most 
of the mutations which were expected to occur were isolated. Only 5 mutations were 
not isolated; the majority of these were situated towards the 5* or 3' termini of the 
mutagenic oligonucleotides. "Melting" of the termini of the oligonucleotides during 
mutagenesis may have led to inefficiencies in either primer utilization or ligation after 
synthesis of the completed second strand, resulting in the failure to obtain these 
mutations. Several double mutations were isolated, most of which duplicated single 
mutations previously isolated. In the majority of cases these were not analysed further. 
One base pair deletion mutant was isolated from a round of mutagenesis with the LA 15 
olignucleotide. This deletion resulted in a frameshift in the IE-3 coding region, and 
introduction of a stop codon at codon 454. Expression of this mutation would lead to 
truncation of the Vmwl75 DNA binding domain before the proposed turn of the motif, 
and analysis of the in vitro properties of this mutant could possibly reveal the function 
of this portion of the Vmwl75 DNA binding domain.
The majority of point mutations were analysed further. The mutations 
analysed for in vitro DNA binding activity are summarized in Figure 3B.7 and Table 
3B.2.
In-frame deletion mutations were introduced within the motif in order to 
remove large regions of either proposed helix. Analysis of these mutations would 
provide information on the function <of either helix, a technique which has proved 
useful in delineating the function of other helical protein motifs (Williams and Tjian, 
1991). Two rounds of mutagensis were caried out to introduce these deletions into the
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Table 3B.2: Mutants Isolated From Spiked Oligonucleotide-Directed Mutagenesis. 
Analysed for DNA Binding Activity.
Construct
(a)
Site of G to T 
mutation 
(b)
Site of amino acid 
alteration 
(c)
Amino acid 
alteration
(d)
Name
(e)
LA15 no. 2 1351 451 Ala to Ser 451 A/S
LA15 no. 3 1351
1357
451
453
Ala to Ser 
Ala to Ser
451/3 A A/S S
LA15 no. 5 1345 449 Ala to Ser 449A/S
LA15 no. 9 1336 446 Ala to Ser 446A/S
LA 15 no. 36 1357 453 Ala to Ser 453A/S
LA15 no.74 1348 450 Ala to Ser 450A/S
LA16 no. 16 1357 453 Ala to Ser 453A/S
LA16 no. 39 1370 457 Arg to Leu 457R/L
LAI6 no. 48 1375 459 Asp to Tyr 459D/Y
LA 16 no. 49 1367 456 Arg to Leu 456R/L
LAI7 no. 6 1381 461 Ala to Ser 461A/S
LA17 no. 29 1390 464 Gly to Cys 464G/C
LA 17 no. 31 1386 462 Gin to His 462Q/H
LA 17 no.35 1389
1390
463
464
Lys to Asn 
Gly to Cys
463/4KG/NC
LA 18 no. 1 1415 472 Arg to Leu 472R/L
LA18 no.14 1412 471 Arg to Leu 471R/L
LAI8 no. 19 1406 469 Ser to lie 469S/I
LA 18 no. 26 1423 475 Ala to Ser 475A/S
LA15 no. 57 1355(del) 452 Stop codon at 
454
452del
Legend to Table 3B.2.
(a) The original name of the mutant clone, showing the oligonucleotide used for the 
mutagenesis reaction and the clone number isolated.
(b) The site of G to T mutation is shown as nucleotide number within the IE-3 open 
reading frame, numbered from +1 at the ATG start codon. In the case of the mutant 
452del, the base pair mutation introduced was not a G to T mutation, but a base pair 
deletion.
(c) The site of amino acid alteration is shown as codon number within the IE-3 open 
reading frame, numbered from 1 at the ATG start codon
(d) The type of amino acid alteration introduced by the G to T mutation. Amino acids 
are represented as three letter codes.
(e) The final construct name, showing the position of mutation as codon number, 
followed by the amino acid alteration. Amino acids are represented as one letter codes.
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motif, as described in Section 3B.3. The mutation efficiency achieved with the 
"deletion” oligonucleotides was close to the expected efficiency of the Amersham 
system, and deletion mutations of the correct sequence were obtained for further 
analysis.
3C. Expression and Purification of Wild Type and Mutant 
Polypeptides Encompassing the DNA Binding Domain of 
Vmwl75
In order to investigate the in vitro properties of the mutations whose 
construction is described in Section 3B, the mutations were introduced into a bacterial 
expression system. Mutant polypeptides encompassing the DNA binding domain of 
Vmwl75 expressed from this system provided a means of analysing the effects of the 
mutations on the in vitro properties of Vmwl75. This section describes the expression 
and purification of wild type and mutant DNA binding domain polypeptides.
3C.1. The pET Expression System.
Previously, portions of the IE-3 coding region have been expressed in a 
bacterial T7 expression system in order to assess the in vitro properties of the isolated 
DNA binding domain of Vmwl75 (Pizer et al., 1991; Everett et al., 1991a, b). The 
bacterial expression system used in these studies and for the work presented in this 
thesis is based on the pET expression system of Studier et al. (1990). The plasmid 
pA585.4 (obtained from C. M. Preston, Institute of Virology, Glasgow) is a derivative 
of the plasmid pET8c, constructed by the removal of the Hindlll site of the parent 
pBR322 vector and the insertion of an oligonucleotide linker containing a Hindlll 
restriction site between the Ncol and BamHI sites of the T7 promoter/terminator 
sequences (see Figure 3C.1). The plasmid series pA585T7 (obtained from J. Tyler, 
Institute of Virology, Glasgow) were further derivatives of pA585.4, created by 
removal of the Sphl/PvuII restriction fragment; removal of the EcoRI restriction site; 
and the insertion of NcoI/EcoRI oligonucleotide linkers and the EcoRI/Hindlll 
restriction fragment containing the pUC18 polycloning site between the Ncol and 
Hindm sites of pA585.4 (see Figure 3C.1). The plasmids pA585T7a and pA585T7t>2
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contain unique NcoI/EcoRI oligonucleotide linkers enabling expression of cloned 
coding regions in two reading frames. The plasmids pJI9 and pJIlO contain the 19/110 
EcoRI/BamHI restriction fragments encompassing IE-3 nucleotides 752-1725 and 823- 
1725, as described in Section 3B.1, cloned into the EcoRI and BamHI restriction sites 
of pA585T7t>2 and pA585T7a respectively, thus enabling expression of portions of the 
IE-3 coding region in bacteria. pJI9 expresses codons 252 to 523 and pJIlO expresses 
codons 276 to 523 of Vmwl75, both with an additional five residues encoded by vector 
sequences at the N-terminus, and another 20 spurious residues at the C-terminus (see 
Figure 3C.lb).
Mutations created as described in Section 3B were transferred as 
EcoRI/BamHI restriction fragments into plasmids pJI9 or pJIlO. In order to remove the 
20 C-terminal vector encoded residues, "X" versions of the plasmids were made by 
insertion of Xbal blunt-ended oligonucleotide linkers containing stop codons in all 
three reading frames into the blunt-ended BamHI restriction site immediately preceding 
the T7 terminator sequences (see Figure 3C.1). The sequence containing the proposed 
mutation was verified by dideoxy sequence analysis after each step of the cloning 
procedure.
The cloned Vmwl75 coding sequences within these plasmids also 
contained a unique Nrul restriction site, situated at residue 920 of the IE-3 open reading 
frame. This restriction site provided a means by which mutations could be transferred 
between different expression vectors. Mutations were transferred between 19 and 110 
plasmids as NruI/BamHI fragments, whereas mutations were transferred between I9X 
and II OX plasmids as Nrul/Xbal fragments.
3C.2. Production of Bacterial Extracts Containing Wild Type and Mutant 
Polypeptides for Gel Retardation Analysis.
Mutations were transferred to the relevant pA585T7 based vector and 
resultant vectors transfected into the E. coli strain BL21(DE3)pLysS. This bacterial 
strain carries a lysogen (DE3) which directs the transcription of T7 RNA polymerase 
upon induction with IPTG, and therefore the expression of the cloned polypeptide.
The expression of cloned polypeptides, and the preparation of bacterial 
extracts containing these polypeptides was carried out as described in Sections 2B.27 
and 2B.28. Various methods were employed to obtain bacterial extracts containing 
mutant and wild type forms of the Vmwl75 DNA binding domain, due to problems 
with the solubility and stability of expressed proteins, as detailed below.
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3C.2.1 Induction and Extraction of 19 Polypeptides.
Initially, mutations were introduced into the pJI9 vector and expression 
from these vectors induced to produce mutant and wild type forms of the 19 
polypeptide. SDS-polyacrylamide gel electrophoresis of samples taken during the 
extraction of wild type 19 polypeptide showed that the 19 polypeptide yield was 
relatively low, due mainly to insolubility of the protein and possible association of 19 
with DNA in the cell debris. As the induction of 19 expression was poor, the 
concentration of 19 polypeptide in the final extract was low.
It was found that mutant polypeptides in general were expressed to lower 
quantities and were less soluble than their wild type counterparts. Therefore, it was 
concluded that, with the exception of the mutant 452 del, expression of mutations in the 
background of the 19 polypeptide would yield insufficient quantities of mutant 
polypeptide for in vitro analysis (see Tables 3C.1 and 3C.2).
3C.2.2. Induction and Extraction of 110 Polypeptides.
Mutant polypeptides were next expressed as 110 DNA binding domain 
polypeptides. SDS-PAGE analysis of an 110 extraction procedure is shown in Figure 
3C.2. Comparison of tracks 1 and 2 shows that the induction of 110 polypeptide was 
still low; however, less 110 polypeptide was lost in the centrifugation of cell debris or 
in the final solubilization of ammonium sulphate precipitated proteins.
The induction and solubility of mutant 110 polypeptides were lower than 
that of the wild type polypeptide, as shown by SDS-polyacrylamide gel elctrophoresis 
of final bacterial extracts (see Figure 3C.3). The solubility of mutant polypeptides was 
extremely variable, as illustrated in Tables 3C.1 and 3C.2.
Table 3C.1. The Expression and Purification of Mutant Vmwl75 DNA Binding 
Domain Polypeptides.
Mutant Name 
(a)
Expressed as 
(Polypeptide)
(b)
Method of 
Extraction 
(c)
Further
Purification
(d)
Solubility
(e)
Properties
Determined
(f)
451 A/S 19 2B.27.1 - ++ DNA binding
451/3 AA/SS 19 2B.27.1 - +/- DNA binding
446A/S 19 2B.27.1 - +++ DNA binding
449A/S 19 2B.27.1 - ++ DNA binding
453A/S 19 2B.27.1 - +++ DNA binding
452del 19 2B.27.1 - +++ DNA binding
450A/S 19 2B.27.1 - + DNA binding
472R/L 110 2B.27.1 - ++ DNA binding
471R/L 110 2B.27.1 - +++ DNA binding
475A/S 110 2B.27.1 - + DNA binding
469S/I 110 2B.27.1 - - N/D
453A/S I9X 2B.27.2 - +++ DNA binding
463/4KG/NC I10X 2B.27.2 - +++ DNA binding
459D/Y I9X 2B.27.2 ++ DNA binding
456R/L I9X 2B.27.2 - ++ DNA binding
464G/C I10X 2B.27.2 +++ DNA binding
462Q/H I10X 2B.27.2 _ +++ DNA binding
il2 I10X 2B.27.2 - - N/D
461 A/S I10X 2B.27.2 - +++ DNA binding
DH1 I10X 2B.27.2 - + DNA binding
457R/L I10X 2B.27.2 - + DNA binding’
ril2 I10X 2B.27.2 - + DNA binding
DH2 I10X 2B.27.2 - ++ DNA binding
Legend to Table 3C.1.
(a) The final construct name, showing the position of mutation as codon number, 
followed by the amino acid alteration. Amino acids are represented as one letter codes.
(b) The version of the DNA binding domain of Vmwl75 used to express the individual 
mutations. The various constructs are described in the text.
(c) The method of extraction is indicated by the relevent Section number.
(d) Indicates whether the polypeptide was purified further by ion exchange 
chromatography.
(e) The qualitative solubility of the polypeptide, as measured by the amount of 
polypeptide in the final soluble extract, as determined by Western Blot analysis. The 
solubility of individual mutant polypeptides was measured by comparing to an internal 
wild type polypeptide control. - = barely detectable levels of polypeptide; ++++ = level 
of wild type polypeptide.
(f) The properties measured using the soluble extract shown. DNA binding activity was 
determined by gel retardation analysis as described in Section 3D. N/D = properties not 
determined due to insolubility of the polypeptide.
Table 3C.2. The Expression and Purification of Mutant Vmwl75 DNA Binding 
Polypeptides.
Mutant Name 
(a)
Expressed as 
(polypeptide) 
(b)
Method of 
Extraction 
(c)
Further
Purification
(d)
Solubility
(e)
Properties
Determined
(f)
469S/I 110 2B.28 - - N/D
472R/L 110 2B.28 - +++ DNA binding
471R/L 110 2B/28 - +++ DNA binding
475A/S 110 2B.28 - + DNA binding
451 A/S 110 2B.28 - ++ DNA binding 
Cross-linking
451/3 AA/SS 110 2B.28 - + DNA binding 
Cross-linking
449A/S 110 2B.28 - +++ DNA binding 
Cross-linking
446A/S 110 2B.28 - ++ DNA binding 
Cross-linking
453A/S 110 2B.28 - + DNA binding 
Cross-linking
450A/S 110 2B.28 - + DNA binding 
Cross-linking
452del 19 2B.28 - - N/D
452del 110 2B.28 - - N/D
472R/L 110 2B.28 MonoS +++ Cross-linking
451 A/S 110 2B.28 MonoS + Cross-linking
451/3 AA/SS 110 2B.28 MonoS +++ Cross-linking
472R/L I10X 2B.28 - ++ DNA binding
451 A/S I10X 2B.28 - + DNA binding
451/3 AA/SS I10X 2B.28 ++ DNA binding
471R/L I10X 2B.28 - + DNA binding
469S/I I10X 2B.28 - - N/D
449A/S I10X 2B.28 - ++ DNA binding
446A/S I10X 2B.28 - +++ DNA binding
453A/S I10X 2B.28 - ++ DNA binding
450A/S I10X 2B.28 - +++ DNA binding
tsK I10X 2B.28 - + DNA binding
Mutant Name 
(a)
Expressed as 
(polypeptide)
(b)
Method of 
Extraction 
(c)
Further
Purification
(d)
Solubility
(e)
Properties
Determined
(f)
456R/L I10X 2B.28 MonoS +++ Gel Filtration
463/4KG/NC I10X 2B.28 MonoS ++ Gel Filtration
DH1 I10X 2B.28 MonoS + N/D
Legend to Table 3C.2.
a) The final construct name, showing the position of mutation as codon number, 
followed by the amino acid alteration. Amino acids are represented as one letter codes.
(b) The version of the DNA binding domain of Vmwl75 used to express the individual 
mutations. The various constructs are described in the text.
(c) The method of extraction indicated by the relevent Section number.
(d) Indicates whether the polypeptide was purified further by ion exchange 
chromatography.
(e) The qualitative solubility of the polypeptide, as measured by the amount of 
polypeptide in the final soluble extract, as determined by Western Blot analysis. The 
solubility of individual mutant polypeptides was measured by comparing to an internal 
wild type polypeptide control. - = barely detectable levels of polypeptide; ++++ = level 
of wild type polypeptide.
(f) The properties measured using the soluble extract shown. DNA binding activity was 
determined by gel retardation analysis as described in Section 3D. Dimerization 
activity was determined by glutaraldehyde cross-linking assays or gel filtration analysis 
as described in Section 3E. N/D = properties not determined due to insolubility of the 
polypeptide.
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110
polypeptide
Figure 3C.2. SDS-Poly£crylamide Gel Electrophoresis of an Extraction 
of 110 Polypeptide.
Proteins were extracted from  induced cultures o f BL21(DE3)pLysS as described in 
Section 2B.27.2. Samples taken at particular stages during the extraction protocol 
were electrophoresed on 12.5% SDS-polyacrylamide gels and stained with 
Coomassie blue.
Track 1 : Polypeptide profile o f uninduced BL21(DE3)pLysS bacteria.
Track 2 : Polypeptide profile o f induced BL21 (DE3 jpLysS bacteria expressing 110 
polypeptide.
Track 3 :1/300 vol.supernatant after centrifugation o f cell debris.
Track 4 :1/100 vol. cell debris pellet.
Track 5 :1/450 vol. supernatant after ammonium sulphate precipitation.
Track 6 :1 /2  vol. insoluble protein pellet.
Track 7 :1/30 vol. fina l bacterial extract.
Track 8 : Molecular weight standards : 66kDa, 45kDa, 36kDa, 29kDa, 24kDa,
20.1kDa, 14.2kDa.
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110 polypeptide
1 2 3 4 5 6
Figure 3C.3. SDS-Polyacrylamide Gel Electrophoresis of Mutant and 
Wild Type 110 Polypeptide Extracts.
Proteins were extracted from  induced cultures ofBL2l(DE3)pLysS as described in 
Section 2B.27.2.1/30 vol. o f the final extracts were analysed on a 125%  
SDS-polyacrylamide gel and stained with Coomassie blue.
Track 1 : 472R/L110 
Track 2 :471RILI10  
Track 3 : 469SII110 
Track 4 :475A/S 110 
Track 5 :110
Track 6 : Molecular weight standards : 66KDa, 45kDa, 36kDa, 29kDa, 24kDa,
20.1kDa, 14.2kDa.
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3C.2.3. Induction and Expression of I9X and I10X Polypeptides.
Mutations were finally expressed within I9X and IIOX polypeptides. 
Although mutant polypeptide induction and solubility were again lower than that of 
wild type, the final yield of protein was sufficient for gel retardation analysis. Figure 
3C.4 shows a representative SDS-PAGE analysis of the extraction of the IIOX 
polypeptide.
The solubility of mutant I9X and II OX polypeptides was extremely 
variable, as summarized in Tables 3C.1 and 3C.2.
- I f
— II OX polypeptide
1 2 3 4 5
Figure 3C.4. SDS-Polyacrylamide Gel Electrophoresis of an Extraction 
of the I10X Polypeptide.
Proteins were extracted from  induced bacterial cultures as described in Section 
2B.27.1. Samples taken at various stages during the extraction protocol were 
electrophoresed on 12.5% SDS-polyacrylamide gels and stained with Coomassie 
blue.
Track 1: Polypeptide profile o f induced BL21 (DE3) pLysS bacteria 
expressing the IIOX polypeptide.
Track 2:1/300 vol. supernatant following centrifugation o f cellular debris.
Track 3:1/2 vol. insoluble protein pellet.
Track 4:1130 vol. final extract.
Track 5: Molecular weight standards: 66kDa, 45kDa, 36kDa, 29kDa, 24kDa,
20.1kDa, 14.2kDa.
3C.2.4. Methods of Extraction of Mutant and Wild Type Polypeptides for Gel 
Retardation Analysis.
Various extraction methods were emplioyed to obtain samples of mutant and 
wild type polypeptides for gel retardation analysis. Initially, extracts were obtained as 
described in Section 2B.27.1. This method was found to result in smeared complexes 
upon gel retardation analysis. This problem was resolved in two ways. Firstly, the
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expression of DNA binding domain polypeptides as "X" versions (described in Section 
3C.1) increased the stability of the polypeptides and resulted in clearly resolved 
complexes upon gel retardation analysis. Additionally, the method of extraction of the 
polypeptide was adapted for various purposes.
It was found that adaptation of the extraction protocol as detailed in Section 
2B.27.2 resulted in extracts with relatively low yields of DNA binding domain 
polypeptides, but which gave clearly resolved complexes upon gel retardation analysis.
Finally, the extraction procedure was adapted to increase the purity of the 
expressed polypeptide. This adapted procedure is described in Section 2B.28, and was 
mainly used to prepare extracts for dimerization studies (see Section 3C.3). However, 
several mutant polypeptide extracts prepared in this way were analysed in gel 
retardation assays. The different methods used to prepare bacterial extracts containing 
wild type and mutant DNA binding domain polypeptides for gel retardation analysis 
are summarized in Tables 3C.1 and 3C.2. The results illustrated in Section 3D 
regarding gel retardation analysis of DNA binding domain polypeptides were obtained 
using bacterial extracts prepared as described in Sections 2B.27.2 and 2B.28.
3C.3. Production of Bacterial Extracts Containing Wild Type and Mutant 
Polypeptides for Dimerization Studies.
Mutations were tested for their ability to disrupt the dimerization 
properties of the I9X or II OX polypeptides, using the extraction protocol described in 
Section 2B.28.
Figure 3C.5 shows SDS-polyacrylamide gel elctrophoresis of samples 
taken during the extraction of selected mutant and wild type I9X and II OX 
polypeptides, and illustrates the improved yield and purity achieved with this extraction 
procedure. Certain mutant polypeptides, for example the mutant 459D/Y, were found 
to be insoluble under these conditions, and could not be analysed further. As with all 
other extraction procedures, the solubility of mutant polypeptides was found to be 
variable. Table 3C.2 summarizes the results obtained with this extraction procedure.
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I10X
459 D/Y
463/4 K G / N C ^  §  J | |  a  19X
---------------------II----------------------II 1 M
463/4KG/NC 459D/Y DH1
IlOX I9X IlOX
I _U________________ II_________________ I M
DH1 I9X IlOX
IlOX
Figure 3C.5. SDS-Polyacrylamide Gel Electrophoresis of Mutant and 
Wild Type I9X and IlOX Polypeptides.
Proteins were extracted from  induced cultures as described in Section 2B.28. 
Samples taken at particular stages during the extraction protocol were 
electrophoresed on 12.5% SDS-polyacrylamide gels and stained with Coomassie 
blue.
For each polypeptide shown, the following samples were analysed:
Track 1: Polypeptide profile o f induced BL21 (DE3) pLysS bacteria expressing
the relevant polypeptide.
Track 2:1/300 vol. supernatant after centrifugation o f cell debris.
Track 3:1/100 vol. cell debris pellet.
Track 4:1/2 vol. insoluble protein pellet.
Track 5:1/30 vol. final extract.
M: Molecular weight standards: 66kDa, 45kDa, 36kDa, 29kDa, 24kDa,
20.1kDa, 14.2kDa.
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3C.4. Further Purification of Bacterial Extracts Containing Wild Type and 
Mutant Polypeptides for Dimerization Studies.
In order to carry out gel filtration chromatography, it was necessary to obtain 
preparations of various polypeptides at purities of 90% or greater. Bacterial extracts 
obtained as described in Section 2B.28 were further purified by FPLC ion exchange 
chromatography, as detailed in Section 2B.29.
Initially, ion exchange chromatography was carried out on bacterial 
extracts which had been treated with polyethylenimine to remove digested nucleic 
acids. Under these conditions, it was found that wild type I9X and IlOX polypeptides 
were eluted in sharp peaks at 0.8M and 0.5M NaCl respectively. SDS-PAGE analysis 
of fractions from this purification showed that peak fractions were approximately 90% 
pure on Coomassie blue stained gels (see Figure 3C.6). Some IlOX polypeptide was 
also eluted in flow-through fractions, as seen in Figure 3C.6, tracks 1 and 2. Mutant 
polypeptides were eluted from the MonoS column at various ionic strengths. 456R/L 
I9X was eluted at 0.8M NaCl, 472R/L 110 was eluted at 0.25M NaCl and 449A/S 110 
was eluted at 0.28M NaCl.
IlOX polypeptide
1 2 3 4 5 6 7 8 9  
Figure 3C.6. SDS-Polyacrylamide Gel Electrophoresis of Fractions from 
Ion Exchange Chromatography of the IlOX Polypeptide.
IlOX protein was extracted from  induced BL21 (DE3) pLysS cultures as described in 
Section 2B.28. Following dialysis, the extract was loaded on to a Pharmacia MonoS 
ion exchange column and the polypeptide eluted with a salt gradient, as described in 
Section 2B.29. 2ml fractions were collected and 20ul o f each fraction analysed by 
electrophoresis on a 125%  SDS- polyacrylamide gel/followed by staining with 
Coomassie blue.
Tracks 1-2: Flowthrough fractions.
Tracks 3-8: Peak fractions.
Track 9: Molecular weight standards: 66kDa, 45kDa, 36kDa, 29kDa,
24kDa, 20.1kDa, 14.2kDa.
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Mutant polypeptide extracts which had not been treated with 
polyethylenimine during the extraction procedure were eluted from the MonoS column 
in the flow-through fractions (see Figure 3C.7). Mutant polypeptides eluted in this way 
were further purified as described in Section 2B.29. Final fractions from this procedure 
were again approximately 90% pure on Coomassie blue stained gels (see Figure 3C.8).
■T r  ' _ 66kDa
_ 45kDa
-  36kDa
-  29kDa 
-  —  —  —  -  24kDa
-  20.1kDa
-  14.2kDa
1 2 3 4 5 6 7
Figure 3C.7. SDS-Polyacrylamide Gel Electrophoresis of fractions 
from Ion exchange Chromatography of the ril2 IlOX Polypeptide.
ril2  IlOX protein was extracted from  induced BL21 (DE3) pLysS cultures as 
described in Section 2B.28, omitting treatment with polyethylenimine. Following 
dialysis, the extract was loaded onto a Pharmacia MonoS ion exchange column, 
and the protein eluted with a salt gradient, as described in Section 2B.29. lm l 
fractions were collected and 20ul o f each fraction analysed by electrophoresis on 
a 125% SDS-polyacrylamide gel, followed by staining with Coomassie blue.
Track 1: Input extract.
Tracks 2-7: Flowthrough fractions.
ril2  IlOX
v.
V
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_ — 66kDa
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Figure 3C.8. SDS-Polyacrylamide Gel Electrophoresis of a 
Purification of a Mutant IlOX Polypeptide Following Ion Exchange 
Chromatography
463/4KG/NC IlOX polypeptide was extracted from  induced BL21 (DE3) 
pLysS cultures as described in Section 2B.28, omitting treatment with 
polyethylenimine. Following dialysis, the extract was loaded onto a Pharmacia 
MonoS ion exchange column and the protein eluted with a salt gradient as 
described in Section 2B.29. The majority o f the protein was eluted in the flow ­
through fractions. Protein was purified further from  these flowthrough fractions 
as described in Section 2B.29. Samples taken at various stages during this 
purification protocol were analysed by electrophoresis on 12.5% 
SDS-polyacrylamide gels, followed by staining with Coomassie blue.
Track 1: Purified fraction following concentration.
Track 2: Purified fraction before concentration.
Track 3: Flowthrough fraction.
3C.5. Discussion.
Expression of wild type and mutant versions of the DNA binding domain 
of Vmwl75 led to many problems, mainly due to the low induction and solubility of 
the expressed polypeptides. Initially, it was found that induction of bacterial cultures 
transformed with the pJI9 vector led to low levels of expression of the wild type 19 
polypeptide. This could have been due to an inherent instability of the isolated 
polypeptide. Extraction of the polypeptide from bacterial cells led to a further reduction 
in yield, as the 19 polypeptide was precipitated both during the centrifugation of cell 
debris and the centrifugation of insoluble ammonium sulphate precipitated proteins. 
Loss of 19 polypeptide during centrifugation of cell debris may have been caused by 
the incomplete disruption of the interactions between the 19 polypeptide and cellular 
DNA. Loss of 19 polypeptide during both centrifugation steps would also occur due to 
the low solubility of the expressed protein. As shown in Section 3C.2.2, expression of 
110 polypeptides led to an improvement in the final yield of polypeptide, as the 110 
protein appeared to be slightly more soluble. It would have been preferable to test the
463/4KG/NC
IlOX
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effects of the mutations on the DNA binding properties of the 19 polypeptide, as the 19 
polypeptide had been shown to bind to DNA with a specificity similar to that of the 
whole Vmwl75 protein, and to produce a DNAasel footprint at the Vmwl75 
consensus binding site situated at the IE-3 capsite; whereas 110 polypeptide exhibited a 
slightly more relaxed specificity in binding ability as measured by gel retardation 
analysis, and did not produce a pronounced DNAasel footprint at the IE-3 capsite 
(Pizer et al., 1991; Everett et al., 1991; Everett, unpublished observations). Also, 
previous studies had shown that the 19 insertion mutation produced no detectable 
alteration in the transactivation, repression and in vitro DNA binding properties of 
Vmwl75 (as measured by transient transfection and gel retardation assays); whereas 
the 110 mutation led to slight reductions in these properties, suggesting that the site of 
the 110 mutation may be within a region important for the conformational stability of 
the whole protein and for the isolated DNA binding domain (Paterson, 1989). 
However, due to the improved yield of 110 polypeptide, it was thought necessary to 
express the mutations within 110 instead of 19 polypeptides, in order to obtain sufficient 
polypeptide concentrations for gel retardation analysis.
Ongoing studies showed that gel retardation analysis with 19 and 110 
polypeptides produced smeared complexes which were not easily resolvable, 
presumably due to degradation of the polypeptides. Removal of the 20 C-terminal 
amino acids by insertion of a stop codon within the BamHI restriction site at codon 523 
of the IE-3 coding sequence of the pJI9 and pJIlO vectors, to yield I9X and IlOX 
polypeptides, resulted in a clearly resolved protein-DNA complex upon gel retardation 
electrophoresis (see section 3D for gel retardation analysis). Therefore, mutations were 
expressed within I9X or IlOX polypeptides.
It was observed consistently throughout these extraction procedures that 
the expression and purification of all mutant polypeptides were lower than that of the 
wild type polypeptide. This observation correlates closely with results obtained in 
transfection experiments with plasmids containing insertional mutations within the 
Vmwl75 DNA binding domain. In the case of the insertional mutants 114-118, situated 
at IE-3 codons 329, 337, 373, 398 and 438 respectively, it was found that cells 
transfected with versions of pl75 containing these mutations produced lower quantities 
of mutant Vmwl75 protein compared to transfections with wild type pl75. It was 
suggested that this low yield of mutant protein may again have been caused by lower 
protein solubility or reduced stability of expressed proteins (Paterson, 1989). These 
solubility and stability problems led to a wide variation in polypeptide content of 
bacterial extracts containing mutant versions of DNA binding domain polypeptides.
Tables 3C.1 and 3C.2 summarize the methods employed to produce 
bacterial extracts containing mutant and wild type DNA binding domain polypeptides 
for DNA binding and dimerization assays. These tables also illustrate the relative
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solubility of mutant DNA binding domain polypeptides as compared to wild type 
polypeptides, and demonstrate the variable solubility of the mutant proteins. These 
differences in solubility cannot be attributed to specific sequence changes, as it was 
found that the solubility of a mutant polypeptide as measured by the final yield of the 
protein in the bacterial extract varied between subsequent inductions, as well as with 
different expression systems and extraction procedures. However, certain mutations 
drastically decreased the solubility of the polypeptides consistently, such that the 
properties of such mutant proteins could not be determined. This is true of the mutants 
469S/I and il2. As each mutant polypeptide was compared to an internal control wild 
type polypeptide for the determination of qualitative solubility, these tables do not 
illustrate the differences in yield observed with different extraction procedures. The 
main advantages obtained from the adaptation of extraction protocols described in 
Sections 3C.2 and 3C.3 were an improvement in the purity and stability of the final 
polypeptide extracts rather than a quantitative increase in the yield of certain 
polypeptides.
The adaptation of the polypeptide extraction procedure described in 
Section 3C.3 greatly improved the purity of I9X and IlOX polypeptides. The one-step 
purification of polypeptides upon ion exchange chromatography yielded peak fractions 
of sufficient purity for further analysis by glutaraldehyde cross-linking and gel 
filtration chromatography. The loss of some wild type and mutant polypeptides in the 
flow-through during such purification procedures was presumably due to over­
saturation of the column's binding capacity. In contrast, when nucleic acids had not 
been removed from polypeptide extracts by precipitation with polyethylenimine, the 
majority of the polypeptide was eluted in the flow-through. This change in behaviour 
of the polypeptides during ion exchange chromatography was presumably due to the 
presence of nucleic acids in the bacterial extracts which interfere with the binding of 
the polypeptides to the ion exchange matrix. The observation that the wild type I9X 
polypeptide was eluted from a MonoS column at a much higher ionic strength than 
previously noted for the IlOX polypeptide (around 0.8M NaCl for I9X, 0.29M NaCl for 
IlOX) implies that the I9X polypeptide binds more stongly to the negative ionic matrix 
of the MonoS column. It is interesting to note that the region removed from the IlOX 
polypeptide which is present in the I9X polypeptide (codons 253-275) contains a 
stretch of basic amino acids which may contribute to its strong interaction with the 
negative ionic matrix of the MonoS column.
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3D. Determination of the I n  V i t r o  DNA Binding Activity 
of Wild Type and Mutant Polypeptides Encompassing the 
DNA Binding Domain of Vmwl75.
One approach used to investigate the function of the "helix-tum-helix" 
motif of the DNA binding domain of Vmwl75 involved the analysis of the DNA 
binding activities of the mutant polypeptides whose construction, expression and 
extraction has been described in Sections 3B and 3C. In order to determine the DNA 
binding activities of these polypeptides, gel retardation analysis was carried out using a 
DNA probe which encoded the Vmwl75 consensus DNA binding site situated at the 
capsite of its own IE-3 gene.
In addition to this analysis, the DNA binding activity of another mutant 
polypeptide, designated ril2, was determined. The ril2 mutation, described in Section 
1C.3, is situated towards the N-terminus of the DNA binding domain of Vmwl75, 
outwith the limits of the "helix-tum-helix” motif.
These assays would be useful in determining the contribution, if any, of 
these regions of the protein towards the in vitro DNA binding properties of the isolated 
DNA binding domain of Vmwl75.
3D.1. Western Blot Analysis of Bacterial Extracts.
In order to ensure that equivalent amounts of DNA binding domain 
polypeptides were assayed for DNA binding activity, the Vmwl75 polypeptide content 
of bacterial extracts was quantified by Western blot analysis. The polypeptides were 
detected with a polyclonal anti-Vmwl75 antibody, as described in Section 2B.6.3.
Initially, Western analysis was carried out on expressed 19 polypeptides 
containing various mutations. It was found that the mutation 452del led to the 
expression of a truncated polypeptide of 22kDa molecular weight, which is close to the 
predicted molecular weight of the 19 polypeptide truncated at codon 454 (Figure 3D.1, 
track 2) Additional polypeptides of higher molecular weight than the 19 polypeptide 
were also detected (see Figure 3D.1). Analysis of uninduced BL21(DE3)pLysS extracts 
showed that these bands were due to interaction of the anti-Vmwl75 antibody with 
bacterial proteins. The 19 protein was found to be unstable; degradation products were 
observed in extracts even without previous incubations at room temperature or 37°C
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(see Figure 3D.1, track 9). The degradation products were presumably due to 
proteolysis of the protein during the extraction procedure.
1 2 3 4  5 6 7  8 9
Figure 3D.1. Western Blot Analysis of Mutant and Wild Type 19 
Polypeptides.
Polypeptides were extracted from  induced BL21 (DE3) pLysS cultures as described it 
Section 2B.27.1. Extracts were electrophoresed on 12.5% SDS-polyacrylamide gels, 
oroteins transferred onto nitrocellulose and immunoblotted as described in Section 
2B.6.3. Proteins were immunoblotted with a polyclonal rabbit antibody raised to a 
bacterial fusion protein containing the Vmwl 75 DNA binding domain, used at a 
1:1000 dilution.
Track 1 :450A/S19 Track 2: 452del 19
Track 3 : 449A/S19 Track 4: 453A/S 19
Track 5 : 446AIS19 Track 6: 451/3AA/SS 19
Track 7:451 A/S 19 Track 8: 451 A/S 19
Track 9:19
Mutations were also assayed for their ability to interfere with the DNA 
binding ability of I9X and IlOX polypeptides. Again, Western blot analysis was used to 
determine the volume of bacterial extracts containing equivalent quantites of Vmwl75 
polypeptide. The IlOX extracts were frequently observed to contain a degradation 
product (see Figure 3D.2) and mutant and wild type I9X polypeptides still showed 
evidence of proteolysis (see Figure 3D.3). Several mutant I9X polypeptides yielded 
large quantities of a degradation product approximately 1000-2000Da smaller than the 
I9X polypeptide (Figure 3D.3, compare tracks 3, 9, 11 and 12). Interestingly, wild type 
I9X extracts did not appear to be contaminated with this particular degradation product.
Certain mutant polypeptides, such as the mutant 469S/I IlOX, 453/5AS/SI 
I9X and i l 2 IlOX were consistently expressed to very low levels (see Figure 3D.2, 
track 1 and Figure 3D.3, tracks 2 and 8). The low yield of polypeptides may have been 
due to their insolubility during the extraction procedure or instability during 
expression, as discussed in Section 3C.5. Due to these problems, several mutants could 
not be analysed further.
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The amounts of polypeptide in each extract were roughly quantitated by 
densitometric analysis of Western blots, and equivalent amounts analysed in gel 
retardation experiments (see Section 3D.4).
IlOX
1 2 3 4 5 6
Figure 3D.2. Western Blot Analysis of Mutant and Wild Type IlOX 
Polypeptides.
Polypeptides were extracted from  induced BL21 (DE3) pLysS cultures as described in 
Section 2B.27.1. Extracts were electrophoresed on 12.5% SDS-polyacrylamide gels, 
proteins transferred onto nitrocellulose and immunoblottedas described in Section 
2B.6.3. Proteins were immunoblotted with a polyclonal rabbit antibody raised to a 
bacterial fusion protein containing the Vmwl75 DNA binding domain, used at a 1:100* 
dilution.
Track 1: 469S/I IlOX Track 2:471R/L IlOX
Track 3: 451/3AA/SS IlOX Track 4:451 A/S IlOX
Track 5 : 472R/L IlOX Track 6: IlOX
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Figure 3D.3. Western Blot Analysis of Mutant and Wild Type I9X and 
IlOX Polypeptides.
Polypeptides were extracted from  induced BL21 (DE3) pLysS cultures as described if 
Section 2B.27.1. Extracts were electrophoresed on 12.5% SDS-polyacrylamide gels, 
proteins transferred onto nitrocellulose and immunoblotted as described in Section 
2B.6.3. Proteins were immunoblotted with a polyclonal rabbit antibody raised to a 
bacterial fusion protein containing the Vmwl 75 DNA binding domain, used at a 
1:1000 dilution.
Track 1: 457R/LI9X Track 2 : 469S/II9X
Track 3: 451 A/S I9X Track 4: DH1 IlOX
Track 5:461 A/S IlOX Track 6: 464G/C IlOX
Track 7: 462Q/H IlOX Track 8: il2  IlOX
Track 9: 453A/S I9X Track 10: 463/4KG/NC110X
Track 11: 459D/YI9X Track 12 :456R/LI9X
Track 13 :19X
3D.2. Detection of Further Degradation of I9X and IlOX Polypeptides 
Upon Incubation at Room Temperature or 37°C.
Due to the degradation of polypeptides observed in previous Western blot 
analyses, experiments were carried out to determine the stability of expressed 
polypeptides at room temperature and 37°C, in order to ensure that any loss in binding 
activity observed upon gel retardation analysis was not due to protein degradation. 
Bacterial extracts were incubated at room temperature or 37°C for 20min in gel 
retardation buffer. SDS boiling mix was added and polypeptides detected as described 
in Section 2B.6.3.
Analysis of the mutant polypeptide ril2  IlOX in this way showed that 
incubation of the polypeptide at room temperature or 37°C did not lead to further 
degradation than that seen in the original extract (see Figure 3D.4). Analysis of other 
mutant polypeptides resulted in similar results, and so it was concluded that any loss of
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DNA binding activity observed was not due to proteolysis during the incubation of 
protein with DNA.
1 2 3 1 2 3 1 2 3
Jm
I_________________II________________ II_______________ I
Control Room 37° C
Temperature
Figure 3D.4. Western Blot Analysis of il2 and ril2 IlOX Polypeptides.
H2 and ril2  IlOX polypeptides were extracted from  induced BL21 (DE3) pLysS  
cultures as described in Section 2B.27.1. The extracts were incubated at room 
temperature or 37°C fo r 20 minutes in gel retardation buffer and then electrophoresed 
on 125%  SDS-polyacrylamide gels. Proteins were transferred onto nitrocellulose and 
immunoblotted as described in Section 2B.6.3. Proteins were immunoblotted with a 
polyclonal rabbit antibody raised to a bacterial fusion protein containing the Vmwl75 
DNA binding domain, used at a 1:1000 dilution.
At each temperature, the following extracts were analysed:
Track 1: il2  IlOX 
Track 2: ril2  IlOX 
Track 3: IlOX.
3D.3. Wild Type DNA Binding Domain Polypeptides Bind to a Consensus 
Vmwl75 Binding Site.
Gel retardation analysis was carried out on extracts from non-induced 
BL21(DE3)pLysS cultures and induced cultures of BL21(DE3)pLysS which expressed 
the wild type IlOX polypeptide. Proteins were tested for their ability to bind to 45bp 
Aval-BamHI or 130bp EcoRI-BamHI DNA restriction fragments, both of which span 
the IE-3 capsite. Extracts were prepared as described in Section 3C, and equivalent 
amounts of polypeptide incubated for 20min at room temperature with the DNA probe 
as described in Section 2B.8.
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Uninduced bacterial extracts produced a high mobility complex with the 
IE-3 capsite probe, designated "bac" (see Figure 3D.5, track 2). The presence of the 
II OX polypeptide led to the formation of a specific, lower mobility I10X-DNA 
complex designated "P" (see Figure 3D.5, track 1). It was frequently observed that 
bacterial extracts containing induced Vmwl75 DNA binding domain polypeptides 
produced both "bac" and "P" complexes upon gel retardation analysis.
Probe
1 2 3
Figure 3D.5. Gel Retardation Analysis of the Wild Type IIOX Polypeptide.
Bacterial extracts were incubated with a radiolabelled probe spanning the IE-3 capsite 
fo r  20 minutes at room temperature. The conditions o f the binding reaction are 
described in Section 2B.8. Free and bound probe were separated by electrophoresis on 
a non-denaturing 4% polyacrylamide gel. Complexes were visualized by 
autoradiography.
Track 1: Bacterial extract containing IIOX polypeptide.
Track 2: Bacterial extract containing no induced polypeptide.
Track 3: Free probe.
"P": Complex form ed between IIOX polypeptide and probe.
"Bac": Complex form ed between bacterial protein(s) and probe.
Incubation of the DNA probe with high concentrations of the IIOX 
polypeptide led to the formation of a low mobility complex which migrated only a 
short distance into the gel. Titration of the IIOX extract led to the resolution of a ladder 
of specific I10X-DNA complexes, presumably formed due to multiple protein-DNA 
interactions (see Figure 3D.6). At higher dilutions, the formation of the specific 
primary complex "P" was again observed (see Figure 3D.6, tracks 6 and 7).
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Figure 3D.6. Gel Retardation Analysis of the Wild Type IIOX Polypeptide.
Bacterial extracts were incubated with a radiolabelled probe spanning the IE -3 capsite 
fo r  20 minutes at room temperature or 37°C. The conditions o f the binding reaction 
are described in Section 2B.8. Free and bound probe were separated by 
electrophoresis on a non-denaturing 4% acrylamide gel. Complexes were visualized by 
autoradiography.
A t each temperature, the same dilutions o f the bacterial extract were analysed:
Track I : undiluted extract. Track 2 :1 :2 dilution.
Track 3 :1 :5 dilution Track 4:1:10 dilution.
Track 5 : 1 :15 dilution. Track 6 :1 :20 dilution
Track 7:1:30 dilution. F: Free probe
"P": Complex formed between IIOX polypeptide and the probe.
Data presented in Figure 3D. 12(b) repeats data presented in Figure 3D.6.
3D.4. Gel Retardation Analysis of Truncated and Wild Type DNA Binding 
Domain Polypeptides.
The mutation 452del was transferred to the pJI9 vector for analysis of its 
DNA binding properties. Extracts containing the mutant and wild type versions of the 
19 polypeptide were subjected to Western blot analysis in order to roughly determine 
their polypeptide concentration (shown in Figure 3D.1). Equivalent amounts of mutant
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and wild type polypeptide were tested for their ability to bind to a consensus Vmwl75 
DNA binding site. The incubation with DNA was carried out at 0°C  for 20min. as 
described in Section 2B.8.
It was found that the 19 polypeptide containing the 452del mutation 
produced a truncated polypeptide as expected (see Figure 3D.1, track 2), and showed 
no DNA binding activity at 0°C (Figure 3D.7, track 1). The 19 polypeptide at similar 
concentrations produced a clearly resolvable DNA-protein complex (Figure 3D.7, track 
2). The faint, higher mobility band appears to be a secondary complex formed between 
19 and DNA; it was produced with high concentrations of 19 polypeptide, whereas high 
concentrations of bacterial extracts containing no induced protein produced only a 
higher mobility complex ("bac", see Figure 3D.1).
v complex
probe
1
Figure 3D.7. Gel retardation Analysis of a Wild Type and a Truncated 19 
Polypeptide.
Bacterial extracts were incubated with a radiolabelled probe spanning the IE-3 capsite for  
20 minutes at 0 <C. The conditions o f the binding reaction are described in Section 2B.8. 
Free and bound probe were separated by electrophoresis on a non-denaturing 4% 
polyacrylamide gel. Complexes were visualized by autoradiography.
Track l:452del 19.
Track 2:19.
3D.5. Gel Retardation Analysis of DNA Binding Domain Polypeptides 
Containing Point Amino Acid Mutations.
3D.5.1. Certain Point Amino Acid Mutations Result In a Temperature Sensitive DNA 
Binding Phenotype.
Mutant I9X and IIOX polypeptides were quantified by Western blot 
analysis, and equal amounts of the polypeptides assayed for DNA binding activity.
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Incubation of the protein with DNA was carried out at room temperature or 37°C for 
20min as described in Section 2B.8.
Incubation of wild type IIOX polypeptide with DNA at 37°C had no 
effect on the formation of the "P" complex. Some extracts produced a doublet of 
complexes upon gel retardation analysis, designated "P" and "P The "P1 " complex 
appeared with both mutant and wild type polypeptides and was found to be due to the 
presence of a higher concentration of a degradation product of the IIOX polypeptide, 
which is obviously able to interact with DNA.
Certain point mutant polypeptides showed a DNA binding activity 
indistinguishable from wild type polypeptides; that is, they produced similar amounts 
of complex both at room temperature and at 37°C (see Figure 3D.8, compare tracks 1, 
3 and 5 at both temperatures). Although it was observed in several instances that point 
mutant polypeptides exhibited slightly lower DNA binding activity at room 
temperature than the wild type polypeptide, this reduction was variable between 
different extracts of the same polypeptide, and therefore difficult to quantitate.
Analysis of the binding activity of polypeptides at room temperature and 
37°C showed that certain mutant polypeptides exhibited greatly reduced binding 
activity at 37°C; that is they exhibited a temperature sensitive DNA binding phenotype 
(Figure 3D.8, compare tracks 2 and 4 at both temperatures). A summary of the DNA 
binding activities of the mutant polypeptides is given in Table 3D.1. Interestingly, the 
single amino acid mutation tsK, which results in a temperature-sensitive phenotype 
when present within the viral IE-3 open reading frame (Preston, 1979a;Davison, 1984) 
also results in a temperature-sensitive DNA binding phenotype when expressed within 
a DNA binding domain polypeptide (see Table 3D.1).
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Table 3D.1. DNA Binding Properties of Mutant Polypeptides.
Construct
(a)
Site of G to T 
mutation 
(b)
Site of 
amino acid 
alteration 
(c)
Type of 
alteration 
(d)
Name
(e)
DNA
binding
activity
(f)
LA15 no. 2 1351 451 Ala to Ser 451 A/S WT
LA15 no. 3 1351
1357
451
453
Ala to Ser 
Ala to Ser
451/3AA/SS TS
LA15 no. 5 1345 449 Ala to Ser 449A/S TS
LA15 no. 9 1336 446 Ala to Ser 446A/S WT
LA15 no. 36 1357 453 Ala to Ser 453A/S TS
LA15 no. 74 1348 450 Ala to Ser 450A/S WT
LA16 no. 16 1357 453 Ala to Ser 453A/S TS
LA 16 no. 39 1370 457 Arg to Leu 457R/L TS
LA 16 no. 48 1375 459 Asp to Tyr 459D/Y no binding
LA 16 no. 49 1367 456 Arg to Leu 456R/L no binding
LA 17 no. 6 1381 461 Ala to Ser 461A/S WT
LA 17 no. 29 1390 464 Gly to Cys 464G/C WT
LA 17 no. 31 1386 462 Gin to His 462Q/H WT
LA 17 no. 35 1389
1390
463
464
Lys to Asn 
Gly to Cys
463/4KG/NC no binding
LAI 8 no. 1 1415 472 Arg to Leu 472R/L TS
LA 18 no. 14 1412 471 Arg to Leu 471R/L WT
LA18 no. 19 1406 469 Ser to lie 469SA N/A
LA18 no. 26 1423 475 Ala to Ser 475A/S TS
LA 15 no. 57 1355(del) 452 stop codon 
at 454
452del no binding
LA21 no. 5 1334-1356 445-453 del DH1 no binding
LA22 no. 9 1409-1441 470-481 del DH2 no binding
tsK 1424 (C to T) 475 Ala to Val tsK TS
Legend to Table 3D.1,
(a) The original name of the mutant clone, showing the oligonucleotide used for the 
mutagenesis reaction and the clone number isolated.
(b) The site of G to T mutation is shown as nucleotide number within the IE-3 reading 
frame, numbered from +1 at the ATG start codon. In the case of the mutant 452del, the 
base pair mutation introduced was not a G to T mutation, but a base pair deletion.
(c) The site of amino acid alteration is shown as codon number within the IE-3 open 
reading frame, numbered from 1 at the ATG start codon.
(d) The type of amino acid alteration introduced by the G to T mutation. Amino acids 
are represented as three letter codes.
(e) The final construct name, showing the position of mutation as codon number, 
followed by the amino acid alteration. Amino acids are represented as one letter codes.
(f) The DNA binding phenotype of a DNA binding domain polypeptide containing the 
mutation indicated. DNA binding activity was measured by gel retardation analysis, 
using a DNA probe containing the consensus DNA binding site situated at the IE-3 
capsite. WT = DNA binding activity indistinguishable from a wild type DNA binding 
domain polypeptide. TS = DNA binding activity reduced at temperatures of 37°C and 
above. No binding = no binding activity at any temperature.
1 2 3 4 5  1 2 3 4 5
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Figure 3D.8. Gei retardation Analysis of Wild Type and Mutant IIOX 
Polypeptides.
Bacterial extracts were incubated with a radiolabelled probe spanning the IE-3 
capsite fo r  20 minutes at room temperature or 37°C. The conditions o f the binding 
reaction are described in Section 2B.8. Free and bound probe were separated by 
electrophoresis on a non-denaturing 4% acrylamide gel. Complexes were visualized by 
autoradiography.
A t each temperature, the following polypeptides were analysed:
Track 1: IIOX Track 2 : 472R/L IIOX
Track 3:451 A/S IIOX Track 4 : 451/3AA/SS IIOX '
Track 5:471R/L IIOX F: Free probe.
3D.5.2. Certain Point Amino Acid Mutations Result in the Loss of DNA Binding 
Activity.
Gel retardation analysis of more point amino acid mutations within I9X or 
IIOX polypeptides revealed that certain single and double amino acid mutations 
resulted in a loss of DNA binding activity.
Polypeptide extracts were analysed by Western blot assays, and equal 
amounts of polypeptide tested for their ability to bind to a consensus Vmwl75 DNA 
binding site, as described previously. Western analysis showed that certain mutant I9X 
polypeptides produced large amounts of a degradation product 1000-2000Da smaller 
than the I9X polypeptide (Figure 3D.3, tracks 9, 11 and 12). In the case of the mutant 
453A/S, it was found that the presence of this degradation product did not interfere 
with the DNA binding activity of the polypeptide (see Figure 3D.9, track 1). This
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mutant exhibited a temperature sensitive DNA binding phenotype, as described in 
Section 3D.5.1. (Figure 3D.9, compare track 1 at both temperatures).
Other mutant I9X and IIOX polypeptides showed no DNA binding 
activity at either temperature (see Figure 3D.9, tracks 2, 3 and 4 at both temperatures). 
This loss of DNA binding activity was not due to a reduction in the amount of 
polypeptide in the extract; the exact volumes of extracts used in this assay had been 
shown to contain roughly equivalent amounts of polypeptide (Figure 3D.3). Also, the 
loss of DNA binding activity was not due to degradation of the I9X polypeptide - one 
DNA binding negative mutant 463/4KG/NC was expressed within an IIOX polypeptide 
which showed limited evidence of proteolysis (see Figure 3D.3, track 10). Western blot 
analysis of mutant polypeptides after incubation in gel retardation buffer had shown 
that no further proteolysis occurred during the incubation at room temperature or 37°C 
(described in Section 3D.3). Therefore, this loss of DNA binding activity is a true 
reflection of the effect of the mutation on the isolated DNA binding domain. A 
summary of the mutations resulting in an elimination of DNA binding activity is shown 
in Table 3D.1.
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Figure 3D.9. Gel Retardation Analysis of Wild Type and Mutant I9X and IIOX 
Polypeptides.
Bacterial extracts were incubated with a. radiolabelled probe spanning the IE-3 capsite 
for 20 minutes at room temperature or 37° C. The conditions o f the binding reaction 
are described in Section 2B.8. Free and bound probe were separated by 
electrophoresis on non-denaturing 4% acrylamide gels. Complexes were visualized by 
autoradiography.
At each temperature, the following polypeptides were assayed:
Track 1 :453A/SI9X ' Track 2 :463/4KG/NC IIOX
Track 3 : 459D/YI9X Track 4 : 456R/L I9X
Track 5 : 19X Track 6: IIOX
F: Free probe.
3D.6. Gel Retardation Analysis of DNA Binding Domain Polypeptides 
Containing Internal In-Frame Deletions.
Internal, in-frame deletions constructed as described in Section 3B.3 were 
expressed within IIOX polypeptides, and bacterial extracts prepared as described in 
Section 2B.27.2. The concentration of mutant and wild type polypeptide in the bacterial 
extracts was quantified by Western blot analysis, and equivalent amounts of 
polypeptide assayed for their ability to bind to a consensus Vmwl75 DNA binding site, 
as described above.
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Removal of seven amino acids from the first proposed helix, or ten amino 
acids from the second proposed helix resulted in the loss of DNA binding activity of 
the IIOX polypeptide at both room temperature and 37°C (Figure 3D. 10). At both 
temperatures, the mutant polypeptides failed to form a specific "P” complex with DNA. 
The higher mobility complex observed upon incubation of the DH2 IIOX extract with 
DNA was formed by the interaction of bacterial DNA binding proteins with DNA. 
(Figure 3D. 10b, tracks 3,4 and 5).
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Figure 3D.10. Gel retardation Analysis of Wild Type and Deletion 
Mutant I9X and IIOX Polypeptides.
Bacterial extracts were incubated with a radiolabelled probe spanning the IE -3 capsite 
fo r  20 minutes at room temperature or 37°C. The conditions o f the binding reaction 
are described in Section 2B.8. Free and bound probe were separated by 
electrophoresis on non-denaturing 4% acrylamide gels. Complexes were visualized by 
autoradiography.
(a): Track 1: DH1 IIOX room temperature. Track 2 : 19X room temperature 
Track 3: IIOX room temperature. Track 4: DH1 IIOX 37°C
Track 5 : 19X 37<>C Track 6: IIOX 37°C
Track 7: Free probe.
(b): Track 1: IIOX room temperature Track 2: IIOX 37°C  
Track 3: DH2 IIOX room temperature Track 4: DH2 IIOX 37°C 
Track 5: Bacterial extract with no induced protein.
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3D.7. Gel Retardation Analysis of DNA Binding Domain Polypeptides 
Containing the il2  and ril2 Mutations.
The il2  and ril2  mutations, described in Section 1C.3 are mutations 
within the N-terminal portion of the DNA binding domain of Vmwl75.
BamHI "y" restriction fragment DNA from the virus vril2 was kindly 
provided by Dr. N. A. DeLuca (University of Pittsburgh School of Medicine). Dideoxy 
sequence analysis of this fragment revealed the presence of the i 12 four amino acid 
insertion mutation at codon 320 of the IE-3 reading frame, and a second C to T 
mutation at nucleotide 1034 resulting in an alanine to valine substitution at codon 325. 
This observation differs from that made by Shepard and DeLuca (1991b), who stated 
that the ril2 molecule contained an alanine to valine substitution at codon 345, and no 
substitution at codon 325. There appears to be no explanation for this discrepancy. The 
il2  and ril2 mutations were cloned on NruI/BamHI restriction fragments inserted into 
the pJIlO expression vector, and X versions of these plasmids were constructed as 
described in Section 3C.1. The mutant polypeptides were expressed from these vectors, 
and bacterial extracts containing the polypeptides prepared as decribed in Section 
2B.27
As illustrated in Figure 3D.3, the il2  IIOX polypeptide was found to be 
expressed at very low levels, probably due to the low stability and solubility of the 
mutant polypeptide. However, the ril2 IIOX polypeptide was expressed successfully to 
concentrations sufficient for gel retardation analysis, and Western blot analysis of the 
ril2 IIOX polypeptide showed it to be stable upon incubation at room temperature and 
37°C (see Figure 3D.4). Extracts containing ril2  IIOX and wild type IIOX 
polypeptides were quantified using Western blot analysis and equivalent amounts of 
polypeptide assayed for their ability to bind to a consensus Vmwl75 DNA binding site, 
as described in Section 2B.8.
Initially the binding activity of both polypeptides was tested in the 
presence of varying amounts of non-specific DNA competitor, as it had been noted that 
Vmwl75 molecules containing the ril2  mutations had been able to form complexes 
with the IE-3 capsite probe only in the presence of low concentrations of non-specific 
competitor (Shepard and DeLuca, 1991b). The ril2 IIOX polypeptide formed specific 
"P" complexes with the IE-3 capsite probe in the presence of up to 5pg of 
polydLpolydC competitor (Figure 3D.11). At lower concentrations of polydLpolydC, it 
was found that both ril2 IIOX and wild type IIOX polypeptides formed low mobility 
complexes, presumably due to additional and perhaps non-specific protein-DNA 
interactions.
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Figure 3D.11. Gel Retardation Analysis of Wild Type and ril2 IIOX 
Polypeptides.
Bacterial extracts were incubated with a radiolabelled probe spanning the IE-3 caps 
for 20 minutes at room temperature with varying amounts ofdldC.The conditions o f 
the binding reaction are described in Section 2B.8. Free and bound probe were 
separated by electrophoresis on a non-denaturing 4% polyacrylamide gel. Complext 
were visualized by autoradiography.
Track 1: IIOX with Oug dldC Track 2: IIOX with lug  dldC
Track 3: IIOX with 2ug dldC Track 4: IIOX with 5 ug dldC
Track 5: ril2  IIOX with Oug dldC Track 6: ril2  IIOX with lug  dldC
Track 7: ril2  IIOX with 2ug dldC Track 8: ril2 IIOX with 5ug dldC
Track 9: Free probe.
Analysis of the DNA binding properties of the ri 12 IIOX polypeptide at 
room temperature and 37°C in the presence of non-specific competitor DNA showed 
that the mutation resulted in a temperature sensitive DNA binding phenotype when 
expressed within the isolated DNA binding domain of Vmwl75. When increasing 
concentrations of the polypeptide were incubated with an IE-3 capsite probe at room 
temperature, a ladder of primary and secondary complexes were seen upon gel 
retardation analysis. The number and amount of complexes formed were very similar to 
those formed with roughly equivalent concentrations of wild type IIOX polypeptide. 
When the incubation temperature was raised to 37°C, the IIOX polypeptide still 
produced the specific primary and secondary complexes with the IE-3 capsite probe, 
whereas the ril2  IIOX polypeptide exhibited no specific DNA binding activity (Figure 
3D. 12).
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Figure 3D. 12. Gel Retardation Analysis of Wild Type and r il2  IIOX 
Polypeptides.
Bacterial extracts were incubated with a radiolabelled probe spanning the IE-3 capsite 
fo r  20 minutes at room temperature or 37°C. The conditions o f the binding reaction 
are described in Section 2B.8. Free and bound probe were separated by 
electrophoresis on non-denaturing 4% acrylamide gels. Complexes were visualized by 
autoradiography.
At each temperature, the same dilutions o f the bacterial extracts were assayed:
Track 1: undiluted extract Track 2:1:2  dilution
Track 3 :1:5  dilution Track 4:1:10 dilution
Track 5:1:15 dilution Track 6:1:20 dilution
Track 7:1:30 dilution F: Free probe.
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It has previously been demonstrated by several studies that the isolated 
DNA binding domain of Vmwl75 will bind to, and produce a DNAasel footprint at, 
consensus Vmwl75 DNA binding sites (Wu and Wilcox, 1989; Pizer et al., 1991; 
Everett et al., 1991; Everett, unpublished observations). These studies have also led to 
the determination of the limits of the Vmwl75 DNA binding domain to within a region 
encompassing codons 262-490 of the IE-3 open reading frame.
Gel retardation analysis of the wild type IIOX polypeptide (encoding 
Vmwl75 codons 275-523) presented in this thesis has shown that bacterial extracts 
containing wild type DNA binding domain polypeptides will produce specific 
complexes with DNA; that uninduced bacterial extracts will produce higher mobility 
complexes; and that both types of complex were frequently observed to be formed with 
bacterial extracts containing Vmwl75 DNA binding domain polypeptides. These 
observations suggest that bacterial DNA binding proteins are not recruited into the 
Vmwl75 DNA binding domain-DNA complex, and show that formation of the "P" 
complex is specific to the presence of a Vmwl75 polypeptide.
In vitro studies have shown that the isolated DNA binding domain of 
Vmwl75 binds to DNA as a dimer (J. Tyler, personal communication). The formation 
of multiple secondary protein-DNA complexes with higher concentrations of Vmwl75 
DNA binding polypeptides as seen in Figure 3D.2 could be due to two types of 
interactions - the interaction of multiple protein dimers with DNA or the interaction of 
protein dimers with more than one DNA molecule leading to the formation of higher 
order complexes. Additional binding studies with highly purified DNA binding domain 
polypeptides and DNA probes of differing lengths showed that the secondary 
complexes were produced only with longer DNA probes, suggesting that multimer 
complexes occur through the binding of additional proteins on DNA flanking the 
authentic binding site (R. Everett, unpublished observations). The possibility of 
cooperativity in the formation of these higher order complexes has not yet been 
investigated.
Analysis of mutant DNA binding domain polypeptides showed that 
mutations within the "helix-tum-helix" motif lead to three different DNA binding 
phenotypes: (1) the ability to bind to DNA both at room temperature and 37°C; (2) the 
ability to bind to DNA only at temperatures of 33°C and lower (the temperature 
sensitive phenotype); and (3) no detectable DNA binding activity at any temperature. 
The DNA binding properties of all the mutations analysed are shown in Table 3D.1.
The temperature sensitive phenotype was probably caused by the 
destabilizing effect of the mutation on the secondary structure of the polypeptide
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molecule at 37°C, resulting in a reduction in its ability to interact with DNA. Analysis 
of the occurence of temperature sensitive mutations within the "helix-tum-helix" motif 
revealed no definite pattern of occurence. No particular amino acid alteration resulted 
in a consistently greater disruption of the DNA binding activity. For example, 10 out of 
the 18 point mutations analysed contained an alanine to serine alteration. However, this 
alteration resulted in both a wild type and a temperature sensitive phenotype in DNA 
binding activity, depending on the position of the alteration. As no particular amino 
acid substitution of itself showed a detrimental effect, it is likely that the temperature 
sensitive phenotype was caused by the position at which the mutation was made. 
Analysis of the temperature sensitive mutations within the motif showed that they were 
not concentrated within any stretch of the motif.
Temperature sensitive mutations were not concentrated on certain faces of 
the proposed helices. Figure 3D. 13 shows the position of the mutations and their DNA 
binding phenotypes, represented on the helical wheel models discussed in Section 
3A.5. In helix 1, a temperature sensitive and a wild type Ala-Ser mutation at codons 
453 and 446 respectively are juxtaposed on the same face of the helix, implying that 
there is no one face more sensitive to mutation. The single Ala-Ser mutation at codon 
451 showed a wild type DNA binding phenotype whereas a double Ala-Ser mutation at 
codons 453 and 451 showed a temperature sensitive DNA binding phenotype. It was 
assumed that the temperature sensitive phenotype of the double mutant was due to the 
Ala-Ser mutation at codon 453, since the Ala-Ser mutation at codon 451 by itself had 
no effect on the DNA binding properties of the polypeptide.
The situation with the second helix is more complex, due to the different 
types of amino acids present in the helix and the differing amino acid alterations 
introduced (see Figure 3D. 13b). Many DNA binding proteins seem to contact DNA 
through clusters of basic amino acids (Davis et al., 1990; Busch and Sassone-Corsi,
1990). In this helix, although there is not an obvious concentration of basic amino acids 
on any one face, interesting mutations to study would be ones which involve changes 
of basic amino acids to neutral or even acidic residues. Several such changes have been 
introduced and their effects range from elimination of DNA binding activity (see 
further discussion), through loss of DNA binding activity at higher temperatures to 
negligible changes in DNA binding activity. As discussed later, mutations which result 
in the loss of DNA binding activity are situated towards the proposed turn of the motif, 
and their detrimental effect on DNA binding activity may be due more to their position 
within the motif rather than the type of amino acid mutation. In the case of the 
mutations 471R/L and 472R/L, they lead to wild type and temperature sensitive DNA 
binding profiles respectively, suggesting that neither amino acid is essential for the 
interaction of protein with DNA, and that the mutations solely affect the secondary 
structure of the polypetide molecule.
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Another interesting observation is that an individual mutation at codon 
464 (464G/C) results in a temperature sensitive phenotype, whereas the double mutant 
carrying both this mutation and a mutation at codon 463 (463K/N) results in 
elimination of DNA binding activity. A possible explanation of this observation is that 
the accumulation of these mutations results in the destabilization of the local secondary 
structure sufficient to disrupt the interactions with DNA, a situation not observed with 
the other double mutant that has been analysed. Alternatively, the elimination of DNA 
binding activity may have been caused by the single mutation at codon 463, which was 
not isolated and therefore could not be investigated. As discussed in Section 3A.6, 
analysis of the Vmwl75 amino acid sequence by the GCG Peptidestructure programme 
produces different secondary structure predictions to those published previously 
(Shepard et a l , 1989). The double mutation discussed above could be situated in the 
proposed turn of the motif or within the proposed second helix, depending on the 
method used to predict the secondary structure of the proposed "helix-tum-helix" 
motif.
The overall conclusion is that no one face of either helix is more sensitive 
to mutation, a phenomenom observed with other helical DNA binding motifs (Busch 
and Sassone-Corsi, 1990). This implies that the designation of the proposed helices 
may be incorrect. An alternative explanation is that, whilst existing in the predicted 
secondary structure, neither helix presents a face for interaction with DNA.
Several point amino acid mutations, the deletion mutation leading to the 
truncation of the expressed polypetides at codon 454 and the two internal, in-frame 
deletion mutations result in the elimination of the DNA binding activity of the 
polypeptides. These mutations may be exerting their effects in one of two ways. The 
mutation could result in a disruption of the local secondary structure of the polypeptide, 
sufficient to interfere with its interaction with DNA. Alternatively, the point mutations 
and deletions may lead to alteration or removal of residue(s) within the polypeptide 
which is/are essential for contact with the DNA helix, as seen with mutational analyses 
of other DNA binding proteins (Gentz et al., 1989; Davis et al.t 1990; Marmorstein et 
al.y 1992). It is difficult to distinguish between the two mechanisms without a means to 
probe the secondary structure of the mutant and wild type DNA binding domain 
polypetides. It is interesting to note that the point mutations which eliminate the DNA 
binding activity of the polypeptide cluster within or near to the turn of the proposed 
"helix-tum-helix,, motif (see Figure 3D. 13), as predicted by Shepard etal. (1989). This 
apparent sensitivity of the turn region to mutation may represent a conformational 
effect of the mutations on the motif, or may imply that residues within this region are 
important in the interaction of the domain with DNA.
The internal deletions of portions of the proposed helices will lead to a 
reorientation of residues on a different face of the helix, and probably lead to a gross
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conformational change in this region of the "helix-tum-helix" motif. However, 
deletions removing codons 162-229 or 209-236 of the IE-3 reading frame have a much 
less significant effect on the transcription and repression activities of Vmwl75, as 
measured by transient transfection assays (Paterson, 1989). The fact that small in-frame 
deletions, truncations and even point mutations can disrupt the binding of the isolated 
DNA binding domain illustrates the importance of the region encompassing codons 
445-482 towards the conformational stability and DNA binding properties of Vmwl75.
The result obtained with the il2  IIOX and ril2 IIOX polypeptides further 
complicate the situation. The fact that an insertion mutation and a point mutation 
approximately 120 amino acids N-terminal to the "helix-tum-helix" motif can disrupt 
the DNA binding properties of the IIOX polypeptide suggests that this portion of the 
DNA binding domain is also involved in the interaction of the protein with DNA. 
Another possible explanation for these observations is that the mutations disrupt a 
portion of the DNA binding domain responsible for maintaining the secondary and 
tertiary conformational stability of the molecule. This hypothesis is supported by 
previous suggestions that the region encompassing codons 263-338 may be involved in 
stabilising low affinity interactions of the DNA binding domain with DNA (Shepard et 
al., 1989). In addition, previous mutational analyses have demonstrated that mutations 
within this region of Vmwl75 disrupt the in vitro DNA binding and transactivation 
properties of the protein (Paterson and Everett, 1988a, b; Paterson, 1989; Shepard et 
al., 1989; see Figure 1C.3).
3E. Determination of the I n  V i t r o  Dimerization Activity 
of Wild Type and Mutant Polypeptides Encompassing the 
DNA Binding Domain of Vmwl75.
Vmwl75 has been purified from infected cells as a homodimeric complex 
(Metzler and Wilcox, 1985). In addition, bacterial expression and in vitro translation 
studies have illustrated that the isolated DNA binding domain of Vmwl75 exists as a 
dimer in solution (Everett et al., 1991b; J. Tyler, personal communication), implying 
that the DNA binding domain of Vmwl75 also contains a potential dimerization motif.
In order to fully assess the effects of various mutations on the in vitro 
properties of the isolated DNA binding domain of Vmwl75, the dimerization 
properties of certain mutant and wild type polypeptides were investigated.
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3E.1. The Dimerization Properties of a Polypeptide Containing the 
Mutation 456R/L.
The point mutation 456R/L, situated close to or within the proposed turn 
of the "helix-tum-helix" motif has been shown to eliminate the DNA binding activity 
of the isolated DNA binding domain of Vmwl75 (see Section 3D.5.2).
In order to determine the dimerization properties of this mutant 
polypeptide, gel filtration chromatography was carried out on purified preparations of 
mutant and wild type I9X polypeptides. The polypeptides were extracted from induced 
cultures (1 litre) as described in Section 2B.28, and mutant and wild type polypeptides 
purified from the final extracts by chromatography on a Pharmacia MonoS ion 
exchange column as described in section 2B.29. Both mutant and wild type 
polypeptides were eluted in a sharp peak at 0.8M NaCl. Peak fractions were pooled and 
concentrated by centrifugation in Centricon 10 concentrators. Concentrated samples 
appeared to be approximately 95% pure on Coomassie blue stained acrylamide gels 
(see Figure 3E.1).
1 2  3 4
Figure 3E.1. SDS-Polyacrylamide Gel Electrophoresis of Purified 
Wild Type and Mutant I9X and IIOX Polypeptides.
Polypeptides were extracted from  induced BL21 (DE3) pLysS cultures as describea 
in Section 2B.28 and purified by chromatography on a Pharmacia MonoS ion 
exchange column, as described in Section 2B.29. Peak fractions containing DNA 
binding domain polypeptides were pooled and concentrated by centrifugation in 
Centricon 10 concentrators. Concentrated proteins were analysed by electrophores 
on 125% SDS-polyacrylamide gels followed by staining with Coomassie blue. 
Track 1 .I9X  
Track 2: IIOX 
Track 3 : 456RILI9X
Track 4: Molecular weight standards: 66kDa, 45kDa, 36kDa, 29kDa, 24kDa, 
20.1kDa, 14.2kDa.
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The concentrated preparations of polypeptide were fractionated on a 20ml 
Superose 12 columnas described in Section 2B.29.1ml fractions were collected and the 
peak fractions analysed by electrophoresis on 12.5% SDS polyacrylamide gels 
followed by detection by Western blot analysis. The wild type I9X polypeptide was 
eluted at a peak position of 12.98ml, as determined by the uv monitor and the 456R/L 
I9X polypeptide was eluted at 12.99ml (Figure 3E.2), showing that the behaviour of the 
mutant polypeptide was indistinguishable from that of the wild type polypeptide upon 
gel filtration chromatography analysis. A "shoulder” peak was observed prior to elution 
of the major peak for both wild type and mutant polypeptides. This shoulder peak 
could possibly contain tetrameric forms of the polypeptides. The molecular weight 
standards bovine serum albumin (BSA, native molecular weight 66kDa), carbonic 
anhydrase (CA, native molecular weight 29kDa) and cytochrome C (Cyt. C, native 
molecular weight 13kDa) were eluted at peak positions of 12.59, 14.37 and 15.31mls 
respectively. Analysis of these molecular weight standards enabled the construction of 
a calibration curve for the Superose 12 column. From this, the molecular weights of 
I9X and 456R/L I9X were calculated to be 57kDa, close to the predicted dimeric 
molecular weight of 56kDa (see Figure 3E.3).
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Figure 3E.3. Standard Curve for the Superose 12 Gel Filtration Column.
50ng of molecular weight standards as indicated were analysed on a 20ml Superose 12 ge, 
filtration column. The column was equilibrated in 50mM HEPES pH75 , 0.5MNaCl, 
0.01% CHAPS, O.lmM DTT and ImM PMSF and proteins eluted in the same buffer. The 
graph shows the elution volume of the proteins, together with the elution volume of wild 
type and the mutant 456R/L form of the 19X polypeptide. The molecular weights of the I9X 
polypeptides were estimated from the standard curve, and were found to be 57KDa.
3E.2. The Dimerization Properties of a Polypeptide Containing the 
Mutation 463/4 KG/NC.
The double point mutation 463/4 KG/NC also contains mutations situated 
close to or within the proposed turn of the "helix-tum-helix" motif. This mutation 
resulted in the loss of the DNA binding activity of the isolated DNA binding domain of 
Vmwl75 (see Section 3D.5.2).
In order to determine the effect of this mutation on the dimerization 
properties of the IIOX polypeptide, gel filtration chromatography was carried out on 
purified preparations of the wild type and mutant polypeptides. The polypeptides were 
extracted from 1 litre induced bacterial cultures as described in section 2B.28, with the 
ommission of the treatment with polyethylenimine. Mutant and wild type polypeptides
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were purified from the final extracts by chromatography on a Pharmacia MonoS ion 
exchange column, as descibed in Section 2B.29. In this experiment, the polypeptides 
were eluted in the flow through fractions from the MonoS column; this behaviour was 
discussed in Section 3C.5. The polypeptides were further purified from the flow 
through fractions as described in Section 2B.29. Final preparations were shown to be 
approximately 80-90% pure on Coomassie blue stained acrylamide gels (see Figure 
3C.8).
The concentrated polypeptides were fractionated on a Superdex 75 
column as described in Section 2B.29. 1ml fractions were collected and peak fractions 
analysed by electrophoresis on 12.5% SDS-polyacrylamide gels and detection by 
Western blot analysis. The wild type IIOX polypeptide was eluted at 9.84mls and 463/4 
KG/NC IIOX eluted at 9.82mls (see Figure 3E.4), showing that the behaviour of the 
mutant polypeptide was indistinguishable from that of the wild type polypeptide upon 
gel filtration chromatography analysis. The molecular weight standards bovine serum 
albumin (BSA, native molecular weight 66kDa), carbonic anhydrase (CA, native 
molecular weight 29kDa) and cytochrome C (Cyt. C, native molecular weight 13kDa) 
were eluted at 9.53, 11.81 and 13.48mls respectively. Analysis of these molecular 
weight standards enabled the construction of a calibration curve for the Superdex 75 
column. From this, the molecular weights of IIOX and 463/4 KG/NC were calculated 
to be 60kDa, close to the predicted dimeric molecular weight of 52kDa (see Figure 
3E.5).
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Molecular Weight
Figure 3E.5. Standard Curve for the Superdex 75 Gel Filtration 
Column.
50 ng of the molecular weight standards indicated were analysed on a 20 ml 
Superdex 75 gel filtration column. The column was equilibrated in 50mM HEPES 
pH7 5 , 0.5M NaCl, 0.01% CHAPS, O.lmMDTTand ImMPMSF and proteins 
eluted in the same buffer. The graph shows the elution volumes of the proteins, 
together with the elution volume of wild type and the mutant 463/4KG/NC form of 
the IlOX polypeptide. The molecular weights o f the IlOX polypeptides were 
estimated from the standard curve, and were found to be 60KDa.
3E.3. Investigation of the Dimerization Properties of a Polypeptide 
Containing the Mutation DHL
The mutation DH1 is an internal, in-frame deletion of seven amino acids 
from the first proposed helix of the "helix-tum-helix" motif. Analysis of the DNA 
binding properties of an IlOX polypeptide containing this mutation showed that the 
deletion eliminated the DNA binding properties of the isolated DNA binding domain of 
Vmwl75 (see Section 3D.6).
In order to determine the dimerization properties of this mutation, it was 
necessary to obtain relatively pure preparations of the DH1 IlOX polypeptide for 
glutaraldehyde cross-linking assays or gel filtration chromatography. As the DH1 IlOX
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polypeptide had exhibited low solubility upon previous extractions, the polypeptide 
was extracted from a 1 litre induced bacterial culture in the absence of 
polyethylenimine, as described in Section 2B.28. A high proportion of the polypeptide 
was lost at the centrifugation stages of the extraction procedure, however the final 
soluble extract contained a sufficient quantity of protein for glutaraldehyde cross- 
linking or gel filtration chromatography analysis. The soluble extract was dialysed and 
insoluble proteins removed by centrifugation as detailed in Section 2B.29. SDS- 
polyacrylamide gel electrophoresis of the pellet and supernatant fractions from this 
centrifugation step showed that the DH1 IlOX polypeptide had precipitated and the 
soluble extract contained a very low concentration of the mutant polypeptide (see 
Figure 3E.6, tracks 1 and 2). The soluble protein extract was loaded onto a Pharmacia 
MonoS ion exchange column and polypeptides eluted with a 20ml 0.1-1M NaCl 
gradient. It was expected that the DH1 IlOX polypeptide would be eluted in the flow­
through fractions from this column, as had been previously observed with preparations 
of purified polypeptides extracted in the absence of polyethylenimine (see Figure 
3C.6). However, due to the low concentration of DH1 IlOX polypeptide in the input 
sample (Figure 3E.6, track 2), the concentration of DH1 IlOX in the flow through 
fractions was too low for further purification (see Figure 3E.6, tracks 3-6). After 
several attempts to purify this mutant polypeptide, it was concluded that the low 
solubility of the polypeptide prevented the purification of sufficient quantities of the 
protein for glutaraldehyde cross-linking or gel filtration analysis.
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DH1
IlOX
f
I
1 2 3 4 5 6
Figure 3E.6. SDS-Polyacrylamide Gel Electrophoresis of fractions 
from Ion exchange Chromatography of the DH1 IlOX polypeptide.
DH1 IlOX polypeptide was extracted from  induced BL21 (DE3) pLysS cultures as 
described in Section 2B.28, ommitting treatment with polyethylenimine. Following 
dialysis, the extract was loaded onto a Pharmacia MonoS ion exchange column, and 
the protein eluted with a salt gradient, as described in section 2B.29 Fractions were 
analysed by electrophoresis on a 12.5% SDS-polyacrylamide gel followed by staining 
with Coomassie blue.
Track 1: Insoluble proteins following dialysis.
Track 2: Soluble input fraction.
Tracks 3-6: Flowthrough fractions.
3E.4. The Dimerization Properties of Polypeptides Containing Point 
Mutations Resulting in a Temperature Sensitive DNA Binding Defect.
Bacterial extracts of point mutant IlOX polypeptides which exhibited 
temperature sensitive or wild type DNA binding phenotypes and wild type IlOX 
polypeptide were prepared from 100ml induced bacterial cultures, as described in 
Section 2B.27.1. The dimerization properties of these polypeptides were investigated 
using a glutaraldehyde cross-linking assay. Glutaraldehyde is an aldehyde polymer 
which forms covalent Schiff base linkages with lysine residues of protein molecules, 
leading to the covalent cross-linking of oligomeric protein molecules in solution. Such 
oligomeric molecules may be identified by SDS-polyacrylamide gel electrophoresis 
analysis of the reaction mixture. This method was utilized to analyse the dimerization 
properties of point mutant polypeptides which exhibit temperature sensitive defects in 
DNA binding activity, as it allows for the assay of dimerization activity at various 
temperatures.
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Bacterial extracts containing containing mutant and wild type IlOX 
polypeptides were incubated with glutaraldehyde at 29°C or 37°C as described in 
Section 2B.30. The samples were boiled for 5 min before electrophoresis on 12.5% 
SDS-polyacrylamide gels. The experiments were carried out at low protein 
concentrations using extracts containing insufficient amounts of IlOX polypeptide for 
visualization on Coomassie blue stained acrylamide gels. Therefore, monomeric and 
dimeric forms of the polypeptides were visualised by Western blot analysis as decribed 
in section 2B.6.3.
Western blot analysis of proteins incubated in the absence of 
glutaraldehyde illustrated the extent of degradation of the mutant and wild type 
polypeptides (Figure 3E.7a).The extent of protein degradation was unchanged between 
reactions carried out at 29°C and reactions carried out at 37°C (Figure 3E.7b). Cross- 
linked dimers of the IlOX polypeptides were formed at both 29°C and 37°C, regardless 
of whether the mutant polypetpide exhibited a temperature sensitive or wild type DNA 
binding phenotype. As shown in Figure 3E.7b, only a small percentage of the 
monomeric polypeptide molecules were incorporated into the cross-linked dimeric 
molecules, and the amount of cross-linked dimeric molecule formed with the various 
polypeptide extracts was not consistent. Possible explanations for these observations 
are discussed in section 3E.6.
3E.5. The Dimerization Properties of a Polypeptide Containing the 
Mutation ril2.
The double mutation ril2 consists of a four amino acid insertion mutation 
at codon 320 and a valine to alanine substitution at codon 345 of the IE-3 open reading 
frame. Analysis of DNA binding domain polypetides containing the ril2  mutation 
showed that the mutation resulted in a temperature sensitive defect in DNA binding 
activity (see Section 3D.7).
In order to determine the effects of this mutation on the dimerization 
activity of the IlOX polypeptide at various temperatures, glutaraldehyde cross-linking 
analysis was carried out. The mutant and wild type polypeptides were extracted from 1 
litre induced bacterial cultures in the absence of polyethylenimine, as described in 
Section 2B.28. Mutant and wild type IlOX polypeptides were purified from the final 
bacterial extracts by chromatography on a Pharmacia MonoS ion exchange column, as 
described in Section 2B.29. The polypeptides were eluted from this column in the flow 
through fractions and polypeptides further purified as described in Section 2B.29.
153
o•i 8
2 ia<U D-
.2P o
JG o
1
I
I
I
*
<N
03
T3
>»
-C
<u
2
03J -
+->
3
00
+
ro +
(N i
CM
+
on +
<u
3
&
<u
B
3
B
T5
B
SO
o
&
►>
H
"O
j£ »
a
B<
00
B
•  m l
s
M2Ml
£
o
O
T3
X
4>
'B
e
3
3
3
00
W
r >
£
s00 •  IMt
u -
05
£2
05
-S3
s
o
•S
s .
£03
•S
o
S.
o-o^o
•SQ
Co C3 
»o ‘S>2
s  ^  
s  ^<-> C<3j 02
r-< <32
>2
s>
0OCM
03
CM
S3
03
O
03
r \
fn
Sv.
02
D
&
CM
-«-4
03
03
t-»
3
S3
“OS
-S3
0)
S3
X
S3-§ s  
§ - . § OS
^  03 
C' *"-*
0* OS
. ^Cr\ «0 i >f 
SO
t$ o  tq QQ .s
tO
•S
os
0)03
0 3
03
03
"03
s .
03
Ci,
s .
<^3S.
^3
33
03
OS
H . S
■ & , £  
Lt, */~( 
$2
Qh 03
OS
£
* §
o c
. g
OS
S3
-S3
*o
OS
?  '£  §  £^3 <43 w-v£ os {Q 
*> a
K -5?
^  £ 
os o03 -33 
-S3
<42
-S3
^0
.S3
£
§
S3s  iS> ^  s ?o f t , ^>13 £i«q °
.os
(a
): 
ri!
2 
(b
) 
IlO
X 
(c)
 C
ar
bo
ni
c 
an
hy
dr
as
e
Tr
ac
ks
 
1 
an
d 
3: 
29
°C 
Tr
ac
ks
 
2 
an
d 
4: 
37
°C
Chapter 3. Results
Polypeptides were incubated with glutaraldehyde at 29°C or 37°C as 
described in Section 2B.30. Samples were boiled for 5 min before electrophoresis on 
12.5% SDS-polyacrylamide gels. Monomeric and oligomeric forms of the polypeptide 
molecules were visualised by staining with Coomassie blue.
The incubation of the wild type IlOX polypetide and carbonic anhydrase 
in the presence of glutaraldehyde led to an increase in protein degradation (Figure 
3E.8b and c, compare tracks 1 and 2 with tracks 3 and 4). Cross-linking analysis of the 
IlOX polypeptide at 29°C and 37°C led to the visualization of a ladder of bands upon 
SDS-polyacrylamide gel electrophoresis (Figure 3E.8b, tracks 3 and 4). These ladders 
were not seen when the polypeptide was incubated in the absence of glutaraldehyde. 
Incubation of the monomeric protein carbonic anhydrase with glutaraldehyde did not 
result in the formation of cross-linked molecules of higher molecular weight (Figure 
3E.8c, tracks 3 and 4).
Glutaraldehyde cross-linking analysis of the ri 12 IlOX polypeptide led to 
the visualization of higher order bands, corresponding to cross-linked dimers of the 
mutant polypeptide, which were not observed when the polypeptide was incubated in 
the absence of glutaraldehyde (Figure 3E.8a, compare tracks 1 and 2 with tracks 3 and 
4). The dimeric molecules were formed at both 29°C and 37°C, indicating that the 
higher incubation temperature did not disrupt the dimerization activity of the ri 12 IlOX 
polypeptide.
3E.6. Discussion.
Analysis of bacterially expressed polypeptides has shown that the isolated DNA 
binding domain of Vmwl75 exists as a dimer in solution (Everett et al.y 1991b). In 
addition, in vitro translated polypeptides encompassing the DNA binding domain of 
Vmwl75 bind to a DNA probe as dimers upon gel retardation analysis (Roberts and 
Hayward, 1991). Although the in vitro translation studies suggested that within the 
DNA binding domain dimer molecule there may only be a requirement for one DNA 
binding functional monomer to interact with the DNA probe (Roberts and Hayward,
1991), the existence of an interaction between DNA binding domain monomeric 
molecules and DNA has not been shown to occur. In fact, it is possible that disruption 
of the dimerization activity of the DNA binding domain of Vmwl75 may lead to the 
disruption of the DNA binding activity of the molecule. Therefore, investigation of the 
dimerization activity of the mutant polypeptides which exhibited a defect in DNA 
binding activity may yield information about the mechanism of the association of 
Vmwl75 with DNA.
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Sections 3E.1 and 3E.2 present results obtained from gel filtration analysis of 
two mutant DNA binding domain polypeptides. These polypeptides contain point 
mutations within the proposed "helix-tum-helix" motif, and exhibit no DNA binding 
activity at any temperature, enabling the analysis of dimerization activity to be 
conducted at room temperature by FPLC analysis. Although gel filtration 
chromatography is not a means by which to calculate the exact molecular weight of a 
protein molecule, comparison of the migration of the mutant polypeptides relative to 
the migration of known dimeric molecules of the same monomeric molecular weight 
can reveal the native form of the mutant molecules in solution. If the wild type and 
mutant polypeptides are eluted from the gel filtration column in the same elution 
volume, then it can be concluded that the mutant polypeptide also exists as a dimer in 
solution.
Analysis of the migration of of the mutant I9X polypeptide 456R/L as 
compared with the wild type I9X polypeptide on a Pharmacia Superose 12 column 
revealed that the two polypeptides were eluted in sharp peaks at nearly identical elution 
volumes (12.98 and 12.99mls respectively), indicating that both polypeptides exist in 
the same native state in solution. From a standard curve constructed from the elution 
volumes of known molecular weight standards, the molecular weight of the two 
polypeptides was estimated to be 57kDa, which is closer to the predicted dimeric 
molecular weight (56kDa) than to the predicted monomeric molecular weight (28kDa). 
Similar results were obtained from analysis of the migration of the mutant IlOX 
polypeptide 463/4 KG/NC as compared with the migration of the wild type IlOX 
polypeptide on a Pharmacia Superdex 75 column. The polypeptides were eluted as 
sharp peaks of nearly identical elution volumes (9.82 and 9.84mls respectively) and 
their molecular weight was estimated to be 60kDa, closer to the predicted dimeric 
molecular weight (52kDa) than to the predicted monomeric molecular weight (26kDa).
Therefore, the two mutant polypeptides which have lost the ability to bind to 
DNA still retain dimerization activity. This fact suggests that the DNA binding activity 
and the dimerization properties of the isolated DNA binding domain of Vmwl75 are 
functions of separable regions of the polypeptide. As the mutants retain the ability to 
dimerize, the secondary structure of the polypeptide has not been grossly altered by the 
point mutations, implying that the effect of the mutations has been to alter only the 
local secondary'conformation of the region spanning codons 445-487, or to alter the 
essential residues of the "helix-tum-helix" motif. The fact that mutations that obviously 
eliminate the function of this "helix-tum-helix" region do not affect the dimerization 
activity of the polypeptide suggests that portions of the polypeptide outwith the region 
spanning codons 445-487 are responsible for the dimerization function of the DNA 
binding domain of Vmwl75.
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In order to attempt to define the functions of the proposed helical regions of the 
"helix-tum-helix" motif further, it was necessary investigate the dimerization properties 
of polypeptides containing deletions within the two helices, which have been 
previously shown to eliminate the DNA binding activity of the DNA binding domain 
polypeptide (see Section 3D.6). Unfortunately, the deletion of these regions appeared 
to drastically reduce the solubility of the isolated DNA binding domain polypeptide. In 
order to investigate the dimerization activity of the IlOX polypeptide mutant DH1, 
which contains a deletion removing seven amino acids from the first helix of the 
proposed motif, it was necessary to obtain relatively pure peparations of the 
polypeptide for cross-linking or gel filtration analysis. Section 3E.3 illustrated the 
problems encountered in the preparation of such samples. Due to the low solubility of 
the deletion mutant polypeptide, soluble extracts prepared from induced bacteria 
contained insufficient amounts of the polypeptide for purification on ion exchange 
chromatography, and were too impure for glutaraldehyde cross-linking analysis.
In order to investigate the effects of other point mutations within the "helix- 
tum-helix" motif and the mutation ril2  on the dimerization activity of the IlOX 
polypeptide, it was necessary to conduct the dimerization assays at various 
temperatures as several of the point mutations and the ril2 mutation eliminate the DNA 
binding activity of the IlOX polypeptide at temperatures of 37°C and above. This made 
it difficult to analyse the dimerization activity of the polypeptides by gel filtration 
chromatography, and it was decided to carry out the analyses using a glutaraldehyde 
cross-linking assay.
The results of the analysis of several point mutant polypeptides, which contain 
mutations within the "helix-tum-helix" region, are presented in Section 3E.4. It was 
found that for the mutant polypeptides investigated, molecules of a molecular weight 
corresponding to dimers of the DNA binding domain polypeptides were irreversibly 
cross-linked at both 29°C and 37°C, regardless of whether the point mutation resulted 
in a wild type or temperature sensitive DNA binding phenotype.
As noted in Section 3E.4, glutaraldehyde cross-linking of various polypeptides 
resulted in a wide variety in the amount of dimeric cross-linked molecules produced 
from different extracts, and as a whole, the percentage of monomeric molecules 
converted to cross-linked dimeric molecules was low. The variety in the rate of 
formation of cross-linked dimeric molecules between different extracts is probably due 
to variation in the concentration of other bacterial proteins present in the reaction mix. 
As the Vmwl75 DNA binding domain monomeric molecules were visualized by 
immunodetection methods, the amounts of bacterial proteins present in the extracts 
could not be shown. However, Coomassie blue stained SDS polyacrylamide gels of the 
bacterial extracts showed that the concentration of Vmwl75 polypeptides as compared 
to the concentration of bacterial proteins varied from extract to extract. The presence of
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bacterial proteins would interfere with the specific cross-linking of Vmwl75 
molecules, as lysine residues on the bacterial proteins would react with the 
glutaraldehyde polymer, resulting in a lower concentration of unreacted glutaraldehyde 
in the reaction mix. The observation that a low percentage of Vmwl75 monomeric 
molecules were converted to cross-linked dimeric molecules could be explained by the 
occurence of intramonomeric as well as intermonomeric linkages. That is, a high 
percentage of the glutaraldehyde cross-linking reagent reacted with and formed 
covalent bonds between lysine residues within one monomeric molecule, leading to a 
lower rate of formation of covalent bonds between lysine residues of the two 
monomeric subunits of a dimeric molecule.
The reaction of glutaraldehyde with carbonic anhydrase, which exists as a 
monomer in solution, did not lead to the formation of higher order cross-linked 
complexes. Therefore, it can be concluded that the higher order Vmwl75 DNA binding 
domain polypeptide molecules were formed by specific cross-linking of dimers in 
solution. Therefore, at least for the mutant polypeptides analysed in this section, the 
defect in DNA binding activity at higher temperatures is not due to a dimerization 
defect. As discussed earlier, this again implies that the point mutations are disrupting 
the local secondary conformation of the "helix-tum-helix" region, and that disruption 
of the conformation of this region leads to the elimination of DNA binding activity but 
not to the elimination of dimerization activity. Cross-linking analysis was not carried 
out on other temperature sensitive point mutant polypeptides as the low solubility of 
the proteins made the preparation of relatively pure extracts difficult to achieve. 
However, the results obtained with the three point mutant polypeptides add support to 
the hypothesis that portions of the Vmwl75 DNA binding domain outwith the region 
spanning codons 445-487 must contribute to the dimerization activity of the isolated 
polypeptide.
The mutation ril2  is situated within the N-terminal region of the Vmwl75 
DNA binding domain, and it is possible that this mutation leads to a local 
conformational change at higher temperatures, which might disrupt dimerization and 
explain the inability of the molecule to bind to DNA at higher temperatures. Again, 
glutaraldehyde cross-linking analysis was carried out to investigate the dimerization 
activity of the ril2  IlOX polypeptide at 29°C and 37°C. It was found that samples of 
the mutant polypeptide of approximately 90% purity formed specific cross-linked 
molecules of a molecular weight corresponding to the dimeric molecular weight of the 
polypeptide upon glutaradehyde cross-linking analysis. Therefore, at temperatures at 
which the DNA binding activity of the polypeptide was eliminated, the ril2 mutation 
failed to disrupt the dimerization of the DNA binding domain of Vmwl75. This result 
implies, as with previous results obtained with mutations within the "helix-tum-helix" 
motif, that the portion of the polypeptide containing the ril2  mutation (ie.
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encompassing codons 320-345) does not contribute to the dimerization properties of 
the isolated DNA binding domain, and that portions of the polypeptide outwith the 
region spanning codons 320-245 are responsible for the dimerization function of the 
DNA binding domain of Vmwl75.
Two other hypotheses may still account for the involvement of either the "helix- 
tum-helix" motif or the N-terminal portion of the DNA binding domain of Vmwl75 in 
the dimerization interface of the protein. Firstly, the mutation introduced may be 
sufficiently disruptive to the dimerization interface to affect the DNA binding activity 
of the isolated polypeptide, but not sufficiently disruptive to eliminate the association 
of polypeptides into dimeric molecules. In the case of the mutation ril2, it should be 
remembered that the original mutation from which this pseudo-revertant developed, the 
il2  mutation, had a more disruptive influence on the DNA binding capacity of 
Vmwl75 (Shepard et aL, 1989, Shepard and DeLuca, 1991b). Multiple attempts at 
expressing an IlOX polypeptide containing the il2  mutation yielded very low 
quantities of the polypeptide - could it be that the polypeptide is unable to form stable 
dimers, and so is rapidly degraded? Other DNA binding domain polypeptides 
containing mutations within this region were also very difficult to express (R. D. 
Everett, personal comm.).
Secondly, the dimerization interface of the polypeptide molecule may be 
composed from different regions of primary sequence to form a "discontinuous" 
dimerization interface. Studies of protein antigenicity have shown that antigenic 
epitopes are composed of both continuous and discontinuous sequences. In order to test 
these hypotheses, it would be useful to isolate and identify mutations which disrupt the 
dimerization activity of the DNA binding domain polypeptide of Vmwl75. At present, 
the existence of such mutations has not been reported, and as discussed above, the 
expression of dimerization deficient mutant polypepetides may be difficult to achieve.
3F. The Strategy for the Construction of Recombinant 
HSV-1 Viruses Containing In-Frame Point, Insertion and 
Deletion Mutations Within the IE-3 Open Reading Frame.
The aim of the work presented in this section was to introduce mutations, 
whose in vitro properties have previously been determined, into both copies of the IE-3 
coding sequence of HSV-1 strain 17 syn+. The construction of these viruses would
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yield information on the ability of mutant Vmwl75 molecules to support viral growth 
in tissue culture, and possibly lead to the further analysis of the transactivation and 
autoregulation properties of mutant Vmwl75 molecules which are able to support the 
growth of HSV-1 in non-complementing cell lines.
3F.1. Complementing Cell Lines M64A and RR1, and Propagation of the 
Mutant Virus D30EBA.
In order to study the effects of mutations on the in vivo properties of the 
Vmwl75 protein, it was necessary to introduce them into both copies of the IE-3 open 
reading frame of HSV-1. As a functional Vmwl75 molecule is essential for the viral 
life cycle (for example, see Watson and Clements, 1978; Preston, 1979), any viruses 
containing lethal mutations within the IE-3 gene must be propagated on cell lines 
which express complementing levels of Vmwl75 from the cellular genome. Previous 
workers (Paterson, 1989; Paterson and Everett, 1990) utilized the cell line M64A, 
which is similar to the cell line M65 (Davidson and Stow, 1985), to propagate and 
purify virus strains containing deleterious mutations within the IE-3 reading frame.
It was decided to utilize a similar strategy to construct a series of recombinant 
viruses containing insertional, point and deletion mutations within the IE-3 open 
reading frame. The virus strain D30EBA (Paterson, 1990) is based on the HSV-1 strain 
17 syn+ and contains large deletions encompassing nucleotides 246-3806 within both 
copies of the IE-3 open reading frame. Cotransfection of D30EBA viral DNA with 
linear plasmid DNA carrying mutant forms of the IE-3 coding sequence results in the 
production of recombinant viruses carrying mutant copies of the IE-3 gene. The effect 
of the mutations on the properties of the Vmwl75 molecule determines the viability of 
the recombinant viruses in non-complementing cell lines.
Early preparations of D30EBA viral stocks propagated on the cell line M64A 
contained 0.001-0.01% of contaminating wild type virus, presumably formed through 
recombination events between D30EBA IE-3 coding sequences and wild type IE-3 
coding sequences within the cellular genome. In order to reduce the background 
contamination with wild type HSV-1, D30EBA viral stocks used for the experiments 
presented in this thesis were propagated on the cell line RR1 (obtained from Dr. P. A. 
Johnston, University of California Medical School). As discussed in Section 3F.4, this 
cell line results in a reduced occurence of recombination betwen mutant and wild type 
IE-3 coding sequences, lowering the contamination of D30EBA stocks with wild type 
HSV-1. As discovered previously (Paterson, 1989), titration of D30EBA stocks on 
M64A cells was difficult due to the low growth of viral plaques and occasional loss of
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complementing cellular activity, and similar problems were encountered when titrating 
stocks of D30EBA on the RR1 cell line. However, stocks of D30EBA of a titre 
estimated at 107pfu/ml on RR1 cells contained wild type HSV-1 contamination at a 
titre of less than 102 pfu/ml on BHK cells, ie. contamination at less than 10_3%. Pulse 
labelling of polypeptides after a 16 hour infection of RR1 and BHK cells with either 
HSV-1 strain 17 syn+ or D30EBA showed that D30EBA in the absence of 
complementing Vmwl75 had limited genetic expression of immediate early genes 
(excluding Vmwl75) and (rather interestingly) large amounts of the large subunit of 
ribonucleotide reductase (see Figure 3F.1, track 6). However, the RR1 cell line allowed 
for the replication of D30EBA, leading to the expression of early and late genes, as 
seen in infections with the wild type virus (Figure 3F.1, compare track 3 with tracks 2 
and 5).
As mentioned above, mutant IE-3 sequences were introduced into HSV-1 by 
cotransfection of D30EB A viral DNA with linear plasmid DNA carrying mutant IE-3 
coding sequences. In order to avoid problems associated with recombination events, 
cotransfections were carried out in BHK cells. This would lead to the isolation of 
recombinant viruses containing mutations which did not disrupt the full in vivo activity 
of Vmwl75. Any lethal mutations within the IE-3 open reading frame would lead to 
the formation of non-viable recombinant viruses; therefore, this strategy does not allow 
for the isolation of such mutant strains of HSV-1.
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RR1
VmwllO
^  Vmw65 Vmw63
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RR1 BHK
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Figure 3F.1. Pulse Labelling of Polypeptides Synthesized During the Infection of 
Complementing and Non-Complementing Cell Lines with Wild Type and Mutant 
Strains of HSV-1.
10mm limbro wells were seeded with 1 x  10s RR1 or BHK cells per well and infected 
the following day at a m. o. i. o f 5 pfu/cell. The infection was allowed to proceed for  
16h. at 37°C and the pulse labelling o f polypeptides was carried out as described in 
Section 2B.6.1. Extracts were electrophoresed on a 12.5% SDS-polyacrylamide gel, 
and polypeptides detected by autoradiography o f the dried gel.
The positions o f several polypeptide products o f late and immediate-early HSV-1 genes 
are indicated adjacent to lanes 5 and. 6, respectively.
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3F.2. Construction of Plasmids Containing Mutations Within the IE-3 
Coding Region.
The construction of a series of insertional mutations within the IE-3 coding 
sequence of the plasmid pl75 has been described (Paterson, 1989). In order to study 
the effects of the point and in-frame deletion mutations on the in vivo properties of 
Vmwl75, these mutations were also introduced into the plasmid pl75.
The strategy for the construction of a series of plasmids, the pGL series, 
containing various point and deletion mutations within the IE-3 coding sequence, is 
represented diagrammatically in Figure 3F.2. Firstly, site directed mutagenesis 
techniques were used to remove the BamHI restriction site situated at nucleotide 1725 
of the IE-3 coding region within the plasmid p ill. The plasmid p i l l  is based on the 
plasmid pl75 and contains a four amino acid insertional mutation and unique EcoRI 
restriction site at codon 292 of the IE-3 open reading frame. A single base pair change 
was introduced within pll 1 which resulted in the removal of the BamHI restriction site 
at nucleotide 1725 without introducing an alteration in the IE-3 amino acid sequence. 
In order to carry out the mutagenesis, the Sstl/EcoRI fragment encompassing 
nucleotides 876 to 2044 of the IE-3 reading frame was cloned into the vector M l3 
mpl8. Single stranded DNA prepared from this vector was used as a template for site 
directed mutagenesis. The oligonucleotide LA20 (5' GCCTCCAGGATGCCGCGGCA 
3')was used to introduce the base pair change, and mutagenesis was carried out using 
the Amersham in vitro mutagenesis system as described in Section 3B. Resultant M l3 
DNA obtained from the mutagenesis reaction was transfected into competent TGI 
bacteria. The clones were screened by restriction enzyme digestion for the loss of the 
155bp BamHI-BamHI restriction DNA fragment and putative mutant clones were 
further analysed by dideoxy sequencing reactions. The BamHI/SstI fragment from 
possible mutant constructs was cloned into the M l3 mpl8 vector and the subcloned 
fragment sequenced with universal M l3 primer and Sequenase™ T7 DNA 
polymerase, as described in Section 2B.21. DNA ladders were electrophoresed on 8% 
denaturing acrylamide gels and the sequence compared to the wild type IE-3 coding 
sequence. Figure 3F.3 illustrates this mutagenesis and shows representative sequence 
analysis of a mutant clone containing the G to C mutation at nucleotide 1722.
Once the mutation had been introduced into the M13 vector, the mutant 
Sstl/EcoRI DNA fragment was cloned into pIlO to yield the plasmid pLIlOIll. The 
plasmid pIlO was digested with SstI in the presence of 40(ig/ml ethidium bromide to 
yield a high percentage of singly cut, linear molecules. Linear plasmid DNA was 
isolated from non-denaturing agarose gels, as described in Section 2B.12.1 and 
digested with EcoRI. Approximately 400ng of this digested DNA was ligated to
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approximately 400ng of the mutant EcoRI/SstI resriction fragment. The ligation mix 
was transfected into competent DH5 bacteria and resultant clones screened by 
restriction enzyme digestion for the presence of three SstI retriction sites and the loss of 
the 155bp BamHI-BamHI restriction fragment.
In order to construct the pGL plasmids, the pLIlOIl 1 plasmid was digested with 
BamHI and PstI and the 6800bp DNA restriction fragment isolated from a non­
denaturing agarose gel. The 2400bp NruI/PstI restriction fragment was isolated in the 
same way from plasmid pl75 and the 600bp NruI/BamHI fragments were isolated from 
plasmids containing the mutations of interest. The three restriction fragments were 
ligated and transfected into competent DH5 bacteria. Resultant clones were screened 
by restriction enzyme analysis in order to isolate the clones containing all three 
restriction fragments. Positive clones were also checked for the absence of the BamHI 
site at nucleotide 1725 and the absence of an 110 or 111 EcoRI restriction site within 
the IE-3 coding sequence. Positive clones identified by restriction enzyme digestion 
were then subjected to dideoxy sequence analysis with the LA 19 primer, as described 
in Section 3B.4.1, in order to verify the presence of the point or deletion mutation.
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Figure 3F.2. Strategy for the Construction of pGL Plasmids.
The plasmids p i  75 and pLIlOIll are described in the text. Plasmid 
pT7XI9/I10 represents the T7 expression plasmids containing the point 
base pair or deletion mutation of interest. pGL plasmids are constructs 
by ligation of the DNA restriction fragments indicated.
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C R G I L E A
TGC CGC GGGATCCTG GAG GCG
BamHI
(b) Sequence resulting from mutagenesis with LA20.
C R G I L E A
TGC CGC GGC ATC CTG GAG GCG
( C )
T C G A
Figure 3F.3. Removal of a BamHI Site from the IE-3 Open Reading Frame 
by Site-Directed Mutagenesis.
(a) The sequence o f the IE-3 open reading fram e spanning codons 572-578 (nucleotides 
1714-1734), showing the position o f the BamHI site.
(b) The above sequence showing the base pair change introduced (in outline).
(c) Representative sequence analysis o f a clone containing the base pair mutation. The 
clone was sequenced by the dideoxy chain termination method, using Klenow DNA 
polymerase, as described in Section 2B.21. Radiolabelled fragments generated by the 
sequencing reaction were electrophoresed on a denaturing 8% acrylamide gel, and 
fragments visualized by autoradiography. The sequencing reaction appeared to generate 
a lower proportion o f fragments terminated at C residues. Therefore, bands appearing in 
the C track represent doublets created by two adjacent C residues.
The sequence shown, starting from  the arrowed G and proceeding upwards, reads: 
5'GTG GCC GTC GAG TGC CTG GCC GCC TGC CGC GGC ATC CTG GAG 
GCG M utated Bam H I site
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3F.3. Marker Rescue of the Vm wl75 Deletion Mutant HSV-1 Virus 
D30EBA.
The strategy utilized to construct the recombinant viruses involved the marker 
rescue of the virus D30EBA by cotransfecting in non-complementing cell lines viral 
DNA with linear plasmid DNAs containing wild type or mutant IE-3 coding sequences. 
Plasmid DNA was linearised by digestion with PstI and cotransfected with HSV-1 
D30EBA viral DNA into BHK cells by the calcium phosphate precipitation method as 
described in Section 2B.7. 3-4 days after the transfection, when viral cytopathic effect 
was visible, cells were scraped into the medium and sonicated to release viral paricles. 
The virus stock was then titrated on BHK cells. Initially, the cotransfection was carried 
out with wild type pl75 DNA or control pUC19 DNA. Cotransfections with pl75 
DNA would indicate whether the IE-3 coding sequences were necessary and sufficient 
for the rescue of the deletion mutant D30EBA. Cotransfections with pUC19 DNA 
would indicate whether the D30EBA viral preparation was contaminated with wild 
type HSV-1 17+ DNA, due to recombination between D30EBA sequences and wild 
type IE-3 coding sequences during the propagation of the virus on RR1 cells, as 
described in Section 3F.1.
Table 3F.1 shows the titres of HSV-1 virus obtained from transfections of 
D30EBA DNA with either pl75 or pUC19 DNA on 50mm plates seeded at 
subconfluence with BHK cells. Marker rescue with pl75 consistently yielded titres of 
around lOMO7 pfu/ml of wild type HSV-1, indicating that the IE-3 coding sequences 
were necessary and sufficient for the replication of the virus D30EBA on BHK cells. In 
contrast, marker rescue with pUC19 DNA consistently resulted in no detectable virus 
growth on subsequent titrations; that is, any wild type virus produced from the 
cotransfection had a titre of 102 pfu/ml or less. Therefore, any contaminating wild type 
virus present within the D30EB A stock was present at such a low level that it could be 
assumed that viral replication detected during cotransfection experiments with mutant 
Vmwl75 sequences was due to the replication of the recombinant virus containing 
mutant IE-3 coding sequences, rather than the proliferation of any wild type 
contaminating genome.
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Co-transfection experiment 
number.
Titre of progeny virus 
obtained from co- 
transfection with pl75
Titre of progeny virus 
obtained from co- 
transfection with pUC19.
1 7x10^11/1111 <lxl03pfu/ml
2 SxlO^fu/ml <lxl03pfu/ml
3 bxlO^fu/ml <lxl02pfu/ml
4 7.5xl07pfu/ml <lxl02pfu/ml
Table 3F.1. Marker Rescue of the HSV-1 Deletion Mutant D30EBA.
Marker rescue was carried out by cotransfecting viral DNA from the HSV-1 Vmwl75 
deletion mutant D30EBA with linearizedpl75 or pUC19 DNA into BHK cells. 3-4 days 
post transfection, transfected cells were scraped into the medium and sonicated to 
release virus particles. Progeny virus was then titrated on BHK cells. The above 
results were obtained from four consecutive transfection experiments.
Representative titres from cotransfection experiments with mutant IE3 genes 
are given in Table 3F.2. These illustrate the wide variability of titres obtained with 
certain mutant pl75-based plasmids that can support viral growth in tissue culture.
Cotransfection Experiment 
Number.
Cotransfected DNA Titre of Progeny Virus.
1 pI9 SxlOSpfu/ml
1 pIlO 2xl03pfu/ml
1 p ill lxlO^fu/ml
2 pI9 SxlOVu/ml
2 piio 1.2x10^^1/1111
2 p ill LSxlO^pfu/ml
3 pI9 S.SxlO^fu/ml
3 pno lxlO^fu/ml
3 -------------- p m — ;-------- SxlO^fu/ml
Table 3F.2. Representive Titres from Consecutive Rounds of Cotransfection 
Experiments.
Cotransfection experiments were carried out with viral DNA from the Vmwl75 
deletion mutant D30EBA and linearized plasmids containing mutant forms of the IE-3 
reading frame, as indicated. Transfections were carried out on BHK cells. 3-4 days 
post transfection, cells were scraped into the medium and viral particles released by 
sonication. Progeny virus obtained from the cotransfection experiment was titrated on 
BHK cells. The above results were obtained from three consecutive cotransfection 
experiments.
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3F.4. Discussion.
Davidson and Stow (1985) initially reported that propagation of HSV-1 IE-3 
mutant viruses on recombinant cells containing genomic HSV origin of replication 
sequences led to noticeable recombination events betwen HSV sequences in the 
cellular genome and sequences within the mutant HSV-1 viruses. For example, after a 
16 hour infection at the non permissive temperature with the virus tsK, (which contains 
a temperature sensitive mutation within the IE-3 gene), on cell lines containing the 
HSV-1 origin of replication, "a" and Vmwl75 coding sequences, progeny virus stocks 
were contaminated with approximately 1.3% wild type HSV-1. Davidson and Stow 
proposed that this recombination was due to the propagation of wild type Vmwl75 
sequences linked to the HSV-1 origin of replication within the cellular genome upon 
infection, followed by recombination between mutant and wild type IE-3 coding 
sequences. M65 cell lines infected in the same way did not yield recombinant wild type 
virus in the progeny stocks; Davidson and Stow suggested that this lack of 
recombination was due to the fact that M65 cells did not contain HSV-1 origin of 
replication sequences. However, Paterson (1989) reported that propagation of the virus 
D30EBA in M64A cell lines resulted in contamination with wild type virus at 0.001- 
0.01%, and that the passage of recombinant viruses containing mutant IE-3 coding 
sequences in the M64A cell line resulted in the emergence of wild type recombinant 
viruses. The recombination events described by Paterson (1989) were suggested to be 
due to recombination via highly repetitive "a" sequences contained within the genome 
of M64A cells. The RR1 cell line was created by transformation of BHK cells with 
DNA fragments containing only Vmwl75 coding sequences, and did not contain either 
the HSV origin of replication or the "a" sequence mentioned above. This may explain 
the lower rate of emergence of wild type recombinant viruses observed during the 
propagation of the deletion mutant HSV-1 virus D30EBA on RR1 cell lines.
Table 3F.2 illustrates the variability of virus titre obtained from repeated 
cotransfection experiments with plasmids carrying mutant IE-3 coding sequences 
which are able to support vims growth in tissue culture. This variability illustrates that 
the yield of recombinant vims was not necessarily representative of the ability of the 
mutant Vmwl75 molecule to support viral growth in tissue culture. The only 
conclusion to be drawn from such cotransfection experiments, therefore, is whether the 
mutation sufficiently disrupts the function of the Vmwl75 molecule such that it is 
unable to support the replication of HSV-1 in tissue culture.
The variability in virus yield could be due to several factors, such as 
inconsistencies in the efficiency of the transfection procedure or changes in the rate of 
recombination between D30EBA and mutant IE-3 coding sequences. However, titres of
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viable recombinant viruses obtained with this protocol were sufficient for the further 
analysis of the growth of mutant viruses in tissue culture, as described in Section 3G.3.
The strategy employed for the construction of recombinant viruses enabled only 
a rough determination of the effects of the mutations on the in vivo properties of 
Vmwl75. Mutant forms of Vmwl75 could only be assayed for their ability to support 
viral growth in BHK cells. Any mutations leading to a gross disruption of the activity 
of the protein and therefore a non-viable recombinant virus could not be analysed 
further. Therefore, the strategy does not allow analysis of the properties of the mutant 
polypeptides, such as whether the mutation affects transactivation or autoregulation by 
the protein. However, comparison of the viability of mutant viruses with the 
characteristics of the mutations which have already been determined in vitro would 
yield information on the in vitro properties of the protein necessary for its full function 
in the viral lytic cycle.
3G. Characterization of Recombinant Viruses.
3G.1. The Ability of Mutant Vmwl75 Molecules to Support Viral Growth 
in Tissue Culture.
As discussed in Section 3F, cotransfection experiments were carried out with 
viral DNA prepared from the Vmwl75 deletion mutant HSV-1 virus D30EBA and 
plasmids carrying wild type or mutant IE-3 coding sequences. Cotransfections were 
carried out in BHK cells as described in Section 2B.7. This allowed for the 
determination of the ability of the mutant Vmwl75 molecule to support viral growth on 
BHK cells, as measured by the production of a viable recombinant virus. 
Cotransfections were carried out at least twice for each mutant plasmid tested and each 
transfection experiment contained control transfections with wild type pl75 DNA and 
pUC19 DNA. Results obtained from the control experiments were similar to those 
described in Section 3F.3.
Initially, cotransfection experiments were carried out with the pi series of 
plasmids, which contain four amino acid insertional mutations throughout the IE-3 
open reading frame (Paterson and Everett, 1988a; 1988b; Paterson, 1989). Only 
plasmids containing mutations within the Vmwl75 DNA binding domain (pI9-pI20)
169
Chapter 3. Results
were tested for their ability to support HSV-1 replication in tissue culture. These 
mutations had previously been assayed for their DNA binding, transactivation and 
autoregulation properties in transient transfection and gel retardation analyses (Paterson 
and Everett, 1988a; 1988b; Paterson, 1989). The results of these assays are presented in 
Table 3G.1, together with the results of the cotransfection experiments. This summary 
illustrates that the mutations which disrupt the functions of Vmwl75 as measured in 
vitro when incorporated into the genome of HSV-1 result in the non-viability of the 
virus in tissue culture. The implications of this observation are discussed further in 
Section 3G.4.
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Mutant
Number
Site of 
Insertion 
(codon)
Trans-
activation
(a)
Auto-
regulation
(b)
DNA
Binding
Activity
(c)
Relative 
Amounts of 
Vmwl75 
(d)
Viability of 
recombinant 
Virus 
(e)
19 252 127(43.2) +++ +++ 263 +
110 275 25.8(4.6) - ++ 142 +
111 292 30.8(6.3) ++ +++ 276 +
112 310 20.0(4.4) + +/- 97 -
113 324 10.0(2.9) - +++ 226 -
114 329 4.9(0.9) - - 38 -
115 337 4.5(0.9) + - 18 -
116 373 16.5(2.8) - - 18 -
117 398 11.8(1.9) - + 39 -
118 438 15.5(4.4) - + 65 -
119 494 49.2(10.4) +++ +++ 170 N/D
120 518 47.2(10.2) +++ +++ 85 +
Table 3G.1 Ability of Mutant Vmwl75 Molecules Containing Insertional 
Mutations to Support HSV-1 Replication in the Non-Complementing BHK Cell 
Line.
(a) The activation o f the gD promoter (using pgDCAT in conjunction with VmwllO 
provided by p i l l )  is given as a percentage o f that obtained in parallel experiments 
with p i  75. Figures shown represent mean values from several experiments, with 
standard error o f the mean given in brackets. Reproduced from Paterson, 1989.
(b) The qualitative ability to repress the IE-3 promoter ofpIE3CAT compared to pl75 
in cotransfection titration experiments. Repression activity is scored from - (essentially 
no activity) to +++ (wild type activity). Reproduced from Paterson, 1989.
(c) The ability o f nuclear extracts made from HeLa cells transfected with each of the 
mutants to bind to the IE-3 capsite. Binding activity is scored from visual inspection of 
autoradiographs. - no binding, +/- barely detectable, + to +++ increasing binding 
activity. Reproduced from Paterson, 1989.
(d) Relative amounts in the nuclear extracts used in the in vitro assays (a) to (c), 
determined by ELISA. pl75  = 100. Reproduced from Paterson, 1989.
(e) The viability o f recombinant viruses containing the mutant Vmwl75 molecule in 
non-complementing cell lines, as determined by co-transfection experiments with the 
Vmwl75 deletion mutant virus, D30EBA. N/D = not determined.
A series of plasmids containing point mutations and one plasmid containing an 
in-frame internal deletion within the DNA binding domain of Vmwl75 were also 
tested in cotransfection experiments, as described above. These mutations had been 
previously assayed for their ability to disrupt DNA binding (data presented in Section 
3D) and certain mutations had also been tested for their ability to disrupt dimerization 
(data presented in Section 3E). The introduction of these mutations into the viral
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genome would provide a means for testing whether they disrupted Vmwl75 function 
during the viral replicative cycle.
The mutations tested in the cotransfection experiments had all been shown to 
disrupt the DNA binding activity of the isolated DNA binding domain of Vmwl75. 
Some point mutations and the deletion mutation had been resulted in the elimination of 
the DNA binding activity; other point mutations resulted in a temperature sensitive 
DNA binding phenotype (see Setion 3D). In order to determine whether the 
temperature sensitive DNA binding phenotype of certain point mutations was reflected 
in a temperature sensitive phenotype of the Vmwl75 molecule when the mutations 
were introduced into the HSV-1 genome, cotransfections were carried out at 31°C and 
the resultant cell associated virus stocks were titrated on BHK cells at 31°C and 
38.5°C. The results of these transfection experiments and the effects of the mutations 
on the DNA binding activity and, where applicable, the dimerization activity of the 
isolated DNA binding domain are summarized in Table 3G.2.
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Mutant
Number
Site of 
alteration 
(codon)
Type of 
alteration
DNA
binding
phenotype
(a)
Dimerization
phenotype
(b)
Viability of 
recombinant virus 
(c)
31°C 38.5°C
LI 574 removal of 
BamHI 
site
N/D N/D + +
DH1 445-453 del no binding N/D - -
463/4
KG/NC
463
464
Lys to Arg 
Gly to Cys
no binding WT - -
459D/Y 459 Asp to Tyr no binding N/D -
453A/S 453 Ala to Ser TS N/D + +
457R/L 457 Arg to 
Leu
TS N/D -
Table 3G.2. The Ability of Vmwl75 Molecules Containing Point and Deletion 
Mutations to Support HSV-1 Replication in Non-Complementing Cell Lines.
(a) The DNA binding phenotype o f DNA binding domain polypeptide containing the 
indicated mutation. DNA binding activity was determined by gel retardation analysis 
with a DNA probe containing the consensus DNA binding site situated at the IE-3 cap 
site. WT = DNA binding activity indistinguishable from that o f a wild type DNA 
binding domain polypeptide. TS = DNA binding activity reduced at temperatures of 
37°C and above. No binding = no binding activity at any temperature. N/D = not 
determined
(b) The dimerization phenotype of a DNA binding domain polypeptide containing the 
mutation o f interest, as determined by gel filtration chromatography or glutaraldehyde 
cross-linking assays. N/D = not determined WT = dimerization properties 
indistinguishable from that o f a wild type DNA binding domain polypeptide.
(c) The viability o f recombinant viruses containing the mutant Vmwl75 molecule in 
non-complementing cell lines, as determined by co-transfection experiments with the 
Vmwl75 deletion mutant virus D30EBA.
Again, the results illustrate that the majority of mutations which disrupt the in 
vitro properties of the isolated DNA binding domain of Vmwl75 when incorporated 
into the HSV-1 genome result in the non-viability of the recombinant viruses in non­
complementing cell lines. The two temperature sensitive mutations 453A/S and 
457R/L produced interesting results when introduced into the viral genome. Whilst one 
mutation resulted in a recombinant virus viable in BHK cells at both 31°C and 38.5°C, 
the second mutation resulted in a virus which was non-viable in a non-complementing
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cell line. Section 3G.4 presents a discussion of possible reasons for these observations, 
and the implications of the results presented in Table 3G.2.
3G.2. Southern Blot Analysis of Recombinant Virus Genomes.
As the summary in Table 3G.1 shows, of the twelve insertional mutant 
Vmwl75 coding sequences which were tested for the ability to support viral replication 
in tissue culture, only four mutant IE-3 genes were incorporated into viable 
recombinant viruses. In order to verify that the virus stocks obtained from these 
cotransfection experiments contained the mutations of interest, and were not 
contaminating wild type HSV-1, the viral DNA was subjected to Southern blot 
analysis.
Total infected cellular DNA was prepared from viral stocks as described in 
Section 2B.5. The DNA was digested with EcoRI and BamHI at 37°C for 16-20 hours 
and DNA fragments electrophoresed on 1.5% non-denaturing agarose gels at 8V/cm. 
The DNA fragments were transferred onto a solid membrane as described in Section 
2B.25. Initial Southern blot analyses were carried out using nitrocellulose membranes. 
These were found to lead to a low efficiency in the detection of fragments spanning the 
IE-3 coding region, as previously noted by others (Davidson and Stow, 1985; Clements 
et al., 1979). This low efficiency of detection was thought to be due to the high G + C 
content of the IE-3 coding sequences, and was improved by the use of Hybond N+ 
charged membrane. Restriction fragments were probed by incubation with a 
radiolabelled BamHI "y" HSV-1 DNA restriction fragment, as described in Section 
2B.26. The probe DNA was radiolabelled to a high specific activity using the random 
prime method, as detailed in Section 2B.24.3.
Southern blot analysis of the wild type HSV-1 genome in this way led to the 
identification of the uncut BamHI "y" fragment, which spans the 5' portion of the IE-3 
open reading frame (see Figure 3G.la, tracks 14, 18 and 24). The three mutations 
incorporated into the IE-3 open reading frame in recombinant HSV-1 virus genomes 
result in the incorporation of unique EcoRI restriction sites within the BamHI "y" 
fragment. As each mutation specifies a unique site at various positions within the IE-3 
reading frame, digestion of the viral genome with EcoRI and BamHI and identification 
of the DNA fragments which hybridize to the radiolabelled BamHI "y" restriction 
fragment led to the detection of a pair of restriction DNA fragments characteristic of 
the particular insertional mutation. Figure 3G.1 shows Southern blot analysis of virus 
stocks obtained from multiple cotransfection experiments with the plasmids pI9, pi 10 
and p i l l ,  and illustrates the detection of the two unique EcoRI/BamHI restriction 
fragments. Longer exposure of these Southern blots in principle would enable the 
detection of any contaminating wild type genomes present in the mutant virus stocks.
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Figure 3G.2. Growth Curve Analysis of the HSV-1 Virus Strains nsvn^vIQ. 
vIlO and v lll .
Legend to Figure 3G.2.
Linbro wells seeded at 105 BHK cells /  well were infected with each viral strain at a 
multiplicity of infection of 0.0 J.pfu/cell. Infections were carried out at 37°C for 24 
hours. At the time points indicated, cells were scraped into the medium and sonicated to 
release viral particles. Progeny virus was titred on BHK cells. The graph represents the 
progeny virus titre for each virus strain at the time points indicated.
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Stocks of viruses containing the 19-111 mutations (vl9-vlll respectively) had no 
detectable contaminating wild type HSV-1; they were analysed further as described in 
Section 3G.3.
3G.3. Growth Curve Analysis of the HSV-1 Recombinants vI9, vIlO and 
v l l l .
The viruses vI9, vIlO and v l l l ,  containing four amino acid insertional 
mutations at codons 252, 275 and 292 of the IE-3 open reading frame, were analysed 
for their rate of replication on BHK cells. Viruses were analysed by the determination 
of the titre of progeny virus obtained at specific time points during a 24 hour viral 
infection. 10mm linbro wells seeded with BHK cells were infected at a multiplicity of 
infection of 0.02 pfu/ cell. The infection was allowed to proceed at 37°C for 24 hours 
and at specific time points during the infection, cells were scraped into the medium and 
sonicated to release infectious virus particles. Resultant virus stocks were titrated on 
10mm linbro wells seeded with BHK cells. The titres obtained over a 24 hour infection 
with HSV-1 strains 17 syn+, vI9, vIlO and vll 1 are shown in Figure 3G.2.
All four viral infections showed a drop in virus titre between 2-4 hours post 
infection. This is the eclipse phase of viral infection during which viral genomes are 
undergoing transcription and DNA replication prior to the production of infectious 
particles. In the period 6-24 hours post infection, during which time progeny viruses 
are accumulating in the cell or in the extracellular medium, distinctions can be made 
between the growth cycles of the four viruses. At 24 hours post infection, the virus vI9 
yields progeny virus of a comparable titre to that obtained with wild type HSV-1 (see 
Figure 3G.2). However, titres of progeny virus obtained from a 24 hour infection with 
vIlO or vll 1 are 10 and 100- fold lower, and accumulation of infectious vIlO and vll 1 
particles occurs at comparatively lower rates.
3G.4. Discussion.
A striking point of the results obtained with the cotransfection experiments 
described in Section 3G is that mutations that have previously been shown to disrupt 
the in vitro properties of Vmwl75, when incorporated into the HSV-1 genome result in 
Vmwl75 molecules incapable of complementing the deletion mutant D30EBA in 
tissue culture. This suggests that the conclusions drawn from previous in vitro assays
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are valid, and that the measurement of the in vitro properties of Vmwl75 gives a close 
approximation to the actual in vivo activity of the molecule.
In the studies of the insertional mutant Vmwl75 molecules, one case does not 
entirely fit this hypothesis. The mutant Vmwl75 molecule 113, which is apparently 
functional in DNA binding as measured by in vitro analysis (see Table 3G.1), is unable 
to support the growth of HSV-1 in tissue culture. However, two additional observations 
suggest that the 113 molecule is functionally defective. Firstly, in vitro analysis showed 
that the protein had reduced transactivation properties (see Table 3G.1). Secondly, the 
113 mutation when introduced into a Vmwl75 DNA binding polypeptide eliminated 
the DNA binding activity of the molecule (R. D. Everett, personal communication). 
Therefore, although the results obtained from the in vitro analysis of the Vmwl75 113 
molecule suggest otherwise, it appears that the 113 molecule is functionally defective, 
and therefore cannot support the replication of HSV-1 in tissue culture.
Additionally, results from in vitro analysis suggested that the Vmwl75 110 
molecule may be defective in autoregulation (see Table 3G.1). This mutation when 
introduced into the viral genome resulted in a viable recombinant virus. It would have 
been interesting to investigate the kinetics of Vmwl75 expression during vIlO 
infection in BHK cells, in order to determine whether the protein does actually 
autoregulate expression of Vmwl75 during the viral life cycle, and whether this 
function is essential for replication of HSV-1. However, time did not allow for this 
experiment to be done.
Previous experiments with the 19 and 110 DNA binding domain polypeptides 
have shown that the 19 polypeptide but not the 110 polypeptide can produce a DNAasel 
footprint at the IE-3 capsite (R. D. Everett, unpublished observations). This situation is 
analogous to that observed with DNA binding domain polypeptides of the homologous 
VZV 140K protein (J. Tyler, personal communication). Therefore, it has been 
suggested that the region between the 19 and 110 insertions (spanning codons 252-275) 
is important for the stabilization of protein-DNA interactions. The observation that 
Vmwl75 may bind to certain DNA probes in gel retardation analysis but not footprint 
the same sequences has been described by Papavassiliou and Silverstein (1990), and 
these authors also suggested that the loss of footprinting ability of Vmwl75 was due to 
a reduction in the stability of the protein-DNA interactions. It is possible that the 
disruption of the autoregulation property of Vmwl75 by the 110 insertion results from 
a reduction in the interaction of the whole Vmwl75 molecule containing the 110 
mutation with DNA, and that stable interactions are required for the autoregulation 
function, a theory also proposed by Roberts et al. (1988). The recombinant viruses vI9 
and vIlO could be used to express Vmwl75 molecules containing the 19 and 110 
mutations for in vitro DNA footprinting experiments in order to investigate the 
footprinting activity of the Vmwl75110 protein.
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The results of the growth curve analysis of the vI9, vIlO and v l l l  viruses 
suggests that the ability of the mutant molecules to support viral replication is closely 
related to the in vitro assay of their ability to transactivate, as summarized in Table 
3G.1. The 110 Vmwl75 molecule exhibits a slightly reduced transactivation activity 
and the 111 Vmwl75 molecule exhibits a further reduction in transactivation as 
compared to wild type protein, and the ability of the recombinant viruses to replicate 
also follows this trend (see Figure 3G.1). It is clear from this data that as the mutations 
move further towards the centre of the DNA binding domain region, they exhibit a 
more disruptive effect on the functions of Vmwl75.
With the point mutations and internal in-frame deletion mutations which have 
previously been shown to disrupt the function of Vmwl75 in vitro, the correlation 
between their in vitro and in vivo activity is even more striking. The results of the 
cotransfection experiments show that the mutations also affect the properties of the 
whole Vmwl75 protein in the context of a full viral infection. Because the mutations 
fail to complement the deletion mutant HSV-1 virus D30EBA, it could be predicted 
that they affect the transactivation and possibly the autoregulation properties of 
Vmwl75. As the recombinant viruses containing these mutations are non-viable, they 
cannot be used as expression vectors for the mutant Vmwl75 molecules. However, it 
would be possible to use the pGL series of plasmids in transient transfection and gel 
retardation experiments previously described by Paterson and Everett (1988a; 1988b) 
to study the effects of the mutations on the in vitro properties of Vmwl75 and confirm 
that they correlate to their complementing activity, a situation observed with the 
insertional mutations.
With the two temperature sensitive point mutations tested, the results are not so 
easy to interpret. Whilst both mutations resulted in identical phenotypes upon in vitro 
analysis, incorporation of the mutations into the viral genome produced both a viable 
and a non-viable HSV-1 recombinant virus. It is clear that both temperature sensitive 
mutations somewhat disrupt the functions of Vmwl75, but it is difficult to explain how 
one such disrupted molecule is rescued in vivo and can support the viral replicative 
cycle whilst a second mutant fails to do so. Interestingly, the temperature sensitive 
mutation which fails to support the viral life cycle is situated within the proposed turn 
of the "helix-tum-helix" motif, as predicted by Shepard et al. (1989). Whilst it is not 
clear that the secondary structure of the protein follows these predictions (see Section 
3A), the mutations which most drastically affected the DNA binding activity of 
Vmwl75 lay close to or within this region of the protein (see Section 3D.8). Therefore, 
it is possible that the mutation 457R/L has such a deleterious effect on the Vmwl75 
molecule that it is not able to support the transactivation of viral genes during HSV-1 
infection. In contrast, the mutant Vmwl75 molecule 453A/S, when in the cellular 
environment, may be stabilised by the interaction with other cellular or viral factors,
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allowing it to function fully at higher temperatures. It would be interesting to determine 
the in vitro transactivation properties of these two mutant Vmwl75 proteins, to test 
whether they correlate to the ability of the protein to support viral growth.
Other point mutations shown to result in a temperature sensitive DNA binding 
phenotype when expressed as isolated DNA binding domain polypeptides would 
possibly result in a temperature sensitive recombinant virus. This situation has already 
been shown to occur - the mutation tsK, which results in a temperature sensitive HSV- 
1 virus, consisits of an alanine to valine substitution at codon 475 (Davison et al., 
1984), and this mutation when cloned and expressed as an isolated DNA binding 
domain polypeptide exhibits a temperature sensitive DNA binding phenotype (see 
Section 3D).
These results point to the importance of region 2, and in particular the "helix- 
tum-helix" region within the Vmwl75 molecule, and suggest that the intrinsic stability 
of this region is essential for the full function of the protein. The point mutations 
analysed in this section, with the exception of the mutant 453A/S, must result in a 
sufficient disruption of the "helix-turn-helix" motif to affect the function of the 
Vmwl75 molecule.
The question of the contribution of the DNA binding activity of Vmwl75 to its 
full range of functions in vivo is a controversial and complex topic. Amongst the wide 
range of Vmwl75 mutant molecules studied, few mutations have been identified which 
result in the elimination of the DNA binding activity of the Vmwl75 molecule as 
measured in vitro whilst showing little effect on the ability of Vmwl75 to transactivate 
and autoregulate as measured by transient transfection experiments, or to support the 
viral replicative cycle (Paterson and Everett, 1988a; 1988b; Paterson et al., 1990; 
DeLuca et a l, 1984; DeLuca and Schaffer, 1987; 1988; Shepard et al., 1989; Shepard 
and DeLuca, 1991b). Only one mutation, the ril2  mutation (Shepard and DeLuca, 
1991b), results in a Vmwl75 molecule apparently exhibiting no DNA binding activity 
in vitro at any temperature, but fully able to support the viral replicative cycle in tissue 
culture. It should be remembered that the mutant virus from which this pseudo- 
revertant is derived, the virus vil2, contains a Vmwl75 molecule exhibiting no in vitro 
DNA binding activity and is in turn unable to support viral growth (Shepard et al., 
1989).
Several temperature sensitive HSV-1 viruses which contain point mutations 
within the C-terminal portion of Vmwl75 have been isolated (Paterson et al., 1990; 
DeLuca et al., 1984). Vmwl75 molecules from these viruses exhibit a temperature 
sensitive defect in DNA binding activity in vitro but are partially permissive for early 
gene expression at the non-permissive temperature. However, they are unable to 
support the full viral replicative cycle. For a full interpretation of these results, it must 
be remembered that the DNA binding properties of Vmwl75 are measured in artificial
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situations which cannot reproduce the full cellular environment in which Vmwl75 
functions, and that the protein molecule may be stabilised by interactions with other 
cellular proteins, enabling the mutant molecule to overcome its defect in DNA binding 
activity. Some data exists to support this model of the mechanism of Vmwl75 
transactivation within the cell. This data also questions the validity of previous 
conclusions made about the ril2 mutation, and is discussed further in Chapter 4.
The cotransfection experiments presented in this thesis contain no examples of 
DNA binding deficient mutant Vmwl75 molecules able to support viral growth. In 
fact, these results strongly suggest that the ability of Vmwl75 to bind to DNA 
correlates closely with the ability of the protein molecule to function fully during the 
viral replicative cycle. Although the insertional mutation 113 appears to result in a 
binding proficient Vmwl75 molecule that cannot support viral replication, analysis of 
the mutation within the IIOX DNA binding domain polypeptide has suggested that the 
mutation may actually have a disruptive effect on this region of the protein (Everett, 
unpublished observations). Therefore, the majority of the data shows the importance of 
the integral stability of region 2 and the "helix-turn-helix" motif, and the DNA binding 
activity of Vmwl75 for the full in vivo function of the protein.
179
Chapter 4. Discussion
Chapter 4. Discussion.
4A. Structural Motifs Within Vmwl75.
As the work presented within this thesis primarily involves the study of the 
DNA binding activity of Vmwl75, the structural analyses discussed here concentrate 
on the DNA binding domain of the protein.
As shown in Figure 3A.1, the DNA binding domain of Vmwl75 is well 
conserved between the transcriptional regulatory proteins of the a-herpesviruses. This 
is not surprising, since the domain encompasses region 2, which was defined by 
McGeoch et aL (1986) as a conserved region between Vmwl75 and the 140K protein 
of VZV. The highest conserved portion of the DNA binding domain encompasses 
amino acids 445-487, which has been suggested to encode a helix-turn-helix secondary 
structure motif (Shepard et al., 1989), and is the region under study in this thesis. The 
high conservation of this portion of the protein suggests that this sequence plays an 
important role in the in vivo properties of Vmwl75. As it is within the DNA binding 
domain of the protein, it is logical to suppose that the sequence plays a part in the DNA 
binding activity of the molecule, rather than mediating the transactivation function, or 
being a region modified by a post-translational reaction. In vitro studies have also 
illustrated that the DNA binding domain of Vmwl75 exists as a dimer in solution 
(Everett et al., 1991), therefore, the conserved region may also contain a dimerization 
motif.
As discussed in section 3A.6, the region encompassing amino acids 445-487 
exhibits trivial homology to other well conserved protein DNA binding motifs. This 
could imply that the sequence, if it does encompass a DNA binding motif, represents a 
new, evolutionarily diverged motif. Two classes of protein DNA binding motifs, whilst 
consisting of diverse amino acid sequence, still retain a helix-turn-helix secondary 
structure motif, confirming that this structure is well suited to interactions with the 
DNA helix. In fact, virtually all DNA binding motifs, with exceptions such as the (3 
barrel of TFIED (Nikolov et al., 1992) contain helical regions, which track into the 
grooves of the DNA helix, and thus mediate specific protein-DNA contacts. In this 
light, it is interesting to note that the region between amino acids 445-457 of Vmwl75 
exhibits high predictions of a-helical structure, as do the relevant regions of other a- 
herpesvirus regulatory proteins.
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It would also be of interest to investigate the functional relevance of sequences 
encompassing and adjoining amino acids 390-395 of Vmwl75. This five amino acid 
sequence shows homology to evolutionarily conserved and functionally significant 
amino acids within the recognition helix of the homeobox motif. The rest of the 
homeobox consensus motif exhibits little homology to Vmwl75; however, it is 
possible that amino acids 390-395 of Vmwl75 contain an evolutionarily diverged 
version of the homeobox DNA recognition helix. This possibility could be investigated 
by further mutational analysis.
4B. The Effects of Point Mutations and Deletions on the 
I n  v i t r o  Properties of Vmwl75.
The method chosen to mutate the region of interest within Vmwl75 limited the 
amino acid changes that could be introduced. Therefore, specific changes to amino acid 
side chains possibly involved in direct contacts between protein and DNA molecules 
could not be introduced. This leaves the possibility that amino acids that are involved 
in contacting the DNA molecule have not been detected, because some of the amino 
acid changes introduced are relatively conservative and might not disrupt protein-DNA 
contacts. Mutations created during the work presented in this thesis have been analysed 
both in the context of a bacterially-expressed DNA binding domain polypeptide in vitro 
and within the viral genome.
4B.1. Effects on DNA Binding Activity.
The results presented and discussed in section 3D illustrate the effects of the 
mutations upon the in vitro DNA binding activity of bacterially expressed DNA 
binding domain polypeptides of Vmwl75. They are in agreement with previous 
insertional mutational analyses (Shepard et al., 1989; Paterson and Everett, 1988a, b; 
Paterson, 1989). These results are significant in that they show that point mutations can 
disrupt the DNA binding properties of the Vmwl75 DNA binding domain polypeptide. 
With all mutational analyses, there is the possibility that the effects seen are due to 
disruption of the secondary and tertiary structure of the protein, rather than the specific 
result of changing the amino acid sequence. Reducing the size of the mutation
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introduced lowers the possibility of tertiary structure disruption occurring. Therefore, it 
is important that point amino acid mutations can eliminate the DNA binding properties 
of Vmwl75 polypeptides in vitro. It would also be informative to investigate the effect 
of these mutations on the DNA binding properties of the whole protein.
The general conclusion of this study is that the mutations most deleterious to 
DNA binding activity are situated between amino acids 456-464, around the turn of a 
proposed helix-turn-helix motif encompassing amino acids 445-487 of Vmwl75. This 
conclusion does not correlate with the fact that the majority of protein-DNA interfaces 
are a-helical. There is the possibility that the secondary structure proposals for 
Vmwl75 are incorrect. If the suggested secondary structure does exist, there is still the 
possibility that the point mutations are destabilizing this region rather than inhibiting 
specific DNA contacts. In fact, whilst mutations within the region encompassing amino 
acids 456-464 abolish DNA binding activity, there is little evidence to suggest that the 
conserved tract between amino acids 445-487 is involved in contacting the DNA helix. 
These questions can only be answered by further structural studies. However, the 
results do point to a functional significance for this region of Vmwl75.
The purpose of introducing in-frame internal deletions within this region was to 
investigate whether proposed a-helices are important for the DNA binding activity of 
the DNA binding domain. Introduction of such deletions abolished DNA binding 
activity, suggesting that the helices do in fact play some role in determining contact 
between Vmwl75 and DNA. However, as mentioned above, it must be remembered 
that such mutations can disrupt the tertiary conformation and stability of the protein. 
Whilst such deletion mutant polypeptides were obtained in sufficient quantities to carry 
out DNA binding analyses, the polypeptides were relatively insoluble and quantities 
obtained were insufficient to carry out dimerization assays. These observations suggest 
that the deletions may have had some effect on the conformation and stability of the 
polypeptides. In order to investigate the function of proposed a-helical regions of the 
domain, insertion of proline residues within helices may lead to disruption of the 
helical structure whilst lessening the effect on overall conformation of the polypeptide.
Previous analyses of Vmwl75 have suggested that multiple regions of the DNA 
binding domain function in the whole protein (Paterson and Everett, 1988a, b; 
Paterson, 1989; Shepard et al., 1989; Shepard and DeLuca, 1991b). Whilst this study 
does not disagree with these conclusions, it highlights the importance of the carboxy- 
terminal region of the DNA binding domain of Vmwl75.
An aspect of the mutant Vmwl75 polypeptides not investigated within this 
study is the ability of the molecules to bind to DNA containing non-consensus 
Vmwl75 binding sites, such as the sites within the thymidine kinase promoter /  leader 
sequences (Papavassilliou and Silverstein, 1990). Shepard et al. (1989) used the study
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of such non-consensus sites to suggest that certain mutations may affect the specificity 
of DNA binding by Vmwl75. Whilst it can be assumed that mutations which abolish 
the ability of Vmwl75 polypeptides to bind to consensus sites also abolish the ability 
of the protein to bind to non-consensus sites, it would be interesting to investigate the 
binding properties of mutant polypeptides which exhibit lowered DNA binding 
activity. Would such mutant polypeptides, such as the temperature sensitive mutant 
polypeptides, be able to bind to non-consensus sites under permissive or restrictive 
conditions?
4B.2. Effects on Dimerization.
The ability of Vmwl75 to dimerize and the proposal that dimerization is a 
prerequisute for its DNA binding activity seems to be in contrast with studies defining 
a consensus DNA binidng site for the protein. All consensus sites proposed for 
Vmwl75 exhibit asymmetry (DiDonato et al., 1991; Everett et a l, 1991), whilst the 
majority of DNA binding proteins which bind to DNA as dimers bind to sites which 
exhibit palindromic symmetry (see, for example, Vinson et al., 1989). Whilst 
preliminary results suggest that Vmwl75 binds to DNA as a dimer, it is not clear 
exactly how each monomeric subunit contacts the DNA helix. These questions could 
be elucidated by further structural studies. Whatever the mechanism by which 
Vmwl75 dimerizes and binds to DNA, several studies have illustrated that the 
dimerization properties of Vmwl75 are significant in vivo (Shepard and DeLuca, 1989; 
1991a; Shepard et a l, 1990).
The results presented and discussed in section 3E illustrate that point mutations 
in the region encompassing amino acids 445-487 of Vmwl75 do not affect the 
dimerization properties of DNA binding domain polypeptides. It has therefore been 
possible to isolate mutants defective in DNA binding activity, but still able to dimerize. 
The design and expression of polypeptides defective in dimerization has so far proved 
unsuccessful (R. D. Everett, personal communication; this thesis). The isolation of such 
a polypeptide would be useful in delineating the dimerization motif within the DNA 
binding domain, and also in examining the functions of dimerization within the in vitro 
and in vivo properties of Vmwl75. Until such a mutant is obtained, the region(s) of the 
DNA binding domain contributing to dimerization cannot be defined.
In conclusion, the results presented in this thesis have illustrated that the DNA 
binding activity of Vmwl75 can be eliminated in the context of a dimerization- 
functional molecule.
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4C. Effects of Mutations on the I n  V i v o  Properties of 
Vmwl75.
The insertional mutant proteins studies in this thesis have previously been well 
characterized in vitro (Paterson and Everett, 1988a, b; Paterson, 1989). Therefore, it is 
interesting to find that the results obtained in vivo and presented and discussed in 
section 3G mirror the in vitro properties of the mutant proteins. That is, mutants which 
are deficient in transactivation, autoregulation and DNA binding in vitro are unable to 
support the viral replicative cycle in cell culture. Therefore, the regions of Vmwl75 
involved in DNA binding, transactivation and autoregulation in vitro and support of the 
viral replicative cycle in vivo overlap. These results illustrate the validity of the 
previous in vitro studies in determining the activity of mutant polypeptides. In addition, 
they illustrate the importance of region 2 to the full range of properties of Vmwl75. 
The fact that four insertional mutant forms of Vmwl75, 19, 110, 111 and 120, can 
support viral replication suggests that the inability of other mutants to function fully is 
not due to a non-specific effect of the mutations on the conformation and stability, or 
cellular transport of Vmwl75.
As the mutations appear to affect all activities of Vmwl75 in vitro, it is difficult 
to attribute the inactivity of mutant proteins in vivo to the lack of any one property of 
the protein. However, as the mutations examined fall within a region of the protein 
which encompasses the DNA binding domain, rather than a domain solely involved in 
transactivation, the results suggest that the DNA binding properties of Vmwl75 are 
essential for its function in vivo.
This conclusion is supported by results obtained with additional point and 
internal deletion mutant Vmwl75 molecules. These mutations had previously been 
introduced into a bacterially expressed polypeptide encompassing the DNA binding 
domain of Vmwl75 and assayed for DNA binding and dimerization activity (this 
thesis, see discussion above).
The analysis of point mutations and deletions which had previously been shown 
to disrupt DNA binding activity illustrated that these mutant proteins were unable to 
support the viral replicative cycle. Point mutations can therefore disrupt the function of 
the Vmwl75 protein in the cellular environment, illustrating the importance of the 
region encompassing amino acids 456-464. As discussed in section 4B.1, these results 
may infer but do not prove the involvement of the complete conserved tract between 
amino acids 445-487 in the in vivo properties of Vmwl75. The inability of a mutant 
polypeptide containing a deletion between amino acids 445-453 to support viral
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replication suggests that this region too is essential for the function of Vmwl75. 
However, the possibility that such a deletion results in the conformational instability of 
Vmwl75 cannot be eliminated.
The results obtained with two point mutations which resulted in a temperature 
sensitive defect in DNA binding activity in vitro are more difficult to interpret. These 
mutations are present within the conserved tract, one falling inside and one outside the 
region encompassing amino acids 456-464. This latter region has been shown to be 
essential for the in vitro and in vivo functions of Vmwl75 (see above). As discussed in 
Section 3G.4, it is interesting that whilst the two mutations result in a temperature 
sensitive DNA binding phenotype in vitro, the one within region 456-464 exhibits a 
more deleterious effect upon the in vivo function of Vmwl75. The different phenotypes 
of the mutations may be explained by the fact that the mutations differ in their effect on 
the stability of the interaction between Vmwl75 and DNA. Whilst this difference was 
not detected in in vitro assays, perhaps in vivo assays are able to detect these slight 
differences in activity. The two mutations involve different amino acid changes - the 
less deleterious mutation involves an alanine to serine change, whilst the second 
mutation involves mutation of a basic arginine residue to a non-polar leucine. This fact 
may also play a role in determining how the mutant proteins interact with DNA both in 
vitro and in vivo.
One surprising aspect of the results is that the mutation 457R/L results in a 
Vmwl75 DNA binding domain polypeptide apparently able to bind to DNA at lower 
temperatures in vitro, but when introduced into the viral genome, results in a Vmwl75 
molecule unable to function at lower temperatures. It is feasible that within the cellular 
environment, additional protein-protein interactions may occur to stabilize the 
interaction of Vmwl75 with DNA and perhaps cellular transcription factors, and that 
this mutation affects these additional interactions.
The suggestion that additional protein - protein interactions may affect the way 
that Vmwl75 interacts with DNA in vivo is supported by preliminary results from 
Smith and DeLuca (1992). They found that the addition of general transcription factors 
TFHD and TFHB to in vitro DNA binding assays o f Vm wl75 increased the affinity of 
the protein for DNA. Interestingly, they found that the mutant protein ril2, discussed in 
detail in section 1C.3, was able to bind to DNA in the presence of these transcription 
factors. During the viral replicative cycle, these transcription factors will be assembled 
on promoter regions and thus able to interact with Vmwl75. It is therefore feasible that 
these protein - protein interactions will stabilize Vm wl75 - DNA interactions within 
the cell as discussed above. These results appear to explain how a Vmwl75 molecule 
apparently unable to bind DNA in vitro can support viral replication, being able to bind 
DNA within the cellular environment.
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Whatever the mechanisms by which Vm wl75 interacts with DNA within the 
cell, it appears apparent that the simple in vitro assay o f Vm wl75 DNA binding 
activity is insufficient to explain the full properties o f certain mutant forms of 
Vmwl75, both as presented in this thesis and as previously described by Paterson et al.
(1990). However, from the results presented in this thesis, it can be concluded that the 
DNA binding activity of Vmwl75 is extremely important, if not essential, for its full 
transactivation activity in vivo. In addition, the integrity of region 2 of the protein, and 
of a small conserved tract within the carboxy-terminal portion of this domain, is 
essential for its activity both in vitro and in vivo.
4D. Further Research Proposals.
There are still several unanswered questions concerning the mechanism by
I
which Vmwl75 controls HSV-1 gene expression. Firstly, whilst the results presented>
I in this thesis have helped to delineate regions of the protein involved in the interactions
| with DNA, further structural studies could show exactly how the protein binds to DNA.
These studies would also confirm whether amino acids conserved between the 
members of the family of transcriptional regulatory proteins of a-herpesviruses are 
involved in facilitating protein - DNA contacts. Such analysis of the complex formed 
between the Vmwl75 DNA binding domain and DNA would also explain help explain 
how the protein dimerizes and binds to apparently asymmetric DNA sites.
Whilst the DNA binding domain of Vmwl75 has been the subject of various 
studies, it is also of importance to determine which regions o f the protein are involved 
in transactivation. It is generally accepted that transactivation domains act partly 
through the interaction with general transcription factors (see section 1D.2). With this 
in mind, it would be useful to determine how V m w l75 interacts with basal 
transcription factors, an interaction proposed by recent preliminary studies (Smith and 
DeLuca, 1992; Pizer et al., 1992), and to delineate the regions of Vmwl75 involved in 
contacting such factors. Whilst Pizer et al. (1992) proposed that the DNA binding 
domain mediates such interactions, this is in oppostion with preliminary results from 
DeLuca’s group, and also fails to explain the function o f other regions of Vmwl75, 
including the conserved region 4.
It has been proposed that viral transactivators may act as "co-activators", 
mediating the interaction between the TATA binding protein and upstream factors
t
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(reviewed by Lewin, 1990). As it has been suggested that Vmwl75 interacts with the 
TATA binding protein, the possibility exists that Vm wl75 acts as such a bridging 
molecule. Further analysis of interactions between Vmwl75 and upstream factors, such 
as Sp-1 would be of use in such studies.
With these considerations in mind, the investigation o f the function of the 
conserved region 4 of Vmwl75 may yield some interesting results. This portion of the 
protein has been shown to be essential for the activation of viral late genes in vivo 
(DeLuca and Schaffer, 1987, 1988). The region could be involved in mediating protein 
- protein interactions, or in stabilizing the overall conformation of the protein molecule. 
In addition, mutational analysis of this region may define a separable transactivation 
domain, a domain not presently defined in Vmwl75.
Recent studies on other DNA binding transcription factors has highlighted the 
importance of post-translational modifications, especially phosphorylation, in the 
control of such factors within the cell (Hunter and Karin, 1992). It has been shown that 
Vmwl75 is phosphorylated in vivo, and that the phosphorylation state of the molecule 
varies during the viral replicative cycle (Wilcox et al.y 1980). Therefore, the further 
investigation o f phosphorylation sites within V m w l75, and the effect of 
phosphorylation on the in vivo activity of Vmwl75, would be extremely important in 
determining mechanisms of control of Vmwl75 in vivo.
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